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Rheumatology nursing roles have evolved over the last 25 years to include educating 
patients prior to commencing drugs such as Methotrexate in consultations. The expansion 
of their role has not been supplemented by specific training in order to prepare them for 
this undertaking. Thus, this study was developed to explore how Rheumatology Specialist 
nurses gained knowledge about consulting with patients on Methotrexate, how they 




This was a mixed-methods practice based study undertaken in three phases. Training, 
confidence and knowledge were explored with a questionnaire, which constituted Phase I. 
Phase II explored the lived experiences of the nurses with semi-structured interviews. Phase 
III explored the interaction between the nurses and patients during a consultation which 
was video-recorded and analysed using qualitative and quantitative approaches, with the 
interaction scored against items in the Calgary Cambridge consultation model. 
 
Findings 
The results of the survey (n=97) and the semi-structured interviews findings (n=6) revealed 
significant variability in training received by Rheumatology Specialist nurses. Confidence 
took three to 12 months to develop and was related to experience, knowledge and training, 
with nurses expressing a clear desire for more training. Written information was used by all 
participants during consultations, usually in the form of the Methotrexate information 
booklet, which had some benefits, including allowing the nurses to structure their 
consultations, ensuring that all of the information in the booklet was given to patients. 
 iv 
However, it also had the disadvantage of becoming the nurses’ agenda which dominated 
the consultation, leading to overloading the patients with information and restricting 
discussion and questions from the patients. Analysis of consultation videos (n=10) 
supported these findings, demonstrating that whilst all of the important information from 
the booklet was given, there was a lack of involvement during the consultation of the 
patient agenda such as ideas, concerns and expectations, with little checking by the nurses 
to ensure the patients understood the information given. The effect of limited time was 
apparent. Cues from patients were often ignored or missed which may have been as a result 
of perceived time pressures or lack of confidence in dealing with questions. The comparison 
of the nurses’ consultations with the Calgary Cambridge consultation model showed 
variations in the nurses’ scores. It also raised new observations such as in those 
consultations which scored higher, the nurses used more illustrative and fewer batonic 
gestures, whilst the patient did the opposite.  
 
Conclusions  
Whilst Rheumatology Specialist nurses are clearly doing many things well, the education of 
patients starting drugs such as Methotrexate could be improved by training aimed at 
improving consultation techniques with the adoption of a modified Calgary Cambridge 
model consultation technique. Such an approach would benefit from further research to 
identify whether it results in improving patients’ involvement in the consultation process. 
The findings from this thesis have led directly to the development of “Top Tips”, published 
online by Versus Arthritis, to guide nurses during their consultations when giving 
information to patients about Methotrexate. Further work will include writing a handbook 
that aims to give nurses more knowledge about how to conduct a consultation with patients 
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Preface   
 
I have a background in working with Rheumatology patients as a Registered Nurse.  I took 
some time out of nursing to work abroad at the end of 1999, when I returned to the UK in 
2004, I took up a post as a staff nurse in a Rheumatology outpatient clinic.  Much had 
changed since the days of working on busy Rheumatology wards in the 1980s and 1990s and 
I found that most patients were now treated as outpatients.  
 
There have been significant changes in the nursing role over the last 30 years especially in 
Rheumatology and a survey by the Royal College of Nursing (RCN) reported that nurses are 
now doing many roles that were previously carried out by doctors (Royal College of Nursing 
2009).  Even the role of the Health Care Assistant (HCA) has changed enormously, now 
carrying out phlebotomy, independently running clinics and setting up sterile fields (Griffiths 
and Robinson 2010, Robinson, Heslop et al. 2016).  When I returned to work, I found myself 
having to educate patients starting disease modifying antirheumatic drugs (DMARDs) with 
which I was unfamiliar, and for which my training consisted of watching a nurse give the 
education from a pre-printed sheet of A4 paper. Each drug had a different coloured sheet, 
and I was told to just read from the sheet.  It took me months to feel confident to give this 
education, and I increased my knowledge by gleaning information from my nurse colleagues, 
reading the Summary of Product Characteristics for each drug and listening to the 
Rheumatologists in the department.  I reflected on this experience and concluded that, with 
formal training, I would have developed in that role much more quickly and I would have 
been more effective.   
 
It also became apparent that there were a number of other issues to consider that were not 
immediately obvious. It was clear that the service side required some facts to be transferred 
to the patient around safety of taking the drugs and to ensure that patients took the drugs 
as prescribed.  This required documentation that it had been done correctly and the 
document was signed by the nurse and the patient to confirm this.  I felt that this 
documentation represented a disclaimer, so that if errors occurred, it was documented that 
the correct processes had been undertaken. I personally became more concerned with the 
education process that we were undertaking with the patients. I began to question how 
 xvii 
much information they actually absorbed from the education activity, how much knowledge 
they actually took away with them and whether they fully understood the implications of 
taking the medication.  My nurse training and my experience as a ward nurse had not 
prepared me for this. Whilst nurses have always been regarded as educators, I realised that 
we were not really equipped to carry this out as effectively as we could. I also wondered if 
other Rheumatology departments had a different and more effective method of conducting 
this transfer of knowledge to patients.   
 
The science of communication is a complex area of study. I have described elements of the 
communication process which are pertinent to this thesis in the literature review (Chapter 2). 
I observed that my colleagues who were performing the same role as myself, varied 
considerably in their style and enthusiasm for this role and in the amount of time they took 
to convey the information to the patients. Prior to commencing my PhD, I asked my 
colleagues to time every Methotrexate education consultation that they did over a three-
week period. I decided to focus on one drug, and chose Methotrexate as it is the most 
common drug used in Rheumatology. In our Rheumatology service, all patients who were 
prescribed Methotrexate or indeed, any DMARD, had their education session on that day. 
Patients were not given a specific appointment; everything was done on the same day as 
their consultation with the Rheumatologist.  It was therefore difficult to plan the number of 
education sessions which could be carried out in one clinic. (This approach is different to the 
approach taken by The Rheumatology Service, which was studied in this thesis.  In this 
service, patients were prescribed their DMARD then were sent dedicated appointment times 
with a Specialist Nurse when they would be given their education session).  During the three 
weeks the nurses recorded their timing of their education session.   Twenty-eight patients 
started Methotrexate for the first time. The same nurse performed ten of those education 
sessions, a second nurse carried eight out and three other nurses performed the other ten 
sessions, so five nurses in total took part.  The average time taken was 13 minutes with a 
range from six to 20 minutes. Comparing the average time for individual nurses ranged from 
12 to 16.5 minutes for the two main educators. One of the infrequent educators averaged 
only seven minutes. For those patients who were starting their first DMARD (some patients 
had been on other DMARDs before starting Methotrexate) the average time taken to deliver 
the education session was slightly longer at 14 minutes (6-20 minutes). For those patients 
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who were starting a second DMARD, the average was 12 minutes (range 7-15 minutes), which 
is slightly less.  This could reflect an assumption that the patient knew more about DMARDs 
as they had already been prescribed one of these treatments. 
      
The nurses were asked to estimate what percentage of the time was used for questions by 
the patients. This was only an average of 10% (range 0-50%) and eight patients asked no 
questions. I concluded that these consultations are clearly variable and that the patients may 
need more encouragement or empowerment to ask more questions.  I concluded that an 
exploration of this interaction could produce information that may improve training, increase 
competence in the delivery of the education sessions and thus improve patient 
understanding resulting in more effective and safer use of the drug.  
  
A further study which contributed to the concept of my PhD thesis was a survey of 
Methotrexate tolerability (Robinson, Gibson et al. 2016). I had noticed that patients on 
Methotrexate often did not like taking it. They described having a “Methotrexate day” where 
they felt “wiped out” for a day after taking it, or the patient would admit that they would 
take a “Methotrexate holiday” to have a break from it. I was also struck that the doctors 
didn’t seem to be aware of this. The patients seemed much more open with the nurses than 
they were with their consultants. When I raised this I was told, “If they are prepared to take 
it and it is working then I am prepared to prescribe it. Why would I start a discussion about 
tolerability when they will still be on it?” 
  
For the survey, with the help of one of the Rheumatology consultants, 100 consecutive 
patients who were on a stable dose of Methotrexate and planning to continue it, were asked 
to complete a questionnaire about efficacy and side effects. They also rated the severity on a 
visual analogue scale (VAS). 56% had at least one tolerability problem. When I presented this 
at the British Society for Rheumatology annual meeting (Robinson and Walker 2012) the 
general reaction from the delegates was that this was far higher than they would expect and 
thought these figures were incorrect.  The survey was then repeated in six other 
Rheumatology centres across the UK, collecting questionnaire data from 50 consecutive 
patients from each of those sites. The results revealed that 56% was the lowest reporting of 
the number of issues patients had with Methotrexate. The highest tolerability issues in one 
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centre was reported as 85% of the patients taking it (Robinson, Gibson et al. 2016). Another 
interesting finding was that 51% of participants would be attracted to a regime that didn’t 
include Methotrexate.  
 
Because Methotrexate is a drug that has clear tolerability problems and a delayed onset of 
action, the effectiveness of the initial education given to patients is very important in order 
to ensure that patients are aware of these side effects and that they can become empowered 
to disclose the way they feel to their healthcare providers. If patients do not feel empowered 
to reveal issues they may have with their drugs, it could lead to issues around adhering to 
the treatment as prescribed. 
 
In order to investigate this further, I was interested to establish the knowledge that patients 
established on Methotrexate had about the drug. This led to the development of a project I 
conducted with colleagues.  We developed a study of knowledge about Methotrexate of 
people who had been on Methotrexate for at least two years and who were on no other 
conventional DMARD as this may have confused the patients. Methotrexate knowledge was 
tested with a Methotrexate Knowledge Questionnaire (MKQ), which we developed from the 
ARUK leaflet written for patients to learn about Methotrexate, and used by most nurses to 
guide counselling (Walker, Robinson et al. 2012). Fifty-two consecutive patients who fit the 
entry criteria were recruited and asked to complete the MKQ. Most were suffering from 
Rheumatoid Arthritis (RA) (89%) one had gut associated arthritis and the rest Psoriatic 
arthritis. Average age was 59 (range 24-84) and average duration of Methotrexate therapy 
was 6.2 years (range 2-15). 
 
Average score on the MKQ was 12.9 out of a maximum 18 (range 6-18). All but one patient 
knew how to take the drug, but there was less certainty about how long it took to work. 
There was a range of knowledge about vaccinations, in line with the total score. Side effect 
knowledge was less good, with 12 patients (23%) not identifying shortness of breath as a side 
effect. Monitoring requirements were well known. Other worrying misconceptions included 
eight people (15%) thinking it was acceptable to become pregnant with 13 patients (25%) 
failing to answer the question. Twelve patients (23%) thought it was acceptable to be on 
antibiotics in conjunction with Methotrexate and four (8%) thought there was no limit 
around alcohol consumption. 
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We concluded that the patients were well aware of the practicalities of taking the drug. 
These are things that would be reinforced at each monitoring visit. However, there were 
deficiencies in some patient knowledge that might lead to sub-optimal immunisation, 
inappropriate action in the event of dyspnoea and worrying possibilities around pregnancy, 
alcohol and infections. More effective education and updates seemed to be required. This 
was presented at the BSR annual meeting as a poster (Walker, Robinson et al. 2012).  The 
next phase of this journey towards my PhD was to question some of my nurse colleagues 
working in different Rheumatology Departments in the region and in other parts of the UK 
regarding the training they had to carry out this education role.  I also wanted to determine 
whether there was a “Gold Standard” education programme that could be accessed by all 
Rheumatology Specialist nurses. However, I discovered that there was no gold standard 
professionally endorsed training for Rheumatology Specialist nurses.  Thus, began the 
development of the proposal for this thesis.  I wanted to determine firstly, what all nurses 
were doing in the UK, how they were trained to carry out their roles, how confident they 
were and to test their knowledge around DMARD drug treatments.  The next phase was to 
explore the experience of giving education from the nurse’s perspective more deeply.  I 
decided to concentrate only on Methotrexate as this is the most widely used drug of choice 
to treat one of the most common conditions in Rheumatology; Rheumatoid Arthritis and all 
of the nurses would have experience in managing patients on this drug. Finally, I wanted to 
explore and analyse the actual process itself between the nurse and patient, which involved 
video-recording the consultation.  Together with Dr David Walker, Consultant 
Rheumatologist, we successfully applied for funding from Arthritis Research UK (now known 
as Versus Arthritis), to carry out this work and I applied to Northumbria University to develop 
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It has been a long journey, during this time, my 15-year-old niece Abbie, was diagnosed with 
a rare and aggressive skin cancer, she lost her valiant fight aged 17 years.  My father Joe, died 
three months later in September 2016.  Those 2 1/2 years were lost in terms of working on 
my PhD, but Northumbria University allowed me to extend my study time.  With only three 
months to go to finally submitting my completed thesis, the COVID-19 pandemic hit our 
country in 2020 and, as a nurse, my job was to support my colleagues, patients and the NHS, 
so again my submission was delayed. My mother Ellen, was diagnosed with lung cancer and 
died in April 2021 after a short but valiant fight. Their courage and determination in the face 
of such adversity gave me the strength and resolve to keep going when things got tough, so 
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Chapter 1: Introduction 
 
Rheumatoid Arthritis (RA) is an incurable chronic disease (Ward, Hill et al. 2007), the 
symptoms of which can have an enormous impact on a sufferer’s daily life, affecting 
everyday activities such as domestic, work and leisure (Hill 2006).  Management of the 
disease therefore requires a range of interventions such as physiotherapy, occupational 
therapy and pharmacological treatments which focus on relieving the symptoms of pain, 
swelling, joint stiffness and the provision of daily living aids resulting in the preservation of 
joints, minimising deformity and maintaining the activities of daily living (Hill and Ryan 2000, 
Hill 2006).  Patients need an understanding of their disease, the value of the treatment they 
have been prescribed, the importance of adhering to that treatment and understand side 
effects so that they can be reported quickly. This knowledge helps patients to self-manage, 
ensures that drugs like Methotrexate are taken safely and involves them in the decision-
making processes around their own treatment (Hill, Bird et al. 1991, Mäkeläinen, 
Vehviläinen‐Julkunen et al. 2007, Salt and Frazier 2010). Hill et al (2001) carried out a 
randomised controlled trial comprising 200 patients with Rheumatoid Arthritis who had all 
been prescribed a disease modifying drug called D-penicillamine.  Their aim was to explore 
the effects of patient education on drug treatment adherence which contributes to 
successful management of rheumatic disease.  The chosen intervention of the study was a 
taught education programme about D-penicillamine, which was carried out by a 
Rheumatology Nurse Practitioner.  Fifty-one patients received the intervention and 49 
received standard care.  The authors found that those patients receiving the education 
programme had significantly increased adherence levels to drug treatment, with 86% 
adhering compared to 55% not, after 12 weeks.  Thus, patient education regarding taking 
specific drugs is of critical importance in adherence to drug treatment for chronic long-term 
conditions.  However, this is dependent upon other factors such as knowledge and attitudes 
of the nurses themselves and how they communicate this information to patients in order 
to educate them about taking their drug therapy, which is the focus of this thesis. 
Disease modifying anti-rheumatic drugs (DMARDs) reduce disease activity, joint destruction 
and improve long-term joint function (de Klerk, van der Heijde et al. 2003).  In the field of 
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Rheumatology, toxic DMARDs such as Methotrexate have delayed effects and anticipated 
side effects for which patients are monitored. It is essential therefore, before commencing 
any drug for the patient to understand what the expected benefit is, how that will manifest 
and to know the risks of the intervention. Patients therefore require information prior to 
starting Methotrexate to allow them to take the medication more safely and effectively. 
Patients must have an understanding of illness, risks, and benefits of various treatment 
options in order to make informed decisions about medical care (Street Jr, Makoul et al. 
2009). Clinicians also need to understand patient’s values, preferences, and beliefs about 
health. But, achieving this status can be difficult because clinicians and patients often have 
different perceptions of health and illness (Street Jr, Makoul et al. 2009).  Thus, the 
consultation between the nurses and patients when giving information about Methotrexate 
is an important process. Understanding how nurses are trained to carry out this role and 
exploring their perceived confidence led to the development of the aims of this study, which 
will be described below.  Further, in order to understand and explore the training, 
knowledge base and confidence that nurses have, Phase I, a national survey was developed.  
Exploration of the experiences and perceptions of nurses conducting this role, led to the 
development of Phase II of this study, the semi-structured interviews.  Finally, to further 
explore how nurses conduct their consultations when giving information about 
Methotrexate to patients, video-recording ten consultations formed the final Phase III of 
this study.  These will be further discussed below. 
 
1.1 The Research Question 
Underpinned by the points above the research question was developed: 
How do Rheumatology Specialist nurses gain knowledge about consulting with patients on 
Methotrexate and do they deliver the information to patients using a consultation 
technique, further can elements of their consultation be identified for development? 
The research question was investigated by: 
 Investigating, using a survey, the processes which nurses undertake to become 
knowledgeable about consulting with patients on Methotrexate and to understand 
how much knowledge and confidence they have in giving this information. 
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 Exploring, through semi-structured interviews, the nurses’ experiences and 
perceptions of the delivery of information about Methotrexate to patients. 
 
 Identifying, through video analysis of consultations, the processes used by the nurses 
in their consultations with patients when giving information about Methotrexate and 
how the consultations may be further developed using the Calgary Cambridge 
model. 
The underpinning research philosophy was based on the three dimensions of critical realism 
using a mixed methods approach to collect the data and a phenomenological methodology 
to analyse the data. 
 
1.1.1 Phase I Aims   
The aims of the national survey were to explore the training that Rheumatology Specialist 
nurses had received for educating patients about Methotrexate.  Further, to identify their 
confidence in conducting this role and to evaluate their knowledge around clinical situations 
relevant to Methotrexate use.  The aim of this is to reveal if any further training is required. 
 
1.1.2 Phase I Objectives 
1. To obtain data regarding training, qualifications and experience through a national 
questionnaire. 
2. To gauge nurses’ views regarding confidence and the time it takes to become 
confidence in conducting this role. 




1.1.3 Phase II Aim 
To explore the nurses’ experiences and perceptions of the delivery of information about 
Methotrexate to patients, using semi-structured interviews. 
 
1.1.4 Phase II Objectives 
1. To explore the training nurses had in order to carry out their role of giving 
information to patients on Methotrexate and how useful this was. 
2. To understand how confident nurses are carrying out this role and how they feel 
about the training they had. 
3. To understand how nurses, use written information to inform their consultations. 
4. To explore how nurses, respond to patient cues putting them at the centre of care. 
 
1.1.5 Phase III Aims 
To investigate how nurses, deliver information about Methotrexate to patients, and how 
they ensure that patients have received and understood that information during the 
consultation process. 
 
1.1.6 Phase III Objectives 
1. Video record ten nurse/patient consultations. 
2. Analyse the video recordings using the Medical Interaction Process and the Calgary 
Cambridge Model. 
3. To understand the processes nurses, use in their interaction with the patients when 
giving information about Methotrexate. 
4. To understand the processes nurses, use to ensure that patients have understood 
the information given. 
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1.2 The Structure of the Thesis 
Chapter 1 gives a general introduction to the thesis and overview of the structure. 
Chapter 2 presents the literature review providing a general overview of the topic and 
concepts as relevant to the whole thesis, with some in-depth background to the literature 
relevant to each phase presented at the start of each phases’ chapter. Rheumatoid Arthritis 
is the disease which is most commonly treated by Methotrexate, therefore this disease is 
discussed thoroughly to understand the issues that patients have and why they need to 
have treatment.  Particular reference will be made to Methotrexate as it is an important 
focus of this thesis and the evolution of the Rheumatology Specialist nurses’ role will be 
discussed in order to explain the impact of the changing expectations placed on nurses.  
Patient education will be explored and the impact of shared decision-making as it is a 
central concept of the healthcare professional and patient interaction and should underpin 
practice.  Further, an exploration of the literature around nurses’ knowledge of 
Methotrexate will be undertaken to determine the impact of this on the information giving 
process and consultation models will also be reviewed to identify or adapt a model which 
could be applied to the nurse patient interaction within the context of this thesis. 
Chapter 3 introduces the epistemological and ontological assumptions of the study which sit 
within critical realism.  These are framed within the methodological approach of mixed 
methods.  The chapter provides discussion on qualitative and quantitative research and how 
these can be combined using a mixed methods approach.  Also addressed in this chapter are 
the ethical considerations of the study and the impact of insider research and a reflexive 
perspective of this researcher. 
Chapters 4, 5 and 6 present the findings of the three phases of this study.  Each of these 
chapters have a different data collection method which will be discussed.   
Chapter 4   discusses Phase I which consisted of a national online survey and the resulting 
data was analysed using quantitative methods. A questionnaire survey was specifically 
developed to capture demographics, experience, knowledge of Methotrexate and delivery 
of information.  It was piloted by ten Specialist nurses who work in the field of 
Rheumatology and was modified according to the findings.  It was made available online and 
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targeted members of the Royal College of Nursing Rheumatology Forum members of which 
there are over 1,200 members. They were asked to complete the questionnaire and 
distribute it amongst their colleagues who give information to patients about Methotrexate, 
which allowed a wide spread of representation from Rheumatology Specialist nurses who 
carry out this role.   
Chapter 5 addresses Phase II which consisted of the semi-structured interviews with 
Rheumatology Specialist nurses.  The interviews were audio recorded and then transcribed.  
The data was analysed using a thematic methodological approach. The semi-structured 
interviews explored the feelings and perceptions of the nurses on how they conduct this 
role. This built on the national questionnaire aimed at exploring the general representation 
of how nurses are educated to conduct their role and how confident they feel in that role. 
Chapter 6 explores Phase III of the study, the video-recordings of nurses giving information 
about Methotrexate to patients.  Ten consultations between nurses and patients during the 
Methotrexate education process were undertaken.  All of the nurses worked in the same 
Rheumatology service in one Trust.  The nurse participants had a wide range of experience 
from less than two years’ experience to more than ten years’ experience.  Participation was 
completely voluntary and consent was taken from both the nurses and patients prior to the 
video-recording. All resultant data was fully anonymized.   
A qualitative analysis of the videos was undertaken using a thematic approach and they 
were also evaluated against the Calgary Cambridge consultation model. Additionally, the 
videos were analysed using a novel methodology, which had not been used to analyse nurse 
videos previously.  The Medical Interaction Process System is based on the work of Roter 
(1991), which was developed to code the interactions between doctor and patient during a 
consultation process.  Verbal coding is based on an “utterance” and non-verbal coding 
includes head nodding and smiling.  The first ten minutes of each video recording were 
examined minute by minute and every verbal and non-verbal interaction was coded.  This 
allowed for a detailed analysis of the interaction between nurses and patients. 
Chapter 7 restates the aims and objectives of the study before providing a discussion of the 
findings.  In this chapter the findings are discussed within the context of extant literature 
 7 
and there is explanation of how these findings contribute to original knowledge.  Discussion 
of these findings in relation to current practice and identification of areas requiring further 
research are presented along with the limitations of the study.  Finally, this chapter 
discusses the next phase of this study based on the four publications which were generated 
by this work. 
 
1.3 Original Contribution to Knowledge 
The above will contribute to knowledge by exploring the processes through which nurses 
gain training to carry out their role of giving information to patients about Methotrexate. It 
will contribute to the extant literature regarding how nurses conduct their consultations 
with patients when carrying out this role and will reveal their experiences and perceptions 
of that role.    This study will also contribute to the understanding of how nurses ensure that 
patients understand the information given to them and how they incorporate consultation 
techniques in their interactions with patients. Further, it will reveal possible aspects of their 
consultations which may need further training and identify a consultation model which 














Chapter 2: The Literature Review 
 
2.1 Introduction  
A narrative thematic approach, which was deemed relevant to this thesis, has been 
undertaken in the organisation of this review.  The aim was to summarise the available 
evidence in each theme and develop the conceptual framework for this thesis. Therefore, 
this chapter will present an overview of the relevant literature relating to Rheumatoid 
Arthritis, including epidemiology, causes and its impact on the patient. Rheumatoid Arthritis 
is the focus as this is the disease area which is most commonly treated by Methotrexate, and 
thus is the overall focus of this thesis.  Further review of the literature concerning the 
treatment of Rheumatoid Arthritis will also be presented in order to contextualise the range 
of treatments that are available and the breadth of knowledge Rheumatology Specialist 
nurses should have. Particular reference will be made to Methotrexate as this is the drug 
which is the focus of this thesis, specifically concerning the information-giving interaction 
process between nurses and patients.   Literature on the evolution of the Rheumatology 
Specialist nurses will be reviewed in order to understand the background and influences 
which have led to the Rheumatology Specialist nurse today. A review of patient education 
with particular reference to shared decision-making will also be presented, as shared 
decision-making is a central concept of nurse-patient interaction and should be 
underpinning the evidence-based practice of Rheumatology Specialist nurses.  Further, the 
literature on nurses’ knowledge of Methotrexate will be reviewed to scrutinise what the 
existing evidence describes about nurses’ knowledge of Methotrexate and to determine 
whether this could impact on the information giving process between nurses and patients.  
As with shared decision-making, consultation skills and models are also important for this 
thesis and therefore this review also focuses on the literature in this area.  The consultation 
models will be examined with the aim of identifying a model which could be adapted to be 
used in the information giving process between nurses and patients, and indeed, the 
determine whether this has been carried out in Rheumatology or other chronic disease 
areas.   
 9 
This widely themed review therefore sets out to identify the problems faced by the patient 
with Rheumatoid Arthritis and understand the treatment options with particular reference 
to Methotrexate.  It also aims to put into context the amount of information which could be 
given to a patient, and therefore reveal the importance of ensuring that the patient 
understands and receives that knowledge in order to make informed decisions and choices.  
This literature review further focussed on the development of the Rheumatology Specialist 
nurse in order to understand the evidence base practice they employ to carry out their role 
and to reveal the opportunities available to them to broaden their knowledge base.  
Emphasis is placed on shared decision-making and consultation technique which will reveal 
the current evidence for incorporating good technique into practice.  This review will then 
uncover those gaps in the literature which will become the focus of this thesis.  
 
2.2 Rheumatoid Arthritis 
The following sections will describe a brief history of Rheumatoid Arthritis, the epidemiology 
of the disease and possible causes.  There will also be presented some descriptions of 
symptoms of this disease and the impact of these on sufferers.  It is essential to consider 




Rheumatoid Arthritis is an auto-immune disease, and is the commonest form of 
inflammatory joint disease in the world (Tobón, Youinou et al. 2010).  Historically, detecting 
Rheumatoid Arthritis in the archaeological record is difficult (Leden, Persson et al. 1988) 
because bone erodes and decays easily therefore leaving little archaeological evidence 
which makes it difficult to determine how long Rheumatoid Arthritis has been around. 
However, some periods have been more extensively studied, such as the Roman period and 
the quality of the archaeological remains indicate that life expectancy was lower than it is 
today at around 40 years (Montagu 1994), meaning that it is possible that not many people 
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would live long enough to develop Rheumatoid Arthritis. However, an examination of 41 
skeletons from Ancient Mendes in Egypt which date back to the Old Kingdom (c. 2613-2181 
BC), revealed that two skeletons exhibited signs of inflammatory joint erosions in their 
metacarpo-phalangeal joints (Mant 2014).  Further, an examination of 416 skeletons from 
the Roman period in Britain (43 – 410AD) also showed inflammatory changes to the joints in 
the hands of two individuals (Thould and Thould 1983).  However, as previously mentioned, 
the study of skeletal remains is not straightforward.  Changes to bones can occur as a result 
of many different factors such as the soil, climate bacterial and fungal influence.  A number 
of different conditions can cause joint changes such as gout, infection, or Marfan’s Syndrome 
(Buchanan 1994). A study of Flemish paintings dating to 1400-1700 suggests that 
Rheumatoid Arthritis can be seen in five individuals on the paintings (Dequeker 1977), but 
this can be misleading because art is not always a reflection of reality and artistic styles 
changed throughout different periods of history (Honour and Fleming 2010).  Some believe 
that Rheumatoid Arthritis is a New World (The Americas) disease which spread to the rest of 
the world population. Rothschild et al (1992) examined 129 skeletal remains of Native 
American men and women dating from 4,300 to 4,050 years ago and identified five women 
and two men with changes consistent with Rheumatoid Arthritis.  They also examined 
archaeological remains from 63 archaic sites in the same area and did not find any evidence 
for Rheumatoid Arthritis.  The first patients with a classical description of Rheumatoid 
Arthritis appear in the documentary evidence around 1800 when a French medical student 
called Augustin-Jacob Landre-Beauvais described these signs and symptoms in a series of 
patients for his doctoral thesis (Panush 2012).  The description “Rheumatoid Arthritis” was 
introduced by Garrod in 1859 (1859).  It does appear that Rheumatoid Arthritis was fairly 
uncommon prior to the 18th century.  The 18th Century onwards saw the growth of trade and 
the Industrial Revolution.  The sugar trade witnessed considerable growth and therefore the 
increase of periodontal disease, with a suggested pathogenic link between Rheumatoid 
Arthritis and periodontal disease (Kubetin 2010, Rosenstein, Scher et al. 2012).  However, 
other researchers argue that the link is environmental (Hutchinson 2015) and a sharp 
increase in environmental pollutants after the Industrial Revolution may have contributed to 
the emergence of Rheumatoid Arthritis.  It remains unclear when Rheumatoid Arthritis 
emerged; whilst it is possible that is has been around for hundreds of years, it appears that 
there was a significant increase in the incidence of the disease following the industrial 
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revolution which may have been the result of pollution, environmental changes, lifestyle 
transformations or genetic susceptibility (Shlotzhauer 2014). 
 
2.2.2 Epidemiology 
Rheumatoid Arthritis is a geographically widespread disease, which affects two thirds more 
women than men  (Kourilovitch, Galarza-Maldonado et al. 2014); this is represented in Table 
2.1 which demonstrates the prevalence of Rheumatoid Arthritis by gender in Europe and 
North America  (Tobón, Youinou et al. 2010).   
 
TABLE 2. 1 PREVALENCE OF RHEUMATOID ARTHRITIS BY GENDER (TOBÓN, YOUINOU ET AL. 2010) 




















In 2006 Alamanos et al (2006) conducted a systematic review of incidence and prevalence 
studies of Rheumatoid Arthritis to determine geographical variation and frequency of the 
disease over time.  They identified 28 studies, nine of which were incidence studies, 17 were 
prevalence studies and two were both.  There were no incidence studies from developing 
countries.  They revealed that there was a significant difference between prevalence of 
Rheumatoid Arthritis in Northern Europe and North America, compared to the developing 
countries.  Tobin et al (2010) demonstrate this difference in Table 2.2. 
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TABLE 2. 2 INCIDENCE AND PREVALENCE OF RHEUMATOID ARTHRITIS   (TOBÓN, YOUINOU ET AL. 2010) 
Populations Incidence (cases per 
100,000 population 






29 (24 – 36) 
16.5 (9 – 24) 
38 (31 – 45) 
No data 
0.5 (0.44 – 0.8) 
0.33 (0.31 – 0.5) 
0.5 
0.35 (0.24 – 0.36) 
 
Thus, it is clear that the lack of evidence from developing countries will impact on the 
understanding of a worldwide view of the incidence and prevalence of Rheumatoid Arthritis.  
Indeed, the influence of the different health care systems in countries around the world 
where medical care is limited will further contribute to the underestimation of the incidence 
and prevalence of this disease. 
 
2.2.3 Causes of Rheumatoid Arthritis 
A single cause of Rheumatoid Arthritis is unknown; however, multiple causal factors have 
been identified which may contribute to the triggering and course of the disease.  In 1996 
Silman et al (1996) undertook a study comparing twins with Rheumatoid Arthritis and their 
unaffected co-twin.  79 identical twins and 71 non-identical twins enrolled onto the study.  
The aim of the study was to determine whether smoking had any effect on the susceptibility 
to developing Rheumatoid Arthritis. They found that there was a greater incidence of 
Rheumatoid Arthritis in the twin that smoked cigarettes than the twin that did not.  
However, a major limitation of this study was that the numbers were very small as the 
majority of twins both smoked.  Further work has since been undertaken investigating the 
possible link with smoking and the development of Rheumatoid Arthritis.  De Hair et al 
(2013) recruited 55 individuals considered at risk from developing Rheumatoid Arthritis.  
These individuals all had Rheumatoid Arthritis specific autoantibodies, but did not present 
any of the clinical features of the disease upon examination.  Smoking was assessed as either 
never or ever smoked.  They found that after 13 months, 27% of these individuals developed 
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arthritis in association with smoking.  After 27 months, this increased up to 60% in patients 
with a smoking history and had a Body Mass Index (BMI) greater than 25.  They concluded 
that smoking and obesity increased the risk of developing Rheumatoid Arthritis, and lifestyle 
factors should be critically examined with the aim of disease prevention. 
The connection between obesity and Rheumatoid Arthritis has been further investigated in 
recent years.  A study by Lu et al (2014) enrolled participants in America into two studies.  
109,896 women were enrolled in the Nurses’ Health Study and 108,727 women were 
enrolled in the Nurses’ Health Study II.  They collected data through questionnaires and 
categorised body weight into normal (BMI 18 - 25), overweight (BMI 25 - 30) and obese (BMI 
30).  Lu et al validated a total of 1181 incident cases of Rheumatoid Arthritis and revealed a 
trend towards an increased risk of developing the disease in those individuals who were 
overweight and obese.  There was a 37% increase in risk in those individuals who had ten 
cumulative years of being obese.  The Swedish Pharmacotherapy Trial (SWEFOT) (Levitsky, 
Brismar et al. 2017) was a two-year open-label multi-centre randomised early Rheumatoid 
Arthritis trial where patients were given Methotrexate for three months and then assessed 
for response to therapy.  The data collection for this trial also collected BMI data and it 
revealed that obesity was associated with worse clinical outcomes.  Further, if obesity was 
present at diagnosis of Rheumatoid Arthritis, it was a strong predictor of non-remission after 
two years of treatment.  Smoking and obesity are modifiable environmental factors; thus, 
effective health education may have a tangible impact on the progression of this disease in 
many individuals. 
The influence of an individual’s genetic make-up has been much studied, and there are some 
indications that certain genes may make that individual more susceptible to developing the 
disease (Choy 2012, Korczowska 2014, Levitsky, Brismar et al. 2017).  This is a specific area of 
scientific enquiry and beyond the scope of this thesis.  The work around the influence of 
pathogens, in particular the pathogen causing periodontal infection is of particular interest. 
Leech and Bartold (2015) express that the relationship between Rheumatoid Arthritis and 
poor dental health has been recognised for decades and that there is a clear association 
between periodontitis and the risk of developing Rheumatoid Arthritis. Araujo et al  (2015) 
conducted a literature review of 26 articles and concluded that the majority of the work 
confirmed the connection between periodontitis and Rheumatoid Arthritis.   Kharlimova et 
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al (2016) further suggest that the link between Rheumatoid Arthritis and periodontitis is the 
pathogen Porphyromonas gingivalis and conclude that it is a strong candidate for driving 
autoimmune disease in some patients with Rheumatoid Arthritis.  Periodontitis is an 
inflammatory condition which is a major cause of tooth loss which is preventable by 
reducing lifestyle factors such as smoking and by sustaining high standard of plaque removal  
(Chapple, Van der Weijden et al. 2015).  Thus, the intervention of early health education 
could have an impact on the incidence and severity of Rheumatoid Arthritis. 
 
2.2.4 Definition and Clinical Features 
Rheumatoid Arthritis is characterised by progressive and irreversible damage to the joint 
spaces of synovial-lined joints (Grassi, De Angelis et al. 1998).   In a normal joint, the joint is 
surrounded by a fibrous capsule which is lined with synovial membrane.  The articular 
surfaces of the joints are protected by cartilage.  Within the capsule, the synovial membrane 
secretes synovial fluid which further reduces friction on joint movement.  The synovial fluid 
is constantly being absorbed and replaced by the synovial membrane in the joint cavity 
(Levick and McDonald 1995). 
In people with Rheumatoid Arthritis there is an increased production of cells called 
synoviocytes.  In normal joints these cells appear to be responsible for synovial fluid 
production and reabsorption (Iwanga, Shikichi et al. 2000), however in people with 
Rheumatoid Arthritis  an over-production of these cells leads to the overgrowth of the 
synovial membrane, which, on appearance, looks like long villous-like folds (Isaacs 2011).  
This in turn results in a pannus-like structure which extends into the joint space 
(Bustamante, Garcia-Carbonell et al. 2017) and an increased production of synovial fluid.  
New blood vessels infiltrate the pannus-like structure which produces molecules and 
proteins such as cytokines, destroying the cartilage, tendons and bones which form the joint.   
The most common joints to be affected in the early stage of the disease are the small joints 
of the hands and feet, then wrists, ankles, elbows, shoulders and knees, although any 
synovial joint can be affected (Jeffery 2014).  Most people will present with pain and swelling 
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of their joints, often with morning stiffness in the joints which is caused by a build-up of 
synovial fluid overnight (Isaacs 2011).   
The initial diagnosis can be difficult as there are a number of other causes of these 
symptoms, Table 2.3 describes some other causes of painful swollen joints. 
 











Renal Bone Disease 
Lyme Disease 
Subacute Bacterial Endocarditis 
Multiple Myeloma 
Septic Arthritis (usually affects one 
joint) 
 
A variety of other clinical features are associated with Rheumatoid Arthritis: neuromuscular 
complications can lead to muscle wasting around affected joints, cervical spine disease 
which can cause atlanto-axial subluxation and spinal cord depression (Isaacs 2011).  
Systematic features of Rheumatoid Arthritis can present as nodules commonly seen around 
the wrists, hands and elbows, lymphadenopathy and amyloidosis.  Haematological 
conditions such as anaemia can occur and lung disease such as interstitial pneumonitis can 
also be features of Rheumatoid Arthritis. It is therefore essential that early diagnosis of this 
disease is carried out in order to treat this progressive and potentially destructive condition 
(Isaacs 2011).  In 1987 the American College of Rheumatology (ACR) and the European 
League Against Rheumatism (EULAR) produced criteria to classify Rheumatoid Arthritis 
which were updated in 2010 (Van Der Heijde, Van Der Helm-Van et al. 2013), Table 2.4 
shows this criteria.  
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 TABLE 2. 4 ACR/EULAR 2010 CLASSIFICATION CRITERIA FOR RHEUMATOID ARTHRITIS 
Clinical Finding Score 
Joint Involvement 
1 large joint 
2 – 10 large joints 
1 – 3 small joints ( large joint involvement) 
4 – 10 small joints ( large joint involvement) 
 10 joints (with at least one small joint) 







Negative Rheumatoid Factor (RF) and negative Anti-
Citrullinated Protein Antibodies (ACPA)        
 
Low positive RF or low positive ACPA 
High positive RF or high positive ACPA 





Acute phase reactants (inflammatory markers) 
Normal C-reactive Protein (CRP) and normal Erythrocyte 
Sedimentation Rate (ESR) 
 
Abnormal CRP or abnormal ESR 




Duration of Symptoms (patient reported symptoms) 
 6 weeks 
 6 weeks 




The aim of the criteria was to classify and diagnose Rheumatoid Arthritis early in the 
disease, and those patients who fit the criteria were then highly likely to develop the 
disease. However, some individuals who did not fit the criteria for Rheumatoid Arthritis 
would still go on to develop it (van der Helm-van and Huizinga 2012). 
In order to apply the above criteria, there must be at least one swollen joint present with no 
other explanation for this and the patient must score at least six points.  Early detection of 
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the disease is essential to reduce or halt joint damage (Smolen, Aletaha et al. 2007).  Smolen 
et al also comment that people with Rheumatoid Arthritis not only have pain and swelling, 
they also have loss of physical function which can be due to inflammation or joint damage.  
Inflammation can be reversible but joint damage cannot and damage will increasingly 
progress without treatment. In 1957 Duthie et al (1957) published a report on the course 
and progress of Rheumatoid Arthritis, it makes interesting reading and illustrates the 
prognosis of Rheumatoid Arthritis at that time.  Duthie et al carried out three assessments 
on a cohort of 307 patients with Rheumatoid Arthritis between June 1948 and July 1951.  
Table 2.5 shows the composition of the patient cohort over the three assessments. 
 
TABLE 2. 5 COMPOSITION OF COHORT OF PATIENTS OVER THREE ASSESSMENT (DUTHIE, BROWN ET AL. 
1957) 
Data Total 
Mean duration of stay in hospital (weeks) 9.4 
Average period between discharge and first assessment (months) 24.4  
Number of deaths between discharge and first assessment 15 




Average period between discharge and second assessment (months) 52.4 
Number of deaths between discharge and second assessment 26 




Average period between discharge and third assessment (months) 67.4 
Number of deaths between discharge and second assessment 36 





After only three years following discharge, 36 people with Rheumatoid Arthritis had died 
and a further 24 were lost to follow up.  Six of those individuals who had died were under 
the age of 50 years and 21 were between 50 and 70 years.  Functional capacity was assessed 
as a grade, described in Table 2.6. 
 
TABLE 2. 6 GRADES OF FUNCTIONAL CAPACITY (DUTHIE, BROWN ET AL. 1957) 
Grade Definition Remarks 
I Fit for all normal activities Full employment in usual work, full 
house duties 
II Moderate restriction Usual employment with 
modifications 
Light or part-time work 
All housework except the heaviest 
No dependency on others 
III Marked restriction Only very light work or light house 
work 
Some degree of dependency on 
others 
IV Confined to chair or bed Not capable of any work 
Completely dependent on others 
 
Table 2.7 shows the functional capacity of the participants at the three assessments and 
illustrates the progressive nature of Rheumatoid Arthritis at a time when treatment for this 
disease was limited, and the progress and impact of treatment will be discussed later in this 





TABLE 2. 7 FUNCTIONAL CAPACITY OF STUDY PARTICIPANTS (DUTHIE, BROWN ET AL. 1957) 
Timepoint Functional Grades (%) 






























The significance of this report and the reason for including it in this review, is that it 
illustrates that patients who had Rheumatoid Arthritis were very ill and debilitated by their 
disease, requiring hospital admission and treatment.  However, the treatment that these 
patients received in the 1950s consisted of bed rest, the application of plaster splints to try 
to prevent deformities of the joints and the maximum dose of aspirin that the patient could 
tolerate.  Whilst, with this care, the patients appeared to regain some functionality during 
their hospital admission, their disease slowly progressed over the three years they were 
assessed, with just over one third of patients being classified as requiring some or a lot of 
help from others. It highlights that Rheumatoid Arthritis was a very debilitating and 
progressive disease, sometimes requiring lengthy stays in hospital undergoing conservative 
treatment.  Today, the prognosis for people with Rheumatoid Arthritis is a lot brighter, 
because the treatment regimens for this disease have progressed enormously, and will be 
discussed later in this chapter.  However, it still has an impact on people’s daily lives and it is 
important to remember that individual sufferers need to understand why their treatment is 
so important and the advantages of taking it as prescribed. 
 
2.2.5 Impact on Daily Living 
Much has been written about the impact of Rheumatoid Arthritis on the lives of those 
people who suffer from this disease. Lempp et al (2006) conducted a qualitative study with 
26 individuals living with Rheumatoid Arthritis.  They wanted to understand the direct and 
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personal experiences of these people who lived with Rheumatoid Arthritis on a daily basis to 
gain further understanding of the impact this disease had on the lives of these patients.  For 
example, their ability to care for others, their public roles and responsibilities and their self-
image. Semi-structured interviews were conducted with these patients and several themes 
were identified, including the impact of their disease on their mental health, loss of 
independence and feelings of stigmatization which related to deformities of their hands or 
because they needed to use a stick or a scooter.  Whilst Lempp et al recognise that the 
findings of their study are not generalisable, they revealed details of patients’ daily lives 
which may not have been captured by questionnaires.   However, questionnaire studies have 
disclosed that quality of life can be affected by Rheumatoid Arthritis  (Haroon, Aggarwal et 
al. 2007).   Haroon et al investigated the quality of life of patients with Rheumatoid Arthritis 
using a short form of a questionnaire designed by the World Health Organisation called the 
World Health Organisation Quality of Life Scale (WHOQOL-BREF),  which is a shorter form of 
the original WHOQOL-100  (Power, Bullinger et al. 1999).  The long form of the questionnaire 
consists of 100 items divided into four domains; physical capacity (including independence), 
psychological (including spirituality), social relationships and environment.  The short form 
consists of 26 items based on the same domains which is far easier to administer during a 
clinic.  One hundred and thirty-six patients completed the WHOQOL-BREF and all patients 
had Rheumatoid Arthritis. The study revealed that physical health was the domain that most 
patients felt affected their quality of life the most.  However, a limitation of the study was 
that it did not assess depression and anxiety, which are important considerations that are 
discussed in the following section.  
 
2.2.6 Depression 
Rheumatoid Arthritis is a disease which has a debilitating impact on the lives of the 
sufferers; it not only has a physical impact, as outlined in the previous sections, but a 
psychological impact also. It has long been known that people with Rheumatoid Arthritis can 
also suffer from depression or have depressive symptoms (Frank, Beck et al. 1988).  
Matcham et al (2013) conducted a systematic review in order to describe the prevalence of 
depression in people with Rheumatoid Arthritis. They highlighted that the prevalence 
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estimates of depression in patients with Rheumatoid Arthritis was widely variable and 
ranged between 9.5% and 41.5%.  However, they regarded that the identifying depression 
was not straightforward.  There are a number of different methods for collecting data on 
depression from patients, but these can be very time consuming.  Therefore, self-report 
questionnaires such as the Patient Health Questionnaire (PHQ) and the Hospital Anxiety and 
Depression Scale (HADS) are often utilized because they can collect a large amount of data 
from a bigger population of subjects.  Other confounders could be study quality and 
sampling strategies which could influence prevalence estimates.  Matcham et al (2013) 
concluded that depression was defined in 40 different ways and three subtypes; major 
depressive disorder, minor depressive disorder and dysthymic disorder, a chronic depressive 
disorder.  Only seven studies used the longer psychiatric assessment tools, the remaining 66 
used the shorter diagnostic tools, and 30 studies used the HADS, making it the commonest 
questionnaire used.  On examination of the seven studies which used the longer assessment 
tools, it was suggested that 16.8% of patients with Rheumatoid Arthritis could have major 
depressive symptoms.  Whilst the remaining 66 studies used the shorter assessment tools, 
the PHQ and the HAD, the evidence suggests that between 14.8% and 48% of the population 
under study had significant depressive illness (Hughes 2010). Rezaei et al (2014) assessed 
100 patients with Rheumatoid Arthritis, who completed four questionnaires; including the 
Rheumatoid Arthritis Pain Scale (RAPS) and the HADS.  The findings revealed that 66% of the 
patients had a clinically significant level of depression. Rezaei et al concluded that a negative 
perception of uncontrollable pain was associated with a higher level of symptoms of 
depression in this group of patients. They postulated that this could be mediated through a 
perceived lack of personal control over their illness, functional impairment and possible 
poor medication compliance due to their depressive symptoms. Thus, it is possible that 
engaging the patient at the beginning of their treatment, ensuring that they have a clear 
understanding of why they are taking drugs like Methotrexate, which could lead to improved 




Fatigue is commonly reported by patients with Rheumatoid Arthritis, and has been the focus 
of study for some time (Wolfe, Hawley et al. 1996).  Wolfe et al measured fatigue on a visual 
analogue scale on 1488 consecutive patients with Rheumatic disease and found that 
significant levels of fatigue were present in around 41% of patients with Rheumatoid 
Arthritis.  An early qualitative study by Hewlett et al (2005) considered that fatigue is multi-
dimensional, the consequences of which can have an impact on every aspect of daily life. 
Interviews with 15 patients with Rheumatoid Arthritis and fatigue, who had rated seven on a 
visual analogue scale, zero being no fatigue and ten being the worst fatigue, identified that 
the patients experienced two different types of fatigue; severe weariness and dramatic 
overwhelming fatigue, which had far reaching effects of every aspect of their lives.  The 
patients also reported that they did not discuss fatigue with their clinicians which highlights 
the importance of good consultation to draw out these symptoms.  One of the limitations of 
this study is that the patients they interviewed had gross fatigue symptoms to begin with 
and this may not necessarily be representative of the general Rheumatoid Arthritis 
population.  Therefore, this study does lack generalisability.  Nevertheless, it does highlight 
that fatigue can be a very real and debilitating symptom of Rheumatoid Arthritis which was 
not necessarily recognised in the Rheumatology speciality at that time.  The measurement of 
fatigue was also not an important outcome measure in clinical trials either (Hewlett, 
Cockshott et al. 2005).  Hewlett et al interviewed 15 patients with Rheumatoid Arthritis and 
fatigue and concluded that validated assessment tools to measure fatigue in people with 
Rheumatoid Arthritis, could yield more robust evidence on the existence and extent of 
fatigue and indeed, determine whether levels of fatigue changed due to participation in a 
clinical trial. 
The OMERACT group (Outcome Measures in Rheumatology Clinical Trials) was convened in 
1992 as an international initiative to improve outcome measurements in Rheumatology 
(Tugwell, Boers et al. 2007) and consisted of 80 participants including 20 patients from ten 
countries, and they measured the impact of fatigue on patients. This provided a turning 
point in highlighting to healthcare professionals the impact of fatigue on patients with 
Rheumatoid Arthritis (Choy and Dures 2019).  As a result of this, Choy and Dures point out 
that more researchers have focussed on understanding the underlying causes of fatigue in 
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Rheumatoid Arthritis and thus contributed to the management of these patients.  But the 
overarching challenge is that the fundamental causes of fatigue remain unclear.  Choy and 
Dures suggested that the current evidence points to a complex interaction of clinical factors, 
such as pain, inflammation and immobility, psychosocial factors such as coping factors, 
mood beliefs and behaviours, and personal factors such as work, caring responsibilities and 
comorbidities.  Katz (2017) carried out a review of current understanding on fatigue in 
Rheumatoid Arthritis and reviewed existing treatment.  Katz reported that drugs used to 
treat Rheumatoid Arthritis had limited effect, but physical activity interventions showed a 
moderate, but significant impact on fatigue.  Further Katz conveyed that psychosocial 
interventions have also resulted in moderate but significant effects.   It is clear that fatigue in 
Rheumatoid Arthritis is a significant burden to the sufferer, however, research continues and 
a richer understanding of the causes and treatment of fatigue will eventually lead to 
enhanced disease management for people with Rheumatoid Arthritis. 
 
2.2.8 Work Disability 
Rheumatoid Arthritis can also have an impact on employment.  Verstappen et al  (2004) 
carried out a literature review of 27 cross-sectional and longitudinal studies that examined 
risk factors associated with work disability amongst people with Rheumatoid Arthritis.  On 
analysis of the longitudinal studies, work disability was found to increase with duration of 
disease from 10% in the first year of disease to 90% at 30 years of duration of disease. 
Among the cross-sectional studies, work disability varied from 13% after six months disease 
duration to 67% after a mean disease duration of 15 years.  They also highlighted a number 
of variables associated with work disability, the most frequently presenting were 
socioeconomic factors, clinical variables and work-related reasons.  Socioeconomic factors 
often related to age, those patients who were older were more likely to stop work due to 
their symptoms of Rheumatoid Arthritis.  They also found that those patients who were less 
well educated and had low incomes were more likely to stop work due to their Rheumatoid 
Arthritis. The clinical variables related to symptoms, those patients who were work disabled 
had higher levels of inflammation, higher pain scores and higher disease activity.  The work-
related factors which led to work cessation, included the population who were in more 
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physically and emotionally demanding jobs.  Whilst it seems apparent that Rheumatoid 
Arthritis can lead to a loss of work productivity and employment, this study did not describe 
the assessment tools used to measure work disability.  It is clear that being able to work and 
function at work is an important outcome for people with Rheumatoid Arthritis, and 
standardised measurement tools are required in order to understand and manage these 
factors.  
In a study of patient derived targets for treatment, Robinson et al, (2011) carried out a 
survey of 100 patients with Rheumatoid Arthritis. They negotiated a target for treatment 
with each patient, so that if, when the patient was reviewed after three to six months, the 
target was achieved, then it would be considered that treatment was successful.  If the 
target was not achieved, then it may be considered that the patient required a further 
change or escalation of treatment. The target was chosen by the patient in consultation with 
the researcher.  There were 44 patients who fell into the working age population (men <66 
years and women <60 years) and 40% of these were in paid employment (n=21), whilst the 
rest of that population had stopped work.  Twelve of those patients who were in paid 
employment chose as their target, to remain in work, one patient chose the target of 
increasing their current paid employment.  None of the working age population, who were 
not in work, chose regaining employment as their target.  This study suggested, that once 
work is lost, then it was no longer a target for them to get back to work.  It is therefore likely 
that preventing work loss would be the better strategy.  Thus, it is important that patients 
have the knowledge to understand that taking drugs like Methotrexate as prescribed could 
have a positive impact on maintaining their employment. 
 
2.3 Treatment of Rheumatoid Arthritis 
The next few sections will review the historical treatment of Rheumatoid Arthritis, the 
development of the disease modifying drugs used to treat Rheumatoid Arthritis with 
particular reference to Methotrexate, as it is the focus of this study.  There will also be a 
brief discussion of the biologic drugs which are used to treat this disease, as many of them 
require Methotrexate to be prescribed in combination with their use. 
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2.3.1 Historical Treatment 
The treatment of Rheumatoid Arthritis before the 1950s was bleak for people who suffered 
from this painful and debilitating disease.  Patients resorted to remedies with no scientific 
basis that were at best harmless, to relieve their suffering, such as suspending a copper coin 
on a gut string and tying it around the waist.  Today people still wear copper bracelets in the 
hope that they will ward off and control arthritis symptoms. Other remedies involved fluids 
and salts of different sorts taken by mouth, special herbs, diets and baths. Bloodletting and 
leeching were popular in the distant past, but even in the 1970s cupping, acupuncture, wax 
baths were common forms of treatment.   
The only effective disease modifying agent was Myocrisin, a gold salt (sodium 
aurothiomalate) (Ellman, Lawrence et al. 1940, Sutcliffe, O'brien et al. 1973). In the late 18th 
Century gold cyanide was being developed intravenously for the treatment of Tuberculosis.  
After initial encouraging reports, experimental use in other conditions occurred.  In the 
1920s favourable results were seen with gold salts given intramuscularly in the treatment of 
Rheumatoid Arthritis and its use for this condition spread rapidly around Europe (Fraser 
1945, Sigler, Bluhm et al. 1974). The 1930s saw the first use of gold in the UK as a therapy for 
the treatment of Rheumatoid Arthritis.  It was used as a last line of drug treatment because 
of the risks of side effects; patients would be expected to have signs of permanent damage 
such as erosion to justify its use. Instead, analgesia and non-steroidal anti-inflammatories 
were used as first line drugs to treat Rheumatoid Arthritis.   Gold injections continued to be 
prescribed for the treatment of Rheumatoid Arthritis until 2019 when it was withdrawn 
worldwide as no company could manufacture it because of supply problems with the 
ingredients (Sanofi 2019). 
A real breakthrough for the treatment of chronic long-term conditions like Rheumatoid 
Arthritis was the discovery of cortisone, Compound E, by Philip Hench in 1948, for which he 
won the Nobel Prize for Physiology or Medicine in 1950 (Burns 2016) along with his co-
workers Edward Kendall and Tadeus Reichtein.  Compound E was rated to be of equal 
importance to the discovery of insulin and penicillin; the effect of Compound E, “is almost 
beyond comprehension, the time is not far distant for Rheumatoid Arthritis to be wiped out” 
(Karsh and Hetenyi Jr 1997).  At that time the mode of action of Compound E was unknown, 
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but from the onset the major confounder in the widespread use of this drug was its 
availability; it was extremely scarce, difficult and costly to produce.  A series of 
Parliamentary debates between 1949 and 1954 around the availability of Cortisone (see 
Appendix 1), reflected on the increased recognition of side effects associated with 
hydrocortisone usage which are associated with long-term use, including osteoporosis, 
diabetes, cataracts, infections and mood changes. It was therefore recognised that 
corticosteroids such as hydrocortisone could not be used in high doses over long periods, 
and they are now mainly used for short term “boosts” to other therapies. 
Aspirin was first synthesized in 1897 and marketed as an anti-inflammatory drug, but its 
mode of action remained elusive until 1971 when John Vane showed that aspirin and other 
similar drugs such as indomethacin, inhibited the production of prostaglandins which 
produced an anti-inflammatory effect.  However, prolonged use of these drugs caused 
damage to the stomach mucosa, toxicity to the kidneys and inhibition of platelet aggregation 
(Botting 2010).  Other NSAIDs have since been developed which are less harmful to the 
stomach mucosa such as the COX-2 inhibitors (Brune and Hinz 2004).  NSAIDs are still 
important drugs in the treatment of Rheumatoid Arthritis but their limitation is that they 
only act on the symptoms of the disease and not the disease process itself.  In 2018 the 
National Institute of Health and Care Excellence (NICE) updated their guidelines on the 
management of patients with Rheumatoid Arthritis.  They recommended that NSAIDs should 
be used to treat inadequate control of pain and stiffness at the lowest possible dose for the 
shortest possible time (Allen, Carville et al. 2018). 
 
2.3.2 Development of DMARDs 
Gold was in retrospect the first drug thought to slow the progression of Rheumatoid 
Arthritis. Drugs that do this are now called Disease Modifying Anti Rheumatic Drugs 
(DMARDs). The next drug in this group was Sulphasalazine, introduced in the late 1970s.  
Sulphasalazine was developed in Stockholm by Professor Nana Svartz (1948) but it remained 
unused because of the introduction of cortisone in the 1950s.  However, studies carried out 
in the late 1970s awakened interest in this drug (McConkey, Amos et al. 1980).  In the 1950s 
 27 
a drug called Penicillamine was found to be anecdotally effective in the treatment of 
Rheumatoid Arthritis and a meta-analysis of studies showed it to have a statistically 
significant benefit on disease activity (Suarez‐Almazor, Belseck et al. 2000) It was thought 
that it could useful in the management of patients who had stopped or failed to respond to 
gold injections (Tsang, Patterson et al. 1977).  However, it has declined in use with the 
development of other more effective DMARDs.   
Hydroxychloroquine is a drug which was principally prescribed to treat malaria, however 
since the 1950’s studies showed that it was useful in the treatment of Rheumatoid Arthritis 
(Ryan 2007).  Hydroxychloroquine has a low toxicity profile but it tends to be used in 
combination with other drugs as it is slightly less effective than other DMARDs (Ryan 2007).  
Cyclophosphamide is a drug that was developed for the treatment of cancer and it was 
shown to have immunosuppressant and immunostimulatory effects (Miller and North 1981).  
It found some use in the treatment of Rheumatoid Arthritis in the 1960’s, but it proved to be 
more effective in the treatment of some of the systemic effects of this disease (Ryan 2007). 
 
2.3.3 Methotrexate 
Methotrexate is a compound that was first used to treat Rheumatoid Arthritis in 1951 
(Gubner, August et al. 1951). Unfortunately it emerged at the same time as cortisone, thus 
receiving little attention until it came back into focus in the early 1980's (Hoffmeister 1983).  
Methotrexate, which is a folate antagonist, was developed in the late 1940’s after the 
discovery that a dietary deficiency of folic acid resulted in a decrease in leukaemia cell count 
(Heinle and Welch 1948).  Further investigation with Methotrexate found it had a role in 
many different types of cancer, though it was more effective when used with other cytotoxic 
drugs (Bryan 2019).  Methotrexate found use in the treatment of Psoriasis (Coe and Bull 
1968) but the observed liver toxicity meant that routine liver biopsies were performed. 
However, the pick-up rate was low and they have since been discontinued as a routine 
treatment (Boffa, Chalmers et al. 1995). 
In 1972 Hoffmeister (1972), carried out an observational clinical study on 29 patients who 
had Rheumatoid Arthritis and prescribed them intramuscular Methotrexate.  He reported 
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that 11 of his patients had a major improvement of the symptom and signs of their disease, 
and 14 had moderate improvement.  When he discontinued the Methotrexate 80% of these 
patients had major flares. This report was only published as an abstract because his 
Rheumatology colleagues responded so negatively, he did not want to waste time on a 
manuscript, which would be rejected (Weinblatt 2013).  In 1983 Weinblatt (1985) initiated a 
randomised, placebo-controlled, 24-week crossover trial of 28 patients with Rheumatoid 
Arthritis in which 2.5mg to 5mg twice a day was prescribed three days per week. The 
Methotrexate group showed a significant improvement in both tenderness and swelling of 
the joints, by week 12.  However, side effects were noted; 12% reported diarrhoea and one 
patient was withdrawn due to severe diarrhoea, and 21% of the Methotrexate group 
exhibited raised liver enzymes.  They concluded that Methotrexate was effective in the short 
term but longer trials were required, so 26 patients agreed to continue taking Methotrexate  
(Weinblatt, Trentham et al. 1988).  Ten patients withdrew from this long-term study, so at 
month 36, only 16 patients were still taking Methotrexate. Adverse events such as nausea, 
headache, increased infections, diarrhoea, raised liver enzymes and neutropenia were 
noted.  However, these adverse events resolved after short term withdrawal of 
Methotrexate.  Further, the disease remained well controlled in the remaining patients and 
radiographic joint damage showed improvement.  Weinblatt et al concluded that drug 
toxicity could be managed with regular monitoring of the patient, thus confirming 
Methotrexate an effective drug for the treatment of Rheumatoid Arthritis. 
A further pivotal study conducted in the mid 1980”s was developed by Williams et al (1985).  
One hundred and ten patients completed an 18-week placebo-controlled randomised trial.  
All patients were naïve to Methotrexate and all patients had six or more swollen joints on 
entry into the study. Fifty-seven patients were randomly allocated to the Methotrexate 
group and 53 into the placebo group. The starting dose for the Methotrexate group was 
7.5mg per week; 33% of patients remained on this dose, whilst the rest stepped up to 15mg 
per week. Joint pain and tenderness in the Methotrexate group had decreased by more than 
50% at the end of week 18 and only by 11% in the placebo-controlled group. There were 
also significant improvements in the duration of morning stiffness, grip strength and walking 
time in the Methotrexate group.   
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However, despite the evidence from these studies, Methotrexate was used very slowly 
initially and usually as a last resort treatment for patients with severe disease.  But during 
the 1990s further long-term data from studies reported sustained clinical response, which 
increased the interest of Rheumatologists worldwide and Methotrexate became more 
universally used as a monotherapy and in combination with other drugs.  Williams et al 
(1992) entered 335 patients into a 48 week prospective, controlled double-blind trial and 
were randomly assigned to one of three groups: 
 Methotrexate monotherapy – 7.5 mg weekly 
 Auranofin monotherapy 3mg twice a day 
 Combination of Methotrexate and Auranofin 7.5 mg weekly and 3mg twice a day 
respectively 
All patients had active Rheumatoid Arthritis with at least six swollen joints and all patients 
were monitored every three weeks for adverse events. Whilst a similar trend of the 
reduction of the number of tender joints was seen across all three groups, patients 
responded to Methotrexate more quickly, but by week 18 all groups were comparable.  Of 
the 124 patients who were withdrawn, it was more frequent in the combination group (21%) 
compared to 14% in the Auranofin group and 15% in the Methotrexate group.  Twenty-five 
patients were withdrawn because of lack of efficacy and of these 13% belonged to the 
Auranofin group.  The total withdrawal of patients for any cause over the entire study were 
40% in the Auranofin group, 34% in the Methotrexate group and 37% of patients in the 
combination group.  Increase liver enzymes were only seen in the Methotrexate group and 
was the most common cause of withdrawal.  No increase in efficacy was seen in the 
combination group, but withdrawals because of lack of response was more common in the 
Auranofin group. 
Despite the increasing amount of evidence from clinical trials, Rheumatologists were still 
initially reluctant to use Methotrexate during the 1990’s, which could have been for three 
reasons (Pincus, Yazici et al. 2003); that Rheumatologists were more comfortable using the 
established DMARDs, that they perceived that more potent drugs were more toxic and that 
they were concerned about possible irreversible harmful effects. 
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2.3.3.1 Methotrexate Side Effects and Toxicity  
The side effects of Methotrexate can be diverse and life threatening (Gaies, Jebabli et al. 
2012).  As Methotrexate was initially used to treat cancer and was administered in doses 
much higher than used in the treatment of Rheumatoid Arthritis, there was initially very 
limited information on common side effects.  Also the drug was not formally licenced for 
Rheumatoid Arthritis until a subcutaneous injection was studied (Mims 2006) and most of 
the early information came from case studies (Steinsson, Weinstein et al. 1982).  
Methotrexate had not, therefore, been subjected to large phase III studies that would 
satisfy regulators and thus confidence to use it was gained mainly from experience. 
Weinblatt and colleagues (1985) report the toxicity in 587 trial patients reporting effects on 
the gastro-intestinal tract, the bone marrow, alopecia and fever. A cross-sectional 
observation study point was conducted by Gilani and colleagues (2012) on patient who were 
receiving a low dose of Methotrexate. They showed that 27% of the study population 
(n=140) suffered side effects.  These were mostly hepatological and haematological, with 
the commonest problem being raised liver enzymes.  But the main draw back with this study 
was that they only examined blood samples, whilst the patients themselves were not asked 
about the side effects they encountered taking Methotrexate. 
Tolerability of Methotrexate is a problem for many patients, van Ede et al  (1998) found that 
30% of patients starting Methotrexate stopped because of side effects (van Ede, Laan et al. 
1998), making it clear that drug and dose limiting side effects are frequent and have a 
significant impact on adherence. Similarly, Alarcon, Tracy and Blackburn (1989) surveyed 152 
patients over five years and found that 71.2% were self-reporting that they were still taking 
Methotrexate at one year, 55.5% at three years and only 50% at five years.  However, the 
data were collected from patient notes, rather than surveying the patients themselves, 
which may not consider the number of patients who do have side effects but do not report 
them.  Robinson et al (2016) carried out a survey of patients taking Methotrexate in seven 
centres around the UK. The total number of patients who experienced side effects ranged 
from 57% in one centre to 85% in another centre.  The patients were asked to complete 
visual analogue scales to score the severity of side effects they experienced.  Fatigue scored 
the highest, whereas mouth ulcers and hair loss were scored much lower.  This study 
reported a high frequency of side effects endured by patients, which could indicate that 
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patients are tolerating Methotrexate because of the benefit they receive from it.  It was also 
revealed through this survey, that patients occasionally take a “Methotrexate holiday”, ie 
they will miss out doses if they go on holiday or if they intend to consume alcohol at a party.  
Whilst it is possible that patients manage their Methotrexate in order to suit their needs, 
there are dramatic and life-threatening side effects of Methotrexate.  Pneumonitis is 
inflammation of the lining of the lungs and fibrosis, where the lungs can become damaged 
and scarred, can occur as a result of taking Methotrexate (Carson, Cannon et al. 1987). 
Guidelines produced by the British Society of Rheumatology advise using caution when 
using drugs such as Methotrexate in patients with poor respiratory reserve and therefore 
investigation of the lungs is now routine prior to commencing Methotrexate therapy 
(Ledingham, Gullick et al. 2017).  There is a suggestion that there may be genetic factors 
which predispose the patient to increased risk of toxicity (Fisher and Cronstein 2009), but 
this has not found a clinical position at this time.   
Lloyd et al (1999) published a review in which they highlighted that a number of studies had 
shown that there was a link between Methotrexate and birth defects.  Feldcamp (1993) 
suggested that the lowest dose which would produce adverse effects on pregnancy was 
10mg, the most vulnerable period of gestation being between six to eight weeks.  Lloyd et al 
(1999) reported that skull and limb abnormalities were the most common effects of 
Methotrexate exposure and there was a 10:42 chance of abnormalities of the foetus in the 
event of exposure to the drug, thus it was recommended that Methotrexate should be 
withdrawn six months prior to pregnancy.  However,  as drug treatment during pregnancy 
may be required to control maternal symptoms a EULAR task force was established to 
conduct a systematic literature review and to formulate recommendations for the use of 
anti-rheumatic drugs during pregnancy (Skorpen, Hoeltzenbein et al. 2016).  Whilst many 
drugs used to treat Rheumatoid Arthritis could be continued with caution, Methotrexate 
was one of the drugs which they advised should continue to be withdrawn before 
pregnancy.  Therefore, females and males of childbearing age who are taking Methotrexate 
should be clearly aware that this drug should be withdrawn prior to any planned pregnancy. 
A further complication of the use of Methotrexate is the link with liver cirrhosis.  In 1977 
liver biopsies were carried out on 160 patients who were all taking Methotrexate up to a 
maximum dose of 25mg (Nyfors 1977) discovered that 26% had liver cirrhosis.  Further 
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studies were carried out, leading to guidelines for hepatic monitoring  (Kremer, Alarcón et al. 
1994).  The association between alcohol and liver was known (Savolainen, Liesto et al. 1993) 
therefore the guidelines published by the American College of Rheumatology recommended 
complete abstinence (Kremer, Alarcón et al. 1994). However, somewhat more recently, the 
British Society of Rheumatology suggested that alcohol consumption should be limited to 
“within the UK national recommendations” (Chakravarty, McDonald et al. 2008).  
Humphreys et al (2017) felt that there was a lack of evidence to reveal the toxic effects of 
alcohol and Methotrexate combined, thus they identified 11839 patients with Rheumatoid 
Arthritis from an electronic database of routinely collected medical records in primary care 
of patients starting Methotrexate after 1987.  Humphreys et al identified episodes of raised 
liver enzymes, alanine transaminase (ALT) or aspartate aminotransferase (AST), which were 
greater than three times above the upper limit of normal, which could indicate liver toxicity, 
and predispose liver cirrhosis.  They found that most patients drank low amounts of alcohol 
– less than seven units per week or did not drink at all.  They also demonstrated that there 
was not a significant risk of liver toxicity in those patients who drank less than fourteen units 
per week and concluded that it was relatively safe for patients taking Methotrexate to 
consume alcohol in line with the UK guidelines.  However, correspondence from Kremer et al 
(2018) in response to Humphreys et al (2017) dispute their findings as they consider that the 
elevation of the AST and ALT to be greater than three times the upper limit of normal as a 
measure of the potential for liver cirrhosis as being very misleading.  In their work, they 
consider that liver biopsies were a far better measure of hepatic toxicity and measuring the 
ALT and AST alone could seriously underestimate the risk for patients.  It is clear from this 
work, that there is a risk of increased hepatic toxicity with the consumption of alcohol whilst 
on Methotrexate and this is an important message to patients who are taking this drug. 
There are relatively few drug interactions with Methotrexate; Bourre-Tessier and Haraoui 
(2010) conducted a systematic review to determine what drugs could increase side effects or 
toxicity of Methotrexate  and concluded that Methotrexate has limited drug interactions.  
However, two drugs stood out, Trimethoprim (TMP), which is an antibiotic commonly used 
to treat urinary tract infections, and high doses of Aspirin (ASA).  TMP inhibits an enzyme call 
dihydrofolate reductase, this has an important role in the building of DNA. However, 
inhibiting this enzyme can lead to bone marrow suppression.  Methotrexate also inhibits 
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dihydrofolate reductase, therefore a combination of both can lead to serious bone marrow 
toxicity (Rushworth, Mathews et al. 2015).  Bourre-Tessier and Haraoui (2010) also report 
that there is some evidence to suggest that a combination of Aspirin and Methotrexate 
could produce drug reactions, however, small doses of Aspirin did not reveal any significant 
signals for toxicity.  The increase in the number of available Non-Steroidal Anti-Inflammatory 
Drugs (NSAIDs) over the years have negated the need to use high doses of Aspirin and 
Bourre-Tessier and Haraoui did not observe any significant drug reactions with these NSAIDs.   
Vaccinations are an area of concern for patients who are taking immuno-suppressant 
therapies such as Methotrexate, because live-attenuated vaccines contain live micro-
organisms which can cause infection in an immuno-suppressed person (Furer, Rondaan et al. 
2020).  As a result, the European League Against Rheumatism (EULAR) provided 
recommendations for the use of vaccines in patients with autoimmune inflammatory 
diseases such as Rheumatoid Arthritis, firstly in 2011 (Van Assen, Agmon-Levin et al. 2011) 
and further updated in 2019 (Furer, Rondaan et al. 2020).  Generally, non-live vaccines such 
as the flu vaccine and pneumococcal vaccine are recommended yearly, however EULAR still 
recommend that live vaccines should be avoided during immunosuppression with a possible 
exception of the MMR vaccine for children and the Herpes Zoster vaccine.  The yellow fever 
vaccination particularly, should generally be avoided.  Thus, it is clear that patients require 
information which would direct them to resources which would give advice about 
vaccinations and which ones were safe to receive.  
A survey of Rheumatologists carried out in 1992 indicated that Sulphasalazine was the drug 
of choice for Rheumatoid Arthritis (Kay and Pullar 1992) but by 2004 46.5% of 
Rheumatologists in the UK were choosing Methotrexate as their first choice of drug 
(Jobanputra, Wilson et al. 2004). In 2002 the results of an observation study were published 
(Aletaha and Smolen 2002) which underscored the importance of Methotrexate dosing.  
Aletaha and Smolen analysed and recorded the DMARD history of 593 patients with 
Rheumatoid Arthritis from clinics carried out in 1999.  They looked at the effect of drug dose 
on duration of treatment and they found that 59% of patients taking low dose Methotrexate 
(10mg/week) discontinued the drug whilst only 36% of patients taking doses of 12.5mg 
stopped treatment and they also revealed that patients on the higher doses remained on 
Methotrexate significantly longer than the lower doses. They also observed there was a 
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higher toxicity rate in the lower dose group which led to withdrawal rather than lack of 
efficacy.  This was an important finding, because it revealed that once patients were 
established on higher doses of Methotrexate they were well tolerated and less likely to 
discontinue treatment. Due to its clinical effectiveness, Methotrexate became the drug of 
choice for the early treatment of Rheumatoid Arthritis (Albrecht and Muller-Ladner 2010). 
Whilst other drugs such as Leflunomide and Sulphasalazine, have been approved with 
evidence of effectiveness, (Olsen, Strand et al. 1999), the most widely used drug in the UK is 
Methotrexate and thus is the focus of this thesis.  There are many potential side effects of 
the drug therapies and could have serious consequences for patients and those giving the 
information, such as the Rheumatology Specialist nurses, as well as those receiving it, the 
patients, need to understand those risks. 
 
2.3.4 Introduction of Biologics for the Treatment of Rheumatoid Arthritis 
Improvements in the understanding of the pathogenesis of RA led to the development of a 
new class of drugs.  These drugs, referred to as biologics, are agents made by living cell lines 
and target specific inflammatory cells, cell interactions and cytokines which medicate 
Rheumatoid Arthritis related tissue damage (Curtis and Singh 2011).  They are large proteins, 
either antibodies or receptors, directed against specific mediators of inflammation. The first 
biologic drugs were developed in the late 1990s (Hsia, Ruley et al. 2006, Amgen 2008), since 
then other drugs have become available that are often prescribed with Methotrexate (Choy, 
Freemantle et al. 2019, Genovese, Kalunian et al. 2019).  Fig 2.1 shows the site of action for 








FIGURE 2.1 SITE OF ACTION OF BIOLOGICAL DRUGS FOR RHEUMATOID ARTHRITIS  
 
 
2.3.5 Current Practice for Managing Rheumatoid Arthritis 
The previous section has discussed the evolution of drug therapies for the treatment of 
Rheumatoid Arthritis with an emphasis on Methotrexate.  It shows that there are a wide 
range of drugs now available to patients for the treatment of their disease.  The next section 
will now discuss the literature on how those drugs are applied to the management of patient 
with Rheumatoid Arthritis which has changed considerably over the last 30 years. In the 
1980s, few drugs with any real therapeutic effect existed, and those that were available 
were started late in the disease, when the joints were irreversibly damaged (Smolen, 
Landewé et al. 2017).   Therapeutic targets had not been defined, as it seemed that 
controlling the pain was the most important objective. To date, there are now numerous 
effective agents to treat Rheumatoid Arthritis and Methotrexate has become the anchor 
drug for therapy (Visser and van der Heijde 2009, Smolen, Breedveld et al. 2016). 
Methotrexate is likely to be a mainstay of treatment for many years to come, primarily based 
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on price. As Methotrexate is off Patent and relatively cheap compared to the biologic 
alternatives, these more modern and effective drugs will remain less cost/effective for the 
foreseeable future (Schipper et al 2011).  The direction of travel is to treat earlier with 
quicker escalation of drugs, often used in combination, and treating to a target of remission 
or low disease activity, ie treat to target. Use of the newer drugs has been restricted by cost, 
but more recently prices have fallen with the drugs going off patent and “biosimilars” 
replacing the more expensive originators (Gulacsi, Brodszky et al. 2015).  A biosimilar is 
defined by the World Health Organisation as: 
“a biotherapeutic product that is similar in terms of quality, safety and efficacy to an 
already licensed reference biotherapeutic product”  (WHO 2009). 
As originator drugs come off patent, other drug companies can start producing their own 
version of the drug, biosimilars.  These drugs are cheaper than the originators as they do not 
require the extensive drugs trials required by originator drugs and are therefore cheaper to 
produce.  It has been estimated that Germany, France and the UK could save between €2.3 
billion and €11.7 billion between 2007 and 2020 with the introduction of biosimilars for the 
treatment of Rheumatoid Arthritis (Haustein, de Millas et al. 2012).  Thus, whilst it is clear 
that there have been substantial changes in both the drugs and the way they are used for 
the treatment of Rheumatoid Arthritis, the impact of treat to target on disease management 
and the extent to which the patients themselves are involved in this process through shared 
decision-making needs to be explored. 
Schoels et al. (2010) reviewed evidence around the existence of a target-oriented approach 
the Rheumatoid Arthritis management. They reviewed 24 trials and four trials randomised 
patients to routine or targeted treatment, two compared different randomised targets and 
one compared targeted treatment to historical control. The targets for treatment in most of 
these trials were lowered Disease Activity Score (DAS28), lowered C-Reactive Protein (CRP a 
protein which can be detected in the blood and measures levels of inflammation) or reduced 
joint tenderness and swelling.  None of the aims of treatment were negotiated between the 
Clinician and patient.  The only reference to patient involvement is a Health Assessment 
Questionnaire (HAQ), completed by the patient and asks a series of questions of activities of 
daily living.  
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Kjeken et al (2006) examined the level of information received by patients, how involved 
they were with medical care and how satisfied they were with their care.  A total of 1,193 
patients with RA and Ankylosing Spondylitis (AS) completed self-reported health status 
questionnaires and questions about Rheumatology care.  Questions regarding information 
received, involvement with decisions and satisfaction with care were also asked.  The 
majority of patients were satisfied with their care but about a third felt that they had unmet 
needs most frequently relating to pain, fatigue and joint dysfunction.  Interestingly those 
patients who reported unmet needs also reported significantly worse health status (Kjeken, 
Dagfinrud et al. 2006).  It does suggest that more patient involvement during the 
consultation around making medical decisions could lead to improved outcomes.  Patients 
need to be informed about medications and alternative options in order to feel competent 
to participate in such decisions (Cahill 2002). In 2010 EULAR convened a task force to 
develop a set of recommendations for the management of Rheumatoid Arthritis, aiming at a 
treatment target of remission or low disease activity.  The objective of the task force was to 
formulate a consensus on a set of recommendations aimed at improving the management of 
Rheumatoid Arthritis in clinical practice. The consensus finding was based on evidence 
obtained from a systematic literature review that revealed improved outcomes with 
strategic therapeutic approaches (Smolen, Aletaha et al. 2010). Recommendations were 
then presented for discussion, amendment and voting to more than 60 experts from Europe, 
North and Latin America, Japan and Australia, including five patient representatives.  Table 
2.8 shows the final recommendations for treating to target and it is interesting to note that 
the first recommendation was unanimously voted and reflects the growing importance 







TABLE 2.8 THE 2016 EULAR RECOMMENDATIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS 
(SMOLEN, LANDEWÉ ET AL. 2017) 
Over Arching Principles 
Treatment of patients with Rheumatoid Arthritis should aim at the best care and 
must be based on a shared decision between the patient and the Rheumatologist 
Treatment decisions are based on disease activity and factors such as progression 
of structural damage, comorbidities and patient safety 
Costs of care should be considered 
Recommendations 
Treatment with DMARDS should start as soon as the diagnosis is made 
Treatment targets should be sustained remission or low disease activity 
Monitoring should be every one to three months during active disease, if no 
improvement after three months, or the target has not been achieved by 6 
months, therapy should be adjusted 
Methotrexate should be part of the first treatment strategy 
If Methotrexate is contraindicated or the patient is intolerant, then Leflunomide or 
Sulphasalazine should be considered instead 
Short term steroids should be considered 
If the treatment target is not achieved with the first DMARD then other DMARDs 
should be considered 
Biologics therapies should be considered if the treatment strategy with DMARDs 
has not achieved the target 
If the patient is in persistent remission tapering treatment could be considered 
 
The treatment target of remission or at least, low disease activity is measured by a Disease 
Activity Score (DAS).  The score is a calculation based on an assessment of pain and swelling 
of the patient’s joints, a patient rated score of their disease activity and a blood test to 
assess inflammation (Van Riel 2014).  A score of greater than 5.1 implies that there is active 
disease, a score of less than 3.2 represents low disease activity and a score of less than 2.6 
represents remission (Fransen and Van Riel 2009).  Therefore, the aim of treat to target is a 
 39 
DAS of less than 3.2.  The 2016 EULAR recommendations (Smolen, Landewé et al. 2017) 
state that the treatment of patients with Rheumatoid Arthritis must be based on shared 
decision-making between the patient and the Rheumatologist.  
 
2.4 The Evolution of the Rheumatology Specialist nurse 
Over the last 30 years the care of Rheumatology patients has moved from a predominantly 
doctor-based outpatient service and rehabilitation in-patient service, to a multi-disciplinary 
outpatient-based service. For people with Rheumatoid Arthritis, the Specialist Nurse has 
become a key co-ordinating person within the team, as promoted by the British Society of 
Rheumatology (BSR) guidelines for the treatment of Rheumatoid Arthritis (Deighton et al 
2008) where a “named” nurse to coordinate treatment was recommended. This has been 
accompanied by a substantial increase in the number of Specialist Rheumatology Specialist 
nurses in post in the NHS and the roles they undertake (Royal College of Nursing 2009). The 
following sections will review the development of the Rheumatology Specialist nurses’ role 
and the increased responsibilities which were undertaken; shared decision-making and the 
impact of this on patient management; the current literature around patient knowledge of 
Methotrexate; nurses’ knowledge of Methotrexate and a discussion of literature concerning 
consultation models and the relevance of those models to the nurses’ and patients’ 
interactions. 
 
2.4.1 Development of the Role 
The first Rheumatology Specialist nurse roles evolved within the National Health Service in 
the 1980s and they carried out functions such as assessing joint swelling, mobility and 
function (Bird 1981).  As the development of the new drugs and their use increased, so the 
role of the Specialist Nurse evolved, with nurses gradually taking on the role of monitoring 
side effects of drugs and patient education (Hill, 1985, 1992).  By 1997 duties that were once 
carried out by junior doctors were now provided by the Specialist Nurse (Flasher 1997). 
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More areas for service provision were identified and nurses’ skills extended. Mullally (2001), 
Chief Nursing Officer for England in 2001, identified ten key roles for nurses (Table 2.9). 
 












Carr et al (2001) carried out a survey to explore the extended role of Allied Healthcare 
Professionals in Rheumatology and revealed that not only were Rheumatology Specialist 
nurses already fulfilling the 10 key roles outlined by Mullally (2001), but had incorporated 
other roles (Hill, Thorpe et al. 2003) such as joint examinations, assessing disease status, 
formulating and implementing disease management plans, referring to other healthcare 
professionals, recommending changes of drug therapy and addressing physical and 
psychological needs. 
1. To order diagnostic investigations such as pathology tests and xrays. 
2. To make and receive referrals direct, say to a therapist or a pain 
consultant. 
3. To admit and discharge patients for specified conditions and with agreed 
protocols. 
4. To manage patients for specific conditions and within agreed protocols. 
5. To run clinics, say for ophthalmology or dermatology. 
6. To prescribe medicines and treatments. 
7. To carry out a wide range of resuscitation procedures and defibrillation. 
8. To perform minor surgery and outpatient procedures. 
9. To triage patients using the latest information technology to the most 
appropriate health professional. 
10. To take the lead in the way local health services are organised and in the 
way that they run. 
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By 2006, nurses were also undertaking nurse prescribing and teaching medical students 
(Goh, Samanta et al. 2006).  In 2009 the Royal College of Nursing (RCN) published the results 
of a survey in which they explored the performance and activity of Rheumatology Specialist 
nurses (2009).  This report found that nurses had increased the number of clinics they were 
running per week, and they were now undertaking cognitive behavioural therapy and 
biomechanical assessments.  In terms of the qualifications that the nurses had to undertake 
these tasks, the RCN 2009 survey found that a number of different courses had been 
undertaken. What it didn’t highlight was the restriction that the limited geographical siting 
of the courses placed on nurse participation.  At the time of writing there are nine 
postgraduate Rheumatology courses, six of these are aimed at doctors and the other three 
include Specialist nurses. These three courses are at Kings College London, Keele University, 
and the University of South Wales.   Geographical access may limit most nurses and there 
are only a finite number of places on each course, which is open not just to nurses, but all 
healthcare professionals. There are therefore likely a large number of nurses in the UK with 
little opportunity to undertake any postgraduate training in Rheumatology. At the time of 
the Royal College of Nursing report (Royal College of Nursing 2009) it was narrated that the 
Rheumatology Nursing Forum had 1,216 members and that the British Society of Healthcare 
Professionals in Rheumatology had 554 members.  These figures only represent a proportion 
of Rheumatology Specialist nurses in the UK as membership to these bodies is not 
compulsory.  The Royal College of Nursing report (Royal College of Nursing 2009) also 
highlighted the wide range of tasks performed by these nurses and the wide range of pay 
bands of the nurses carrying out those tasks.  This seems to suggest that the Rheumatology 
nurse role has evolved differently in various parts of the country.  There appeared to be little 
uniformity in that role and little agreed education to meet the varying professional needs to 
carry out that role. 
Shields et al (2012) commented on the standard of nurse training in England.  The level of 
education for a nurse training then was Diploma standard, as opposed to the all-degree 
educated profession characteristic of Scotland and Wales at that time.  They considered that 
this training lagged behind most of the world, commenting that opportunities to progress 
the training to degree level in England were abandoned in order to maintain a high supply of 
poorly paid nurses to work on the wards of the NHS.  However,  a white paper published 
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2010, ”Front Line Care: A Report by the Prime Ministers Commission on the Future of 
Nursing and Midwifery in England” which  predicted that all new nurses in England would 
hold a degree level qualification by 2013 (Department of Health 2010).  The Nursing and 
Midwifery Council (NMC) developed the content and standards of proficiency for the degree 
course, which are regularly reviewed to ensure they remain fit for purpose.  These standards 
specify the skills and knowledge that registered nurses must have in order to deliver safe, 
compassionate and effective nursing care.  There is no national curriculum for the training of 
new nurses, however, educational institutions running the training courses must ensure that 
the curriculum they provide complies with all of the standards.  The standards are grouped 
into seven  platforms  (Table 2.10) followed by two annexes with communication only 
appearing in Annex A  (Nursing and Midwifery Council 2018) (Appendix 2). 
 
TABLE 2. 9 THE NMC STANDARDS (NURSING AND MIDWIFERY COUNCIL 2018) 
1. Being an accountable professional 
2. Promoting health and preventing ill health 
3. Assessing needs and planning care 
4. Providing and evaluating care 
5. Leading and managing nursing care and working in teams 
6. Improving safety and quality of care 
7. Co-ordinating care 
Annexe A Communication and relationship management skills 
Annexe B Nursing Procedures 
 
This appears to suggest that communication skills are less important in some fields of 
nursing than others and the standards described in Annexe A whilst having all of the 
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elements of communication required to conduct a consultation, there is no onus on 
developing consultation skills as part of nurse training. The NMC clearly recognises the 
importance of communication as they comment: 
“Effective communication is central to the provision of safe and compassionate 
person-centred care.  Registered nurses in all fields of nursing practice must be able 
to demonstrate the ability to communicate and manage relationships with people of 
all ages with a range of mental, physical, cognitive and behavioural health 
challenges” (NMC, 2018).   
The NMC further highlights the importance of expertise and knowledge recognising that 
there may be varying levels required depending on the field of practice that the nurse is 
working in:  
“…the level of expertise and knowledge required will vary depending on the chosen 
field of practice”.   
It is also clear that the NMC Approved Educational Authority (AEI) are responsible for 
ensuring that nurse education programmes meet their standards  (Leigh and Roberts 2018).  
The AEI is also responsible for ensuring that the practice experience received by student 
nurses is of the highest quality; which will be assessed by the practice supervisor assessor.  
The NMC intend that the qualified nurses in each learning area will carry out the practice 
supervisor and assessor roles.  The AEIs are responsible for ensuring that these nurses are 
equipped to carry out these functions.  However, in this age of overburdened, overworked 
and understaffed nursing personnel (Massey, Esain et al. 2009) the added responsibility of 
supporting the learning experience of the student nurse could be very challenging.  Also, it 
could be said that the learning experience will only be as good as the person providing it and 
the environment in which they are.  The NMC does not categorically state that student 
nurses need to understand good consultation techniques; therefore, it will not be a priority 
in the learning environment, which could have an impact post qualification when that nurse 
is faced with carrying out consultations.   
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2.5 Shared Decision-Making 
The integration of patient education into the communication between healthcare 
professional and patient has evolved over the last 60 years (Hoving, Visser et al. 2010).  
Hoving et al describe the physician as the ultimate authority who was responsible for the 
diagnosis, treatment and healing of patients in the 1960s and 70s.  The patient had a passive 
role and even decisions to tell patients who were terminally ill about their prognosis was left 
up to the physician.  This paternalistic approach to patient care continued throughout the 
1960s and 1970s but began to change in the 1980s, which saw a growth of patient advocacy 
and legal rights to be informed about health condition and treatments (Deccache and 
Aujoulat 2001).  Patients were now becoming more actively involved in improving their own 
health by making lifestyle changes which resulted from patient education by healthcare 
professionals (Hoving, Visser et al. 2010).  The 1990s saw further development of the role of 
patients in their own disease management (Hoving, Visser et al. 2010); patients were now 
being taught skills on how to self-manage their diseases, and the physician was no longer 
always being seen as the ultimate authority, the relationship between physician and patient 
was becoming more equal.  Families and the broader social network of patients were now 
being recognised as having a contribution to disease management and behaviour change 
interventions (Cohen, Hyland et al. 1999).  The development of the internet also resulted in 
patients being able to look up information for themselves and became more informed 
(Ullrich Jr and Vaccaro 2002, McMullan 2006). 
Sassen (2018) describes three steps which lead to optimal health management for patients; 
disease prevention, the aim of which is to prevent health problems but if they are already 
present, then to manage those health issues in order to prevent further deterioration.  
Patient education, the aim of which is to optimise behaviour in order to deal with health 
issues, and self-management which focusses on how patients manage their own health.  
Rheumatoid Arthritis is not necessarily a preventable disease, and the possible contributory 
factors leading to the onset of Rheumatoid Arthritis have already been discussed in this 
Chapter, and it has already been shown that smoking and overweight can contribute to the 
onset of Rheumatoid Arthritis (de Hair, Landewé et al. 2013).  Thus, patient education 
around smoking and obesity could prevent or delay the onset of this disease. 
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Patient education is a complex process which is intended to facilitate learning and improve 
health outcomes (Flanders 2018) and it is based on several foundations; professional, social 
and economic and political and legislative (Deccache and van Ballekom 2010).  It is closely 
related to disease prevention and is aimed at optimising behaviour to improve health status 
and deal with health problems (Sassen 2018).  Sassen believes that patient education should 
be about the interaction between the health problem that patient has and their behaviour 
towards it.  It should fit the patient’s lifestyle because dealing with health problems is often 
associated with lifestyle changes.  Sassen also believes that it is important for patients to be 
able to think medically about their own health, which she terms as “proto-professionalizing”.  
She believes that if patients are better informed about medical issues and health and have a 
better knowledge of the healthcare system, then this could empower them to communicate 
with healthcare professionals more effectively resulting in stronger, healthier behaviour.   
The concept of patient self-management has been around for a while (Hanson and Gerber 
1990), including self-management in Rheumatoid Arthritis.  Hammond (1998) investigated 
common self-management techniques used by a cohort of 41 patients with Rheumatoid 
Arthritis, with only half of them recalling being given any self-management advice by their 
Rheumatology team, despite most having been given books and leaflets.  She found that two 
thirds of the cohort used aids such as hot packs and rest on a daily basis, but exercise and 
joint protection was less used, even though the patients recognised the benefits.  She 
reported that an increase in the amount of education people with Rheumatoid Arthritis 
received would increase the use of these self-management strategies.   
A study by Chaleshgar-Kordasiabi et al (2018) conducted semi-structured interviews with 30 
patients with Rheumatoid Arthritis, and revealed three main themes relating to barriers.  
The first theme was behavioural barriers, which included lack of awareness of self-
management, lack of motivation and lack of belief in the process of self-management.  The 
patients also reported that they felt the lack of a good physician-patient relationship and 
unavailability of good educational materials contributed to the barriers they faced.  The 
second theme was described as environmental barriers, which included expenses, in-home 
equipment, their social situation and the educational status of the individual.  The third 
theme identified was described as reinforcing factors, such as social and emotional support.  
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Some patients lost motivation to apply self-management techniques because they did not 
have family support.   
Whilst these studies were conducted in the United States and Iran respectively they are still 
very much in line with a literature review of 26 studies which was conducted by Van Zanten 
et al (2015).  They revealed that the most common barriers to self-management exercise 
was lack of time and cost, but arthritis specific barriers were fatigue and pain.  Further 
barriers identified were the patient’s lack of knowledge of the exercise regimes and lack of 
support from the healthcare provider.  It appears that there are a number of barriers which 
some patients perceive as inhibitory to the application of self-management.  But self-
management is about identifying problems and looking at ways of solving those problems, 
by making shared decisions around options available to the patient and also fitting it into the 
patient’s lifestyle.  This shared decision-making involves both the patient and the healthcare 
professional equally considering the patient and their families and arriving at decisions for 
treatment where barriers can be overcome. 
Shared decision-making is a process where patients and healthcare providers consider the 
various treatment options and patient preferences to reach a health management decision 
which is based on mutual agreement (Frosch and Kaplan 1999).  The key principles of shared 
decision-making involve a process that includes at least two participants, the patient and the 
doctor.  Additionally, this process could incorporate the patient’s family and other healthcare 
professionals.  Elwyn et al (2000) developed a series of steps for the development of shared 
decision-making (Table 2.11). They then developed a model of how to implement shared 
decision-making as they felt that there was a lack of guidance around how to apply the 
principles in practice (Elwyn, Frosch et al. 2012).  Their model has three steps: Introducing 
choice; describing options and helping patients explore their own preferences and make 
decisions. This model is dependent on a process of negotiation with the patient, 






TABLE 2.10 STEPS FOR SHARED DECISION-MAKING (ELWYN ET AL 2000) 
· Develop a partnership with the patient  
· Establish or review the patient’s preference for information, e.g. amount and format  
· Establish or review the patient’s preferences for role in decision-making  
· Ascertain and respond to patients’ ideas, concerns, and expectations  
· Identify choices and evaluate the research evidence in relation to the individual    
patient 
· Present (or direct to) evidence, considering the above steps, and help the patient 
reflect upon and assess the impact of alternative decisions with regard to their values 
and lifestyles  
· Make or negotiate a decision in partnership, manage conflict  
· Agree upon an action plan and complete arrangements for follow-up                                     
 
Patients do not expect shared decision-making and generally they do not object if it does 
not take place, at least not to the physician (Godolphin 2009). Patients are generally 
disempowered in their encounters with physicians; they feel intimidated and unable to make 
a difference in the relationship, are reluctant to bother the doctor, especially in the current 
climate of belief that the healthcare system is “a wreck” (Godolphin 2009). Patients want to 
have a good rapport with health professionals, and they generally feel that this will 
contribute to their likelihood of getting good care.  Patients tend to avoid assertiveness, 
which may jeopardize the rapport (Towle, Godolphin et al. 2003). This disempowerment of 
patients, when they confront the healthcare system, leads to misunderstandings and 
“wimpish” behaviours that can have important adverse outcomes (Britten, Stevenson et al. 
2000, Berland 2007).  But the doctor/nurse-patient relationship is changing. Society is 
changing into a more consumerist model, with better-informed patients (e.g., from their use 
of the Internet), a greater public involvement in healthcare institutions and a gradual 
movement away from paternalism and closer to the ethical imperative of autonomy (Coulter 
2002).  This shift towards the redistribution of power away from the physician and to the 
patient focussed on patient centred care (Castro, Van Regenmortel et al. 2016) in which the 
patient was considered empowered once they had the knowledge, skills and attitudes which 
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would influence their own health behaviour and therefore have a positive impact on their 
lives (Garattini and Padula 2018).  The UK Government (Donaldson 2003) was the first in 
Europe to introduce the concept of the expert patient who should have full access to 
information which was critical to their healthcare. In 2015 a landmark court ruling made it 
clear that any intervention must be based on a shared-decision-making process and that the 
patient is aware of all options for treatment and is supported by the healthcare professional 
to make that choice (Ward, Kalsi et al. 2020) .  This ruling was based on a case where a baby 
was born to a diabetic mother who had not been informed of the risks of a normal delivery 
despite raising concerns that her baby was large and she was small and she was not 
informed of other potential options, the baby suffered severe disabilities as a result and lead 
to the Montgomery Judgement (Montgomery and Montgomery 2016). However, whilst it is 
clear that shared-decision-making can have a positive impact on the lives of patients, 
adoption of this process has been slow because of perceived challenges to its 
implementation (Kalsi, Ward et al. 2019).  Kalsi et al reviewed literature from different 
specialities which recognised the positive impact of shared-decision-making within those 
specialities, but highlighted challenges such as perceived lack of time, lack of quality support 
tools, lack of decision aid tools and cultural issues.  Kalsi et al consider that support tools and 
training are needed to support clinicians in the shared-decision-making process.  Garattini 
and Padula (2018) conducted a literature review of the expanding publications around 
patient empowerment, which is described by the World Health Organisation as (Garcimartin, 
Comin-Colet et al. 2017): 
“a process through which people gain greater control over decisions and actions 
affecting their health”. 
Garattini and Padula reviewed 129 articles published between 2000 and 2017 on patient 
empowerment and revealed that whilst patient empowerment is linked to higher literacy 
levels, it also required behavioural change and without this, it can lead to an over-
dependent on physicians, regardless of the level of literacy.  They also indicated that data 
from two surveys in coronary care units and palliative care, showed that most patients were 
content to leave the decision-making to their healthcare professionals and had no desire to 
take part in this process.  It is therefore an important consideration to ensure that the 
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patient actually wants to take part in decision-making and may actually prefer a paternalistic 
model of care. 
 
2.5.1 Shared Decision-Making in Patients with Rheumatoid Arthritis 
In order for patients to develop more collaborative relationships with their physicians and 
nurses to empower them to negotiate targets for treatment they need to be more informed 
about their own disease. Helliwell et al (1999) carried out a 12 month study on a group of 
patients diagnosed with early Rheumatoid Arthritis. The objective was to determine 
whether educational programmes not only imparted knowledge, which empowered the 
patient, but also to establish whether that knowledge changed behaviour.  The outcome 
measures were radiological examination and quality of life assessments using 
questionnaires. There was a cohort of 34 patients for the control group and 43 patients for 
the education group who were to receive a four-week education programme; all patients 
had Rheumatoid Arthritis for less than five years. The education group showed a significant 
improvement in general health perception and social functioning.  There was no significant 
difference in outpatient visits and in-hospital admissions between the control group and the 
education group but the education group showed a slight increase in changes of second line 
drug therapy for their disease.  The education group also showed a slightly better 
radiological progression than the control group which may relate to improved self-care, 
better strategies for joint protection and possibly better drug compliance.  Although this was 
a small study, it does illustrate a trend that better education could lead to improved disease 
outcome for the patient.  However, most patients do not receive a four-week education 
course when they have been diagnosed with Rheumatoid Arthritis, they usually receive a 
booklet describing Rheumatoid Arthritis produced by Arthritis Research UK (formerly 
Arthritis Research Campaign ARC) which is widely used throughout the country by 
Rheumatology services.  Walker et al (2007) carried out an interesting study comparing the 
use of the booklet (see Appendix 3) with a mind map describing Rheumatoid Arthritis (see 
Appendix 4) and further work was carried out by Robinson et al (2007). Walker et al consider 
that patient education has become an integral part of the therapeutic approach to helping 
patients with Rheumatoid Arthritis to self-manage their arthritis. They believe it is integral to 
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the promotion of both adherence and safety in relation to what are now complex treatment 
regimes. They feel that accessibility of educational material is key to successful knowledge 
transfer and low levels of literacy may limit understanding of traditional forms of patient 
information. 
A further aspect of the interface between patient and healthcare professional is the written 
information which is given.  This information forms an essential part of the communication 
with patients about their drug treatment. The information in the form of booklets, are 
produced by Versus Arthritis and are written for patients.  They contain information on 
rheumatological diseases, treatments, coping strategies and provide answers to common 
questions. It is important to consider these sources of patient information as they are 
integral to the management of patients with Rheumatoid Arthritis (Walker, Adebajo et al. 
2007).  Walker et al consider that not only are the booklets an important source of 
information for patients, but that it is also essential to consider their literacy status.  A study 
in Glasgow (Gordon, Hampson et al. 2002) showed that one in six of their RA patients were 
functionally illiterate. This could indicate that around 16% of patients with Rheumatoid 
Arthritis may be functionally illiterate, suggesting that a booklet format may not be the most 
appropriate education tool. Arthritis Research UK (now Versus Arthritis) produced pictorial 
mind maps based on some of the booklets. The concept of mind mapping was developed by 
Buzan and Buzan (2006). Information is presented in diagram form and it uses key words and 
images, which explode from a central theme in a format that aids cognitive processing. In 
this way the mind map can focus on meaning and therefore grammar becomes less 
important which could indicate that this technique may be more appropriate for less able 
readers.  Mind maps have generally been used as a study technique in educational settings 
to aid revision. They have been shown to improve the recall of factual knowledge by 10–15% 
in a randomized study of medical students with follow-up at one week (Farrand, Hussain et 
al. 2002). However, in a study of the effect of three different patient education methods on 
recall in orthodontic patients, small but significant advantages in recall gained through the 
use of mind maps were not maintained at six weeks (Thickett and Newton 2006).  
Walker et al (2007) recruited a cohort of 363 patients with Rheumatoid Arthritis.  Their 
reading ability was assessed using the REALM score (see Appendix 5) and they also 
completed knowledge scale questionnaire for Rheumatoid Arthritis.  Patients were 
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randomized into two groups; one group received the booklet alone and the other group 
received the booklet and the mind map.  They were given a week to read the material and 
then knowledge scale questionnaire was repeated over the telephone.  The outcome of the 
study was that Walker et al were unable to show any significant increase of knowledge of 
poor readers using the mind map.  The effect of the mind map appeared to increase the 
knowledge of the better readers. Walker et al reasoned that the poor readers, who also had 
poor educational attainment, were unable to improve their knowledge with either format of 
information that could relate more to understanding than simply literacy.   
The work by Walker et al (2007) and others have highlighted how complex it is to impart 
knowledge and achieve understanding for some patients.  They revealed that around 16% of 
the Rheumatoid Arthritis population have poor reading ability, which is a significant number, 
similar to that in Glasgow (Gordon et al 2002), and this must be recognized by healthcare 
professionals when they are negotiating treatment targets. This figure reflects the national 
statistics on adult literacy in the UK; The National Literacy Trust (2021) have published 
literacy statistics for the four nations in the UK.  In England 16.4% of adults are considered to 
have very poor literacy skills, in Wales 12% lack basic literacy skills, in Scotland 26.7% of 
adults experience challenges due to their lack of literacy skills and in Northern Ireland 17.9% 
of adults have very poor literacy skills. Everyone has their own framework of perception and 
ability to retain and understand knowledge and healthcare professionals need to adopt 
negotiation techniques, which are appropriate to that person in order to achieve a shared 
goal for treatment.  More recently, Barton et al (2014) designed a cross sectional study to 
explore whether English language proficiency, health literacy and trust in the physician 
impacted on shared decision-making in patients with Rheumatoid Arthritis. They conducted 
telephone interviews with two cohorts of patients from two different areas of America, the 
RA Panel (n= 275) based in Northern California and the UCSF RA Cohort (n= 234) which was 
based in San Francisco.  The characteristics of each cohort were very different; the RA Panel 
were predominantly white and all spoke English as their first language whereas the UCSF RA 
Cohort spoke English (64%) Spanish (22%) Chinese (14%) as their first languages and 39% 
had limited English language proficiency.  Further only 5% of the RA Panel had less than high 
school education, whilst it was 28% for the UCSF RA Cohort.  Also, the RA Panel appear to 
have had a higher disease duration with an average of 26 years compared to twelve years in 
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the UCSF RA Cohort.  Interestingly, whilst both cohorts reported a high degree of trust in 
their physicians, low trust in the physician was associated with suboptimal shared decision-
making in both cohorts but lower education attainment was associated with suboptimal 
shared decision-making in the UCSF RA cohort.  However, worse global ratings of disease 
were associated with the RA Panel.  Whilst the study reported that about one third of all 
patients reported suboptimal shared decision-making, it is unclear how much the patients 
themselves understood the processes of shared decision-making and their expectations of 
their consultation with their clinician.  Further, this study reviewed physicians only, therefore 
whilst it is useful to identify groups which may require more understanding and support in 
the shared-decision-making process, it is unclear what the impact of a nursing intervention 
may have had on this population. 
Rowlands et al (2015) conducted an observational study to assess the literacy and numeracy 
skills which are required in order to understand commonly used health information 
materials in England.  64 examples of health information were used in the study, all 
contained text and 50 contained numeracy.  They found that 43% of the population who 
completed the study fell below the competency threshold expected to be achieved by the 
age of 16 for literacy and 61% were below the literacy and numeracy threshold.  They 
concluded that health educational materials were too complex to be understood by a 
significant proportion of the population and rigour should be applied when developing these 
materials in order to ensure they meet the needs of all groups.  This further reinforces the 
importance of ensuring that information given to patients should be tailored to suit each 
individual patient’s needs. 
A European League Against Rheumatism (EULAR) task force was convened (Zangi, Ndosi et 
al. 2015) to develop a set of recommendations to inform patient education for people with 
inflammatory arthritis, to identify the need for further research and to define the 
educational needs of healthcare professionals to provide evidence based patient education, 
thus ensuring that shared decision-making practice was at the core of all patient education. 
The overarching principles of the recommendations are: 
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1. Patient education is a planned interactive learning process designed to support 
and enable people to manage their life with inflammatory arthritis and optimise their 
health and well-being. 
2.  Communication and shared-decision-making between people with inflammatory 
arthritis and their healthcare professionals are essential for effective patient 
education. 
Following a systematic literature review, the EULAR task force developed 8 
recommendations (Table 2.12). 
 
TABLE 2. 11 EULAR RECOMMENDATIONS FOR PATIENT EDUCATION FOR PEOPLE WITH INFLAMMATORY 
ARTHRITIS (ZANGI, NDOSI ET AL. 2015) 
 Recommendation 
1 Patient education should be provided for people with inflammatory arthritis 
as an integral part of standard care in order to increase patient involvement in 
disease management and health promotion 
2 All people with inflammatory arthritis should have access to and be offered 
education throughout the course of their disease 
3 The content and delivery of education should be individually tailored and 
needs-based 
4 Education should include individual and/or group sessions through face-to-
face, online, phone calls, written and multimedia resources 
5 Education programmes should have a theoretical framework and be evidence 
based 
6 The effectiveness of this education should be evaluated and outcomes used 
must reflect the objectives of the patient education outcome 
7 Education should be delivered by competent healthcare professionals and/or 
trained patients, if appropriate, in a multidisciplinary team 
8 Providers of education should have access to and undertake specific training in 
order to obtain and maintain knowledge and skills 
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However, the EULAR task force recognised that the effective implementation and evaluation 
of these eight recommendations will require a clear implementation strategy and 
appropriate training and support must be provided.  But they do conclude that the 
dissemination and application of these recommendations could lead to the establishment of 
core standards for patient education across Europe.    
Miedany et al (2016) recognised that several shared decision-making tools had been 
developed in other disease areas, but there was a lack of focus in the area of chronic 
arthritic disease management.  They developed a study to develop a shared decision-making 
tool which would inform patients about their ongoing disease activities and the risks and 
benefits associated with their drug therapies.  They hypothesized that this decision aid 
would result in more effective treatment decisions enhancing patient care.  They further 
assessed an online version of the shared decision-making tool and postulated that it could 
improve patients’ compliance and adherence to their treatment therapies.  The shared 
decision-making tool was piloted twice, firstly to test language and formatting to ensure it 
would be acceptable to the target population and easy to complete, and secondly to test the 
tool in a clinical setting which would allow the researchers to calculate the sample size for 
the study.  The target population were patients with inflammatory arthritic conditions such 
as Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis, who were to start a 
new treatment, either a disease modifying drug or biologic therapy.  174 patients comprised 
the study group and 172 patients were involved in the control group who received standard 
care.  Patients were randomised into each group and all patients had access to a telephone 
line.  Half of the patients in the study group received the paper version of the tool and half 
used the on-line version.  It was unclear how the tool was presented to the patients and 
when it was given.  All patients undertook the standard care model of three-monthly 
reviews for twelve months, but they were instructed not to reveal which group they had 
been randomised into; therefore, the shared decision-making tool appears not to have been 
discussed with the clinician. Whilst the researchers reported that every participant in the 
study completed a five-item questionnaire at the end of 12 months, two these five items 
were based on their experiences using the shared decision-making tool. Further, the 
questionnaire appears to have consisted of five questions; did the shared decision-making 
tool help you understand effect of the treatment on disease activity; did the shared 
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decision-making aid motivate you to take medication; trust in the treating doctor; concerns 
about the future; coping with daily life.  Responses were made using a visual analogue scale.  
The researchers concluded that the tool helped the healthcare professional to share 
information with the patient in an evidence based, standardized format, and they showed 
that patients who had gained more knowledge were more confident and more involved.  
The weakness of this study was their outcome measure.  The design of the five-item 
questionnaire was brief and yielded little to discuss, in fact there was little discussion of their 
results in the text.  Further, it was unclear how the shared decision-making tool was 
administered and who was involved. Moreover, whilst the researchers described this as a 
shared decision-making tool, there was no description of that shared decision-making 
process between the patient and the healthcare professional.  This could be a useful tool to 
prepare the patient for the consultation and give them information, but it was not used with 
the healthcare professional and patient to enhance the shared decision-making process.  
Robinson et al (2010) completed a survey of 100 patients. A number of questions were put 
to them around expectations of treatment and their understanding a Disease Activity Score 
(DAS 28) [which is a calculation based on the number of tender and swollen joints the 
patient has, an assessment of how the patient regards their disease activity on a one to ten 
visual analogue scale and a blood test measuring amount of inflammation the patient has].  
Some of the patients surveyed were taking part in a study where monthly DAS 28 scores 
were carried out and therefore may have been familiar with their DAS score. However, out of 
all of the patients surveyed only one person reported that they had heard of the DAS score 
but they were unsure what it actually meant.  A series of questions were asked on how the 
patients would define the best outcome of treatment for them. All patients eventually 
negotiated a treatment target of an activity that they could currently carry out and would 
like to continue with.  Or an activity that they could once perform, but could no longer 
partake in because of the restrictions of their Rheumatoid Arthritis.  Once the target for 
treatment was agreed between the patient and the healthcare professional, it was recorded 
in the patient notes and treatment was tailored in order to reach that target. When the 
patient returned for review, the target for treatment was discussed with the patient to 
ensure that it had been met and treatment could be altered if necessary.  Whilst this 
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method was easy to apply during the consultation, the survey did not provide longer term 
data to evaluate the impact of negotiating a treatment target with the patient in this way. 
A systematic review  of randomised and non-randomised trials was conducted by  Legare et 
al (2018) aimed to determine whether healthcare professionals involved patients in 
decisions about their care, and whether it was effective, They analysed 87 identifying  which 
activities were most successful in helping healthcare professionals involve patients in their 
care.  They concluded that the studies revealed that many different activities to increase 
shared decision-making by healthcare professionals were adopted, but they could not 
conclusively say that these activities made an impact in shared decision-making.  However, 
they did comment that the quality of the evidence was inadequate, often poorly reported 
and that there were many potential sources of error in the results of the studies. A study 
carried out in Holland by Mathijssen et al (2020) audio recorded routine consultations with 
168 different patients with Rheumatoid Arthritis.  The level of shared decision-making was 
scored using the OPTION scale which is based on five items; the justification of the decision-
making, ie that alternative treatments or management exists; justification of working as a 
team, ie that the clinician will support the patient to become informed; describes options 
and checks understanding; the clinician makes an effort to determine patient preferences in 
response to the provided options; the clinician works with the patient in order to integrate 
the patient;’ preferences as decisions are made.  Each of these items were scored on a five-
point scale from zero to four.  The researchers found that only a low to moderate level of 
shared decision-making was implemented in the care of patients with Rheumatoid Arthritis.  
The level of shared decision-making varied with the type of treatment or management being 
discussed and the length of the consultation, longer consultations, tended to score higher.  
They concluded that there is room for improvement in the use of shared decision-making.  It 
was not clear whether any Specialist nurses had carried out any of the consultations, as 
throughout the paper the word “clinician” was used. However Mathijssen et al (2020) did 
conduct an online survey of 77 Rheumatologists and 70 nurses to explore knowledge and 
attitudes to shared decision-making.  They concluded that whilst most of the healthcare 
professionals lacked a full understanding of the concept of shared decision-making, 92% of 
Rheumatologists and 100% of nurses were very positive about the notion of shared decision-
making and believed it would lead to improved treatment adherence by patients.  It does 
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appear that whilst there is general agreement amongst healthcare professionals that shared 
decision-making could make an impact on the management of patients with Rheumatoid 
Arthritis, more training and education is required in order for this to be applied during the 
consultation process. 
The literature has revealed that through patient education, individuals can become more 
empowered leading to a greater understanding of their disease which could necessitate 
lifestyle changes.  It also reveals the impact that shared decision-making can make on these 
processes of understanding and change.  However, it seems clear that not all healthcare 
professionals apply these practices in their management of patients with Rheumatoid 
Arthritis and other diseases (Légaré, Adekpedjou et al. 2018, Mathijssen, Vriezekolk et al. 
2020).  Further, the significance of considering the written information given to patients is an 
important part of this thesis.  There is a sustained lack of literature around how nurses 
impart information to patients, and whether a shared decision-making process is applied. 
This thesis therefore, aims to explore the process nurses employ in that information 
exchange about Methotrexate with patients, starting this therapy.  Written information in 
the form of a booklet may be a fundamental part of that process and an understanding how 
nurses use these booklets and how effective that process is, is a principal consideration and 
therefore warrants further exploration. 
 
2.6 Knowledge 
The subject of knowledge and how it is acquired is a wide-ranging topic and outside the 
scope of this thesis. Therefore, this section will briefly define knowledge in the context of 
how nurses acquire knowledge and skills in order to carry out their roles. Further discussion 
will examine how they assess their own clinical competency to ensure that they have the 




2.6.1 Definition of Knowledge 
The term “knowledge” is an abstract yet powerful concept but so far is without a well-
defined definition (Bolisani and Bratianu 2018). Dombrowski et al (2013) provide three 
definitions of knowledge which are applicable within the context of this thesis and will be 
further investigated;  experiential knowledge – that knowledge which is gained from our 
environments and sensory experiences: skills – hands on knowledge, those physical tasks 
that we have learned to do: knowledge claims – this is knowledge that we know, or think we 
know, which is learned from books or at school. 
The Dreyfus model of skills acquisition is a model of how experiential skills are acquired 
through formal instruction and practice and was developed by Dreyfus and Dreyfus (1980). 
Dreyfus and Dreyfus consider that the novice strictly adheres to taught rules and does not 
exercise discretionary judgement.  They described the advanced beginner has having limited 
perception around circumstances and treats all aspects of work with equal importance, but 
the competent learner can cope with multiple activities, and has developed perceptions in 
relations to goals.  They also consider that the learner can also plan and formulate routines.  
And that the proficient learner can view a situation holistically and prioritise what is 
important. The proficient learner can also think outside the box and adapt to a situation if it 
is required.  Dreyfus and Dreyfus describe the expert as not needing to rely on rules and 
guidelines; that they have a deep and intuitive understanding of situations, visualising 
possibilities and uses an analytical approach when confronted with new situations or 
problems. 
Benner (1984) is one of the main proponents of this model for the development of skills 
acquisition in nursing practice.  She describes knowledge as either being formal and explicit 
as opposed to involving practical reasoning and intuition; which is embedded in practice. 
Benner describes three studies conducted between 1982 and 1997 in which nurses of 
varying experience and skills in adult intensive care units (Benner 2004) were interviewed. 
These were US based studies, the first involving 83 nurses and six preceptors from six 
different hospitals; the second 130 nurses and the third a further 75 nurses extending study 
two. The participants were selected based on the number of years they had been qualified 
and for those who had been qualified over five years, their supervisors were asked to 
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consider the quality of the nurses’ practice.  The nurses were interviewed about situations 
they had been in and their responses to those situations.  Benner applied these responses to 
the Dreyfus model, which were largely in concordance with the developing processes from 
novice to expert.  However, it was not clear how long each nurse took to reach the expert 
level of competence.  Dreyfus and Dreyfus (1980) do not describe or apply a timeframe to 
the model, but there appears to be an assumption by Benner that it takes time to gain the 
experience needed to develop insights and intuition which will result in expert competency. 
It was also unclear how many of those nurses had indeed gone on to do further training post 
qualification which may have resulted in requiring less time to gain the confidence and 
experience required to achieving expert knowledge.  Indeed, Cash‘s interpretation of 
Benner’s earlier work, expresses that it fossilises nursing practice and minimises nursing 
knowledge (Cash 1995).  
Richards and Hubbert (2007) conducted a study of the experiences of expert nurses in caring 
for patients with postoperative pain, and based on Benner’s study (Benner 2004) they 
interpreted an expert nurse as being qualified for over five years working in the same area.  
This perspective appears to negate the need for nurses to undergo any postgraduate 
training, it seems to describe that after five years working in one place a nurse will then 
become an expert.  Later studies, for example Bringsvor et al (2014) undertook an interview 
survey of intensive care nurses in Norway exploring their sources of knowledge focussing on 
evidence-based practice.  All of the participants had undertaken 18 months of postgraduate 
education to specialise as ITU nurses and there was a wide variation in experience from 
three months to more than thirty years.  There was no indication of what that postgraduate 
training had consisted of and when the individuals had carried out that training. Because the 
breadth of experience from three months to over 30 years was so wide it does raise a 
possible variance of training which could impact on their results.  It is also not clear whether 
the length of time the participants had worked on ITU or the length of time they had been 
qualified influenced their responses in terms of evidence-based knowledge and experiential 
learning.  However, the study did attempt to balance the importance of having a scientific 
evidence-based approach to practice as well as an intuitive, experiential perspective.  It has 
been suggested that experience alone is not enough. Postgraduate training for nurses and 
specialisation results in increased confidence, critical thinking and a sense of having a more 
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equal weighting amongst their professional colleagues (Graue, Rasmussen et al. 2015).   In a 
recent large scale European study, Wangensteen et al (2018) carried out a survey of nurses 
undertaking postgraduate programmes in different treatment areas across Europe.  The aim 
of the study was to describe nurses’ self-assessment of their clinical competency and they 
rated themselves most highly when taking full responsibility for their own actions.  They 
rated themselves less in areas such as medication interactions, identification of differential 
diagnoses and giving health promotion advice.  This suggests that nurses are less confident 
in areas, which require more scientific knowledge.  The implication of this does advocate the 
importance of having sound knowledge foundations in areas such as giving patients 
information about toxic drugs such as Methotrexate in order for nurses to competently give 
information to patients. 
 
2.6.2 What do patients need to know about Methotrexate? 
Formal studies of what information patients need to take drugs safely and effectively are 
difficult to perform and therefore rare. There is evidence that understanding why a drug is 
prescribed and the importance of taking it per the prescription improves adherence to that 
drug (Hill, Bird et al. 2001). Education, both verbal and written, can reinforce beliefs about 
the necessity of the drug, but may increase fear of side effects and a dissonance may arise 
between beliefs and experience (Hayden, Tarrant et al. 2014). Decision aids to help patients 
decide whether to take Methotrexate are popular in the USA and also provide education, 
but mainly on the theoretical benefits and toxicities (Li, Adam et al. 2013).  A study 
conducted by Sowden et al (2012) involved 51 patients taking Methotrexate and 94% had 
documented evidence of being given Methotrexate education.  A combination of interviews, 
patient notes reviews and patient administered questionnaires revealed that only 11.8% of 
the patients recognised potentially dangerous drug interactions and less than 60% 
recognised possible major adverse events associated with Methotrexate.  Therefore, despite 
consistent baseline education, end-user knowledge appears to be limited. 
Patients need knowledge in order to make informed decisions and choices.  They require 
information around how to take drugs, how often they should take the medicine and the 
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number of tablets they need to take.  They require information around the importance 
blood monitoring for safety and how to access this service. It is important that patients have 
information around what to expect in terms of drug efficacy and how to recognise 
indications of side effects and how to deal with these and how to report them. It is vital that 
patients understand the impact of taking Methotrexate on their health as it could, for 
example, render them more susceptible to infections and possible drug interactions 
(Boerbooms, Kerstens et al. 1995, Gaies, Jebabli et al. 2012).  Therefore, they need to know 
how to minimise those risks by consuming less alcohol, receiving recommended 
immunisations and thinking carefully about planning pregnancies, which could mean 
stopping the drug for a period of time.  Some patients want more information about how 
the drug works, others are not interested.  A cross-sectional study of 600 patient or carer 
interviews carried out by Krueger et al (2011) showed that only 58% of patients wanted 
information about adverse reactions, 32% wanted information around basic instructions and 
31% wanted information on drug interactions.   The study also revealed that a review of 
information at a later opportunity was more likely to be requested by those patients who 
had higher educational achievements.   It does indicate that the information given should be 
tailored to the individual needs of the patient. The Versus Arthritis booklet on Methotrexate 
(Versus Arthritis 2019)  was designed as an information booklet for patients.  The booklet is 
divided into sections:  
 What is Methotrexate and how is it used?  
 Is Methotrexate suitable for me?  
 When and how do I take Methotrexate?  
 Possible risks and side effects  
 Taking other medicines  
 Vaccinations  
 Having an operation  
 Alcohol  
 Fertility, pregnancy and breastfeeding.  
As discussed previously in this chapter, the main issues a patient could be challenged with 
are covered in this booklet, but it needs to be supplemented by information about the local 
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service, such as help-line telephone numbers and how the monitoring system works.  It is 
clear that a substantial amount of information is required for the patient to make informed 
decisions and choices and remain safe on the drug. Therefore, patients need to fully 
understand the information given to them and the nurses’ role is to facilitate this 
understanding which is the focus of this thesis.   
 
2.6.3 Nurses’ Knowledge of Methotrexate  
EULAR make clear recommendations around the education of patients with Inflammatory 
Arthritis (Zangi, Ndosi et al. 2015), but they also highlight that applying these 
recommendations effectively will require appropriate training and support. They conclude 
that the dissemination and application of these recommendations could lead to the 
establishment of core training standards for giving patient education across Europe, which 
implies that there are no current core standards for Rheumatology Specialist nurses.  
Therefore, this section will review the literature to discuss the current position regarding the 
training and knowledge Rheumatology Specialist nurses have in order to give information 
about Methotrexate to patients. 
It has been recognised that patients require a certain depth of knowledge in order to take 
Methotrexate safely and as prescribed (Al-Awadhi, Dale et al. 1993, Burma, Rachow et al. 
1996).  More recently Sowden et al (2012) undertook an audit of patients who were 
prescribed Methotrexate, 94.1% of whom had been given their education by a nurse.  Only 
11.8% recognised major side effects, which could be related to Methotrexate, concluding 
that patients require regular knowledge testing in order to address the lack of core 
knowledge.  However, what was not clear was how the information had been given to the 
patients and how those nurses had been trained and assessed for competency.  Fayet et al 
(2016) conducted a survey of patient knowledge in 183 patients who were taking 
Methotrexate, and concluded that patients have poor knowledge of the serious side effects 
such as pneumonitis (36%) and Trimethoprim interaction (21%), of Methotrexate and they 
also recognised that few studies have been published in this area.  Most of the patients in 
their survey had been given the information by their Rheumatologists only, and had not had 
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a dedicated session for this process.  Additionally, Fayet et al did not describe the process of 
information giving or whether the patient had received any written information.  Fayet et al 
concluded that using different therapeutic educational tools was indicated to improve the 
knowledge base of patients taking Methotrexate.  However, they fail to identify what those 
tools should be and any justification for their statement.  They did observe that the group 
with the poorest knowledge base were older less educated people.  Perhaps this highlights 
that education should be tailored around the individual rather than “one size fits all”. It could 
therefore be argued that these types of sessions around information giving should be 
delivered by a health care professional, with the appropriate educational underpinnings of 
Methotrexate and the ability to tailor that session around the individual person.  As 
previously discussed in this chapter, education should be tailored to fit the individual (Sassen 
2018), one size does not fit all and it is therefore not surprising that studies such as that 
undertaken by Fayet et al (2016) revealed differences in the amount of knowledge 
individuals retain from different age groups and educational status.  This literature review 
has revealed little documented evidence of the processes undertaken when the 
Rheumatology Specialist nurses deliver information to patients about Methotrexate and 
whether the patients have actually understood that information. Therefore, due to the 
limitations highlighted in this chapter, the current study will explore the process by which 
nurses transfer knowledge and understanding to the patients. This will include exploring 
consultation skills within the nurse-patient encounter.  
 
2.7 Consultations 
2.7.1 Definition of a Consultation 
The word “consultation” can have several meanings; “a discussion between people or groups 
before they make a decision”; “in consultation with someone”; “a meeting in which people 
or groups have a discussion before decisions are made”; “a meeting with an expert or a 
professional person to get advice or discuss a problem, especially a meeting with a doctor”; 
“the process of getting advice from an expert or a professional person”’ “the process of 
looking in  a book or at a map or list in order to find information” (Cambridge 2020).  The 
 64 
traditional understanding of a medical consultation in the NHS was that of a paternalistic 
interaction between a doctor and a patient (Hoving, Visser et al. 2010), as previously 
discussed in this chapter.  But as the roles of Nurses and AHPs expanded there was a growing 
recognition that nurses and AHPs should be developing consultation skills; which would lead 
to more meaningful interventions benefiting patient care (Termini and Ciechoski 1981).  
However, Termini and Ciechoski describe the context of the consultation as leaning towards 
emotional/psychological support for patients and their families.  In 1983 Bird (1983) 
discussed a two-tier system of care with nurse practitioners in Rheumatology consulting in 
rooms next to Rheumatologists being “almost upon us”.  There was a general feeling that 
Rheumatologists would be threatened by the function of the nurses, taking over the 
education aspects of their role, however he does see some advantage in that the nurses: 
“seem unlikely to supplant the surfeit of young doctors emerging from medical 
schools.  They will complement them and leave doctors free to direct and co-ordinate 
treatment” (Bird 1983 p 355). 
The success of new drug therapies led to the reduction of Rheumatology inpatients and 
ward closures (Kjeken, Dagfinrud et al. 2006).  Rheumatology became an outpatient 
speciality with the extra burden of additional clinics to provide the care, education and 
monitoring of patients on these therapies. It was therefore inevitable that the nursing role 
would expand to take on the consultation role and become an integral part of the 
Rheumatology Service. 
 
2.7.2 Consultation models 
Fundamental to deciding on which model to use for this thesis is to consider the aim of the 
consultation in which the model will be applied.  The consultation model should consider 
those communication skills which are required to ensure that the aim of the interaction has 
been achieved. Therefore, the history of consultation models from the early work of Balint, 
through Pendleton and Neighbour to the Calgary Cambridge consultation model will be 
discussed.  Whilst there are a number of consultation models which have been developed 
for different encounters, the models which will be discussed in this section are more 
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applicable to the process the nurse could apply when giving information to patients about 
Methotrexate. 
 
2.7.3 The Development of Consultation Models 
In order to understand the focus of this thesis on the Calgary Cambridge consultation model, 
a brief discussion of the early work of Balint, Pendleton and Neighbour will be discussed.  
These consultation models moved in the direction of the patient centred approach, and they 
had an important impact on the development of the Calgary Cambridge consultation model. 
Pawlikowska et al (2007) and Denness (2013) describe, among others, a number of patient 
centred consultation models which have varying key structures (Table 2.13). 
 
TABLE 2. 12 CONSULTATION MODELS BASED ON PAWLIKOWSKA, LEACH ET AL. 2007  PAWLIKOWSKA, 
LEACH ET AL.  AND DENNESS 2013  
Model or Approach Key Structure Comments 
Balint Doctor/patient interaction Attentive listening 
Pendleton  Understand the problem 
and the patient 











Calgary Cambridge Initiate the session 
Gather the information 
Build the relationship 
Explain and plan 
Close the session 
Patient centred and 
collaborative 
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The Balint model is based on the implication that both the doctor and the patient bring their 
own emotions into the consultation (Balint 1957). It does help the healthcare professional to 
think about those encounters; which can often leave them feeling emotional and physically 
drained (Denness 2013), but it is the beginnings of putting the patient at the centre of care.  
However Byrne and Long (1976) described a consultation process which very much kept the 
doctor in control (Table 2.14). 
 
TABLE 2. 13 BYRNE AND LONG CONSULTATION PROCESS 
Phase I The doctor establishes a relationship with the patient 
Phase II The doctor attempts to discover the reason for the 
patient’s attendance 
Phase III The doctor conducts a verbal and/or physical 
examination 
Phase IV the doctor or the doctor and patient or the patient (in 
that order of probability) consider the condition the 
patient presents with 
Phase V The doctor and occasionally the patient, detail further 
treatment and or investigations 
Phase VI The consultation is terminated, usually by the doctor 
 
This model favours the paternalistic approach to consultations which was practiced widely 
during the 1970s (Hoving, Visser et al. 2010).  Stott and Davies (1979) also favour a 
paternalistic approach to consultation style, however, they do introduce the concept of 
patient self-management.  They describe four aspects to the consultation; the management 
of the presenting problem, which is key to the consultation as they consider that if this is not 
dealt with the patient will not be receptive to any other activities.  The modification of help-
seeking behaviours is then considered, which includes discussion on how to manage certain 
conditions themselves without the need to approach the doctor, for example, managing a 
sore throat at home.  They then consider that reviewing current long-term healthcare 
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problems should be undertaken at the consultation, for example, reviewing a blood pressure 
and the final aspect of the consultation is around health promotion, ie taking this 
opportunity to discuss smoking cessation, or weight management with the patient. The 
Pendleton model further encourages the healthcare professional to involve the patient in 
the plan of care and to take some ownership of that process.  It puts the patient at the 
centre of the consultation and encourages the individual to take some responsibility for their 
own disease management (Table 2.15). 
 
TABLE 2. 14 PENDLETON’S SEVEN TASK CONSULTATION MODEL 
1. Define the reason for the patient’s attendance, nature of the problem, 
patient’s ideas, anxieties and expectations and effects of the problem 
on the patient 
2. Consider other problems and risk factors 
3. Choose an appropriate action for the problem with the patient 
4. Achieve a shared understanding with the patient 
5. Involve the patient in managing the problem and encourage them to 
accept responsibility 
6. Use time and resources appropriately 
7. Establish and maintain a positive relationship with the patient 
 
Neighbour (2004) first published his book “The Inner Consultation” in 1987 and describes a 
five-stage model where he talks about connecting described as establishing a rapport.  The 
model involves summarising what the patient has said, which aims to check that the 
healthcare professional has understood what the patient has come to see him for.  
Handover, at this stage the healthcare professional agrees a management plan with the 
patients, involving them in their care and agreeing areas where that patient can take 
responsibility.  Safety netting, this is where a contingency plan is formed, just in case the 
diagnosis is incorrect. The final stage is housekeeping, which deals with any emotions or 
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issues; which could have arisen as a result of the consultation.  This consultation is very 
patient-centred, but it lacks elements on how to end a consultation, which some healthcare 
professionals can find challenging. 
(Kurtz and Silverman 1996) developed the Calgary Cambridge Referenced Observation 
Guides that identified the skills required to underpin the healthcare professional and patient 
communication.  These guides were developed to be part of medical education in order to 
provide an evidence-based model, which can be applied to teaching skills required for the 
medical dialogue.  However, it was not clear how to integrate these skills into the traditional 
approach to taking a medical history (Kurtz, Silverman et al. 2003).  The guides cover how to 
determine the main problem of the patient; how to take a history of that problem and past 
medical history; how to determine family history; the recording of personal and social 
history; recording of drug and allergy history reviewing body systems and functioning.  Kurtz, 
Silverman et al (2003) reviewed their guides and modified them to produce a more 
comprehensive framework for the application of the model.  They produced diagrams in 
order to visually represent the concepts of the model. Figure 2.2 shows the basic framework, 















Figure 2.3 shows the expanded framework where Kurtz, Silverman et al (2003) have broken 
down the components of each of the communication elements in order to refine the 
conceptualization of the model in order that the healthcare professional can apply it to the 







FIGURE 2. 3 THE EXPANDED FRAMEWORK OF THE CALGARY CAMBRIDGE MODEL (KURTZ, SILVERMAN ET 
AL. 2003) 
 
In Figure 2.4 Kurtz, Silverman et al (2003) have taken one element of the process, gathering 









FIGURE 2. 4 GATHERING INFORMATION (KURTZ, SILVERMAN ET AL. 2003) 
 
 
Whilst the Calgary Cambridge consultation model was originally developed for use in 
medical education, it has been adapted and used to provide a framework for other 
professional consultations (Greenhill, Anderson et al. 2011), and has even been adapted for 
use in veterinary practice (Adams and Kurtz 2006, Englar, Williams et al. 2016) which 
demonstrates its flexibility.  
(Munson and Willcox 2007) argue that consultation skills are the most important skills 
required by a practice nurse in general practice.  They identify that the core tasks of any 
consultation are to identify what the patient’s main problems are and what worries that 
individual the most, then assess the impact this has on the physical and emotional well-
being of that person and their family.  They reviewed other consultation models but 
concluded that the Calgary Cambridge consultation model is the most appropriate to be 
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used by practice nurses as it complements the holistic approach already practiced by those 
healthcare professionals. 
2.7.4 Relevance of Consultation Models to the Nurse-Patient Interaction 
As previously discussed, a number of different consultation models have been developed for 
use in different settings, but the basic aim of the consultation is to uncover the issues, 
problems and symptoms a patient may have (Willcox and Munson 2007).  Further the 
models have generally been aimed primarily at doctors (Harper and Ajao 2010) and 
therefore need to be adapted for the nursing role.  The early models were paternalistic in 
their approach, but as medical beliefs changed, the focus of the consultation also changed.  
The models are useful for doctors in the management of problems that the patient may 
present with; however, the focus of this thesis is how nurses give information on 
Methotrexate to patients and how they ensure that the patient understands that 
information.  Therefore, the need to determine an underlying medical problem with the 
patient is not necessarily useful in that information giving interaction.  The Calgary 
Cambridge consultation model,  (Kurtz, Silverman et al. 2003) clarifies the consultation 
process in more detail and Table 2.16 shows how this could be applied in the Methotrexate 










TABLE 2. 15 THE NURSE CONSULTATION PROCESS BASED ON THE CALGARY CAMBRIDGE MODEL 
The Calgary Cambridge Model The Nurse Consultation 
Initiate the Session 
Establish Rapport 
Involve the Patient 
 
Initiate the Session 
    Introductions – Nurse 
                                 Patient 
Nurse orientates the patient 
Gather Information 
Explore the problems 
Understand the patient’s perspective  
Provide structure to the consultation 
Gather Information 
Nurse gains an understanding from the 
patient why they are there 
Nurse establishes the patient’s current 
knowledge  
Nurse explains how the consultation will 
proceed 
Building the Relationship 
Develop a rapport 
Involve the patient 
 
Building the Relationship 
The nurse asks the patient about their 
disease, how they feel and any other 
issues they may have 
Nurse introduced the concept of shared 
decision-making and patient self-
management 
Explanation and Planning 
Provide the correct amount and type of 
information 
Aid accurate recall and understanding 
Achieve a shared understanding 
Planning – shared decision-making 
 
Explanation and Planning 
Nurse gives information about 
Methotrexate to the patient in small 
segments 
Nurse stops at each segment and 
discusses recall of the information with 
the patient, to ensure understanding 
Nurse observes verbal and non-verbal 
cues in this process 
Nurse makes decisions around relevant 
information to give each individual 
Decisions are made between the nurse 
and the patient regarding planning of 
follow up sessions 
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Thus, the Calgary Cambridge consultation model appears to be the most appropriate model 
and has the adaptability to apply to the consultation process between the nurse and the 
patient during the Methotrexate information giving encounter.  
 
2.7.5 Skills required to conduct a Consultation  
The following two sections will review the literature around those skills which are required 
to deliver a consultation and the current literature on how Rheumatology Specialist nurses 
conduct their consultations. 
 
2.7.5.1 Communication and Interpersonal Skills 
It is beyond the scope of this thesis to describe communication and all of its complexities; 
therefore, the focus will be on those skills that are necessary to conducting a consultation 
between a healthcare professional and patient during the process of giving information on 
drug treatment in Rheumatology. 
Communication is a fundamental skill required by nurses across all of the settings of patient 
care; it is a cornerstone of practice and it is essential that nurses have the skills to 
understand the patient and the experiences they express and also to be comprehensible and 
acceptable (Kourkouta and Papathanasiou 2014).  Communication is an inherent part of 
human nature but it is a complex interaction that occurs on many levels. There are many 
definitions of communication but in the context of this thesis it can be described as being 
“…about the reciprocal process in which messages are sent and received between two 
people” (Balzer–Riley 2004 p3). Communication, particularly in the context of a consultation, 
involves both verbal and non-verbal aspects (Ali 2018), the verbal aspect encompasses what 
is said or written. Tone, pitch, volume, pauses, fluency and speed of dialogue can have a 
conscious or unconscious impact on the meaning of those words.  Non-verbal 
communication can relate to body language as demonstrated in Table 2.17. 
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TABLE 2. 16 EXAMPLES OF NON-VERBAL COMMUNICATION BASED ON ALI (2018) 
Non-Verbal Communication 
Body Position • Arms Folded/Open 
• Facing or turned away in relation to 
others 
• Head tilted or straight 
• Sitting/standing 
• Personal space 
Facial Expression • Smiling 
• Frowning 
• Eyebrows raised 
• Inexpressive 





Touch • Handshake 
• Pat on the back 
• Avoidance 
 
Non-verbal as well as verbal communication can play an important role in healthcare 
professional and patient encounters (Vogel, Meyer et al. 2018).  Those communication styles 
which demonstrate a closer connection with patients, relate to increased patient satisfaction 
than those with a more paternalistic style (Buller and Buller 1987, Stevenson, Barry et al. 
2000).  It is also important to consider that there could be cultural/personal differences that 
patients may have, which requires empathetic judgement. For example, touching someone 
could be offensive, and permission to do so should be considered.  Some individuals may 
find eye contact uncomfortable, such as people with Asperger’s (Ali, 2018).  Thus, reading 
body language is a skill and could be regarded as being as important as observing clinical 
signs (Ali 2018).   
Patients often exhibit cues indirectly rather than express openly their concerns (Butow, 
Brown et al. 2002), and it could be regarded that it should be a core skill of nurses to 
recognise these cues  (Eide, Quera et al. 2004).  Sheldon et al (2011) carried out an analysis 
of thirty-one randomly selected audio-recordings from an existing  data set of oncology 
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visits.  Their main goal was to observe patient cues of distress and the healthcare 
professional responses to those cues.  They found that cues ranged from zero to 13 cues per 
visit and the healthcare professional acknowledged 57% of these cues, however they only 
explored 22% of the cues.  Their conclusions were that the healthcare provider may have 
lacked knowledge, time and confidence in dealing with these cues, and recommended that 
education for the healthcare professional in managing cues could improve patient 
outcomes. Hall (2011) also considered that accuracy in interpreting cues is multi-layered.  It 
is important to understand the healthcare professionals’ cues in order to accurately decode 
the cues that the patient is responding to.  
Charlton et al (2008) undertook a review of literature up to 2005, describing nurse 
practitioner/patient interactions in order to evaluate best practice.  They identified two 
different styles in the literature; biomedical and biopsychosocial.  The biomedical approach 
is authoritative and controlled focussing only on the signs and symptoms of the complaint.  
The biopsychosocial approach is person-centred that involved shared decision-making and 
ultimately empowering the patient to become part of the treatment pathway.  This style had 
a much more positive influence on patient satisfaction, adherence to treatment options and 
overall patient health than the biomedical. 
 
2.7.5.2 Rheumatology Nurse Consultations Skills 
A number of studies have been conducted relating to Rheumatology nurse-led 
consultations.  Hill et al (2003) carried out a randomised controlled trial with eighty people 
who had the diagnosis of Rheumatoid Arthritis.  The study was designed to assess 
effectiveness of care in a nurse led Rheumatology clinic, the results of which indicated that 
there was a greater level of patient satisfaction with the nurse led clinic than the doctor led 
clinic, but the confounder here was that the doctors changed with their rotation every six 
months and therefore there was less consistency with who the patient saw. It was also not 
clear which consultation technique the nurses used, or whether indeed, they had been 
trained in any consultation method at all.  Further, their main outcome measure was a 
disease activity score which remained stable in both groups. Therefore, it appears that 
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consultations skills had not been considered to have an important impact on the interaction 
between nurse and patient.  Ryan et al  (2006) hypothesised that a Rheumatology Specialist 
nurse would have a measurable impact on the well-being of patients with Rheumatoid 
Arthritis.  They designed a single blinded randomized controlled trial to test this hypothesis.  
Seventy-one patients with Rheumatoid Arthritis who were starting a new DMARD, were 
recruited and randomised into two groups over a one-year period.  One group was allocated 
to review by a Rheumatology Specialist nurse clinic, whilst the control group received the 
standard care of being seen by outpatient staff for their blood safety monitoring.  The 
Rheumatology Specialist nurse further used Pendleton’s consultation framework (Pendleton 
1984) to assess patient needs as well as carrying out safety blood monitoring.  Ten minutes 
were allocated to each consultation with the Rheumatology Specialist nurse and during this 
time, safety assessments were undertaken as well as assessment of pain, mood, and 
functionality.  Furthermore, during this short consultation, advice was given on the use of 
analgesics, exercise and goal setting and referrals to other healthcare professionals such as 
physiotherapy and occupational therapy, was made if necessary.  The results of the study 
showed that there was a significant improvement in disease activity in the group who had 
been seen by the Rheumatology Specialist nurse, which indicates that the nurse had a 
positive impact on disease outcomes for patients with Rheumatoid Arthritis.  However, it is 
not clear how the consultation was actually structured and whether there was any shared 
decision-making in that process.  The time allocated to the consultation suggests that the 
Pendleton consultation model was used to frame questions to explore other problems that 
the patient may have.  Whilst this approach certainly benefitted the patient in comparison 
to the control group who had no intervention other than safety monitoring, it is unclear 
how far the patient was at the centre of the Rheumatology Specialist nurse consultation 
process. 
The objective of a randomised controlled trial conducted by Koksvik et al (2013)  was to 
determine patient satisfaction with nurse consultations in a Rheumatology outpatient clinic.  
68 patients with inflammatory arthritis who had started a DMARD three months previously 
were randomised for their follow up to either a clinic led by a nurse or a clinic led by a 
doctor.  The patients remained in their allocated groups for their three-month, nine-month 
and 21-month follow up appointments.  Two Rheumatology Specialist nurses conducted the 
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visit in the nurse led clinics. Both had more than ten years’ experience in Rheumatology and 
had undertaken Rheumatology courses at advanced level. This study was conducted in 
Norway.  The patients saw the same nurse at each visit.  Six doctors conducted the medical 
clinics and two of those were in their last year of training as Rheumatologists.  There was no 
consistency with which doctor the patient saw at each visit timeline.  Consultations for each 
lasted approximately 30 minutes.  The primary outcome measure was patient satisfaction, 
assessed by the Leeds Satisfaction Questionnaire (Hill, Bird et al. 1992).  The overall 
satisfaction rate was relatively high in both groups; mean scores were 3.96 (3.8 – 4.2) in the 
Rheumatology Specialist nurse group and 4.08 (3.9 – 4.2) in the doctors’ group.  However, 
there was a significant difference in satisfaction levels in the nine month and twenty-one 
month follow up appointments.  Patients who had been seen by the doctors showed less 
satisfaction around the provision of information and access and continuity of care.  This 
could reflect the lack of continuity of care in the doctors’ group and the varying practices 
each doctor will exhibit.  Whilst both nurses in this study had many years’ experience in 
Rheumatology and had undertaken advanced level courses, it was not clear which 
consultation model they adopted.  Indeed, assessment of the patient’s disease status was 
carried out in a thematic check-list fashion.  They did provide education and counselling 
which addressed self-management strategies, but there was no indication that a patient 
centred approach had been utilised, or what information was actually given and whether 
they checked to ensure the patient understood. The weakness of this study around 
comparing the nurses’ consultation to the doctors’ consultation is the lack of consistency.  
The nurses were able to establish a longer-term rapport with the patient, as they saw the 
same patient each time, whereas the doctors did not.  Further the principal investigator was 
one of the Rheumatology Specialist nurses and her investment in the study may have had an 
impact on her performance.   
The literature of the randomised controlled trials conducted around Rheumatology nurse 
consultations have been designed to test their effectiveness against doctors.  Whilst this is 
important to justify the existence of nurse-led clinics, the literature is not specific in the 
description of the consultation processes Rheumatology Specialist nurses use.  Larsson et al 
(2014) designed a randomised controlled trial to evaluate the effectiveness of a nurse led 
Rheumatology clinic compared to a Rheumatologist led clinic for patients undergoing 
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biologic therapy, where 107 patients were randomised to either standard care with the 
Rheumatologist consisting of a three-minute review appointment at six months and again at 
12 months, or to be seen in a nurse clinic at six months. Thereafter at 12 months the 
patients would be followed up by the Rheumatologist as per standard care. The nurse 
intervention consisted of using a patient-centred approach, the purpose of which was to 
give the patient the opportunity to talk about themselves and their illness, leading to greater 
patient empowerment and self-management.  Nevertheless, it was not clear how this was 
done and whether any particular consultation models were adopted.  The authors 
concluded that the disease activity score did not significantly change, therefore replacing the 
six-month review appointment with a nurse clinic rather than a Rheumatologist clinic was 
safe and effective.  This study does attempt to put the patient at the centre of care, but 
exactly how this was done is not clear. 
Ndosi et al (2014)  took a different approach to justify the value of a nurse led clinic by 
considering the cost-effectiveness of Rheumatology Specialist nurses.  They designed a 
multi-centred randomised controlled trial to explore their objective and recruited 181 
patients with Rheumatoid Arthritis to be randomised to either a nurse clinic or a 
Rheumatologist clinic.  Again, the primary outcome measure was the disease activity score 
which was assessed at weeks 13, 26, 39 and 52.  The authors describe a “holistic approach” 
adopted by the nurse clinic which involves taking account of patients’ physical, 
psychological, social and spiritual needs, yet there was no description of how nurses were 
trained to provide this consultation model in the different centres where the trial took place, 
therefore the overall consistency of the nurse led clinics may be questionable.  Further, the 
nurses had 30 minutes in which to conduct their clinics, whereas the Rheumatologists only 
had 15 minutes.  The authors also highlight that in the follow-up period the proportion of 
patients receiving biologic drug treatments remained fairly constant in the nurse led clinics, 
whilst it doubled in the Rheumatologist clinics.  This may reflect that Rheumatologists are 
often the decision makers when prescribing biologic therapies for patients, and it could even 
indicate that drug changes were missed by the nurse-led clinics leading to less than optimal 
treatment for the patients. 
A  systematic review was carried out by Garner et al (2017), the aim of which was to assess 
the quality of care for patients with Rheumatoid Arthritis, in nurse-led clinics.  They 
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reviewed the literature to identify measures of quality of care used as outcomes in each 
study and calculated the number of studies reporting superior, equal and inferior results for 
nurse-led clinics with the comparator.  Seventeen articles were selected; however, the 
inclusion criteria were not reported.  They mapped out the outcome measures against six 
dimensions: effectiveness, acceptability, efficiency, safety, appropriateness and accessibility.  
Whilst they reported that nurse-led clinics were safe and were supported by patient 
outcomes such as satisfaction, coping and functional status, they noted that evidence in 
some dimensions such as efficiency, appropriateness and accessibility as under-represented.  
These dimensions related to cost-effectiveness, relationship with the care provider such as 
holistic care and provision of information and continuity of care.  They concluded that 
further work needs to be undertaken to address these gaps in the research. 
 
2.8 Chapter Summary  
It is clear that Rheumatoid Arthritis is a debilitating disease which requires careful 
management and treatment.  Some drug therapies such as Methotrexate can occasionally 
have harmful side effects; therefore, it is of the utmost importance that the patient 
understands how to take the drug safely, understand warning signs of side effects and to 
take the drug as prescribed.  It is a part of the role of the Rheumatology Specialist nurse to 
advise the patient on the management and administration of this drug, in order for the 
patient to make informed decisions and choices about their own treatment.  It remains 
unclear following this literature review, how nurses are trained to give this information, and 
how deep their knowledge of drugs such as Methotrexate is.   
An examination of the literature on nurse consultations reveals that it primarily focusses on 
the comparison of the nurse with a Rheumatologist undertaking consultations, perhaps with 
the aim of justifying nurses in this role. However, what is not clear is how those nurses were 
trained to carry out their consultations and how effective their technique was. Further, it is 
unclear how the practice of shared decision-making underpins the nurse consultation 
process.  The majority of papers and articles relating to specific drug therapies for the 
treatment of Rheumatoid Arthritis revealed that the decisions were made by the clinician 
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without consultation with the patient.  It is clear from this literature search that although 
there is a growing awareness of the value of patient involvement in their care pathway, it is 
relatively under-represented in the literature.  Therefore, the quality of the interaction 
between nurse and patient on knowledge gained as a result of that interaction is 
understated in the literature.  Whilst it can be seen that nurses have a major impact on the 
Rheumatology services delivered throughout the world, there is little evidence available on 
what skills are required and how those skills are achieved.  It is also clear that there is a lack 
of demonstrable standardization for specialist nurse training in many treatment areas 
(Ranchal, Jolley et al. 2015).  
 
2.9 Aims and Objectives 
The literature review has revealed gaps regarding how nurses gained knowledge about 
consulting with patients and how they delivered that information using consultation 
techniques which has contributed to the formation of the aims and objectives of this thesis.   
The overall research question was how do Rheumatology Specialist nurses gain knowledge 
about consulting with patients on Methotrexate and do they deliver the information to 
patients using a consultation technique, further can elements of their consultation be 
identified for development?  This was investigated by: 
 
 
 Investigating, using a survey, the processes which nurses undertake to become 
knowledgeable about consulting with patients on Methotrexate and to understand 
how much knowledge and confidence they have in giving this information. 
 
 Exploring, through semi-structured interviews, the nurse experience and perception 
of the delivery of information about Methotrexate to patients. 
 
 Identifying, through video analysis of consultations, the processes used by the nurses 
in their consultations with patients when giving information about Methotrexate and 
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Chapter 3: Methodology 
3.1 Introduction  
 
Slevitch (2011) describes several fundamental terms used in the philosophy of science and 
research and explains that a paradigm can be defined as a ‘world view’ or set of assumptions 
about the world as well as a cognitive process or the shared beliefs of a particular discipline.  
These paradigms are determined by the ontological perspective which describe what exists or 
is believed to exist and the existence of relationships between different phenomena.  The 
ontological dimension then establishes the epistemological position which is concerned with 
the theory of knowledge.  This then leads to the next term, methodology, which is based on a 
system of theories.  Each methodology specifies the assumptions about reality and human 
nature, beliefs about what is important to research and assumptions about what establishes 
legitimate knowledge and meaningful data.  Each methodology then leads to the creation of 
methods which are the tools, procedures and techniques to be employed in the scientific 
enquiry (Smith and Heshusius 1986).  Hughes and Sharrock (2007) further describe “method“ 
and “methodology” as two different aspects of research practice.  Method refers to those 
procedures and practices which are involved in collecting the research data, whereas 
methodology refers to the underpinning rationality and justification of those particular 
methods.  
This chapter will discuss the ontological and epistemological paradigms which underpinned 
this thesis and how these paradigms influenced the methodological perspective of this work.  
This chapter will also discuss the methods which were applied to this mixed methods research 
thesis to explore how nurses gained knowledge about consulting with patients on 
Methotrexate.  This thesis sought to explore how they delivered that information to patients 
and to identify elements of their consultation for further development.  Both qualitative and 
quantitative data were collected through a national questionnaire survey, semi-structured 
interviews and video-recordings of the nurse-patient consultation, to obtain overall context 
and a richer, more in-depth perspective, therefore further discussion of qualitative and 
quantitative research methods will be conducted.  The philosophy which underpins this thesis 
is critical realism, and will be discussed later in this chapter. 
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3.2 Ontological and Epistemological Perspective 
Research is framed by a series of related assumptions (Arthur 2012) and these can be outlined 
around four questions; what is the form and nature of the social world, how can what is 
assumed to exist be known, what procedures or logic should be followed, and what 
techniques of data collection should be used (Figure 3.1). 
 
FIGURE 3. 1 THE RELATIONSHIP BETWEEN ONTOLOGY, EPISTEMOLOGY, METHODOLOGY AND METHODS 
(ARTHUR 2012)   
 
 
Ontology, as a branch of philosophy, is the science  of what is being, existence, identity, 
processes and relations in every area of reality (Gruber 2018).  Ontological perspectives can be 
viewed as a single line, from realism to constructivism.  From the realism perspective there is 
one single reality which exists independent of individual perception whilst at the other end of 








Ontology - What is the form and 
nature of the social world? 
Epistemology - How can what is 
assumed to exist be known? 
Methodology - What procedures or 
logic should be followed? 
Methods - What techniques of data 
collection should be used? 
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FIGURE 3. 2 ONTOLOGICAL PERSPECTIVES BASED ON ARTHUR (ARTHUR 2012)  
   
 
 
     
 
 
The ontological perspective of the research forms the base on which to determine the 
epistemological viewpoint. The second question that Arthur (2012) poses refers to the 
epistemological position and relates to knowledge. From a positivist position it is possible to 
gain direct knowledge of the word through observation or measurement of the phenomenon.  
But the other extreme is an interpretivist belief where it is not possible to gain direct 
knowledge and that knowledge is developed through a process of interpretations of the world 
(Figure 3.3). 
 








Easterby-Smith et al (2012) summarise the differences between these two concepts.  In the 
strongly positivist position, the researcher has to discover the laws and theories to explain 
reality which is undertaken through experimentation and precise measurements.  But a less 
positivist position accepts that reality cannot be directly accessed and therefore the nature of 
this reality can be achieved through other methods, such as conducting surveys.  The 
interpretivist perspective follows that the researcher needs to collect multiple perspectives 
through quantitative and qualitative methods to gather the views and experiences of 
individuals (Table 3.1). 
POSITIVISM 
Is not affected by the subjective 
opinions of the researcher as it 
deals with verifiable observations 
and measures 
INTERPRETIVISM 
Based on perception rather than 
truth. Conclusions are drawn 
from interpretation rather than 
abstract theories 
REALISM 
Single objective reality 




constructed by individuals 
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Basic Beliefs The world is external and 
objective 
The observer is 
independent 
Science is value free 
The world is socially 
constructed and subjective  
Observer is part of what is 
observed 
Science is driven by human 
interest 
Researcher should Focus on facts 
Look for causality and 
fundamental laws 
Reduce phenomena to 
simplest elements 
Formulate hypotheses and 
then test 
Focus on meanings 
Try to understand what is 
happening 
Look at totality of each 
situation 
Develop ideas through 
stimulation from data 
Preferred methods include Operationalizing concepts 
so they can be measured 
Taking large samples 
Using multiple methods to 
establish different views 
Small samples investigated 
in depth or over time 
 
 
The aim of this thesis was to examine how Rheumatology Specialist nurses gain information on 
how to conduct consultations with patients giving information about Methotrexate.  The 
objectives were to design a national survey exploring how they become knowledgeable, to 
conduct semi-structured interviews to gather the views and experiences of those nurses 
conducting the consultations and to analyse in detail video-recordings of the Rheumatology 
nurse-patient consultation in order to understand the reality of this phenomenon. This 
interpretivist perspective considers the multiple layers of investigation required in order to 
reach an understanding of the phenomenon under study.  Furthermore the interpretivist 
perspective allows and recognises that the researcher is not separate from the investigatory 
process and acknowledges that theories which apply to their research was also relevant to 
themselves (Easterby-Smith, Thorpe et al. 2012).  Whilst the interpretivist paradigm generally 
uses qualitative methods, a pragmatic approach to the paradigm provides the platform in 
which to utilise multiple research methods (Cresswell 2003).  Table 3.2 describes how these 
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methods can cross boundaries, thus suggesting that the paradigm and research question 
determines the method of data collection and analysis which is most appropriate for the 
research question (Mackenzie and Knipe 2006).   
TABLE 3. 2 PARADIGMS METHODS AND DATA COLLECTION (MACKENZIE AND KNIPE 2006)   
Paradigm 
Methods Data Collection  











Visual data analysis 
Transformative Qualitative and Mixed 
Methods 
Diverse range of tools 
Pragmatic Qualitative and/or 
Quantitative Methods 




3.2.1 The Positivist Paradigm 
This term was coined by Auguste Comte, a French philosopher who believed reality could be 
observed and that all genuine knowledge can only be advanced by observation and 
experiment (Mack 2010). Mack further explains that the ontological assumptions of 
positivism maintain that reality is external to the researcher and this reality is represented 
by objects in space which have an independent unconscious meaning.  The epistemological 
assumptions maintain that truth can be reached because knowledge is objective and based 
on firm unquestionable truths from which beliefs can be comprehended. This paradigm 
generally uses quantitative methodology and scientific experimentation, thus the researcher 
is external to the phenomenon and controls the research process (Taylor and Medina 2011).  
Post-positivism however, allows for more interaction between the researcher and the 
phenomenon (Willis, Jost et al. 2007).  Post-positivism methods include surveys, 
interviewing and participant observation (Cresswell 2008). 
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3.3 The Interpretivist Paradigm 
The core belief of the interpretivist paradigm is that reality is socially constructed (Thanh and 
Thanh 2015) and is more concerned with the in-depth variables and factors related to a 
situation (Alharahsheh and Pius 2020).  The ontological position of interpretivism is relativism, 
or the view that reality is subjective and differs from person to person (Guba and Lincoln 
1994).  Scotland (2012) further comments that reality is individually constructed, therefore 
there are as many realities as individuals.  From an epistemological position knowledge is 
based on real world phenomenon where individuals construct meanings in different ways but 
through communication with other people and perhaps for practical reasons, a consensus is 
reached to share the same ideas (Pring 2000).  To illustrate the differences between these 
paradigms, Taylor and Medina (2011) offer three analogies to describe positivism, post-
positivism and interpretivism: 
“A positivist fisherman stands on a riverbank and describes the social properties of a 
species of fish by observing the general tendency of their group behaviour as they 
swim around”. 
“A post-positivist fisherman supplements his quantitative observations of the social 
properties of a species of fish by wearing a wetsuit and conducting structured 
interviews of a random sample of fish to ascertain their reasons for swimming in 
accordance with the inferred social pattern”. 
“The interpretive fisherman enters the water, establishes a rapport with the fish, 
and swims with them, striving to understand their experience of being in the water”. 
 
Coe (2012) considers that the whole notion of a paradigm is problematic.  Whilst he describes 
a simplistic view of opposing paradigms in Table 3.3 there are always inconsistencies which are 
treated as puzzles to be worked out.  But occasionally those inconsistencies lead to such 
significant anomalies that they trigger a new paradigm which cannot be measured against the 






TABLE 3. 3 OPPOSING VIEWS OR PARADIGMS (COE 2012)   
 
 
The next section of this chapter describes the underpinning philosophy of this study which 
emerged through the construction and integration of the mixed methods design required to 
The world and phenomena are real and to 
exist independently of perception  
Social phenomena are always perceived in a particular 
way: they have no reality independent of perception 
There is truth and objective knowledge about 
the world 
Individual social contexts are unique: generalisation is 
neither desirable nor possible 
Research should aim to discover general 
(generalizable explanations for phenomena to 
make generalizable predictions 
Research should aim to understand individual cases and 
situations and to focus on the meaning that different 
actors bring to them 
The kinds of objective knowledge and facts 
discovered by research are not dependent on 
the values and beliefs of particular 
researchers 
Understanding the values and beliefs of researchers is 
crucial to understanding their claims 
Power relationships are not relevant to the 
truth 
Power and particularly imbalances of power, are central 
to understanding social phenomena. A key purpose of 
research is to emancipate and transform 
Research aims to develop and test 
hypotheses. Hypotheses must be clearly 
stated before a study can be designed to test 
them 
Research is inductive, following an unending dialectical 
cycle of thesis, antithesis, synthesis. Hypotheses and 
theory emerge in the course of researching; they are 
critically tested and refined against data and theory. 
Researchers aim to avoid making assumptions before 
collecting data 
The world is fundamentally mechanistic and 
deterministic, in which human behaviour is 
governed by general laws and is capable of 
manipulation 
 
Human beings are active participants in the researched 
world, interacting with rather than reacting to their 
environment, constructing situations by bringing their 
own meanings and acting freely 
Phenomena can be understood by analysis of 
their component parts (reductionist) 
Social phenomena are more than the sum of their parts 
and can be understood only holistically 
Constructs must be operationalized to be 
used in research. Many constructs can be 
quantified and treated as having 
measurement properties. Characteristics such 
as validity and reliability are crucial 
Many constructs cannot usefully be quantified; only 
rich qualitative description can capture their essence. 
Representations of phenomena must be authentic, 
based on studying things in their natural settings 
Generalisation from observed samples is 
justified in terms of statistical 
representativeness and probability sampling 
Observed cases can be a basis for generalizable theory 
and understandings, even where the number of cases is 
small (perhaps even one) and they are selected for 
some particular characteristic 
Quantitative Qualitative 
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explore the research question.  The relationship between the underpinning philosophy and 
the mixed method design will then be discussed. The final sections will then describe the 
methodologies which underpin each of the three phases of this study. 
 
3.4 The Philosophy of Critical Realism  
All individuals have their own understandings and beliefs about the world in which they work 
and live (Proctor 1998). They have their own thoughts about what amounts to, for example, 
good healthcare, what they think is right or wrong about a particular situation, and whether 
they think that someone could do a task in a better way. These can be described as personal 
paradigms or personal philosophies (Proctor 1998) and illumination of these beliefs can 
contribute to perceptions between the ontological/epistemological/methodological 
interactions at the very planning stage of a study. Understanding the philosophical 
underpinnings of a study clarifies the concepts behind the methodological processes of that 
study (Appleton and King 2002).   The aim of this thesis was to examine how Rheumatology 
Specialist nurses gained knowledge about consulting with patients on Methotrexate and how 
they delivered that information to patients.  Therefore, it could be argued that it is not enough 
just to understand the existence of the fact that Rheumatology Specialist nurses give 
information about Methotrexate to patients, but to explore and gain an understanding of the 
underlying reality, or more specifically how the nurses gain their knowledge to carry out 
consultations with patients, which identifies critical realism as the philosophy underpinning 
this thesis. A clear understanding of the philosophical underpinnings of the research strategy 
helps to ensure consistency when applying different methods to a research question. This 
provides the foundation for the research methods within the epistemological paradigm and 
appraise the research design (Proctor 1998).   
 
3.4.1 Critical Realism and Overview of the Key Literature  
The origins of critical realism lie in a series of books by Roy Bhaskar and Margaret Archer 
(Archer, Bhaskar et al. 2013, Vincent and O'Mahoney 2018) in which it is argued that the 
universe is “a stratified and open system of emergent entities”.  Entities can be described as 
those things which make a difference in their own right (Fleetwood 2005).  For example a 
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molecule of water is made up two hydrogen atoms and one oxygen atom; seperately these 
entities are unobservable to the naked eye, but by interacting they become observable as 
water, this then is an emergent property of hydrogen and oxygen (Cruickshank 2012). 
Therefore, Bhaskar’s (2013) proposition is that the world is an open stratified system 
because unobservable underlying laws interact in subjective ways resulting in observable 
change. 
 
Bhaskar was influenced by his tutor Rom Harre who laid the foundations of critical realism 
with his criticism of positivism and believed that there must be underlying propagative 
mechanisms in order to explain the world in terms of cause and effect (Danermark 2019).  Also 
Mario Bunge argued in 1979 and 1993 that reality was arranged in levels, and that there was a 
distinction between the real world and the conceptual one (Danermark 2019).  Danermark  
(2019) describe several distinct stages in the development of critical realism. The first stage is 
generally known as “basic critical realism” which was originally termed “transcendental 
realism” by Bhaskar (1989).  This phase saw the introduction of underlying laws, the structure 
of the world and distinctions between beliefs and being, the aim of this phase was to develop 
a new logic of scientific discovery.  The next stage is known as “dialectical critical realism” in 
which Bhaskar developed a more philosophically robust understanding of change, as reality is 
constantly in a process of change and whilst Bhaskar was aware of this from the beginning of 
his development of critical realism, it still took him about ten years to develop (Danermark 
2019).  During this time, he also became aware of the importance of “absence” which gives 
rise to a want or relieving of a need, in which process, negation and transformation are key 
concepts.  This dialectical, or logical reasoning stage, has an important function in social 
research.  The third stage of the development of critical realism as explained by Danermark is 
the “meta-reality” phase.  This phase has a more reflexive focus; it looks to the inner or 
empirical world. 
 
Bhaskar challenged the traditional view of scientific research which emphasized the belief that 
truth lies with firm law-like observations for phenomena (Clark, Lissel et al. 2008). He believed 
that this approach to truth was problematic as knowledge also lies in the social domain as 
social process and could be seen as relative to the individuals themselves.  There was little 
clarity on who or what could determine truth and indeed, what truth was. Critical realism, 
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therefore, looks to understand the beliefs held by people and how those beliefs interact with 
external influences such as culture, gender and cultural attitudes (Proctor 1998) where reality 
is stratified into three domains (Figure 3.4). 
 
 FIGURE 3. 4 THREE DOMAINS OF REALITY  
 
 
The first layer is the real domain and is described by Schiller (2016) being independent of 
thought, awareness and even the existence of human beings. Schiller considers that it is 
important to understand that whilst the real domain may not be detectable or observable by 
humans it does not make any less present in the critical realist viewpoint. Fletcher (2017) 
describes the second level, actual, where there is no filter of human experiences, and events 
occur even though they may not be witnessed by a person.  Therefore, the actual domain 
includes all those events and phenomena that have been generated in the world regardless of 
whether they have been experienced by an individual or not and this is because not 
everything in the world can be observed (Schiller 2016). The final layer is the empirical domain 
where events or objects can be measured through the human experience or interpretation, 
The Real Domain
Independent of thought, awareness,
existence of human beings
The Actual Domain
Humans are able to experience some 
of those events caused by complex interactions
The Empirical Domain
Comprised of human perceptions and 
experiences
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often called common sense (Fletcher 2017).  This is the level of reality where social ideas, 
meanings and actions occur, where new empirical and non-empirical knowledge is generated 
through researcher endeavours and the creation of theories regarding natural and social 
phenomenon (Danermark 2019).  
 
Williams (2007) considers that sensory knowledge is the cumulative knowledge that is learned 
from sight, sound, touch, movement, smell and taste which provides a level of evidence that 
can be challenged. It also includes a range of sensory experiences including hunger, thirst, 
pain, fright etc. This is classified as “empirical” knowledge. Non empirical knowledge is that 
knowledge which is independent of the sensory experience (Williams 2007). Human social 
processes and perceptions are imperfect therefore beliefs are not necessarily equal to 
objective truth (Clark, Lissel et al. 2008). Examination of these beliefs should consequently be 
deduced with reference to other available data or arguments. For example, if a person with an 
incurable chronic disease believes that they will one day be cured of that disease, from a 
Critical Realism perspective it can be considered that that patient is wrong, based on the 
evidence and knowledge that is available. Epistemologically, it can be considered that the 
patient is wrong, therefore the perspectives of the patient and professionals have been 
considered in conjunction with the available evidence and knowledge, arriving at an 
acknowledgement of the value of the different and reliable sources of evidence which relate 
to that phenomena (Clark, Lissel et al. 2008). Ryan (2019) describes the philosophical 













TABLE 3. 4 THE PRINCIPLES OF CRITICAL REALISM  (RYAN AND RUTTY 2019) 
Critical Realism 
 There is one reality, never completely known, but can be seen differently from 
different perspectives. What is observed, felt, measured or analysed are only 
representations of this reality 
 Reality can be viewed and interpreted by different people in different ways but 
it is still one single reality viewed from different perspectives (modified reality) 
 Social systems are complex and changing, therefore they cannot be controlled 
and free from bias 
 Knowledge evolves and progresses and can change over time 
 What could be a fact in one situation may not be in another 
 
 Knowledge should be generated through a range of sources and methods 
which uses theoretical frameworks, previous knowledge, research and the 
collection of data 
 Knowledge should be fit for purpose ie it should be accessible, applicable, 
usable and relevant 
 
 
Criticial Realism assumes that an ontological theory leads to an epistemological theory 
(Scott 2005). In other words, theorising on what is real, will lead to what is true. Scott puts 
forward two propositions; that empirical research methods needs to be underpinned by a 
meta-theory or an overarching theory or philosphy, such as empiricism or critical realism.  
Even though a researcher may not specifically address the philosophical issues, because 
they engage with the real world providing a explanation of it, those philosophical issues 
underpinn the methodological decisions which are made (Scott 2005). The second 
proposition Soctt puts forward is; believing that an independent reality exists and does not 
necessarily mean that deeming absolute knowledge of that reality is the only way it will 
work.   
 





FIGURE 3. 5  THE PHILOSOPHY OF CRITICAL REALISM UNDERPINNING THIS THESIS  
 
 
It could be argued that when an individual completes a questionnaire survey they complete 
it to the best of their knowledge and beliefs at that time, but what is real to them may not 
be what is observed. Therefore in designing this thesis, further layers of investigation were 
required to observe different perspectives of the same reality. Semi-structured interviews 
allow for a more in-depth exploration of what is real to the individual, but again, there is a 
subjective element in that the individual’s beliefs could influence the interview and their 
perception of the truth. The third layer, video-recording, allows the researcher to view the 
world from a very different perspective. However, a rigorous analytical approach to 
reviewing the data from the video-recording, is essential, as the researcher’s own beliefs 
and truths could influence the outcome. Bhaskar’s view that the world is an open stratified 
system (Bhaskar 2013) where unobservable laws can cause observable change, underpins 
the chosen methodologies for this thesis. The aim of this study was to observe and 
understand those beliefs and events which result in current practice when undertaking 
consultations and shape the way that Rheumatology Specialist nurses undertake 
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Methotrexate education today. The next section in this chapter will examine the literature 
to understand how critical realism aligns itself with a mixed methods research approach. 
 
3.4.2 The Fusion of Critical Realism and Mixed Methods Research  
Shannon-Baker (2016) views mixed methods research as the type of enquiry which has 
philosophical foundations, where there is an intentional use of both qualitative and 
quantitative research methods in one single study.  This results in a richer understanding of 
that phenomenon than using one method alone and this is echoed by other writers such as 
Cresswell (2015).  Maxwell and Mittapalli (2010) consider the application of critical realism 
to mixed methods research and consider its appropriateness to this approach.  They 
consider that by taking a critical realism approach, the research design can be viewed as real 
entities and not simply “models” for that research question.  That critical realism allows real 
concepts and practices to shape the study design,  rather than reconstructing the logic or 
hypothesis from the inquiry process, “reconstructed logic” (Kaplan 1973).  Kaplan’s 
definition of -logic-in-use are the on-going thought processes which govern scientific 
investigation whereas reconstructed logic are those processes which are propagated after 
the fact and could in fact be substantially different to logic-in-use.  Maxwell and Mittapalli 
(2010) also consider that the critical realism philosophy allows the reflexive position of the 
researcher and stakeholders to contribute a meaningful component to the design of the 
study.  Within the qualitative research approach, this reflexive position confirms that the 
researcher is part of the data collection process and that conscious or unconscious 
preferences may affect or contribute to the process (Ormston, Spencer et al. 2014).  
Therefore the adoption of a reflexive position on the design of a study could allow the 
researcher to identify potential preconceptions which may affect the processes of data 
collection and the data itself (Ritchie, Lewis et al. 2013).  A reflexive account of the 
researcher’s perspective will be described at the end of this chapter in section 3.10. 
A critical realism approach undertakes to probe into deeper levels of understanding, 
investigating multiple viewpoints (McEvoy and Richards 2006) and it could be considered that 
within the same reality the three ontological domains of the empirical, the actual and the real, 
can be inferred by combining empirical investigation and theory construction.  From a critical 
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realism perspective, the choice of research method should be dictated by the research 
question and in many cases, this could be implemented by using both quantitative and 
qualitative methods.  Quantitative methods provide reliable descriptions and accurate 
comparisons, whilst qualitative methods can reveal patterns and associations which may not 
necessarily be obvious (McEvoy and Richards 2006)  Thus the first objective of this thesis;  to 
investigate the processes which nurses undertake to become knowledgeable about the 
consulting with patients to give information about Methotrexate,  was undertaken using a 
survey to provide quantitative data to produce accurate descriptions and comparisons.  The 
second objective exploring the experiences and perceptions of nurses in the delivery of 
information about Methotrexate was undertaken through semi-structured interviews and the 
third objective; to identify how the nurse patient consultations could be further developed 
was undertaken through video-analysis.   These approaches embraced qualitative methods 
which as McEvoy and Richards (2006) point out that a key advantage of these methods is that 
they are open ended from a critical realism perspective, this allows themes to emerge which 
may not necessarily have been anticipated. Thus, this study design was based on a mixed 
methods approach with an underpinning critical realism philosophy.  
 
3.5 Mixed Methods Research 
The following two sections will review the literature concerning the development and 
application of mixed methods research and the debate around adopting this approach. 
 
3.5.1 The History of Mixed Methods Research 
There is a general view that mixed methods research established its beginnings in the 1950s 
(McKim 2017), however, Johnson et al (2007) position the beginnings of mixed methodology 
back to Plato and the Sophists. Debates on understanding the world and the philosophical 
truth of everything goes back to Socrates and Plato who argues for multiple truths as 
opposed to relative truths as proposed by the Sophists, Protagoras and Gorgias. Johnson et 
al argue that these deliberations continue to affect how knowledge and truth are 
considered and that the divergent views of Plato and the Sophists could be regarded within 
a mixed methods context in order to determine a solution that covers multiple viewpoints. 
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In its more recent history, mixed methods emerged because researchers considered that 
both the qualitative and quantitative perspective could be adopted in order to examine 
their research questions (Johnson, Onwuegbuzie et al. 2007). However,  as early as the 
1920’s mixed methods approaches to inquiry were being adopted (Lynd and Lynd 1937).  
Lynd and Lynd conducted a complete survey of a small midwestern city in North America 
and in 1931 Jahoda et al (2002) carried out a survey of a town called Marienthal in Austria. 
Whilst their methodologies were not robust and generally developed as the projects 
developed, these studies applied mixed methodology, using for example official statistical 
information, interviews and psychological tests. 
 
3.5.2 The Mixed Methods Debate 
In 1959 Campbell and Fiske developed a technique which measured two traits by, at the 
minimum, two different methods, they termed this the “multi-trait multimethod technique” 
(Campbell and Fiske 1959). Validity is measured by correlation of the values of the different 
methods and should be high enough to reflect convergent validity or common trait variance 
(Lowe and Ryan‐Wenger 1992). The work by Campbell and Fiske has been considered the 
beginnings of mixed methods research (Maxwell 2016).  However, the 1980s and 90s 
witnessed considerable dispute around mixing qualitative and quantitative methods for 
research revealing purists on both sides (Johnson and Onwuegbuzie 2004).  Quantitative 
purists argued that social observations should be viewed as a scientific enquiry, where the 
observer is separate from the objects under study and objectivity should be maintained 
consequentially producing outcomes which are reliable and valid (Nagel 1989).  On the 
other hand, qualitative purists would argue that there are numerous realities and that cause 
and effect are interlinked.  So it would be impossible to separate and differentiate between 
them as knowledge is generated inductively from the resulting data (Johnson and 
Onwuegbuzie 2004).  Further, the data collection methods differ between the two 
paradigms as quantitative data collection tends to be highly structured and organised using 
large samples sizes, whereas qualitative data collection involved exploring and recording 
individual perspectives and experiences which often involve smaller sample sizes.  These 
two opposing viewpoints are summarised in Table 3.5. 
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TABLE 3. 5 SUMMARY OF THE DICHOTOMY BETWEEN QUANTITATIVE AND QUALITATIVE PARADIGMS BASED ON 






Description One Truth 
Objective 
Exists independent of human 
perception 





Socially constructed and 
always changing 
Humans are an intrinsic part 
of that reality 
Investigator interacts with 
object of study 
Findings created within the 




Highly Structured Protocols 






Sample Size Large Small purposeful, not meant 
to be representative of large 
populations 
 
Sale, Lohfeld et al. (2002) go on to describe differences in the language which is used in these 
two paradigms which go beyond the philosophical and methodological debates.  Quantitative 
language describes what is real out in the world and is an accurate reflection of this reality, 
whereas the language of qualitative research describes an interpretation of an individual or 








TABLE 3. 6 DIFFERENCES IN LANGUAGE USE IN QUANTITATIVE AND QUALITATIVE PARADIGMS 
Language Example 
Quantitative Meaning Qualitative Meaning 
Observational Work Case control studies Ethnographic emersion 
Validity Results agree with what is 
out there in the world 
An interpretation or 
description with which one 
agrees 
Research has shown… An accurate reflection of 
reality 
An interpretation which 
becomes reality 
 
The basic argument of the quantitative-qualitative debate is that the underlying philosophies 
and methodologies appear to be so oppositional that these paradigms are completely 
incompatible, and that any attempt to reconcile the differences would destroy the 
philosophical foundations of each paradigm (Lincoln, Lynham et al. 2011).  However, it has 
been argued that the different strengths and limitations of the quantitative and qualitative 
paradigms are complementary and using them together results in a richer understanding of 
the research conclusions than using one paradigm alone (Maxwell and Mittapalli 2010). 
 
Further consideration needs to be given to synthesising of the methods. Creamer (2017) 
describes mixing as the linking or merging of qualitative and quantitative components of a 
mixed methods study which is not present if those strands do not come together. Teddlie and 
Tashakkori (2010) describe that a study which incorporates qualitative and quantitative 
elements, but those components do not link together as a quasi-mixed methods study.  
Therefore, central to a mixed methods study is the synthesizing of the qualitative and 
quantitative elements with at least one point of integration, or the point of interface 
(Schoonenboom and Johnson 2017).  This is the point at which those qualitative and 
quantitative elements are linked.  Teddlie and Tashakkori (2009) describe four points in the 
research process in which integration can take place: the stage of conceptualisation of the 
study; the data collection stage or methodological design; the data analysis stage and the 
inferential or findings stage.  Schoonenboom and Johnson (2017) considered that this 
description needed further refinement, and based on the definition by Guest (2013) they 
define the point of integration as being any point in a study where two or more elements of 
the research methods are linked in some way.  Thus, the study presented in this thesis can be 
described as truly mixed methods.  This study was designed in three phases, each phase 
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dependent on informing the next phase and method.  Phase I was designed as a national 
survey; a questionnaire was developed and the Royal College of Nursing Rheumatology Forum 
was engaged to distribute the questionnaire to its members in order to capture as wide a 
response as possible.  This allowed a general exploration of how nurses are trained to give 
information about Methotrexate to patients in consultations.  This phase then integrated with 
the next phase of the study, Phase II, the semi-structured interviews.  The findings which 
resulted from Phase I contributed to the development of the interview schedule for Phase II.  
Having a broad understanding of how nurses are trained and how confident they are in their 
role, was integral to the interview schedule as it allowed the researcher to explore, in more 
depth, the experiences and perspectives of the training the nurses had and how they felt 
about it.  It also added greater depth to the interview as the researcher was also able to 
explore how confident the nurses were and how they viewed their interactions with the 
patients.  The final phase of the study, Phase III the video-recordings, added another 
dimension to the research.  The first two phases contributed to the general and the nurses’ 
personal perspectives of the phenomenon under study, but Phase III contributed to the actual 
perspective.  The video-recordings allowed the researcher to visualise and score the 
phenomenon resulting in findings which informed and supported the first two phases of the 
study.  Schoonenboom and Johnson (2017) consider that the merging of data sets and the 
connecting of the findings from one set of data collections to a second set of data collection 
constitutes points of integration.  Thus, it can be argued the study presented in this thesis is a 
truly mixed methods study with points of integration as described above.  
 
3.6 Phenomenology 
A phenomenological methodology was applied in the design and analysis of Phase II of the 
project. The concept of phenomena as a philosophy began to take shape in the 18th and 19th 
centuries where things took place in the mind, rather than being observable realities (Smith 
2008, Converse 2012). Immanuel Kant, who was a German philosopher in the later 18th 
Century (Smith 2011, Converse 2012), believed that a phenomenon was a manifestation in the 
human mind which was separate from reality and not perceived by human senses. Hegel et al 
(1977) considered that phenomenology was the way to study the journey from natural 
consciousness to real knowledge. Jasper (1994) proposes that the beliefs which underpin the 
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nature of phenomena are reality, subjectivity, and truth summarised in Table 3.7. 
 
TABLE 3. 7 PHENOMENOLOGICAL PERSPECTIVES (JASPER 1994)  
Feature 
Belief 
Phenomena Objects and events as they appear with the assumption that there is 
a world, and that it is social in nature 
 
Reality Expected to be subjective and perspectival, reality is a matter of 
appearances 
 
Subjectivity As one resides in the world, it becomes real through contact with it, 
this knowledge then shapes experience 
 
Truth This is a combination of realities and these realities are read through 




Phenomenology seeks truth and logic through critical and intuitive thinking (Jones 2001) 
therefore it is a means of discovering human experience going beyond factual accounts 
seeking to give meaning to the experiences of individuals. Husserl, a German philosopher 
(1859-1938) (Converse 2012) considered that in order to reach real knowledge, the researcher 
must strip away their own pre-conceptions about a phenomenon, to revel the true essence of 
that phenomenon. This approach is viewed as a trademark of Husserlian phenomenology 
(Flood 2010) and Oiler (1982:181) wrote that the ability to bracket allowed the researcher to:  
“…look(ing) at the experience with wide open eyes, with knowledge, facts, theories held at bay; 
concentrating on the experience is absolutely necessary. becoming absorbed in the 
phenomenon with being possessed by it, is equally important”. 
However, Heidegger, who studied under Husserl, took phenomenology into a different 
direction. He believed that the person and their experiences were an integral part of the world 
and therefore contributed to that knowledge. He developed the “Hermeneutic Circle” (Figure 
3.6) in which the researcher must be aware of his own conceptions or his “fore-having; fore-
sight and fore-conception” (Heidegger, Macquarrie et al. 1962). 
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Thus, the researcher’s own feelings and judgements are part of the world and the 
phenomenon. Instead of adopting a reductionist approach to phenomenological research as 
argued by Husserl by “bracketing out’ preconceived assumptions, Heidegger shifts the focus of 
the researcher from revealing the essence of the phenomenon to understanding the 
phenomenon in relation to the researcher (Converse 2012). 
 
Heideggerian phenomenology contributes to nursing research as it revels the descriptions and 
meaning of experiences of the people who are the focus of study (Pratt 2012) and was 
therefore considered an appropriate methodology for this project. Phase II of the project 
aimed to understand the experiences of the nurses who were undertaking the Methotrexate 
education consultations and what that experience meant to them. This methodology is 
becoming increasingly relevant to nurse researchers; a fundamental element of nursing 
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practice is the embracing of holistic care, being a patient advocate and providing support both 
physical and psychological to patients, their families and carers and valuing all of the life 
experiences of these people (Moxham and Patterson 2017). Nurses generally have an 
instinctive desire to understand the patients they are caring for, and ultimately want to do 
their best for them (Berkowitz 2016). Therefore, the personal perspectives and lived 
experiences of the nurse researcher would be more aligned with the Heideggerian 
phenomenological standpoint to reach a deeper understanding of the experiences of the 
subjects under study. 
 
The key elements of phenomenology are described by Proctor (1998) as a belief that the world 
is socially constructed and subjective and individuals give meaning to their own world view.  
Proctor believes that the purpose of phenomenological research is to deepen understanding 
of the perceptions and meanings which individuals hold, and that the researcher becomes 
part of the environment under exploration. Proctor also considers that in phenomenology the 
research is neither value free or objective and findings emerge from the field under study 
which results in understanding rather than generalisability.  
 
3.7 Trustworthiness of Qualitative Research 
There are no formulas for working out which qualitative research method to adopt and which 
approach to take when designing a research study, however a number of approaches have 
been developed to assess qualitative research work. Dixon-Woods et al (2004) acknowledge 
that qualitative research can make a significant contribution to healthcare services but they 
recognise that there has been a tendency to treat it as a unified field, which does not take into 
account the number of different methodological approaches which can be utilised. 
  
The trustworthiness of qualitative results is often criticised as being open to manipulation by 
the will of the researcher, for example, how it can be demonstrated that themes and quotes 
extrapolated from the data are not reinforcing a pre-existing view. In contrast, the overall 
impression is that quantitative results are more objective as they are generally based on 
numbers and statistical analysis. Quantitative studies are, however, equally open to biased 
interpretation. For example, a researcher could be selective with the analyses reported, and 
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figures could be manipulated in such a way as to achieve the researchers overarching aims.  In 
the pharmaceutical industry, the opportunity to bias study results has been minimised by the 
registration of these studies with pre-specified analyses and the availability of the raw data for 
scrutiny (Ioannidis, Greenland et al. 2014).   
 
Various recommendations have been made about how to build “trustworthiness “ into 
qualitative research and COREQ have published a checklist of 32 items for people reviewing 
papers for publication (Tong, Sainsbury et al. 2007).  These 32 items were developed to 
promote clear and complete reporting of qualitative work. However, they only reviewed work 
around semi-structured interviews and focus groups as they considered that these were the 
two most common methods used for qualitative data collection. Whilst the 32 items they 
developed are useful, they are limited as they rely on face-to-face contact. However, this 
checklist was a useful guide for Phase II of the study presented in this thesis a completed 
checklist (see Appendix 6). 
 
Houghton et al published a nursing perspective on rigour in qualitative research and describe 
strategies that could be applied to build trustworthiness into qualitative research (Houghton, 
Casey et al. 2013) including triangulation, comparing data from at least two sources for 
agreement,  peer debriefing, the on-going discussion of the study with people unrelated to 
data collection which could be in the form of a  presentation at a conference or discussion 
with a supervisor.  Member checking is the process of checking with the participants that they 
agree with the findings of the study. Reflexivity is a process of self-reflection by the 
researcher concerning how their own beliefs, experiences and perspectives may have 
influenced the findings of the study.  Thick description relates to ensuring that there enough 
of the raw data has been described to allow the reader to judge the conclusions and the 
transferability of the study findings.    Hadi and Closs (2016) describe a similar list of features 
and suggest that a study should use at least two of these. Peer debriefing has been carried out 
throughout the study presented in this thesis.  Regular discussion has been maintained with 
the researcher’s supervisor and emerging findings have been presented at national 
conferences (Robinson, Ryan et al. 2015).  Triangulation of data has also been applied to this 
study; the Phase III data resulting from the video-recordings was analysed using three 
methods, thematic analysis (see Chapter 5 section 5.16.1), Medical Interaction Process System 
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(see Chapter 6 section 6.4.4) and analysis using the Calgary Cambridge scoring (see Chapter 6 
section 6.4.3).  Further, the researcher described a reflexive account in order to maintain 
transparency and highlight any potential biases which may have been introduced to the study 
and findings (see Chapter 3 section 3.10). Hadi and Closs (2016) went on to analysed ten 
qualitative studies consisting of interviews or focus groups with thematic and framework 
analysis and found that the most commonly used strategy was thick description in nine of the 
studies and peer debriefing in five. To this list, Morse (2015) added “negative case analysis” 
reviewing outliers who have a non-typical standpoint. Detailed review of these can give a 
more robust view of the “norm”; clarifying research bias in other words, have the research 
participants been identified in an appropriate manner? External audits Morse suggests are 
only appropriate for “suspect” studies where the results are “too good to be true”. Morse also 
discusses using standardised codes for analysis, which would be used in all similar studies. This 
would certainly make the results more reliable but at the price that insights that would have 
been available with interpretive coding would be lost. Morse recommends five strategies for 
establishing reliability in qualitative research (Table 3.8). 
 
TABLE 3. 8 STRATEGIES FOR ESTABLISHING REALITY IN QUALITATIVE RESEARCH (MORSE 2015)   
Strategy 
Reliability Comments and Cautions 
Development of a 
coding system and 
inter-rater reliability 
Only for semi-structured interview 
research 
Coding system and code 
book are needed 
Member checks Does the researcher 
understand/interpret the 
participant correctly? 
You need to understand 
the participant 
Thick description Provides opportunity for seeing 
replication/duplication 
Interviews overlap, 
verifying the data set 
Peer review debriefing Could be an issue with team 
research 
 
External Audits Do not impact on reliability and 
are rarely used 
If done, it would be after 
the event, therefore too 
late 
 
The five strategies recommended by Morse (2015) appear to relate to semi-structured 
interview research. However, it could be argued that these strategies could be applied to the 
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analysis of video recordings. Whilst Morse seems to say that the development of a coding 
system which contains inter-rated reliability checks should only be used with semi-structured 
interview, this approach would work well with video-recordings. Indeed, these five strategies 
align with the Medical Interaction Process System developed by Ford et al (2000) which was 
used to analyse the video recordings in Phase III of this thesis. Morse (2015) also recommends 
an external audit, which may be too late as the study may have ended. However, Cope (2014) 
would say that the maintenance of an audit trail throughout the research activity, is key to 
enhancing the credibility of qualitative research. This audit trail would comprise of the field 
notes and decisions made by the researcher, during the research journey, this information 
would add to the validity overall conclusions and could be reviewed by others to determine if 
they would arrive at the same deductions. 
 
3.8 Insider Research 
Insider research refers to conducting research in an organisation or culture in which the 
researcher belongs (Hewitt-Taylor 2002).  Historically, insider research was undertaken in 
ethnographic studies in anthropology and sociology (Hellawell 2006).  However, insider 
research is now being conducted across many disciplines including nursing (Toy-Cronin 
2018).  A key advantage of insider research has been described as having the “pre-
understandings” that the researcher brings to the study and therefore have insights from 
the lived experienced  (Brannick and Coghlan 2007, Costley, Elliott et al. 2010). It could be 
considered to lend more credibility to the research as it has been undertaken by a member 
of the community under inquiry (Costley, Elliott et al. 2010). However, insider research can 
also be seen as problematic in that the researcher may have a personal and emotional 
investment in the study and could find it difficult to detach their own experiences from 
those of the participants which may impact on the study findings (Alvesson 2003). The 
individual motivations of the researcher are generally unknown, a reflexive statement on the 
effects of the researcher’s views and their connection to the research would acknowledge 
more transparency and strength to the results. Kitto et al (2008) recommend that throughout 
the study the researcher should maintain a reflexive perspective  adding to the transparency 
of the work.  
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There are arguments that undertaking a process of reflexive awareness, can result in a 
richer research inquiry (Brannick and Coghlan 2007, Finefter-Rosenbluh 2017).  Reflexivity is 
a process in which the researcher turns the inquiry to themselves, and takes responsibility 
for their own position within the research, being transparent about the effect they may 
have had on the data collection, participants and data interpretation (Berger 2015).  With 
reference to this thesis Phase I, was a national survey and whilst it is possible that the 
researcher would have been known by some of nurse participants, the insider viewpoint of 
the researcher did contribute to the development of the survey questionnaire.  Phases II 
and III of this study, did position the researcher as an insider, and thus a reflexive 
perspective was undertaken by the researcher and described in the following sections of 
this chapter. However, further discussion of the ethical considerations when conducting 
insider research will be discussed in the next section. 
 
3.9 Ethical Considerations 
It is beyond the scope of this thesis to present a full discussion of ethical considerations 
when undertaking research, therefore this discussion will centre on the ethical 
considerations of the study presented in this thesis. The twentieth century saw crimes 
committed against racial and ethnic groups and vulnerable populations in the name of 
research, as a direct result of this, a set of rules was developed to attempt to enforce good 
clinical practice when conducting research  (McGraw, George et al. 2010). In the 1990s the 
regulatory authorities for Europe, Japan and the United States formed the International 
Conference on Harmonisation Good Clinical Practice and developed guidelines for research 
and compliance with these guidelines ensures that rights, safety and well-being of research 
participants are protected (Kaur and Choy 2014). 
 
Informed consent is an essential part of the research process and should be given freely 
with full understanding of what is being asked of the participant.  Consent often takes the 
form of a written and signed statement by the participant and the researcher, but in some 
cases it can be implied, through completion of a questionnaire for example (Connelly 2014). 
Thus, consent for Phase I of this study involved implied consent, as this was given through 
the completion of the questionnaire by the participant.  A phenomenological methodology 
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seeks to investigate lived experiences, therefore consideration must be given by the 
researcher of the sensitivity of the data and how far the participant wants to self-disclose 
(Walker 2007).  The next two phases of the study presented in this thesis encompassed a 
phenomenological perspective, therefore the researcher developed Participant Information 
Sheets and Consent Forms, specific to that phase of the study to ensure that the 
participants were aware of the aims and objectives of the study and were therefore fully 
informed that their experiences and perspectives would be discussed.  A further 
consideration of informed consent is that participants must be aware that they can 
withdraw from the study at any time (Polit and Beck 2014) therefore this was written into 
the Participant Information Sheets.  A further ethical consideration considered for this study 
was that the researcher may have revealed behaviour by the nurses which could put 
patients at risk.  This was discussed in the Participant Information Sheets, and participants 
were made aware that should the interviewer have concerns they would be discussed with 
the participant immediately and would agree further action if necessary.  
  
Munhall (2012) argues that one of the most critical and ethical obligations of the researcher 
is to faithfully describe the experiences of the participants being researched.  Thus self-
reflection and external review by the researcher to identify beliefs, assumptions and 
preconceptions about the research topic is an important strategy in order to add 
authenticity to the resultant findings (Burns and Grove 2010).  
 
3.10 Reflexive Perspective of the Researcher 
Several authors believe in the value of revealing the reflexive position of the researcher 
undertaking the data collection and analysis in order to induce transparency and quality 
control (Payne and Payne 2004, Neale 2008).  Researchers need to be cognisant of their 
contributions to the research process (Palaganas, Sanchez et al. 2017).  Therefore, the 
following is a reflexive account of this researcher. 
 
I am a Specialist Nurse who has had no specific training for my role, and I have “learned on the 
job” gaining knowledge whenever it appeared.  My interests lie within the educational 
development of nurses once they have achieved their registration.  The field of Rheumatology 
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has advanced dramatically over the last 25 years, with new and effective, but toxic drugs now 
being used to treat patients.  (Kaneko 2013, Choy, Freemantle et al. 2019, Genovese, Kalunian 
et al. 2019) This resulted in the closure of Rheumatology wards in the UK, with most patients 
now being treated on an outpatient basis.   As a direct result of this, nurses now find 
themselves running outpatient clinics with their own patient lists, making treatment decisions 
and having a direct impact on patient care.  
  
As discussed, in Chapter 2 (section 2.4), nurses working in the field of Rheumatology, do not 
receive any specific training in order to become specialists within this area of Medicine (Royal 
College of Nursing 2009).  There is a strong reliance on the nurses themselves to seek out 
knowledge and apply it within their roles.  This often leaves those nurses, under confident and 
without any depth of understanding of Rheumatological conditions and their treatment.  The 
sources of information that Rheumatology Specialist nurses often use, are designed primarily 
to be used by patients.  It was this situation that prompted me to explore what was happening 
throughout the country, to understand if there were better learning opportunities in other 
Trusts and services, to determine if there were “gold standard” Rheumatology training courses 
that nurses throughout the country could attend.  I understood that this could be a mammoth 
task, therefore I refined my exploration and decided to take one aspect of patient care to look 
at in more depth.  Methotrexate is a widely used drug in the treatment of Rheumatology 
conditions, particularly Rheumatoid Arthritis.  It is a toxic drug and requires the patient to 
understand why they are taking it, how to take it and to recognise possible side effects and 
take appropriate action.  It is one of the prime responsibilities of the Rheumatology nurse, to 
ensure that the patient has this information, understands it and takes the drug appropriately.  
This was a task I had to perform when I became a Rheumatology Specialist nurse over 15 years 
ago.  I was given very little opportunity to gain any in-depth knowledge of Methotrexate and I 
had no training at all in conducting consultations with patients, which was not a satisfactory 
position to be in.  I therefore have a real understanding of undertaking this important function, 
without good training, and the feeling of under-confidence that emerged.  Further, because I 
understand the role, I was able to establish a common relationship with the nurses, which 
helped me to recruit them to be interviewed and video-recorded.  
Phase I of this study was to design the national nurse survey.  I reflected on my own 
experiences to develop the questionnaire used in the survey, how I gained knowledge about 
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Methotrexate, conducting consultations and drawing on situations I have commonly 
confronted.  The questionnaire was validated by Rheumatology nurse specialists at a regional 
meeting.  This ensured that the questions were clear, unambiguous, would commonly be 
confronted by other nurses and reduced any bias that I may have unconsciously contributed.  
An interview schedule was designed for the next phase of the study, in order to ensure that 
the same questions were put to the interviewees.  This interview schedule was also validated 
by experienced colleagues to ensure that the questions were pertinent to the research 
question. Whilst I may have consciously or unconsciously responded at times to the 
interviewee with head nods or umms and ahhs, this was consistent throughout each interview, 
but it may have added limited bias to the interviews.  
 
Throughout conducting this research project, I maintained awareness that my experience may 
not have been everyone’s.  I did understand however, those aspects of conducting a 
consultation with a patient when talking about Methotrexate, which can cause some pressure 
for the nurse.  For example, I understood that time limits create a lot of pressure on the nurse, 
to focus on the job in hand ie giving the patient the information about Methotrexate, which 
left little else for the nurse or patient to discuss.  I also understood the reticence the nurses 
had around being video-recorded.  Unlike other healthcare professionals such as Doctors and 
General Practitioners, who use video-recording to analyse their practice regularly, nurse do 
not, therefore they are less confident with this approach.  However, as I personally knew all of 
the nurses involved, they were more comfortable agreeing to be video-recorded.  They were 
all confident that I would protect their identities and destroy the recordings when the analyses 
were complete.  They were also aware, that if I identified anything during the analysis of the 
recordings, that required their attention, I would approach them first and discuss and plans of 
action that may have been required.   However, this was not required.  In order to maintain a 
comfortable environment for the nurse and the patient, the video was set up and left in the 
room, whilst I waited outside.  The objective of this was to create less pressure on the nurse 
and therefore reduce the awareness that she was being video-recorded.  I found that after the 
first few minutes, the nurse and patient reported that they forgot the video was in the room.  
However, having an awareness of the pressure and feelings of the nurses helped me to 
understand the nurses’ behaviour in a way that other researchers may not relate to. 
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Whilst I did, at all times, try to be aware of my own position, experience and feelings, it is 
possible that some bias did creep into the resultant analysis, however, this would have been 
consistent throughout the data gathering and analysis process and therefore, in my opinion, 
would have limited impact on the conclusions. 
 
3.11 Chapter Conclusion 
The overarching aims of this study required three phases in order to explore these goals.  This 
study was designed with critical realism as the underpinning philosophy as it was felt to be the 
most appropriate for the study.  As discussed in this chapter, critical realism explores three 
domains, the real, the actual and the empirical.  When applied to this study, the real domain 
reflects Phase I, the national questionnaire which seeks to determine how nurses are trained 
and to test their knowledge of Methotrexate.  The second domain, the actual, is represented 
by Phase III, the video-recordings to identify the actual processes which take place when 
nurses give information to patients about Methotrexate during their consultations and the 
third domain the empirical, is represented by Phase II, the semi-structured interviews, which 
seek to explore the feelings and perceptions of nurses when they conduct this role.  Further, 
the methodological approaches to the analysis of the semi-structured interviews and video 
recording transcripts adopted a phenomenological position.  This seeks to understand the 
experiences and feelings of individuals within the world scene. The researcher adopts a 
reflexive position to understand their own perspectives and experiences and how this may 
affect the research.  Further, as an insider researcher, this reflexive position of the researcher 












Chapter 4: Phase I  – A national survey of nurse training: 
confidence and competence in educating patients 
commencing Methotrexate therapy  
 
4.1 Introduction 
This chapter begins by expanding on the previous literature review with a particular 
emphasis on the role of the Rheumatology Specialist nurse.  This role evolved during the 
1980s, with nurses taking on tasks such as assessing joint for tenderness and swelling, 
mobility and function (Bird 1981).  The introduction of new drug therapies for the treatment 
of Rheumatoid Arthritis led to increasing specialisation for Rheumatology Specialist nurses 
and they began to take on the role of managing patients on these revolutionary and life 
changing drugs (Hill 1992).  These roles further developed and nurses took on prescribing of 
drugs and teaching medical students (Goh, Samanta et al. 2006), by 2009 nurses were also 
carrying out cognitive behavioural therapy and biomechanical assessments (Royal College of 
Nursing 2009).  It also showed that whilst there is general recognition amongst nurses of the 
importance of shared decision-making and the impact of this on patient education (Hoving, 
Visser et al. 2010, Flanders 2018, Sassen 2018), it was not clear how the nurses gained their 
knowledge regarding how to implement this in a consultation with patients.  There appears 
to be a general paucity of research that has been undertaken to investigate Rheumatology 
Specialist nurses’ knowledge with regard to their preparedness for the specialist roles, 
which have developed over the last 40 years.  The literature clearly reveals that effective 
patient self-management led to more effective care and patient empowerment  (Bain, 
Sangrar et al. 2016, Bearne, Manning et al. 2017, Garattini and Padula 2018) but the 
learning pathways available for nurses to gain the skills to guide, teach and support patients 
to embrace self-management is, again, not clear in the literature.  A survey conducted by 
Mathijssen et al (2020) explored the knowledge attitude and experiences of shared 
decision-making of doctors and nurses in Rheumatology. Their findings showed that 100% of 
nurses recognise the importance of putting the patient at the centre of care through shared 
decision-making, however they concluded that they were experiencing problems putting 
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this into practice.  What was not clear was how the nurses were trained to conduct 
consultations and give information to patients.  Reviews of literature regarding the 
knowledge that Rheumatology Specialist nurses have about Methotrexate, showed that 
most studies explored patient knowledge rather than nurse knowledge.  The studies around 
patient knowledge of Methotrexate showed that there is a general lack of understanding of 
the side effects of the drug and how to report these side effects (Sowden, Hassan et al. 
2012, Fayet, Savel et al. 2016).  Whilst it is beyond the scope of this thesis to determine 
exactly why many patients appear not to have a clear understanding of the possible harmful 
side effects of Methotrexate, it could be speculated that one of the contributory factors 
could be how the information has been given to the patients. Thus, this phase of the study 
aims to contribute to the extant body of work by exploring though a national questionnaire, 
how nurses gain knowledge about how to give information about Methotrexate, how 
confident they are in this role and how long it takes to become confident.  The 
questionnaire will also explore nurse knowledge of Methotrexate through some scenarios 
which would commonly be encountered by nurses.  
 
Questionnaire surveys have been utilised by researchers to determine knowledge of drugs;  
in 2001 Latter et al (2001) recognised that nurses had a potentially important contribution 
towards the education of patients about medications and carried out a national survey of 
student nurses on their knowledge of drugs and their attitudes towards patient education.  
The results of their study demonstrated that there was little opportunity to apply their 
knowledge and to gain experience and the attitude seemed to be that they would learn on 
the job. Courtenay and Carey (2008) carried out a national questionnaire survey of diabetes 
nurses who were prescribing medication.  The aim of the survey was to determine how 
educationally prepared nurses were for prescribing because:  
 
“there was very little or no evidence on the prescription of medicines by nurses for people 
with diabetes or whether nurses feel prepared for this role” (Courtenay and Carey 2008:404).   
 
The authors recognised that nurses had varying levels of expertise and were working in a 
variety of clinical roles.  All nurses surveyed had undertaken a medication prescribing 
course.  Interestingly, of 439 questionnaires analysed, 45% of respondents did not have 
formal qualification in Diabetes; their education was through study days and in-house 
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training by shadowing a nurse or doctor in their department, which shows a similarity to 
Rheumatology Nurse training. They found that approximately 50% of the questionnaire 
participants felt that their needs were not met by the prescribing course they had 
undertaken.  A further survey in Diabetes was conducted by Hollis et al (2014) to explore 
whether practice nurses had enough knowledge to provide self-management education to 
diabetic patients.  Like Rheumatoid Arthritis, Diabetes is a chronic disease, which requires 
life-long medication and management.  They designed a questionnaire to collect 
demographic data, and 14 multi-choice questions addressing diabetes pathophysiology, 
blood glucose levels and monitoring, dietary issues and medication management.  They 
found that there was a lack of knowledge in some areas of dietary advice and that 
medication knowledge was poor, despite pharmacotherapeutics being a mainstay of 
diabetes management.  They concluded that those nurses that had undertaken a 
postgraduate course had scored better, but there was a general lack of education 
preparedness for this role.  However, they did not specify what kind of training the nurses 
had undertaken or how many of their study population had completed courses or had just 
learned on the job. Surveys have also been carried out around perceptions of the 
Rheumatology nurse’s role (Goh, Samanta et al. 2006, Royal College of Nursing 2009).  
Phase I of the study is the first national survey examining the education and knowledge of 
nurses in Rheumatology who educate patients about Methotrexate. The survey was 
necessary because nurses had expressed variable confidence in their educational role (Royal 
College of Nursing 2009) and the use of Methotrexate had increased dramatically over the 
last twenty years. Discussions with other Rheumatology Specialist nurses at national 
conferences, workshops and meetings, had highlighted that training for nurses performing 
this role is necessary, that it is often organized locally and varies in content, but there is a 
dearth of published material to support this view. 
 
An aim of the questionnaire survey was to determine the basic knowledge that 
Rheumatology Specialist nurses have about Methotrexate.  Much of the information that 
the patient needs to effectively and safely take drugs like Methotrexate is contained in 
patient information leaflets such as that produced by Arthritis Research UK now Versus 
Arthritis (2019). To educate a patient effectively, a nurse will need to understand this 
information, have the skills to enable the patient to understand it, and have the knowledge 
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and understanding to answer the patient’s questions and recognise concerns that they may 
not verbalise as well as provide the opportunity to address any lay beliefs about 
medications. Therefore, the questionnaire survey explored how far the nurse used this 
information leaflet when giving information, and determined if the nurses utilised other 
information sources.  Effective patient education is important; Jones et al (2011) recognise 
that effective patient education enhances knowledge and understanding of disease which 
could affect their confidence in shared decision-making and self-management.  They also 
reported that the failure to provide information for patients about their condition is one of 
the most frequent sources of complaint.  They also go on to state that whilst healthcare 
professionals are well informed, they have rarely been trained to provide patient education 
and therefore they designed a course in Oncology to try to address this gap.  In the field of 
coronary care, Svavarsdottir et al  (2016) report a similar gap in the skills of healthcare 
professionals and they conducted a study to investigate healthcare professionals’ views on 
the knowledge and skills required to give effective patient education.  They interviewed 19 
healthcare professionals including nurses who worked in cardiology, they all agreed that 
advanced knowledge was important, and some informants implied that educating and 
counselling relied on those skills that were picked up through experience. Svavarsdottir et al 
concluded that effective training is needed for healthcare professionals to acquire the 
competencies which would enable their patients to better manage their disease. 
 
To reiterate, this phase of the study aims to contribute to the body of work undertaken on 
nurse training and identify how Rheumatology Specialist nurses are currently trained to 
carry out their role in order to give information on Methotrexate to patients and what 
information sources they use to support their role.  Furthermore, it aims to reveal how 
confident nurses are in actually undertaking this responsibility and how long it takes for 
them to become confident.  Additionally, an exploration of the level of knowledge nurses 
currently have about Methotrexate was undertaken to identify the level of competency they 
have when counselling patients about Methotrexate.  This survey will inform the later 
phases of the study, particularly the interview schedule. 
 
As outlined in Chapter 3 (section 3.4), the philosophical underpinning of this study is critical 
realism. Within this philosophical framework, phase I of the study represents the 
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investigation of the real domain (figure 4.1). The next section of this chapter reports the 
methods used to design the questionnaire and collect data.   
FIGURE 4. 1 INVESTIGATION OF THE REAL DOMAIN- QUESTIONNAIRE 
 
 
4.2 Aims and Objectives of Phase I 
 
4.2.1 Aims  
The aims of the national survey were to explore the training that Rheumatology Specialist 
nurses had received for educating patients about Methotrexate.  Further, to identify their 
confidence in conducting this role and to evaluate their knowledge around clinical situations 




1. To obtain data regarding training, qualifications and experience through a national 
questionnaire. 
2. To gauge nurses’ views regarding confidence and the time it takes to become 
confident in conducting this role. 




4.3.1 Study Design 
In order to capture the responses from Rheumatology Specialist nurses from a wide 
geographical area, a questionnaire was developed.  The questionnaire was designed to 
collect quantitative and qualitative data, using closed and open questions. This 
questionnaire was informed by a review of the literature, as described in Chapter 2 carried 
out for this thesis. The use of questionnaires in healthcare is increasing (Rattray and Jones 
2007, Gupta, Nayak et al. 2015) in order to capture data on areas such as beliefs, training 
and knowledge.  The rationale for adopting a questionnaire design for this phase of the 
study was to ensure it was generalisable across practice in England and collect as much data 
as possible over the widest geographical area using an on-line platform. This phase 
represented the real domain of critical realism and aimed to explore how nurses were 
trained and test their knowledge of Methotrexate on a national level.  The domains of the 




3.  Time to become Confident 
4. Knowledge 
 
Demographic data were not collected as it was not considered that it would add to the 
exploration of the aims of the study, however the year that the nurse had obtained their 
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registration was collected, as the length of time the nurse had been qualified may relate to 
confidence.  The content of the domains was more difficult to determine as relatively few 
questionnaires have been carried out on Rheumatology nurse training.  However, the RCN 
questionnaire (2009) was a starting point as it explored the performance and activities of 
Rheumatology Specialist nurses.  It addressed questions around years working in 
Rheumatology and qualifications since nurses’ graduation and a section on competencies 
and confidence.  Whilst the RCN questionnaire was more detailed, it generated guidance in 
the design of this study questionnaire.  The domain on knowledge was developed from the 
extant literature on the side effects of Methotrexate, discussed in Chapter 2 (section 
2.3.3.1) of this thesis.  The side effects of Methotrexate can be diverse and occasionally life 
threatening  (Gaies, Jebabli et al. 2012) therefore nurses require a competent knowledge of 
these.  Consequently, the survey questions on knowledge were based on common problems 
which have been identified in the literature (Gilani, Khan et al. 2012, Ledingham, Gullick et 
al. 2017).  
 
4.3.2 Questionnaire Design   
A survey is a complex communication process between the researcher and the participants 
where the results of the interaction lead to shared understanding and meaning (Lietz 2010). 
There needs to be agreement about what to ask within the framework of the research 
questions, then the questions are developed which encode the request for information, finally 
participants decode this stimulus and provide an answer. The researchers then decode the 
answer from the participant and derive meaning from it (Hunt, Sparkman Jr et al. 1982). 
Another perspective starts with a cognitive approach to surveys, where responding to surveys 
involves a number of phases of reasoning and information processing (Aday and Cornelius 
2006). It also relies on a truthful judgement from the participant and their motivation, and the 
respondent’s answer is co-ordinated with the questionnaire categories (Holbrook, Cho et al. 
2006, Lietz 2010). The use of surveys in healthcare research is on the increase (Piko 2006, 
Rattray and Jones 2007, Delobelle, Rawlinson et al. 2011, Gupta, Nayak et al. 2015) and nurse 
researchers often use questionnaires to measure domains such as knowledge, attitudes, 
emotion, cognition intention and behaviour. This approach allows the researcher to capture 
the self-reported interpretations of the participant and is often used to measure patient 
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observations of health care (Rattray and Jones 2007).  
 
There are a number of considerations which should be considered when developing 
questionnaire items.  For example Holbrook et al  (2006) identified that longer questions could 
increase the demands on memory for a participant affecting their response, however, a longer 
question may be the result of the researcher taking time to clearly describe the intent of the 
question and this could result in less cognitive demand. It is also suggested that responders 
interpret a question as it is read, and may not reach the end of the question before 
responding. Questions which require higher reading levels could result in greater 
understanding of difficulties as they require more cognitive resources. However, it could be 
said that these questions may be explained more fully allowing the participant to comprehend 
the question better. Abstract questions are those which are not related to a specific context, 
they may be ambiguous or vague which could affect the respondent’s ability to comprehend. 
There are also a variety of formats which can be used for questionnaire items, for example 
open ended questions, closed questions, yes/no, Likert scales. Confusion could arise where 
the response is not clear, for example “sometimes” “occasionally” “somewhat” participants 
may interpret those responses differently. Similarly questions with a numeric response could 
present a challenge for the responder appearing confusing or being misinterpreted. Qualified 
judgement, questions where the time frame is qualified for example; “in the past five years 
have you…” or “how much pain have you had in the past week…” can pose problems for the 
responder as they have to both keep in mind the question and yet qualify their judgement 
when answering. 
There are a number of advantages to using questionnaire surveys as a research method 
(Gillham 2008).  A lot of information can be captured relatively quickly, and the participants 
can take as much time as they need to complete their responses.  The analyses of closed 
questions with a definitive response are straightforward and participants can remain 
anonymous if this is built into the survey.  All participants answer the same questions and they 
can provide data to test a hypothesis.  
Gillham (2008) also describes  some disadvantages of questionnaires as some participants may 
not complete the whole questionnaire.  Motivating potential participants to complete the 
questionnaire may be problematic and could result in a low response rate.  Questions could be 
 121 
misinterpreted and cannot be corrected therefore the wording of questions can have a major 
impact on the answers given.  There could also be issues with language, literacy and cultural 
influences.  Further, the spoken word enables people to give richer and deeper responses to 
questions rather than the written word.  It can also be difficult to check the honesty of 
responses and thus could reflect on the accuracy of the results. 
It is therefore important to consider the context of the questions in survey design, and ensure 
that the wording and length of the questions is appropriate for the target audience in order to 
ensure that the resulting data is as meaningful as possible (Lietz 2010). Because of these 
potential limitations in terms of data reliability, pre-survey testing is essential in order to iron 
out any problems before the questionnaire goes live. It allows the researcher to re-visit and 
refine the questions to ensure, as far as possible, that the resulting questionnaire results are as 
reliable as possible and limit the possible responder misconceptions (Gillham 2008).   A pre-
survey was carried out for the study presented in this thesis in order to test the validity of the 
questionnaire and make any necessary changes and is described in more detail in this Chapter. 
Whilst the study questionnaire was developed by the researcher it was further commented on 
by two Rheumatologists and a Consultant Rheumatology nurse. Their experience in the field of 
Rheumatology was an important contribution to the first draft of the questionnaire.  The 
questions were developed by the researcher and were based on situations which are 
commonly confronted by nurses who manage patients on Methotrexate.  The questions also 
described situations which illustrated the common side effects and contraindications to 
Methotrexate. None of the questions had been used in other surveys; they were unique to 
this study.  The questionnaire consisted of 26 questions which were divided into: 
 
1. Background information about the participants (how many patients per week they talk 
to about Methotrexate, number of years they had been doing this role, number of years in 
Rheumatology, year of qualification). 
2. Training to carry out the role of giving information to patients about Methotrexate 
(what training took place, was it helpful, would more training have been useful and if so what 
kind of training, confidence to carry out the role, how long this took, what written information 
the nurses used and the usefulness of the information). 
3. Assessment of knowledge. 
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An open question was designed to captured data on a description of any prior training that 
had been undertaken by the Rheumatology Specialist nurse.  This allowed the participant to 
describe their perception of how they had been trained and their experience of this could 
then be related. Confidence was evaluated using an eleven-point Likert scale, with zero 
being no confidence and ten being extremely confident.  An 11-point Likert scale was 
adopted as it is easily comprehensible from zero to ten and the increased number of points 
make it closer to reality (Wu and Leung 2017). Knowledge was assessed using a closed 
format in the form of 12 scenarios based on clinical situations with a range of possible 
responses but only one correct answer. These two closed-question techniques allowed the 
responses to be captured numerically and therefore datasets could be compared.   
 
4.3.3 Questionnaire Validity – Pilot Study 
The questionnaire was piloted with a group of ten nurses at a regional Rheumatology 
meeting in order to check for face validity (Gillham 2008). The questionnaire was generally 
well received and the nurses felt that it was easy to complete.  The modifications were 
confined to the clinical questions section where one ambiguous case was removed and two 
new cases added. The clinical cases focussed on scenarios relating to out-of-range blood 
tests, antibiotics which are not compatible with Methotrexate, when to stop Methotrexate 
before pregnancy, and what to do in a patient with shingles. These are common scenarios, 
which would be encountered by the Rheumatology Specialist nurse.  The nurses all agreed 
that these were common and appropriate questions, however, the wording of some of the 
questions on the questionnaire were modified in response to their comments, thus ensuring 
that the focus of the questionnaire remained valid and understandable.  The final 
questionnaire (see Appendix 7) was uploaded onto the Survey Monkey site, this web-based 
survey tool was chosen as it could capture a geographically wide sample of the target 
population and yield the highest number of responses possible (Chang and Vowles 2013). 
 
4.4 Electronic Platform – Survey Monkey 
Consideration of how the questionnaire survey was to be administered required some 
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attention. It is relatively easy to mail out or hand out questionnaires, but it is quite another 
thing to have them returned. A postal questionnaire study was undertaken by Jenkinson et al 
(2002), 3592 questionnaires were posted out to patients’ home addresses, after two 
reminders were sent out, 2249 (65%) of questionnaires were finally returned. It could be said 
that this was not only costly, but time consuming not to mention that the patients had to get 
to a post box to return the questionnaires. Other researchers have opted to use an electronic 
tablet to capture responses to questionnaires (Parker, Manan et al. 2012) as they recognise 
that postal surveys can result in poor response rates. However, the barrier to this method is 
that the researcher has to be on site, capture each participant individually and there is a limit 
to geographical extent. Online survey tools are becoming a much more common platform to 
conduct healthcare research (Strickland 2012, Gill, Leslie et al. 2013, Merolli, Sanchez et al. 
2014). There are many advantages to using online surveys as they are cost effective, quick to 
send, can easily reach the target population over a wide geographical area, participants can 
remain anonymous, reminders can be sent at no cost and results are collected in electronic 
format which makes it easier to build into databases and analyse the data.  There are however 
some disadvantages, such as they require an email address for potential participants, they are 
difficult to police, in that questionnaires could be completed by participants who are not in the 
target population.  It is easy for potential participants to ignore, miss or delete emails and 
without direct contact it could be difficult to motivate potential participants to complete the 
survey. The public and health professionals engage much more with the internet to discuss 
and investigate healthcare (Hamm, Chisholm et al. 2013, Moorhead, Hazlett et al. 2013, 
Denecke, Bamidis et al. 2015).  One of the most common internet platforms is Survey Monkey. 
It is commonly used for market research but it can be used in a number of different domains 
including healthcare (Waclawski 2012). It is an online survey system with many design options 
and can be administered in different ways, such as by email or social media. Data collected can 
be downloaded, responses can be shared and reports can be created. It has many features 
which allow the researcher to send out and capture data effectively and ready to analyse.  
 
4.5 Participants and Sampling 
There are no national databases of Rheumatology Specialist nurses, therefore a web link to 
the survey was distributed through the online Royal College of Nursing (RCN) Rheumatology 
 124 
Nurse Forum and the RCN newsletter.  It was also sent to potential participants and 
colleagues within the UK known to the researcher in order to access as many Rheumatology 
Specialist nurses as possible. Participants were asked to forward the link to colleagues with 
a similar role.  The survey was also distributed at a national meeting of the British 
Healthcare Professionals in Rheumatology (BHPR). There was no limit on how long the 
nurses had been working in Rheumatology.  
 
4.6 Data Collection 
 
4.6.1 Ethical Approval 
Ethical Approval for phases I and II, was obtained from the NRES Committee North East – 
Sunderland in 2013 REC Reference 13/NE/0092 (Appendix 8). Approval was also given by 
Northumbria Healthcare Foundation Trust on 09/07/2013 to act as study Sponsor (Appendix 
9).  In accordance with Good Clinical Practice Principle (European Medicines Agency 2016), 
participant consent was implied through their voluntary action of completing the on-line 
questionnaire.  
 
4.7 Data Analysis  
The survey data were uploaded onto an Excel database and percentages for each response 
were calculated. Pearson’s correlations were calculated to establish any correlations 
between confidence, knowledge, amount of training, time in education role and time to 
become confident. The alpha level was set at 0.05 for all statistical tests. Knowledge 
questions which had a correct or incorrect response were score by giving each correct 
answer one and zero if the response was incorrect.  Qualitative data which was obtained 
through the open ended questions were analysed using content thematic analysis described 
by Green and Thorogood (2018) as firstly developing conceptual definitions, secondly, 
developing typologies and classifications, thirdly to explore associations between attitudes, 
behaviours and experiences, leading to the development of explanations of phenomena.  
Thematic analysis is discussed further in Chapter 5 (section 5.16.1). 
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All n=values are given in brackets are the number of respondents answering the questions, 
as this was not constant throughout the survey. 
4.8 Results 
104 nurses began the questionnaire, but seven (leaving n=97) were excluded as they 
answered no to “do you advise/educate patients with respect to starting Methotrexate 
treatment?”  A further seven nurses (leaving n=90) dropped out of the survey in responses 
to “do you describe yourself as a Rheumatology Nurse Specialist?”  Three nurses (leaving 
n=87) dropped out when asked “did you have any training before you took on this role?”, 
and two more respondents dropped out (leaving n= 85) when asked “how confident are 
you?”  At the beginning of the knowledge questions one nurse (leaving n=84) dropped out 
before question 19, one respondent (leaving n=83) dropped out at question 23, five nurses 
(leaving n=79) dropped out at question 27 and finally one nurse dropped out at question 28, 
resulting in 74% (n=77) of the sample completing the survey.   All responses were included 
in the results; therefore, all values and percentages represented the total of the valid 
sample responses for that question.  Results are given as a percentage of respondents to 
each given question as well as number responding.  
 
4.8.1 Background Information 
68% (n=61) of respondents had qualified in the 1980s and 1990s, but they ranged from 1972 










FIGURE 4. 2 CHART SHOWING YEAR OF QUALIFICATION OF RESPONDENTS 
 
75% (n=68) of the valid sample (n=90) described themselves as Rheumatology Specialist 
nurses.  Whilst 25% (n=22) of respondents described themselves as nurses who were 
involved in the blood safety monitoring of Rheumatology patients, they did have a role in 
giving information about Methotrexate, but did not have any other role in the patient’s 
care.  63.9% (n=62) of valid respondents (n=97) had been giving information to patients 
initiating Methotrexate treatment for more than five years, 16.5% (n=16) of valid 
respondent had been doing this role for 1 – 5 years, 4.1% (n=4) had 6 – 12 months 
experience and 15.5% (n=15) of respondents had been giving information to patients for 
less than six months.   
Most nurses give Methotrexate information to 1 to 4 patients per week (Table 4.1). 
 
TABLE 4. 1 NUMBER OF PATIENTS PER WEEK THAT NURSES GIVE METHOTREXATE INFORMATION 
Number of Patients Seen per Week Responses (n=81) 
1 - 4 52 (64.2%) 
5 - 9 19 (23.5%) 
10 - 15 6 (7.4%) 
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4.8.2 Training  
Respondents were asked to rank their training on a scale from no training; some training or 
a lot of training (Table 4.2).  
 
TABLE 4. 2 AMOUNT OF TRAINING NURSES HAD 
Training Responses (n=87) 
No Training 12 (14%) 
Some Training 61 (70%) 
A Lot of Training 14 (16%) 
 
 
Aimed at those nurses who had received training, respondents were asked if it was helpful 
on a scale of no help; some help; moderately helpful or very helpful, 50% (n=38) considered 
that it was very helpful, whilst 22.4% (n=17) found it moderately helpful and 26.3% (n=20) 
found it of some help (Table 4.3).   The nurses were asked if they would have liked more 
training and 61% (n=53) of valid respondents expressed that they would.  
 
TABLE 4. 3 HELPFULNESS OF THE TRAINING 
Answer Options Responses (n=76) 
Very Helpful 38 (50%) 
Moderately Helpful 17 (22.4%) 
Some Help 20 (26.3%) 
No Help 1 (1.3%) 
 
 
In a four item-ranking question asking “what training do you think nurses need to educate 
patients about Methotrexate” (Table 4.4), of the 85 valid responders who completed this 
question 88% (n=75) of respondents considered that knowledge of Methotrexate was 
needed “a lot”.   
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TABLE 4. 4 WHAT TRAINING DO NURSES NEED  
Answer Options None A Little Some A Lot n= 
Communication skills 1 4 18 62 85 
Consultation skills 1 5 32 47 85 
Knowledge 1 1 8 75 85 
Experience 0 5 40 37 82 
 
 
Some respondents also commented that they would like training on needle safety and 
disposal of cytotoxic materials.  Also, further information on Rheumatological conditions 
and confidence in the drug itself underpinned by research evidence was added by some 
respondents. Seventy-three respondents described the training they had received, which 
included observing other nurses (n=23 31.5%), self-directed learning (n=18 25%) and 
observing Rheumatology clinics (n=10 15%). The results on training are summarised in Table 
4.5.  
 
TABLE 4. 5 REPORTED METHOD OF TRAINING RESPONDENTS HAD PRIOR TO COMMENCING THEIR DRUG 
COUNSELLING ROLE  
Main Training Method Number of respondents (n= 73) 
Observing – other nurses and self-directed 49 (67%) 
Observing – Rheumatologists Clinics 8 (11%) 
In-house chemotherapy course 7 (9.5%) 
In-house competencies 4 (5.5%) 
Rheumatology Course 4 (5.5%) 
Prescribing Course 1 (1.4%) 
 
 
4.8.3 Confidence  
The majority of the valid respondents (60%, n=51) for this question described themselves as 
‘very confident’ in this role, with 24% (n=20) of respondents reporting being ‘confident’ and 
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12% (n=10) of respondents being ‘somewhat confident’. 5% (n=4) of nurses were not 
confident at all (Table 4.6). 
 
TABLE 4. 6 CONFIDENCE OF RESPONDENTS IN THEIR ROLE 
Confidence Level Number of Respondents (n = 85) 
Very Confident 51 (60%) 
Confident 20 (23.5%) 
Somewhat Confident 10 (11.8%) 
Not at all Confident 4 (4.7%) 
 
 
The perceived time it took to become confident in the role was variable with 13% (n=11) 
confident in 0-2 months, 45% (n=38) in 3-6 months 20% (n=17) by a year, (a cumulative total 
of 78% (n=66) of the respondents) and for 21% (n=18) of respondents it took over a year. 
When nurses were asked if the way they gave information had changed from when they 
first started carrying out this role 42% said that it had “changed a lot” (table 4.7). 
 
TABLE 4. 7 RESPONSE TO HAS THE WAY NURSES GIVE INFORMATION TO PATIENTS CHANGED? 
Answer Options Number of Respondents (n=85) 
A lot 36 (42.4%) 
In some ways 41 (48.2%) 
Not at all 8 (9.4%) 
 
 
Participants were also asked to comment on the changes that had occurred (see Appendix 
10).  Many comments related to gaining experience, enhancing knowledge and learning 
from patient’s experiences which changed the way they gave information to patients.  Some 
comments centred around patient empowerment and giving information in short bursts, 
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repeating messages and no longer using prompts.  However, the use of checklists and 
proformas were also stated. 
 
4.8.4 Written Information  
Whilst most nurses reported that they gained confidence with time, most were using a 
variety of written patient information to support them in the process of giving information 
to patients about Methotrexate. Different sources of information were often used together. 
The Arthritis Research UK information sheet was used by 87% (n=74) and judged to be very 
helpful, but in-house information leaflets and information produced by the National 
Rheumatoid Arthritis society (NRAS) was preferred by some respondents (Table 4.8).  
 
TABLE 4. 8 WRITTEN INFORMATION USED BY NURSES 
Answer Options Responses (n=85) 
In-house Information leaflets 41 (48.2%) 
Arthritis Research UK Methotrexate leaflet  74 (87.1%) 
NRAS Methotrexate leaflet 22 (25.9%) 
 
 
Twenty-three respondents reported that they had used other information including the 
National Patient Safety Agency booklet, Royal College of Nursing booklet, checklists and 
diagrams.  The participants were also asked how useful this information was the results of 









TABLE 4. 9  USEFULNESS OF THE WRITTEN INFORMATION 
Answer Options Responses (n=85) 
Not useful 0 (0%) 
A little useful 5 (5.9%) 
Quite useful 21 (24.7%) 
Very useful 59 (69.4%) 
 
4.8.5 Knowledge  
Knowledge was investigated using 12 possible real-life scenarios, the results of which are 
presented in the Table 4.10 to 4.21 below. 
 
TABLE 4. 10 RESPONSE TO QUESTION 15 
Methotrexate is used to treat which of the following conditions? (tick all that apply) 
Answer Options Response (n=85) Answer 
Osteomalacia 1 (1.2%) Incorrect 
Rheumatoid Arthritis 85 (100%) Correct 
Psoriatic Arthritis 83 (97.6%) Correct 
Vasculitis 43 (50.6%) Correct 
 
 
Question 15 was well answered, with only one incorrect response.  Osteomalacia is a 
vitamin D deficiency, whereas Rheumatoid Arthritis, Psoriatic Arthritis and Vasculitis are all 








TABLE 4. 11 RESPONSE TO QUESTION 16 
A 61-year-old man with RA for seven years is going on holiday.  He normally takes 
Methotrexate 20mg weekly, folic acid 5mg weekly and atenolol 50mg for hypertension.  
Which of the following vaccinations should this patient NOT have?  (Tick all that apply) 
Answer Options Response (n=85) Answer 
Flu vaccination 1 (1.2%) Incorrect 
Tetanus 2 (2.4%) Incorrect 
Yellow Fever 85 (100%) Correct 
All of the above 0 (0%) Incorrect 
 
 
Question 16 was also well answered.  Yellow fever is a live vaccination and could cause 
illness in a patient who is immune-compromised with a drug such as Methotrexate (Perry, 
Winthrop et al. 2014). 
 
TABLE 4. 12 RESPONSE TO QUESTION 17 
A 45-year-old lady with RA for seven years arrives at clinic complaining that she has been 
very breathless for the last couple of days.  She has been taking her treatment as usual 
which comprises Methotrexate 15mg weekly, folic acid 5mg weekly, Sulfasalazine 2G daily 
and Cocodamol PRN.  Do you: 
Answer Options Response (n=84) Answer 
Tell her to go to her GP as you suspect a chest infection 10 (11.9%)  Incorrect 
Tell her to increase her folic acid 0 (0%) Incorrect 
Stop the drugs and refer to a Rheumatologist 74 (88.1%) Correct 
Tell her not to worry as this is normal whilst on 
Methotrexate 
0 (0%) Incorrect 
 
 
Question 17 was correctly answered by 88.1% (n=74) of the respondents.  Methotrexate can 
cause pneumonitis (Ledingham, Gullick et al. 2017) and sudden breathlessness needs to be 
investigated.  Whilst breathlessness could result from a chest infection, the correct course 
of action would be to stop drugs and investigate the breathless to ensure the correct 
treatment is given. 
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TABLE 4. 13 RESPONSE TO QUESTION 18 
A 72-year-old with RA for 22 years is normally treated with Methotrexate 20mg weekly, 
folic acid 5mg daily, Ramipril 2.5mg daily and Atorvastatin.  She is about to start 
antibiotics for cellulitis.  Which of the following antibiotics should she avoid? 
Answer Options Response (n=84) Answer 
Amoxycillin 5 (6%) Incorrect 
Erythromycin 1 (1.2%) Incorrect 
Flucloxacillin 0 (0%) Incorrect 
Trimethoprim 78 (92.9%) Correct 
  
 
The response to question 18 was correctly answered by most respondents, 92.9% (n=78).  
There are few drug interactions associated with Methotrexate (Bourré-Tessier and Haraoui 
2010), but Trimethoprim can cause bone marrow suppression (Rushworth, Mathews et al. 
2015) and as Methotrexate also has bone marrow suppressive effects, a combination of 
both could lead to significant bone marrow toxicity (Rushworth, Mathews et al. 2015). 
 
TABLE 4. 14 RESPONSE TO QUESTION 19 
A 76-year-old lady with RA for 15 years normally treated with Methotrexate 20mg weekly, 
folic acid 5mg daily, Bendroflumethiazide 2.5mg daily and Atorvastatin, has suspected 
pyelonephritis and is to start treatment with Kefalexin.  What advice would you give 
regarding the Methotrexate? 
Answer Options Response (n=84) Answer 
Carry on taking the Methotrexate but drink more water 9 (10.7%) Incorrect 
Reduce the dose of Methotrexate until the infection has 
cleared 
0 (0%) Incorrect 
Increase the dose of folic acid 0 (0%) Incorrect 
Stop the Methotrexate until the infection has cleared 75 (89.3%) Correct 
 
 
89.3% (n=75) of respondents answered this question correctly.  Whilst drinking water can 
help to alleviate the symptoms of pyelonephritis, a patient taking Methotrexate is more at 
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risk of developing a serious infection as they are immuno-suppressed which means that 
their immune systems are less effective at combatting infections(Ibrahim, Ahmed et al. 
2019, Furer, Rondaan et al. 2020). 
 
TABLE 4. 15 RESPONSE TO QUESTION 20 
A previously fit 60-year-old man with recently diagnosed RA is to start combination 
treatment with Methotrexate and Hydroxychloroquine.  He asks you whether he can 
continue to drink alcohol when he commences Methotrexate.  Do you advise him: 
Answer Options Response (n=84) Answer 
That it is safe to drink 0 (0%) Incorrect 
That he should not drink any alcohol 8 (9.5%) Incorrect 
To keep to the Government’s recommended amount of 21 
units per week 
34 (40.5%) Correct 
To limit his alcohol intake to no more than 4 units per 
week 
42 (50%) Correct 
 
 
The responses to question 20 posed mixed results, 40.5% (n=34) of respondents thought the 
limit of alcohol intake for patients taking Methotrexate should be the Government 
recommendation, whilst 50% (n=42) of respondents thought it should be no more than four 
units per week.  The confusion over this question arose because the American College of 
Rheumatology recommends a limited intake of alcohol to four units per week, but the 
British Society of Rheumatology consider that the Government guidelines are sufficient 
(Price, James et al. 2010).  As it was unclear which guideline was adopted in the 








TABLE 4. 16 RESPONSE TO QUESTION 21 
A 25 year-old woman has a three year history of RA treated with 
Methotrexate 15mg weekly, Sulfasalazine 2G daily and folic acid 5mg 
weekly.  She and her partner wish to try for a family.  For how long should 
the patient stop Methotrexate before attempting to conceive? 
Answer 
Answer Options Response (n=83)  
2 weeks 0 (0%) Incorrect 
2 months 0 (0%) Incorrect 
3 months 42 (50.6%) Correct 
6 months 41 (49.4%) Correct 
 
 
This question also generated a definite split in responses. Methotrexate can be harmful to a 
foetus (Gromnica-Ihle and Kruger 2010) therefore it is recommended that it should be 
stopped for 3 months to allow it to clear from the system before a woman attempts to 
conceive (Gerosa, Schioppo et al. 2016). However some studies recommend stopping 
Methotrexate for six months prior to attempting to conceive (Lloyd, Carr et al. 1999).  As it 
was impossible to determine whether the local guidelines around Methotrexate and 
pregnancy stated that patients should stop at six months or three months, both answers 












TABLE 4. 17 RESPONSE TO QUESTION 22 
A 30 year-old man with RA for 6 years treated with Methotrexate 20mg weekly and folic 
Acid 5mg weekly mentions that he and his partner have decided to start a family.  He asks 
whether there is any advice with respect to taking his Methotrexate while they are trying 
to conceive.  What do you advise? 
Answer Options Response (n=83) Answer 
No specific action regarding his treatment is required 3 (3.6%) Incorrect 
He should stop the Methotrexate for two weeks prior to 
them trying to conceive 
0 (0%) Incorrect 
He should stop the Methotrexate for two months prior to 
them trying to conceive 
2 (2.4%) Incorrect 
He should stop the Methotrexate for three months prior 
to them trying to conceive 
46 (55.4%) Correct 
He should stop the Methotrexate for six months prior to 
them trying to conceive 
32 (38.6%) Correct 
 
 
The same confusion around the length of time a patient should stop Methotrexate prior to 
conception arose with question 22, 55.4% (n=46) responded that it should be three months 
and 38.6% (n=32) thought it should be six months. Whilst, as question 21,  some literature 
recommends that a man should stop Methotrexate for three months prior to attempting to 
conceive, the evidence around this remains unclear (Gutierrez and Hwang 2017).  Therefore, 
it was impossible to determine how far local guidelines in Rheumatology departments may 











TABLE 4. 18 RESPONSE TO QUESTION 23 
A 36-year-old woman has had RA for five years.  She is currently treated with 
oral Prednisolone 5mg daily, Methotrexate 20mg weekly, Sulfasalazine 2G 
daily and folic acid 5mg weekly.  She attends your monitoring clinic 
concerned that she has been told by her GP that she has shingles affecting 
her left upper limb.  State whether each of the following items is true or false. 
Answer 
Answer Options True False n=  







People are at risk of developing chicken pox from 






A person with a past history of chicken pox is 






Shingles can be more severe in patients taking 






Chicken pox can be more severe in patients 
taking Methotrexate and steroids 
78 
(93.9%) 
5 (6%) 83 True 
 
 
Varicella is the virus which causes chicken pox (Gould 2014) and Methotrexate has been 
considered as a risk factor for the reactivation of varicella zoster, which causes shingles 
(McLean-Tooke, Aldridge et al. 2009).  Adults who develop varicella can have more severe 
infections and can develop complications (Gould 2014).  Because of the immuno-
suppressant effects of Methotrexate, previously discussed, it is important that patients stop 
Methotrexate if they have active disease. The responses to this question revealed much 
confusion around shingles and chicken pox.  41.5% (n=34) of respondents did not know the 
answer to the first part of the question around who could develop shingles from an infected 
person.  The responses to the second part of the question were fairly evenly split between 
true or false.  The correct response was “true”, that people are at risk of developing chicken 
pox from someone who has shingles, if they have not had chicken pox before (Gould 2014).  
65.4% of respondents gave an incorrect response to “a person with a past history of chicken 
pox is unlikely to catch shingles from an infected person”, the correct answer is “true”.  
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Shingles is not a disease that can be “caught”, it is reactivated in a person who has already 
had chicken pox and this reactivation can be cause as a result of stress or low immune 
response (Wilson 2014). 
 

























13.2 5.4 212 85 56 46 21 35 25 
July 1st 12.9 5.8 256 87 85 50 14 39 28 
Aug 
1st 
13.0 5.2 220 84 140 96 17 34 30 
A 56-year-old man with a 10-year history of RA attends the monitoring clinic.  He is taking 
Methotrexate s/c 15mg weekly, folic acid 5mg 6 times a week, Hydroxychloroquine 
200mg daily, Naproxen 250mg four times daily and Atenolol 50mg daily.  His blood tests 
for the last 3 months are shown above.  Which drug is most likely to be a cause of the 
abnormality which has developed in the patient’s results? 
Answer Options Response (n=83) Answer 
Methotrexate 66 (79.5%) Correct 
Hydroxychloroquine 1 (1.2%) Incorrect 
Naproxen 15 (18.1%) Incorrect 
Atenolol 1 (1.2%) Incorrect 
Folic acid 0 (0%) Incorrect 
 
 
79.5% (n=66) of respondents answered question 24 correctly, and almost 20% of the 
population were incorrect, with 18.1% (n=15) of respondents favouring naproxen as the 
correct answer.  Methotrexate is known to be associated with liver toxicity (Conway and 
Carey 2017).   However dose regulation and regular blood monitoring for signs of potential 
problems such as raised liver enzymes, Alkaline Phosphatase (APhos) and Alanine 
Aminotransferase (ALT) (Smolen, Landewé et al. 2017).  Thus, recognising early signs of 
possible liver toxicity is an important role for the Rheumatology Specialist nurse. 
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13.2 5.4 212 82 35 15 21 36 25 
July 1st 11.9 5.8 350 70 45 36 14 39 28 
Aug 
1st 
10.0 5.2 436 65 37 42 17 37 30 
A 56 year-old man with a 10 year history of RA attends the monitoring clinic.  He is taking 
Methotrexate s/c 15mg weekly, folic acid 5mg 6 times a week, Hydroxychloroquine 
200mg daily, Naproxen 250mg four times daily and Atenolol 50mg daily.  His blood tests 
for the last 3 months are shown above.  Which drug is most likely to be a cause of the 
abnormality which has developed in the patient’s results? 
Answer Options Responses (n=78) Answer 
Methotrexate 24 (30.8%) Incorrect 
Hydroxychloroquine 4 (5.1%) Incorrect 
Naproxen 47 (60.3%) Correct 
Atenolol 1 (1.3%) Incorrect 
Folic acid 2 (2.6%) Incorrect 
 
 
60.3% (n=47) correctly responded to question 24, however almost 40% of the respondents 
answered this incorrectly.  Naproxen is a Non-Steroidal Anti-Inflammatory Drug (NSAID) 
which can inhibit the clotting mechanism of platelets leading to the risk of bleeding 
(Crofford 2013).  Therefore, if patients are taking NSAIDs such as naproxen, it is important to 
monitor levels of haemoglobin (Hb) as if levels fall it could indicate bleeding.  In this 
scenario, the Hb has slowly been decreasing and whilst it is impossible to determine 
whether the cause of this is bleeding, the correct course of action is to stop the Naproxen 






TABLE 4. 21 RESPONSE TO QUESTION 26 
Leucocytes 
Protein Nitrites Glucose 
++ Trace Positive Negative 
A 76 year-old woman with longstanding RA attends clinic.  Her treatment comprises 
Methotrexate 10mg weekly, folic acid 5mg weekly, Simvastatin 40mg daily and Ramipril 
5mg daily.  Urine dipstick test is shown above.  What course of action would you take? 
Answer Options Responses (n=77) Answer 
Arrange a mid-stream urine test 63 (81.8%) Correct 
Stop Methotrexate 2 (2.6%) Incorrect 
Start Amoxicillin 0 (0%) Incorrect 
Refer to patient’s GP 6 (7.8%) Incorrect 
Refer to Rheumatologist 6 (7.8%) Incorrect 
 
 
81.8% (n=63) of respondents gave the correct answer to this final question, with almost 20% 
giving the wrong answers.  Urinary tract infections are common, and recognising the signs 
are important for patients taking Methotrexate. In this scenario the patient presents with 
moderately positive leucocytes, a trace of protein and positive nitrites in a urine dipstick 
test.  This is a test which can be comprises of a reagent strip designed to test markers of 
infection in a urine sample (Najeeb, Munir et al. 2015).  The correct course of action in this 
scenario is to arrange a more accurate laboratory test to investigate whether the patient 
has an infection as the dipstick test in this scenario only indicates possible mild infection and 
therefore stopping the Methotrexate at this stage is not indicated. 
 
4.8.6 Correlations with confidence and knowledge  
Confidence was recorded on a four-point scale, not at all confident; somewhat confident; 
confident; very confident, and knowledge was assessed by the total each participant scored 
on the clinical knowledge questions.  As described in section 4.5 of this chapter, Pearsons 
correlations and p-values were calculated.  Confidence and knowledge correlated weakly 
positively (r=0.21) but the p-value showed statistical significance (p=0.05 n=85).  The 
Pearsons calculation weakly correlated confidence with the amount of training received 
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(r=0.24) but the p-value showed a stronger degree of significance between those two 
variables (p=0.013, n=85) but there was no correlation between the time that it took to 
become confident and the amount of training received. The correlations are shown in Table 
4.22. 
 
TABLE 4. 22 PEARSON CORRELATIONS BETWEEN CONFIDENCE, KNOWLEDGE AND OTHER ASPECTS OF 
TRAINING 
 
Confidence Knowledge Amount 
of 
Training 























































*p<0.05  *** P=0.00001 
 
The strongest correlation was between confidence and the time spent in the educational 
role (r=0.7425 p=0.00001 n=85). The Pearsons correlation showed a weak, non-significant 
relationship between the amount the Methotrexate educational interaction changed with 
time and the time it took the nurse to become confident (r= 0.35) but the p-value showed a 
much stronger statistical significance between the two variables (p=.0006 n=85).  Further 
correlation between the year the participant qualified and their level of confidence showed 
a weak negative relationship (r-0.32) but the p-value demonstrated a higher degree of 
statistical significance (p=.0022 n=85). Thus, the longer the participant was qualified and the 
longer they had been performing the role, the more confident they were. Knowledge 
correlated with confidence as above, but did not correlate with the amount or helpfulness 
of training, or the time it took respondents to become confident.  The amount of training 
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received weakly positively correlated with the participants’ perception of how helpful it was 
(r= 0.37) but the p=value demonstrated a higher degree of statistical significance (p= .0006 
n=85). 
Of the nine participants who did not complete all of the knowledge questions, five 
respondents answered they were very confident in this role, one was confident, one 
somewhat confident and two not at all confident of which one did not attempt any 
knowledge questions. 
 
4.9 Summary of the Findings 
The domains of the survey focussed on four areas; training, confidence, time to become 
confident and knowledge.  Eighty-seven respondents answered questions on if they had any 
training, and most respondents described having had some training (70% n=61) whilst 15% 
(n=12) had no training but 16% (n=14) had a lot of training.  The responses to the type of 
training most nurses had (n=73) was largely observational, ie, they were observing peers 
(67% n=49) or Consultant Rheumatologists (11% n=8) whilst a small proportion of 
respondents had undertaken in-house courses on chemotherapy (9.5% n=7) and 
competencies (5.5% n=4).  Fewer respondents had undertaken a structured Rheumatology 
course (5.5% n=4) and one respondent had undertaken a prescribing course. Seventy-six 
valid responses were received for a question around helpfulness of training and most 
respondents agreed that any training they had, was generally helpful, 50% (n=38) 
considered it very helpful, 22.4% (n=20) thought their training had been moderately helpful, 
26.3% (n=20) of the respondents thought it was of some help whilst only one person 
thought it was of no help at all.  When asked what type of training nurses should have, 
almost all responses agreed that communication skills, consultation skills, knowledge and 
experience were required, only one respondent thought that they were not necessary apart 
from experience.  
Most respondents were either very confident or confident in their role of giving information 
about Methotrexate to patients.  Out of the total number of valid responses (n=85) 12% 
(n=10) where somewhat confident and 5% (n=4) were not confident at all.  But most 
respondents agreed that the way they give information had changed over time, and only 
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9.4% (n=8) of the valid responses (n=85) considered that it had not changed at all.  84 
responses were received when asked how long it took to become confident, 13% (n=11) 
confident in zero - two months, and the remaining responses indicated that it took between 
three months to one year to become confident in the role.  
Most nurses used information leaflets to support them during their consultations, 85 valid 
responses were received and 87.1% (n=74) used the Methotrexate information leaflets now 
produced by Versus Arthritis (2019).  A substantial number of respondents used their own 
in-house leaflets (48.2% n=41) and the National Rheumatoid Arthritis Society (NRAS) leaflet 
on Methotrexate was also popular (25.9% n=22). Only 5.9% (n=5) of the valid responses 
(n=85) considered that these materials were only a little useful, and no-one thought they 
were not useful at all, the majority of responses agreed that written materials were useful 
support. 
Knowledge was assessed by describing scenarios which could be encountered by the 
respondents and described in this chapter in section 4.2.1.  Most respondents answered 
correctly to all questions, there were 90-100% accurate responses to questions about 
vaccinations, antibiotics and liver function. Questions on alcohol had a mixed response, 
40.5% (n=34) of responders thought 21 units of alcohol per week was acceptable and 50% 
(n=42) thought the limit was four units. A question on shingles was not well answered with a 
range of responses. with regard to a question about pregnancy for a woman, opinion was 
divided between stopping Methotrexate for three months or six months; this likely reflects 
local Trust protocols and changing national guidelines. 19 respondents completed only the 
first half of the survey and a further eight respondents did not complete all of the single 
best answer questions. 
 
4.10 Discussion 
This phase of the study identified great variation in the training for this educational role and 
an appetite for more education including the need for consultation skill training. The role of 
the nurse in Rheumatology has changed considerably over the last 20 years (Oliver and 
Leary 2012).  This role has evolved as a result of changing treatments in Rheumatology and 
service provision, but the investment into the training of nurses in this role has often been 
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overlooked (Oliver and Leary 2012).  Whilst it is clear that nurses are extremely motivated 
and will seek out their own information, this survey has shown there is little accredited and 
standardised training for nurses in Rheumatology regarding the education of patients on 
Methotrexate. Interestingly, a questionnaire study by Courtney et al (2008) of the training of 
nurse prescribers in Diabetes showed that 23% of the nurses who completed the 
questionnaire had only had informal training involving observing a Specialist Nurse or doctor 
and 20% had no specialist training in diabetes at all. Further, of those respondents who had 
academic training almost half felt that their needs were not met with regards to the 
principles of diabetes prescribing.  It seems that the lack of training for nurses undertaking a 
variety of role extended tasks is not specific to Rheumatology, and that this is a much more 
widespread issue. 
There could be prohibiting factors involved in the lack of training for nurses.  For example, 
Nurses often find it difficult to get time and funding for any training (Haywood, Pain et al. 
2013). A recent survey by the Primary Care Respiratory Society UK (PCRSUK 2015) on nurse 
education, concluded “nurses will need to be increasingly more resourceful and self-
motivated to access training and look beyond traditional study days using innovative 
methods such as online study and development recording”.  Courses where nurses can 
access training at a time that suits them and gain credits for completion may be popular. In 
this context, e-learning modules with associated assessment would seem to hold 
considerable potential. The results suggest that a module which contains the knowledge 
base required for the role, including advice on how to aid patient understanding effectively 
and contains answers to frequently asked questions, would be a useful addition to practical 
experience and may shorten the time to achieve confidence and competence. 
The observation that confidence was most closely associated with time in the role suggests 
that experience leads to confidence.  Nurses are learning as they work and the challenge is 
to shorten the time required to become confident with appropriate training and knowledge.  
The correlations with knowledge and amount of training suggest that it should be possible 
to increase confidence with better training.  It is reassuring however, that confidence and 
knowledge did correlate.  The New World Kirkpatrick Model (2006) has become one of the 
worldwide standards for evaluating the effectiveness of training and it describes the process 
of behavioural change as a result of knowledge.  It is based on the four levels of training 
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evaluation which was developed by Dr Don Kirkpatrick in the 1950’s (Kirkpatrick and 
Kirkpatrick 2016).   The first level, reaction is the degree to which learners find their training 
favourable, engaging and relevant, the second level, learning, is the degree of knowledge, 
skills attitudes confidence and commitment that learners acquire which is based on their 
participation in the training.   Behaviour, the third level relates to the degree to which 
learners apply what they have learned during the training process and lastly results, relate 
to the targeted outcomes of that training. These four levels could be applied as best practice 
to the processes of teaching patients about Methotrexate:  Reaction, where patients need 
to be engaged and find the information understandable and relevant; learning, where the 
evaluation by the nurse to establish how much knowledge the patient has acquired during 
that teaching process; behaviour, whether the patient take the medication as prescribed 
and would they feedback any problems or issues to the nurse and results, whether patients 
feel empowered to communicate to the nurse that they have side effects, cannot take their 
medication as prescribed and have enough understanding of Methotrexate to identify other 
potentially dangerous problems and report them to the healthcare professional.  
 
4.11 Limitations of the Survey 
It is not possible to know if the sample of 104 nurses who started this survey is typical of 
nurses who perform this role, but the numbers include specialist, monitoring and research 
nurses who are the people likely to perform this role. It has also included a wide variety of 
experience and views. It is likely that the participants are more interested and informed 
than average but it also includes people who were not sufficiently confident to complete the 
knowledge questions. Eighty-five participants started the knowledge questions but only 77 
participants completed the entire questionnaire. It could be speculated that participants 
could have been intimidated by the knowledge questions and chose to close the 
questionnaire.  However, the survey’s assessment of knowledge was rudimentary and brief, 
and was clearly not long enough to make a reliable judgement of respondents’ knowledge.  
Nevertheless, it did serve to give some indication of respondents’ understanding of the area 
as it applies to clinical practice. It may also serve to promote discussion of the assessment of 
this important area of practice. Involvement of patients in the design of the questionnaire 
may have raised different types of concern. 
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4.12 Chapter 4 Conclusion 
This Chapter has described the first phase of the study, the national survey.  It has explained 
how the survey was designed, how the survey was distributed to gain as many responses 
possible on a national level, and how nurses who give information to patients about 
Methotrexate are trained to conduct this role.  It also described whether they regarded 
their training as helpful and determined whether it is important to have skills required to 
conduct this role.  It also described how confident nurses are in conducting this role and 
how long it takes for them to become confident.  Further, this chapter explained the 
responses to knowledge questions based on possible scenarios which could be encountered 
by the nurses.  The nurses included in this survey showed a great variation in the training 
they had prior to undertaking the role of counselling patients starting Methotrexate, with 
those nurses performing the role for the longest period of time having the least training. 
Most respondents took three to 12 months to feel confident in this role but even the most 
confident nurses continued to change the way they educated patients with increasing 
experience and knowledge. Most respondents answered that they would have liked more 
training aimed at satisfying the educational needs of nurses to counsel patients about drugs 
like Methotrexate which could lead to nurses gaining knowledge and confidence with this 
role and be able to deliver a competent and comprehensive educational interaction with 
patients.  
The current understanding of how nurses are trained to carry out the role of advising 
patients about Methotrexate is limited, most researchers concentrate on the value of the 
Rheumatology Specialist nurse in conducting consultations rather than how they gained the 
knowledge to carry out this role and how they interact with the patient during this process  
(Hill 1997, Koksvik, Hagen et al. 2013, Garner, Lopatina et al. 2017). The results of this 
survey have provided a general perspective on how nurses gain knowledge about 
Methotrexate in order to instruct patients on how to take it safely and as prescribed.  It has 
shown that most nurses rely on information booklets which are generally developed for 
patients but they do become confident in this role after a period of time.   
The next phase of the study, Phase II, aimed to explore the experiences of nurses and their 
perception of how they delivered information about Methotrexate to patients through 
semi-structured interviews. The contribution of Phase I, the national questionnaire survey, 
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to Phase II was to inform the semi-structured interview schedule.  Phase I identified that 
nurses who responded to the questionnaire generally observed peers and doctors to 
become informed about how to give information to patients about Methotrexate, that they 
used written information to support theses consultations and that they became confident to 
conduct this role over time.   It also showed that these nurses were generally 
knowledgeable and would respond appropriately in specific scenarios.  Thus, the interview 
schedule was designed to determine how individual nurses were trained to carry out their 
role and how they felt about this training; how they used the information leaflets to inform 
their consultations.  Phase II of the study investigated, in more depth, how nurses feel about 
conducting their role and how confident they are.  What was not clear in Phase I, was how 
nurses interacted with patients, and whether they recognised cues and responses from 
patients putting them at the centre of care.    
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Chapter 5: Phase II - An exploration of the experiences of 





5.1.2 Summary of Phase I results 
The domains of the survey in Phase I focussed on four main areas, training, confidence, time 
to become confident and knowledge.  Not all respondents completed all of the questions, 
but of the valid responses received, most nurses were trained to carry out the role of giving 
information to patients about Methotrexate, by observing peers and Rheumatology 
consultants.  Most respondents used the Methotrexate information booklet produced by 
Versus Arthritis (Versus Arthritis 2019) and information produced in-house to support this 
process during their consultations.  Most nurses became confident to carry out this function 
within three to six months.  Knowledge was assessed by multiple choice answers to clinical 
scenarios which would commonly be experienced by the nurses.  Most respondents 
answered the knowledge questions correctly, but there were areas of confusion around the 
amount of time a patient should stop taking Methotrexate prior to pregnancy.  However this 
confusion could have arisen because, whilst most publications recommend that males and 
females should stop Methotrexate three months prior to pregnancy, there is no clear 
recommendation (Gutierrez and Hwang 2017).  Therefore, different protocols which guide 
clinical practice in different Rheumatology services may be different.  Another question 
which caused a range of mixed responses were questions on shingles.  For example, almost 
half of the respondents incorrectly answered that people with a past history of chicken pox 
could catch shingles from an infected person.  Shingles is the result of reactivation of the 
herpes zoster virus in the body of some who has previously had chicken pox and cannot be 
caught from anyone else (Gould 2014). 
Whilst it appeared from the results of the survey that nurses were confident at conducting 
their role and used information booklets to guide their consultations with patients, it was 
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not clear how the nurses felt about their practice, how far the booklets guided their 
consultations and how nurses perceive the patient’s role in this process. Therefore, Phase II 
of the study attempted to fill in these gaps by exploring the nurses’ feelings about their 
roles and how they were educated to conduct it.  Also, to investigate how the information 
booklets are used, and how much reliance there is on these sources of information and 
whether patients have an active role in this process putting them at the centre of care so 
that they understand how to take Methotrexate safely and as prescribed.   
 
This Chapter contains an explanation of the analysis methods adopted to explore the data 
generated by this study and describes the findings and themes generated through thematic 
analysis.  It also contains a summary of the results based on the themes and closes with a 
brief discussion of areas for further consideration, as this will be discussed more thoroughly 
in Chapter 7. 
 
5.1.3 Methotrexate Education for Patients 
The commencement of any medication should be accompanied by some education to 
enable the patient to know how to take it, how and when it is expected to work, what side 
effects to look out for and what, if any, the safety blood monitoring which is required. Hill et 
al (2001) demonstrated that educating Rheumatology patients on their medication 
improved concordance. Zhao et al (2015) carried out a survey of 159 patients with Coronary 
Heart Disease (CHD) in a hospital in China.  They assessed medication adherence with the 
Morisky Medication Adherence Scale (Morisky, Green et al. 1986) and disease knowledge 
with a Medicine/Disease Related Knowledge Test (MDKRT).   The MDKRT was developed by 
the researchers with guidance from an expert panel and a systematic literature review (Al 
Hamarneh, Crealey et al. 2011). Zhao et al (2015)concluded that whilst the majority of 
participants had little knowledge of drug treatment, those participants that had a greater 
knowledge of CDH were more likely to be drug adherent. Despite the paucity of evidence, 
guidelines uniformly recommend education (NICE 2013) and the Department of Health 
(2019) advocates that health professionals promote self-care and shared decision-making, 
enabling patients to make choices.  This would require the patient to be sufficiently 
educated, which, in the case of commencing Methotrexate, commonly is dependent upon 
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education by nurses who may not necessarily have received education themselves in this 
area. 
Patients also require information on their condition to put the treatment into context 
(Thompson 2011).  Thompson conducted a study of patients with Ankylosing Spondylitis, 
and found that at disease presentation, before drug therapy was commenced, patients 
wanted responses to a series of questions which included: ‘Why have I got it?’ ‘What will 
happen to me and my family?’ What can I do about it?’ Nurses need training to allow them 
to develop the skills to engage in effective consultations with the patients and to increase 
their confidence in moving away from a checklist consultation.  Phase II of this study aimed 
at exploring the experiences of Rheumatology Specialist nurses of their consultations with 
patients when giving information about Methotrexate.  Thus, further insights into how 
nurses perceived this process of information giving could be gleaned, adding to the body of 
extant literature.  
 
It is not obvious from a review of extant literature that any studies have been conducted 
concerning how Rheumatology Specialist nurses are taught to carry out specialist roles.  
Latter et al (2001) recognized that nurses make an important contribution to the education 
of patients, and carried out a survey of student nurses to identify drug knowledge and 
attitudes towards patient education, focusing on adult, older person, mental health and 
community programmes.  They concluded that students expected to learn on the job in 
order to gain knowledge and experience. Therefore, this underlying expectation of learning 
on the job in order to gain knowledge and experience may well contribute to the lack of 
formal education nurses seek when developing their careers.  Dury et al (2014) recognize 
that Specialist nurses evolved to meet healthcare needs and the changing context of nursing 
care.  They therefore developed an online questionnaire to explore the competencies and 
educational requirements of these nurses.  However, this was a widely diverse study which 
involved 77 nurses from 29 countries across Europe and most of those nurses had 
undertaken postgraduate or advanced courses and held posts such as Chief Nurses, Nursing 
Administrators or Advance Practitioners, so they are not necessarily representative of the 
general Specialist nurse.  However, even from that very specific population (n=77), 13 had 
no Specialist nurse training.  Jokiniemi et al (2020) carried out ten semi-structured in order 
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to identify the domains of practice of Specialist nurses and their competencies.  Nurse 
managers who had at least one Specialist nurse in their department were the target 
population.  The nurse managers recognized 255 nurses in their departments whom they 
considered to be working as Specialist nurses in various clinical setting. They also recognized 
that these nurses were constantly seeking ways of improving themselves beyond their basic 
training, actively seeking evidence-based knowledge and educating themselves within their 
own specialist area.  There was no discussion of any formal training to gain specialist skills to 
support their roles, it therefore appears that these nurses were also learning on the job.  
Further, the survey results from Phase I of this study, confirm that, of the nurses who 
responded to the survey, the primary source of training was learning from peers by 
observation. 
 
5.2 Summary of Phase II 
This phase of the study generated narrative qualitative data in response to open questions 
through face to face semi-structured interviews.  The interviews explored the nurses’ 
thoughts and feelings of a recalled interaction with a patient during a Methotrexate 
information giving process.  The nurses worked in two different Rheumatology services and 
had different educational opportunities to gain more knowledge about Rheumatological 
conditions and treatment.  The interviews were audio-recorded and transcribed.  Data 
collected were exploratory and thematic analysis of the transcripts developed and 
categorised themes in order to explore how nurses gave information to patients about 
Methotrexate and whether interactions with the patients were part of the consultation 
process. 
  
5.3 Phase II Aims and Objectives 
 
5.3.1 Phase II Aim 
To explore the nurse experience and perception of the delivery of information about 
Methotrexate to patients, using semi-structured interviews. 
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5.3.2 Phase II Objectives 
1. To explore the training nurses had in order to carry out their role of giving 
information to patients on Methotrexate and how useful this was. 
2. To understand how confident nurses are carrying out this role and how they feel 
about the training they had. 
3. To understand how nurses, use written information to inform their consultations. 




5.4.1 Study Design 
 
5.4.1.2 Semi-Structured Interviews 
Semi-structured interviews are a common form of qualitative data collection (Kallio, Pietilä 
et al. 2016) attempting to discover what an individual thinks and feels about a subject and 
how significant it is to them (Mears 2012). Yet, regardless of how carefully questions are 
asked there is always a residue of ambiguity (Fontana and Frey 2005) making interviewing 
more complex than it sounds.  The commonest form of interviewing is face to face, and it 
can be structured, semi-structured or unstructured.  In structured interviews, all 
participants are asked the same question, usually with limited response categories and 
there is little room for manoeuvre.  Semi-structured interviews use pre-set but open ended 
questions to allow further exploration of the topic with the interviewee, thus are widely 
employed by healthcare professionals  (Jamshed 2014).  Semi-structured interviews are 
particularly applicable where the researcher has more specific research questions (Low 
2013). Thus, the rationale for using semi-structured interviews in Phase II of the study is 
because this form of interview allows the researcher to explore themes with the participant, 
but within the boundaries of the research question.    
Semi-structured interviews are commonly utilised in qualitative research, particularly in 
 153 
healthcare research (DeJonckheere and Vaughn 2019).  DeJonckheere and Vaughn reviewed 
the literature on semi-structured interviewing in order to identify key skills and components 
required to implement this key technique.  They recommend 11 key steps which they consider 
are required to design and conduct semi-structured interviews (Table 5.1) 
 
TABLE 5. 1 STEPS TO DESIGNING AND CONDUCTING SEMI-STRUCTURED INTERVIEWS (DEJONCKHEERE AND 
VAUGHN 2019)  
Step Task 
1. Determine the purpose and scope of the study 
2. Identify participants 
3. Consider ethical issues 
4. Planning logistical aspects 
5. Develop the interview guide 
6. Establish trust and rapport 
7. Conducting the interview 
8. Memoing and reflection 
9. Analysing the data 
10. Demonstrating the trustworthiness of the research 
11. Presenting findings in a paper or report 
 
 
Whilst the work by DeJonckheere and Vaughan (2019) was published after the semi-
structured interview phase of the study presented in this thesis, the 11 key steps they describe 
above parallel the stages taken to design this second phase.  The aims and objectives of Phase 
II were identified and sites were identified where potential participants could be recruited.  
Ethical approval was applied for and given before any study activities took place.  The logistics 
of how Phase II would be carried out was identified and organised and an interview guide was 
developed.  The researcher met the nurses who agreed to participate and established a 
friendly rapport before conducting the interviews.  Notes were taken of the whole experience 
which contributed to the reflexive perspective of the researcher before data analysis began.  
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The final two steps are described in following sections of this chapter. 
Whilst the goal of the semi-structured interviews was to gain a rich understanding of the 
nurses’ experiences and perspectives about the way in which they deliver information to 
patients about Methotrexate, it could be considered ethically unsound to collect data which is 
not completely necessary for the research (Kallio, Pietilä et al. 2016).  Further, in order to 
ensure that the researcher remained focussed and no topics are missed an interview guide 
was utilised (Mears 2012, Mitchell 2015).  Following a systematic review, Kallio et al (2016) 
identified key domains to consider when developing an interview guide supporting the 
trustworthiness of the data.  The first consideration is to ensure that semi-structured 
interviews are an appropriate form of data collected in relation to the research question.  The 
use of semi-structured interviews for Phase II of the study presented in this thesis was 
considered an appropriate form of data collection in order to explore further the nurses’ 
perspectives and experience of the phenomenon under study.  Secondly, Kallio et al consider 
that it is necessary to gain an understanding of previous work conducted, which was 
undertaken in a literature review for this study.  Thirdly, the interview guide should be based 
on previous knowledge.  The first phase of the study presented in this thesis, collected data, 
the findings of which informed the semi-structured interviews in the second phase of the 
study.  Previous work was also considered following a literature review.  The next phase 
described by Kallio et al was to validate the structure of the semi-structured interview guide, 
this was undertaken for this study through peer review.  The researcher discussed the semi-
structured interview guide with colleagues and supervisors, to ensure validity and 
appropriateness of the final semi-structured interview guide.   
 
5.5 Data Analysis 
 
5.5.1 Transcript Analysis 
There are a broad range of approaches to analysing transcript data from interviews, but 
essentially, the aim of the transcript analysis is to produce an organised and detailed account 
of the themes and topics which were addressed in the semi-structured interviews undertaken 
(Burnard 1991). Some common approaches were outlined by Green and Thorogood (2018) 
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which they describe as firstly developing conceptual definitions, secondly, developing 
typologies and classifications, thirdly to explore associations between attitudes, behaviours 
and experiences, leading to the development of explanations of phenomena.  Finally 
concluding with the generation of new ideas and theories.  One of the commonest approaches  
in healthcare settings is thematic analysis (Green and Thorogood 2018) and Braun and Clarke  
consider that it should be the first method of qualitative analysis that researchers should learn 
as it helps the researcher to develop core transferrable skills (Braun and Clarke 2006, Braun 
and Clarke 2012). It could then be considered a process which can be utilised within another 
established analytical tradition (Ryan and Bernard 2000). Braun and Clarke produced a six-
phase outline of the process of thematic analysis (Table 5.2).  This process was adopted to 
conduct the thematic analyses for this study and this process is further described in Chapter 6. 
 
TABLE 5. 2 SIX PHASE OUTLINE OF THEMATIC ANALYSIS PROCESS (BRAUN AND CLARKE 2006)  
                
 
A qualitative phenomenological approach (Ritchie and Lewis 2003), was adopted in 
designing this phase of the study (see Chapter 3 for further discussion of Phenomenology) 
as it seeks to understand the experiences of a population which share similar features and 
how they make sense of those situations (Connell, McMahon et al. 2014). As the study 
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population were all qualified nurses, giving information to patients about Methotrexate in a 
consultation-style interaction, they shared similar features in that the salient information 
given about Methotrexate should be comparable.  Thus a phenomenological approach was 
adopted in the thematic analysis of the interviews, as it seeks to understand the experiences 
of a population which share similar features and how they make sense of those experiences 
(Connell, McMahon et al. 2014). The process involves reading and re-reading the transcripts 
(Biggerstaff and Thompson 2008). Husserl (Husserl 1999) would advocate the suspension of 
critical judgement during this process whilst a Heiderggerian approach would embrace the 
researcher’s own experiences in the examination of the transcripts enriching the resulting data 
(Pratt 2012). However, the researcher must also adopt a reflexive perspective, in order to 
understand their own preconceptions which may influence the outcomes. In this analysis, the 
researcher was able to understand their own preconceived ideas around the themes which 
could be drawn out of the transcripts. There was a presumption that the nurses would differ in 
their experience, confidence and knowledge, that the consultation process was not a core part 
of nurse training and experience. These preconceptions were the result of the researcher’s 
own experiences carrying out the same role of conducting Methotrexate education 
consultations. In a Heiderggerian fashion, it could be said that this added to a deeper 
understanding of the nurses’ perspectives and reflections as the researcher could relate to 
their experiences. However, having undertaken a reflexive position, the researcher was also 
able to take a more objective stance when analysing the semi-structured interviews. 
 
Participants were identified for Phase II through known professional contacts in two NHS 
Trusts in England and were purposively sampled to ensure the greatest diversity of experience 
and training.  Purposive sampling also allows identification of a group who will have a common 
understanding of the research question (Connell, McMahon et al. 2014). In Trust A, the nurses 
had set appointments to see patients in order to carry out the Methotrexate consultations, 
contrastingly the nurses in the Trust B had no pre-planned appointment slots, the patients 
were seen in their regular clinics with their Consultants, and they were given their education 
on the same day if they were prescribed Methotrexate. This meant that the nurses did not 
know how many patients they would see in any given day and they had to fit it in around their 
regular work. It did mean, however, that patients did not have to wait several weeks for the 
next appointment and could start their treatment immediately. The nurses who worked in 
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Trust A also had access to a Rheumatology MSc Course which was run by the University 
attached to the Trust, the nurses at Trust B had no access to any training, they learned on the 
job.  The interview schedule was based on the results of the national survey. 
 
5.5.2 Use of Interviews to explore nurses’ perceptions about their role  
Semi-structured interviews allow participants to share their experiences within the 
boundaries of the topic under study (Mitchell 2015). The studies reviewed below use 
interviews to explore nurses’ experiences.  Whilst they are not focused on Rheumatology, 
they use semi-structured interviews to explore how nurses feel about aspects of their role, 
thus informing the decision to adopt semi-structured interviews as a method for Phase II. 
Forsgren et al (2016) conducted a study to explore the experiences of eight nurses working 
with people who have communication disabilities in 6 different nursing homes.  They 
constructed an interview guide addressing general communication and more specifically the 
experiences of the nurses communicating with residents who have communication 
difficulties.  The questions related to four main areas; experiences communicating with 
residents, the nurses’ feelings associated with interactions with residents who have 
communication disabilities, meaning related to these interactions and factors which 
influenced interactions. The study was limited to eight participants from six residential 
homes, and Forsgren et al (2016) explain that the number of participants was regarded as 
sufficient because the study did not aim to collect a representative view, but instead to 
contribute to the body of knowledge about important aspects of managing communication 
barriers. 
A study by Andersson et al (2016) explored nurses’ experiences of caring for dying patients 
on surgical wards.  They recognized that there was a lack of training in this area and this lack 
of preparation could lead to stress, anxiety and burnout.  They interviewed six newly 
graduated nurses from two surgical wards and the interviews focused on six domains; care 
for palliative and curative patients, nursing skills, supporting activities, preparation for end-
of-life situations, use of strategies and emotional aspects in nursing. The authors recognized 
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the limitations of the small number of interviews, but they considered that the 
trustworthiness of the results was ensured through a rigorous systematic analysis process. 
Scrafton et al (2012) explored the experiences of nurses prescribers in secondary care, how 
nurse prescribing is employed and what they perceived the benefits and disadvantages to 
be.  They focused on exploring the views of the nurses regarding how educationally 
prepared they were for this role, to explore their experiences in this role and to formulate 
some recommendations to inform practice.  Six nurses were interviewed and audio-
recorded.  The authors considered that the sample size was in keeping with the 
recommended sample size for qualitative research (Sandelowski 1995).   
The key features of these studies are that they all employ semi-structured interviews, they 
recognized that small sample sizes are appropriate for qualitative research and whilst the 
findings do not represent a general population, they can inform the extant body of 
literature.  Further features of these studies identified key areas for the interview schedule, 
exploration of feelings, confidence and experiences.  These key features contributed to the 
development of Phase II, representing the empirical domain of the philosophical critical 
















FIGURE 5. 1 INVESTIGATION OF THE EMPIRICAL DOMAIN – SEMI-STRUCTURED INTERVIEWS 
 
 
Thus, the semi-structured interviews explored in more detail the nurses’ feelings and 




5.5.2.1 Interview Design 
The interview schedule (Figure 5.2) was developed by the researcher and a steering group 
(which consisted of two Rheumatologists, two nurses and an academic psychologist) who 
have expertise in this area was formed to further review the interview schedule. The results 




FIGURE 5. 2 THE INTERVIEW SCHEDULE 
 
 
Prior to commencement of the semi-structured interviews, all participants were invited to 
describe a recent education session that involved counselling a patient on Methotrexate. 
Their views and experience were sought on: written prompts used during the consultation; 
key information needed by the patient; patient engagement in the session; duration of the 
session; training received to counsel patients on Methotrexate and their confidence in 
counselling and planning for subsequent monitoring appointments. The interviews took 
place in a quiet room within the hospital in which the participants worked and lasted 
between 45 to 60 minutes. Interviews were recorded using a digital recorder and 
Nurse Interview Schedule 
 
1. Can you describe a recent education session? 
 Do the sessions vary? 
 If they do, in what ways do they vary? 
  
2. Do you use any written information or prompts? 
 Can you describe what you use? 
 
3. Are there some key areas you try to cover when educating patients? 
 Can you describe these? 
 
4. Do patients express their views during these sessions? 
 What are their views? 
 What sort of things do patients talk about? 
 
5. Do you have adequate time to do the education sessions? 
 How much time does it normally take? 
  
6. After the education sessions, do you monitor these patients yourself? 
 How does the monitoring/follow up system work in your department? 
 
7. What preparation did you have before you started educating patients starting 
 Methotrexate? 
 Did you have any supervised practice? 
 What did it consist of? 
 How useful did you find it? 
 
8. In an ideal world what training would you like? 
 
9. How do you feel now about educating patients starting Methotrexate? 
 How confident are you with this role? 
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transcribed verbatim by an experienced transcriber and described in section 5.12 of this 
chapter.    
 
5.6 Ethical Approval 
Ethical Approval was applied for at the same time as Phase I of this study, and was obtained 
from the NRES Committee North East – Sunderland in 2013 (see Appendix 8). Approval was 
also given by Northumbria Healthcare Foundation Trust on 09/07/2013 to act as study 
Sponsor (see Appendix 9).  A letter of invitation and study information was emailed to all 
participants. Informed consent was obtained prior to conducting the interviews.   
 
5.7 Sampling Strategy 
Semi-structured interviews were performed with a purposive sample of six nurses from two 
Rheumatology centres in the United Kingdom. The phenomenological method embraced to 
conduct this phase of the study, sought to understand the experiences of the interviewees, 
from a targeted population with similar key attributes (Eatough and Smith 2008).   It is firstly 
important to consider the sampling technique to implement in a research study.  Purposive 
sampling techniques are often used in qualitative research (Teddlie and Yu 2007) and can be 
defined as selecting units, ie groups or individuals, which have particular characteristics in 
common with the research question.  Teddlie and Yu (2007) further describes purposive 
sampling to achieve representativeness or comparability; sampling special or unique cases; 
sequential sampling or sampling using multiple purposive techniques.  Therefore, in 
applying purposive sampling to this phase of the study, it aimed at targeting nurses who had 
the same role of giving information about Methotrexate and may exhibit similar feelings and 
experiences.  Secondly, the small sample size in this phase of the study is in keeping with 
comparable other qualitative studies where the objective is to gain an in-depth 
understanding of the experience of particular individuals through semi-structured 
interviews (Greenhalgh and Taylor 1997; Connell, et al 2014). Further, Polkinghorne (1989) 
recommends that between five to 25 individuals are required to develop the possibilities of 
experience using a phenomenological method (Creswell, Hanson et al. 2007).   
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5.8 Participants 
The participants were identified by the researcher from two Rheumatology units in different 
areas of England. The only eligibility criteria required for participation was that the 
interviewees were involved in the education of patients about to commence Methotrexate. 
All eligible nurses from both units were invited to take part in the semi-structured 
interviews and any nurse who showed an interested was emailed information sheets (see 
Appendix 11) about the study. All potential participants had the opportunity to ask 
questions by email before they made a final decision on whether to participate.  Three 
participants from each unit agreed to take part.  Whilst none of these nurses had any formal 
training, two of them were waiting to start a course in Rheumatology which was 
administered by the local University.  However, their training at the point of the semi-
structured interviews were also by observing colleagues and learning on the job.  Prior to 
signing the consent form, each participant was offered further opportunity to ask any more 
questions.  Informed consent (see Appendix 11) was taken from each participant before the 
interview began.  Participants were informed that the interview would be audio-recorded 
and that these recordings would be transcribed verbatim, however all data which could 
reveal their identity would be either removed or coded.  Each participant was given a 
unique identification number which replaced their name in the final typed transcriptions.  
All participants were given the opportunity to check the final transcriptions before any 
analysis began, to ensure that they were satisfied that they had answered the questions in 
the way that they had intended.  There was no pre-fixed time for each interview, but they 
lasted for between 30 – 60 minutes. 
 
5.9 Interview Setting 
The services offered by the individual units were different.  In one unit, when a patient was 
prescribed Methotrexate by the Rheumatologist, they saw a nurse on the same day.  The 
patient was fitted into the drug monitoring clinic and was given information about 
Methotrexate by one of the nurses working in that clinic on that day.  A clinic room was 
used, but the time allocated to the consultation was not fixed.  The amount of time spent on 
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this interaction would be dependent on how busy the monitoring clinic was at that time.  In 
this service, there was no formal training undertaken by the nurses, they learned through 
experience and watching peers.  In the second Rheumatology service, the patient was given 
an appointment to return to the department to see a nurse.   The nurse was allocated 30 
minutes per appointment to undertake the consultation with the patient.      
 
5.10 Trustworthiness of the Data 
Quantitative approaches would generally be used to answer questions requiring numerical 
data, which uses larger numbers to control for individual variations. Results can be judged in 
terms of reliability, ie consistency of the results; validity, ie accuracy and generalisability, ie the 
results can be applied to other situations (Leung 2015). Qualitative methods, on the other 
hand, explore human experience, recognising patterns in words and behaviour to generate a 
meaningful conclusion without losing the richness and dimensionality of that experience 
(Leung 2015). Qualitative methods can be considered as being subjective, therefore the 
interpretation of data could contain biases from both the participants and the researchers.  
This could in fact, add to the richness and depth of the data  Lueng  (2015). Indeed, bias exists 
in all study designs (Smith and Noble 2014), for example bias could exist in qualitative research 
such as a clinical trial, in the selection of participants.  Whilst this can be reduced through 
random selection; participant drop out, or participants lost to follow up can change the 
characteristics of the participant group (Sica 2006).  Minimising bias is one of the key 
considerations when designing a study and undertaking research allowing evaluation and 
scrutiny of the study findings (Smith and Noble 2014). 
Defining standards for assessing qualitative research in order to judge the robustness of the 
data is important as it will enhance the transferability of the findings, but it should consider 
that the goal of the qualitative approach is to discover the natural order of the way things are. 
Making the assessment of the methods and results too rigid, may lead to losing that important 
and rich reflection of real-life situations. Quantitative research reliability relates on the 
replication of the research processes and results which can be assessed for validity, reliability 
and empirical generalisability (Kitto, Chesters et al. 2008). Applying these criteria to qualitative 
research is beset with difficulties due to the different types of data collection, design and 
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methods of study. Terms such as rigour, credibility and relevance are more applicable to 
qualitative research (Table 5.3). 
 













However, it could be argued that in order to explore and gain deep meaningful knowledge of 
some research questions multiple approaches should be adopted.  A single method may limit 
the perspective and understanding of the research question. 
Lincoln and Guba (1986) explain that the criteria used in the conventional and scientific 
model is the truth value or internal validity; applicability or generalizability; consistency or 
reliability and neutrality or objectivity.  These four domains when fulfilled, remove any 
problems relating to bias, instability etc.  However ontological, epistemological and 
methodological variations between different models may require the application of 
alternative criteria in order to meet the four domains.  Therefore, they suggest that 
credibility as an alternative to internal validity, transferability as an alternative to external 
validity, dependability as an alternative to reliability and confirmability as an alternative to 
objectivity.  They term these as criteria for trustworthiness.  These criteria are still widely 
used and the aim of them is to state that the research findings are “worth paying attention 
to”  (Elo, Kääriäinen et al. 2014). Baillie (2015) summarises these criteria in Table 5.4. 
Credibility: refers to whether the findings are well presented and meaningful 
Evaluation rigour: the transparent description of ethical and political aspects of the conduct 
of the research 
Procedural rigour: the transparent description of the conduct of the research 
Reflexivity: open acknowledgement of the complex influences among the researchers, the 
research topic and subjects on the research results 
Transferability or relevance: refers to how useful the findings are to the context and 
phenomenon under study 
Triangulation: a comprehensive approach to the conduct of research using multiple theories 
data and methods 
  
 165 





Explanation Examples of 
techniques 
Validity 
Credibility The findings make 
sense 
Member checking 





Dependability The research has 
been conducted in 
an auditable way 





Transferability Potential for 
findings to be 
transferred to 
another situation 
Rich description of 
the setting and 
participants 
Objectivity 







5.11 Credibility of the Data 
All of the semi-structured interviews were conducted in the same way using the interview 
guide, by the study researcher.  Interviews were conducted in a quiet room, away from the 
clinical working area, so that the participant could feel comfortable and willing to share their 
experiences (Hove and Anda 2005). The audio-recorder was switched on before the 
interview began to allow time for the interviewee to become accustomed to it. The 
researcher introduced herself, giving a brief background to the study and explained the 
purpose of the interview, the participant was invited to chat about themselves to encourage 
a relaxed rapport, and was invited to ask any other questions before the interviews began. 
All interviews were allocated as much time as necessary for the participants to give their 
own responses to each question, the interviewer attempted not to interrupt the flow of the 
conversation from the interviewee during the process.   At the end of the interview, the 
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researcher played the recording back to ensure that the recording was of good quality and 
informed the participant that they would receive an anonymised typed transcript for their 
confirmation of accuracy or to make changes or additions.   
 
5.12 Data Transcription 
The data transcription was undertaken by an experienced transcriber within the 
researcher’s place of employment at Northumbria Healthcare NHS Foundation Trust.  It was 
considered judicious to engage another person with experience to carry out this task.  
Further, the experienced transcriber could carry out this undertaking in a much timelier 
fashion.  As the transcriber was experienced in this type of assignment, she understood her 
duty to uphold Northumbria Healthcare NHS Foundation Trust’s policy of confidentiality.  
Further, the transcriber also worked within the same department as the researcher, and 
when queries occurred regarding the transcripts they were conveniently placed to have 
discussions.  All identifiers such as name, place of employment or reference to other 
persons during the interview were removed by the transcriber.  The recording was given to 
the transcriber as soon as each interview was complete, it was then transcribed and the 
transcription was checked against the recording to ensure accuracy by the researcher.  All 
transcriptions were stored on a secure platform within Northumbria Healthcare NHS 
Foundation Trust secure IT system. 
The transcript was returned to the participant as soon as it was complete to ensure that 
they were satisfied that anonymity had been upheld and that the data were accurate. All 
transcripts were returned to the interviewees within seven days to ensure they still had a 
recollection of the interviews.  All participants had the opportunity to change or add to the 
transcripts if necessary.  Further, participants were also asked if anonymous quotes could be 
used in this study and any prospective presentations and publications.  All participants 
agreed and no changes were made to the transcriptions.   
Immersion in the data is considered to be the first step of the analysis process (Green, Willis 
et al. 2007).  Green et al also further discuss that the insights gained by the interviewer such 
as the context of the interviews including hesitations, confidence of interviewees in 
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responding to questions, shared experiences with the interviewees, all allow the interviewer 
to draw on this experience and contribute to the subsequent interpretation of the data.  As 
the recordings were not transcribed by the interviewer, further immersion in the data was 
achieved by reading and re-reading the transcripts whilst listening to the recorded 
interviews.  Data immersion allowed for a detailed examination of what the interviewees 
said and started the process of identifying themes and sub-themes, laying down the sub-
structure for further analysis (Green, Willis et al. 2007).  See section 5.16.2 below for further 




A study protocol (see Appendix 12) was developed in order to ensure that each step of the 
study was transparent and reproduceable.  This protocol was reviewed by the Ethics 
Committee and approval given.  Each step of conducting the study is clearly represented in 
the protocol and the researcher conducted the study in accordance with the protocol to 
ensure that consistency and reliability of the data were as robust as possible. 
 
5.14 Transferability 
Transferability refers to whether or not the study findings can be transferred to another 
similar context or situation (Houghton, Casey et al. 2013).  Thick description is a strategy 
which is intended to determine transferability and the original context of the research 
should be comprehensively described so that judgements can be made (Koch 1994). It is 
therefore the researcher’s responsibility to ensure that enough detail about the research 
and findings are described so that a reader can determine whether the outcomes can be 
transferred into their contexts.  These details include accounts of the study context, the 
research methods employed and examples of raw data from which interpretations can be 




Noble and Smith (2015) describe confirmability as centring on the acknowledgement of the 
complexity of the prolonged interaction with the participants in the study, and how the 
research methods used and outcomes are essentially linked to the researchers philosophical 
position, experiences and perspectives.  Therefore, in order to ensure transparency and 
contribute to confirmability of the research findings in undertaking Phase II, the semi-
structured interviews, the researcher maintained a reflexive diary.  The researcher is a 
Rheumatology Specialist nurse who has experience and insights into the processes and 
delivery of giving information to patients about Methotrexate.  The researcher was 
transparent with all interviewees prior to the interview taking place, and explained that she 
also had experience in the role. Her position as an “insider researcher” may well have 
contributed towards firstly, establishing a rapport with the participants, and secondly may 
have generated a shared understanding and empathy between the researcher and 
participant (Blythe, Wilkes et al. 2013).  This connection may have empowered the 
participant to respond with a more frank and transparent discussion than would otherwise 
have occurred.  The researcher was not an experienced interviewer, and as the interviews 
progressed, she became increasingly confident and familiar with the process.  Whilst the 
researcher took care to ensure she conducted the interviews in a similar way with all 
participants and stayed close to the wording of the interview schedule, some interviews 
flowed more easily than others and more information was given.  Reflexivity is a deep 
introspective self-exploration of one’s own perspective  (Patton 2014)  allowing the 
researcher to develop an awareness of their own role and the impact that this may have on 
the research, it allows the researcher to acknowledge how their own experiences and 
beliefs may have affected the research processes and outcomes (Haynes 2012).  The 
reflexive account of Phase II is discussed in the relevant section. 
 
5.16 Data Analysis  
The method used to interrogate the data was thematic analysis as the aim of the analysis 
was to explore the data, identifying specific themes and ideas to achieve an understanding 
of the nurses’ experiences.  But Sundler et al (2019) consider that when researching lived 
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experiences, the principles of phenomenology (see Chapter 3) guides that process, 
particularly the analysis. A phenomenological approach to the thematic analysis focussed on 
the human experience and is commonly used in social sciences (Guest, MacQueen et al. 
2012).  Table 5.5 describes the application of thematic analysis from the phenomenological 
perspective. 
 
TABLE 5. 5 PHENOMENOLOGICAL THEMATIC ANALYSIS (GUEST, MACQUEEN ET AL. 2012) 
Defining Features Focuses on subjective human experiences 
Analysis is generally thematic 
Often used in humanist psychology and has been adapted to be 




Subjective meaning is interpreted and extrapolated from the 
dialogue 
Strengths Good for smaller datasets 
can explore data more deeply and extrapolate beyond text 
Good for cognitively oriented studies 
Limitations Focuses only on the human experience 
May interpret beyond what is in the data 
 
5.16.1 Method - Thematic Analysis 
Analysis was carried out using a thematic analysis approach which systematically identifies, 
organises and offers insight into, patterns of themes across a dataset (Braun and Clarke 
2012).  Braun and Clarke describe six steps; familiarisation or data immersion which 
incorporates reading, re-reading and making notes; coding, where interesting features of 
the data are coded; searching for themes, the collated codes are gathered together into 
emerging themes; reviewing the themes, to ensure that the themes are relevant to the 
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coded extracts; definition of themes, which generates clear definitions; finally reporting, to 
select compelling extract examples to illustrate the themes and research question. 
Firstly, the researcher must familiarise themselves with the data.  This is the process where 
the researcher immerses themselves in the data, reading, re-reading the transcripts, making 
notes and cross referencing.  The data is then organised into a series of “codes”, or short 
statements which capture the meaning of that particular phrase.  This stage of the process is 
important to the whole process as it underpins further analysis.  In order to minimise 
researcher bias, note taking is important at this stage to demonstrate and justify a particular 
phrase selection or rejection through inter-rater comparisons to contribute to the reliability 
of the data.  Secondly, themes are extracted from the data by combining and contrasting 
the codes.  Thirdly, codes are further analysed to ensure all of the themes have been 
captured and to categorise the themes into sub-themes.   The final step of thematic analysis 
is to build a theoretical model from the themes and sub-themes. This is the iterative stage of 
the process, where the themes and sub-themes are scrutinised multiple times by the 
researcher using cognitive and creative processes (Chapman, Hadfield et al. 2015).  The 
following sections describe how these four steps were applied to the data resulting from the 
semi-structured interviews from Phase II of the study. 
 
5.16.2 Data Immersion 
The study researcher and a second researcher, a Consultant Rheumatologist who has 40 
years’ experience in Rheumatology and of managing patients on Methotrexate and was 
familiar with the study analysed the transcripts.  Therefore, both researchers were familiar 
with the process of giving information to patients about Methotrexate.   Both researchers 
worked independently of each other.  They read and re-read each transcript whilst playing 
the interview recording at the same time.  The aim of this was to familiarise themselves with 
the participant’s voice and emphasis placed on words and sentences.  Notes were made 
during this process to highlight areas where the participant may have weighted more 
importance to a statement through the emphasis of their voice.  During the process of 
reading and re-reading the transcripts, the researchers both made notes on emerging 
themes and sub-themes.  Each researcher then summarised every interview, incorporating 
the salient points and statements which arose during their immersion in the data. The 
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researchers then came together to discuss the themes and sub-themes and notes relating to 
the interview data to arrive at agreement and establish inter-rater reliability. There was a 
high degree of agreement between the two researchers and they had both recognised the 
main themes emerging from the data. There was more discussion around the sub-themes, 
and where agreement could not be reached, the data was re-visited by the researchers and 
discussed until mutual agreement was achieved.  The recordings were then deleted once 
this step was complete.   
 
5.16.3 Coding of the Data 
Before commencing the process of coding Stuckey (2015) considers that it is important to 
develop a storyline which is directly linked to the research question ie “what is the data 
revealing which will help understand the research question”.  The summary of each 
interview which was generated through immersion in the data provided the storyline and 
therefore contributed to the decisions around concepts and themes which formed the 
analysis and guided the organisation of the data and coding method (Stuckey 2015).  After 




5.17.1 Demographic Details of the Participants 
Demographic details, including the length of time participants had worked in Rheumatology 
and the duration of years participants had been involved in educating patients on 








TABLE 5. 6 DEMOGRAPHICS AND EXPERIENCE OF THE PARTICIPANTS 






P1 65 25 45 Self-taught 
P2 55 1 50 Watched 
colleagues 




51 8 45 Mentored by 
senior colleague 
P5 58 14 45 Mentored by 
senior colleague 
P6 35 0.5 50 Mentored by 
senior colleague 
 
The duration of time the Rheumatology Specialist nurses had been educating patients on 
Methotrexate varied from 0.5 years to 25 years.  Three of the nurses educated patients 
immediately following the consultation in which they were recommended Methotrexate by 
a Rheumatologist.  Whilst the remaining nurses conducted dedicated clinics with 30 minutes 
appointments to conduct the Methotrexate education.  Three of the nurses had attended a 
degree level Rheumatology course and three nurses had received practical training in the 
workplace by their nurse colleagues.   
 
5.17.2 Themes 
Four main themes emerged from the data analysis: 
1. Using standard written information to structure the content of the consultation 
 a) Overloading patients with information 
 b) Patients asking questions 
 c) On-going support 
2. Patients have different information needs 
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3. Time pressures 
4. Training and evolution of practice 
 
5.17.2.1 Theme One: Using standard written information to structure the content of the 
consultation 
In response to the first question asked of the participants, can you describe a recent 
education session, there were varied responses.  Some participants commented that they 
would commence the consultation by explaining what the purpose of the consultation was: 
 
 “I always start off by having the patient reflecting….how they feel their everyday life 
has been affected by the arthritis and then try and put in context why we are 
starting Methotrexate….. (P5) 
“…when they go to see the doctors they don’t know what they are expecting from 
us…so we have to discuss why they’ve come to see me” (P6) 
 
Whilst other participants tended to start straight away by explaining what Methotrexate is: 
 
“I usually explain to them that this is a medication that does require blood 
monitoring” (P3) 
“I basically go through the booklet” (P2) 
“I would say, talking about DMARDs, particularly Methotrexate…we do follow a chart 
that we use” (P4) 
 
When asked if the sessions varied, the participants responded that they had developed a 
dialogue using specific information to guide the consultation to ensure that the information 
that they felt was necessary to give to the patient was provided and thus ensuring that all of 
the information was given without deviation: 
 
“….the purple booklet (local patient information), the Methotrexate……and that’s…I 
use that as my prompt..….and using it to guide me through and keep me on track 
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and I seem to have my own little like speech and if I get thrown off my speech it sort 
of throws me a little bit” (P2)  
“I usually use one of the ARUK leaflets about the…about Methotrexate…..so that 
we’ve got a plan to follow.” (P4) 
 
All of the participants used standard written information, which was in the form of the 
patient information booklet on Methotrexate. They described underlining or referring to 
important sections of the information booklets to ensure that the patients could read these 
sections again.  The nurses clearly felt that certain sections of the information booklet were 
more important than others, and by highlighting this they were, in their own minds, 
ensuring that the patient had received this information: 
 
“I normally put a little star by what I think are for them to take away important 
things to be read back…” (P4) 
“I go through the purple booklet (local patient material) and use it to guide me 
through…it keeps me on track” (P1)  
 
It was apparent that the literature given to the patients often acted as a check list for the 
nurse which acted as a prompt during the consultation.  Using checklists confirms to the 
nurse that all information is given, ensuring that nothing is missed out and therefore 
satisfies her that the patient has received all of the information required to take 
Methotrexate safely: 
 
  “I use the headings (of the booklet) and then talk around that subject” (P5) 
“I go through it you know …. so I know I’ve said everything I should and then on the 
back of our.…checklist, …and it’s got everything there like a tick so I go through that 
as well as I am going along.” (P6) 
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5.17.2.1.1 Sub-theme: Overloading patients with information 
A sub-theme emerged which disclosed that nurses were often aware of the amount of 
information they were giving to patients.  Participants volunteered that patients were 
“bombarded” or “overloaded” with information and patients were described as being 
“dazed”, “shocked” and “frightened”. Rather than engage the patient more in the 
consultation, and explore their fears or feelings, the nurses encouraged the patients to take 
the information booklets and read them again at home in their own time.  
  
“..all the information I’ve just given you is written in this book, go home and read it 
again’……… because it is, ‘it’s all there for you to read again, if you…you know’ 
because it is a lot to take in…….. you know in 10 minutes ….you can’t possibly take it 
all in so…… ‘you know it’s there so go and read it”(P3) 
“I find that they’ve been totally bamboozled by the consultant they come out to me 
and they are a bit sort of dazed you know shocked at what they’ve been diagnosed 
with and then I feel as If sometimes I am telling them stuff but they are not actually 
taking it all on board” (P2)  
..”they get a little bit frightened…when you talk about it and some patients just don’t 
want to take drugs”. (P1) 
 
5.17.2.1.2 Sub-theme: Patients asking questions 
A second sub-theme emerged around giving patients the opportunity to ask questions.  
When the participants were asked if patients expressed their views during the sessions, it 
emerged that patients did not always ask questions during the consultation with the nurse: 
 
 “I would say the majority don’t, no they just sit and take it all in…”(P3) 
“I just didn’t have enough time because I thought that she still had questions that 
she wanted to ask but didn’t…” (P1) 
 
But on some occasions the patients did ask questions but it seems that the nurses felt that it 
was more of an imposition rather than an opportunity to explore the patient agenda: 
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“..sometimes they want to know everything in that one sitting and you can’t possibly 
do that..” (P4) 
“I think the people who interrupt are the…the sort of the more, it sounds 
terrible….but the more intelligent people tend to interrupt and ask more questions”  
(P3) 
 “How often will I have to come to have for me to have my bloods done…that’s a 
main one….I think that’s it really..” (P6) 
5.17.2.1.3 Sub-Theme: On-going support 
A third sub-theme emerged on continuing support.  All participants provided patients with 
the telephone helpline number to use for any follow up queries following the consultation: 
 
”…but there is always a helpline and help at the other end of the phone”(P1) 
“And we also offer them..…the Rheumatology advice line number and explain how 
and when they need to use that..”(P4) 
 
And one centre offered patients the opportunity to make an appointment at an outreach 
clinic for follow-up support should they need it: 
 
“… they’ve got the option of going to an afternoon appointment to one of the 
outreach clinics but it’s still our staff that do them..”(P4) 
 
The nurses also highlighted to patients that there were opportunities for patients to ask 
more questions and chat to a nurse when they returned to the monitoring and drug 
escalation clinics: 
 
“and it’s the sessions that they come for monitoring afterwards that they start to get 
a bit more involved and ask questions there.”(P2)  
“But quite often they do come back to the DMARD escalation clinic”(P3) 
 “When you come for your first monitoring if you remember anything just write it 




5.17.2.2 Theme Two:  Patients have different information needs 
The nurses recognised that there were important variations between patients with respect 
to their need for information as perceived by participants and described occasions where 
they would give more information to some patients, but others, they felt, were not engaged 
in receiving information about the treatment they were about to start:  
 
”…go into it a little bit deeper than …than others, others just want treatment and no 
matter what it is as long as they can get rid of their pain…” (P1) 
“…I think particularly if they are new patients and they’ve never been on anything 
before they have a lot more concerns..” (P5) 
 
The participants described the challenges encountered when talking to patients who are 
about to commence multiple drug therapy.  Multiple drug therapies have been prescribed 
for patients with early Rheumatoid Arthritis for a number of years (Saunders, Capell et al. 
2008, Moreland, O'Dell et al. 2012).  These patients often find themselves in a situation 
where they have just had a diagnosis of a long-term incurable disease, for which they have 
to take up to 3 toxic drugs.  For these patients, they need information about Rheumatoid 
Arthritis, and the life-long implications of this and they also need to understand how to take 
each drug safely.  The implication of this for the patient can be overwhelming: 
 
“Because triple therapy has come out that’s a problem we find…….I don’t like to 
bombard people with too much so doctors like us really to start the triple therapy 
but you might start Methotrexate and hydroxyzine then come back to the 
sulfasalazine it’s bombarding people and going out and saying ‘Whatever has that 
nurse said to me..” (P5) 
“I do find it hard on the ones who have maybe got...two sets of drugs….you bombard 
them with two lots..” (P2) 
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The nurses reported that they would adjust the amount of information given to patients if 
they already had some knowledge of their disease and treatment.  They therefore did not 
necessarily reinforce the information they already had: 
“..I talked to… about Methotrexate they’d already been on a few DMARDS before so 
it was loads easier because they already know the ins and outs of the disease and 
their condition.” (P6) 
“sometimes you can fly through….because they seem to have grasped everything 
you take in..” (P2) 
 
5.17.2.3 Theme Three: Time pressure 
Time is often a challenge that nurses face on a daily basis (Chan, Jones et al. 2013) and 
whilst nurses value the time they spend with patients they often feel that they find it 
difficult to find time to talk to patients because of the pressures of the other tasks they have 
to undertake (Chan, Jones et al. 2013).  Pressures of time were also apparent for all 
participants in this study and those pressures appeared to influence how they conducted 
the consultation:  
 
“….. because we are under pressure you know if you’ve got a queue of 10, 15 people 
waiting you know” (P3) 
“I mean for example if you got a patient that’s newly diagnosed and Methotrexate is 
the first DMARD that they’ve ever come across that they are going to go on to it I do 
think you have….you need more time really with that patient..” (P4) 
 
One participant also revealed that the process of giving information to patients required 
different amount of time depending on the patient, but also acknowledged that they were 
aware of the time pressure and that other patients may be waiting outside: 
 
“My honest answer is I take as much time as it takes..…if the patient I feel needs that 
extra time to go over it and over it they get it, simple as because if there is anybody 
waiting outside, tough they wait but I know that we are under that pressure ‘Come 
on you know there’s a queue” (P2) 
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There was general agreement amongst the nurses that most patients need information 
spread over several appointments which seems to indicate that they were aware that the 
amount of information given at one session should be spread over several appointments: 
 
“..so it becomes an on education all the time follow on all the time, or it should be it 
should be.” (P1) 
  “Don’t worry, we will go week to week and we will get there” (P5) 
 
One participant also acknowledged that the patients themselves understood the time 
pressure and believed that the nurse’s time was precious.  The nurse here also appeared to 
have a perception of the time pressure on herself, which inhibited her from probing further 
into the needs of the patient: 
 
”I just didn’t have enough time because I thought that she still had questions that 
she wanted to ask but didn’t”  (P1) 
 
One participant had an awareness that sometimes patients needed time to decide to take 
the drug and did not put the patient under any pressure to start taking the drug.  However, 
rather than addressing the patient’s concerns at that meeting, the patient was left to make 
the decision for themselves: 
 
  “..so we leave it open that they can contact us to start it before the review..” (P5) 
 
The nurses also added that some patients simply will not take the drugs at all even though 
reassurance on the safety of Methotrexate is given: 
 
“some patients just don’t want to take drugs…they just don’t want them…they just 
think well I will just master on with some herbal remedy….but we try to spend time 




5.17.2.4 Theme Four: Training and evolution of practice  
Most participants agreed that when they first started giving patients information about 
Methotrexate, it was an experience that they sometimes found frightening and were under 
confident.  One nurse remained underconfident despite having carried out the role on a 
number of occasions: 
  “..at the beginning it might frightened you ……..(P5)  
“Yes.  I mean a lot of the time I’ll check with somebody else something that I know I 
am doing the right thing but it’s just that added reassurance…”(P6) 
”..and although I’ve had lots and lots of patients….and done lots and lots of 
monitoring clinics with Methotrexate and the other DMARDs, I am still not 100% 
satisfied that I know enough about that drug for to educate a patient.” (P1) 
 
Training to carry out the role on giving information about Methotrexate varied between the 
participants.  Some nurses revealed that they had not received any training at all: 
 
“….my training was when we were first started using Methotrexate……..after using 
things like..…drugs like Gold and penicillin mainly and sulfasalazine was none, I didn’t 
have any training what so ever.”(P1) 
 
Other participants described their training as consisting of observing the doctor or nurse: 
 
“..I even tried to get sessions where I could go in with the doctor and sort of listen to 
what they were saying” (P2) 
“It got more clearer when I got on the outpatients because...I didn’t start doing the 
counselling sessions straight off …I sat in with (Name of person) a few times..” (P6) 
 
None of the nurses had been given any formal training about Methotrexate and how to 
deliver information to patients. 
 
All participants described that their practice had evolved with experience and time, picking 
up information from their colleagues and absorbing how they carried out the role: 
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“….but then, I think as time goes on you do, you learn more because you know when 
you are sitting and monitoring you can…..you can hear what other people are telling 
the patients and so you pick up little snippets” (P3) 
“..and to me it’s like driving, you can have your lessons, you take your test but you 
don’t really learn to drive until you are behind that wheel on your own do you?” (P4)  
 
However, it was clear that all of the nurses agreed that there was a need to keep up to date 
with practice as it evolved, but again there was no formal training around this and there was 
no expectation from the nurses that this would be provided.  There appeared to be an 
acceptance, that they would just pick this up as they went along: 
 
“..and even to this day I would still say I need to be educated in it further.” (P1) 
  “It’s like the shingles vaccine there’s been a lot of talk around that.” (P5) 
 
One participant even described learning about side effects from patients who expressed 
their experiences of Methotrexate to her: 
“..but you still don’t learn as much, I don’t think, as you do from patients coming in 
and saying ‘Well I’ve got this side effect, I’ve got that side effect” (P3) 
 
When the nurses were asked if they thought formal training would have helped them carry 
out this role, all of the participants agreed and they offered some suggestions around what 
form this training could take: 
 
“…. like maybe in-house training on the computer that I could maybe read and get a 
background on.…” (P2) 
“I think it’s good to have formal session so that the nurse knows exactly what she is 
supposed to say and then as a backup I think the….that role play thing would be 





5.18.1 Summary of Results of Phase II 
This second phase of the thesis explored how the nurses felt about conducting this role, 
what they observe from their patients and how they felt about their training. The semi-
structured interviews captured the experiences and perceptions of six nurses who give 
information to patients about Methotrexate.  Phase II revealed that the nurses’ 
consultations focussed mainly on their own agenda of giving the information about 
Methotrexate to the patients.  They all used an information booklet about Methotrexate to 
guide their consultations and also considered checklists useful to guide and help them 
during the process.  The nurses recognised that they were giving a lot of information to 
patients; the patients often appearing “bamboozled” or “shocked”, but the challenges of 
time pressures resulted in few opportunities for patients to ask questions and nurses 
described feeling “off track” if they did.  The nurses also recognised that different patients 
have individual learning needs, but questions were not encouraged as the perception of 
time constraints and the need to give the information dominated the consultation.  All of 
the nurses agreed that they had learned of the job from their colleagues, but they would 
have liked a structured formal training which would have had a positive impact on their 
skills, confidence and knowledge. 
The results of Phase I of the study, the national survey, highlighted that there is no gold 
standard formal training for nurses in the UK to carry out the role of giving information 
about Methotrexate in order for patients to take this drug safely and as prescribed.  It also 
revealed that nurses can take between six months to a year to feel confident about carrying 
out this role.  The survey also showed that nurses learn on the job and eventually become 
reasonably knowledge about the salient information around Methotrexate safety.  
However, it also disclosed that nurses basically learn on the job from each other, therefore 
bad habits as well as good habits could be passed on within the same service.   
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5.18.2 Discussion of Themes 
5.18.2.1 Theme One: Using standard written information to structure the content of the 
consultation 
The majority of the consultation focused on the nurse’s agenda of imparting information 
about Methotrexate to patients going straight into that agenda without necessarily 
addressing whether the patient had an agenda. Nurses used an information booklet about 
Methotrexate as their guide (see Appendix 2).  This information booklet was primarily 
produced for use by patients; therefore, it is designed in a language that delivers 
information at a literacy level which will ensure that most patients reading it will absorb a 
basic understanding of Methotrexate.  The ability to understand health-related information 
has a measurable effect on treatment outcomes (Fields, Freiberg et al. 2008).  A study by 
Schillinger et al (Schillinger, Piette et al. 2003) showed that diabetic patients who had higher 
health-literacy levels had better control of their diabetes when their physicians adapted 
their language to the literacy of their patients.   Whilst the Methotrexate booklet is an 
appropriate information source for patients, the use of this booklet as a primary information 
source for nurses could be questioned.  However, the national survey conducted in Phase I 
of this study, clearly revealed that there are few information sources for nurses around 
Methotrexate and how to give this information in their consultations.  It is also clear from 
the literature review, that consultation techniques are not part of standard training for 
nurses (Nursing and Council 2010) thus it is not surprising that nurses structure their 
consultation with written sources.  The nurses also revealed that using checklists was useful 
and helped them to guide their consultation with the patient, ensuring that no information 
was missed.  However, whilst it could be said that checklists encourage safer information 
giving, they could also encourage “mindless” checking, which promote automaticity and 
discourage conceptual thinking (Catchpole and Russ 2015).  Thus, using a checklist during a 
consultation with a patient when giving information, could generate a dialogue which solely 
relies on the checklist without accounting for the patient and their personal needs.  It could 
lead to giving information “rote fashion” without individualising and tailoring the 
consultation from the patient perspective and addressing the patient agenda.  It was clear 
that the nurses interviewed understood the purpose of their consultation, but their practice 
of using a checklist approach to inform the content of the consultation reduced the 
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opportunity for the patient to ask questions and issues that are important to patients and 
which might impact on concordance are unlikely to be discussed.  (Macdonald, Stubbe et al. 
2013) video recorded 35 consultations between ten nurses and 18 patients who had Type 2 
Diabetes Mellitus. The initial consultation involved the extensive use of checklists and was 
driven by the nurses’ clinical agenda rather than what the patient already knew or wanted 
to know. Whilst checklists can be helpful for nurses by ensuring that important information 
has been delivered to the patient, they might prevent the patient asking the questions that 
will influence their decision whether to commence the medication being advocated. 
The nurses also recognised that they were giving a lot of information to the patients, who 
they described as appearing bamboozled, overloaded, dazed, shocked and frightened.  
Patients in this state would probably find it very difficult to absorb any new information 
regarding their medication, which appears to be reflected in participant 3’s account of 
patients sitting and “taking it all in” without asking any questions.  Nevertheless, the 
overriding objective of the nurse was to give this information to the patients.  Again, this 
could reflect the lack of training nurses have to carry out this role and how to conduct 
effective consultations.  Rhodes et al (2006) examined the interaction between nurses and 
patients with a long-term chronic condition, diabetes type 2.  They video-recorded 25 
consultations between nurses and patients with diabetes type 2 and revealed that by using 
checklists the nurses streamlined their interaction with the patients. They also referred to 
“industrialisation” which is characterised by treating large numbers.  If this case, 
“familiarity” may breed “complacency” and some practitioners have come to regard it as “a 
grind” where patients become commodities to be processed rather than individuals.  This 
restricts the patients’ opportunities to become individuals and the nurses reduce the 
potential for patients to disrupt their rapid and streamlined process (Richardson and Kerr 
2002).  This may also account for the few opportunities provided by the nurses during their 
interaction for questions from patients, which is supported by the conclusions of Rhodes et 
al (2006).  They determined that their findings from the analysis of the video-recorded 
consultations between the nurse and patient revealed that there was a failure to conform to 
any of the dimensions of patient centred care. 
All of the nurses ensured that the patients had access to a helpline should they have any 
further questions or concerns.  One service offered an outreach clinic, where patients could 
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make an appointment to see a nurse and have further discussions.  However, there 
appeared to be little discussion around how to use this service, it appeared that the 
signposting to the helpline and outreach clinic was a way of finalising the consultation. 
 
5.18.2.2 Theme Two: Patients have different information needs 
The nurse participants recognised that patients had different information needs which could 
be challenging to respond to within a time bound consultation.  Their lack of standard 
training in consultation technique does not arm the nurses with the knowledge and skills 
required to manage this situation.   Participants reported discussing the purpose, 
administration, contra-indications and side effects of Methotrexate guided by the 
information booklet, but patients then have to make sense of the information given from 
their own perspective. The meanings that patients develop will vary, influenced by factors 
such as their beliefs, past experience, education, culture and intelligence (Goodacre and 
Goodacre 2004). It is therefore necessary to check the patient’s understanding at frequent 
intervals. The nurses did not report using this consultation technique when addressing the 
patients.  Thus, it appears that a patient-centred approach may not have been adopted in 
their encounter with the patient.  Putting the patient at the centre of their care has been 
shown to increase patient engagement, satisfaction and compliance with treatment 
(Mirzaei, Aspin et al. 2013).  Whilst many healthcare professionals accept the concept that 
shared decision-making and putting the patient at the centre of care, can be empowering to 
the patient and have an impact on their disease, it is still not being utilized widely and it is 
difficult to determine whether it is making an impact (Légaré, Adekpedjou et al. 2018, 
Mathijssen, Vriezekolk et al. 2020).  The findings of the semi-structured interviews seem to 
support this perspective as the nurses did not appear to individualize the patient and 
develop the interaction with a shared decision-making approach.  
 
5.18.2.3 Theme Three: Time pressures   
The nurses’ perceptions of the limitation of time for their consultations appeared to have an 
impact on their willingness to encourage questions from the patients.  Participant 3 used 
 186 
the word “interrupt” which could indicate that this nurse was under time pressure to deliver 
the Methotrexate counselling to the patient and therefore did not engage in encouraging 
questions.  Bowers et al (2001) interviewed 18 nurses who worked in a long term care 
environment.  They found that the nurses had too little time to perform all of the tasks 
required of them and this often led to developing strategies to reduce the time allowed to 
complete certain duties.  Effectively, the nurses sometimes would not do those tasks that 
they regarded as “should do” and concentrated on those that they “must do”.   
 
It is reported that there is a global shortage of nurses as a result of lower recruitment and a 
higher turnover rate of qualified nurses (Nantsupawat, Kunaviktikul et al. 2017, Senek, 
Robertson et al. 2020).  Senek et al (2020) conducted a survey of nurses in the UK and they 
found that nurses felt demoralised because of a perceived lack of support, low staffing 
issues and poor management.  Low staffing issues resulted in higher than manageable 
patient to staffing ratios which had a detrimental impact on both the nurse and the patient.  
Thus, the pressures of not having enough perceived time to conduct the role of giving 
information about Methotrexate to patients could result in “rote fashion” consultations.  
Some participants described having a “speech” and “keeping on track” which could imply 
that their agenda was the focus of the consultation resulting in a lack of opportunities for 
patients to ask questions or discuss concerns. 
 
5.18.2.4 Theme Four: Training and evolution of practice 
The emergent role of the Rheumatology nurse was described in Chapter 2 Section 2.4, and it 
revealed that nurses were increasingly taking on more tasks such as joint examination, 
disease management planning and drug prescribing (Hill, Thorpe et al. 2003, Goh, Samanta 
et al. 2006).  A survey undertaken by the Royal College of Nursing (Royal College of Nursing 
2009) revealed that a small number of nurses had undertaken drug prescribing courses, 
cytotoxic drug courses and a small number of Rheumatology courses. The implication of this 
was that most Rheumatology Specialist nurses had no formal training to conduct their 
developing roles.  This lack of training was also apparent within the participants of Phase II 
of this study; the analysis of the transcripts revealed that none of the nurses interviewed 
had undertaken any formal training to carry out their role.  They had generally learned on 
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the job, absorbing the techniques of other colleagues and even expanding their repertoire 
of knowledge from the experiences of patients around side effects.  But, it is difficult to 
understand how far colleagues from the same service, had influenced their consultation 
style.  Whether, good or bad habits had been passed on, or how far the individual nurse had 
sought more information herself to become more informed.  Nonetheless, all nurses agreed 
that formal training would have made a positive impact on their skills, knowledge and 
confidence, which supports the findings of Phase I of the study, the national survey. 
 
5.19 Limitations of the Data  
 
5.19.1 Recruitment Sampling 
As discussed in section 5.8 of this chapter, six nurses were recruited to Phase II, three each 
from two different NHS Trusts.  The Trusts differed in that one Trust offered a structured 
University course on Rheumatology Nursing and nurses who gave information about 
Methotrexate had dedicated appointments for the patients in which to carry out their 
consultations.  The other Trust offered no training, apart from what would be gleaned on 
the job, and the nurses fitted in the task of giving information about Methotrexate to 
patients whilst they were conducting other duties in the outpatient department.  The 
rationale behind recruitment from these two different services was simply because it was 
extremely difficult to engage enough nurses in one Trust to agree to be interviewed.  There 
was a great deal of reluctance on their part despite assurances that all interviews would be 
anonymised and confidential.  Whilst it could be considered that the learning opportunities 
and the dedicated time for consultations could have had an impact on the way information 
about Methotrexate was given, in fact, the same themes emerged from the interviews with 
the nurses from each Trust; for example, all nurses used the Methotrexate information 
booklet as a check list and all of the nurses had their own agenda of ensuring that all of the 
information was given. 
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5.19.2 Data Saturation 
Samples for qualitative research are generally smaller than those required for quantitative 
investigation (Mason 2010), because as the study progresses, it does not necessarily mean 
that more information is obtained.  Mason (2010) articulates that the occurrence of one 
piece of data or code is all that is required for it to become part of the data analysis 
framework, further stating that frequency is rarely important in qualitative inquiry because 
one piece of data can be as important as many in the understanding of a research topic. 
Furthermore, analysing qualitative data can be very labour intensive and therefore large 
sample sizes for some projects can be impractical (Green and Thorogood 2018).  Green and 
Thorogood further believe that whilst data saturation is a credible concept it has 
weaknesses in that some researchers may be limited by time through the conditions of their 
grants and they may also have to identify the number of participants to be interviewed for a 
grant committee or an ethics committee before they study begins.  Mason (2010) reviewed 
560 PhD studies in which  interviews were conducted as part of the projects, the number of 
interview participants ranged from one to 95 and there was no real pattern of how the 
researchers arrived at their sample sizes.  Guest et al (2006) recognised that there were no 
real guidelines around how to estimate sample sizes for purposive sampling interviews. 
They investigated data saturation and variability by conducting semi-structured interviews 
with women from two African countries; 30 participants were from Nigeria and 30 were 
from Ghana.  An interview guide was used and all interviews were audio-recorded then 
transcribed verbatim.  Thematic analysis of the transcripts was carried out and codes were 
defined.  Their aim was to determine whether six interviews rendered as much useful 
information as 12 or 18 for example.  After analysis of all 60 interviews, 36 codes were 
applied and they concluded that of these 34 (94%) had been identified within the first six 
interviews and 35 (97%) within the first 12 interviews.  Therefore, whilst the results may not 
necessarily be considered generalisable, nor be truly representative of the respondents who 
completed the Phase I national questionnaire, six to 12 interviews should yield enough 
information to understand common perceptions and experiences amongst a group of 
relatively similar individuals.  Thus, whilst the findings which emerged from the semi-
structured interviews described in this thesis, may not necessarily be considered 
generalisable, they yielded enough information to be able to contribute to the body of 
 189 
existing knowledge in this particular area of investigation.  They provided further insights 
into how nurses conduct their interactions with patients when giving information about 
Methotrexate.  
 
5.20 Areas for Further Investigation 
As drug counseling/education is regarded as a key role of Specialist Rheumatology Specialist 
nurses (Royal College of Nursing 2009), a training programme could be developed which 
would include effective consultation skills to maximize the time-bound consultation and 
increase confidence to enable a two way communication process where a guide is no longer 
required to structure the consultation and the encounter can be patient-led.   
Further investigation of how nurses conduct their consultations with patients in order to 
understand the underpinning evidence-based practice they employ is required.  It is unclear 
how far the nurses’ practice shared decision-making and which consultation model forms 
the structure of their practice. Direct observation through video recording will allow the 
researcher to observe the process in detail.  Thus, Phase III of this study involved video-
recording ten nurse patient consultations from one Rheumatology service, the aims of 
which were to further explore the consultation skills of the nurses and how shared decision-
making was incorporated into their practice.  Further, by video-recording nurses from one 
Rheumatology service who have observed each other, it allowed the researcher to 
investigate how far the nurses were influenced by each other in a “copy-cat” fashion, or 










Chapter 6: Phase III – An exploration of video-recorded 
consultations between Rheumatology Specialist nurses and 
patients 
 
6.1 Summary of Phase II 
Phase II of this study explored the experiences and perceptions of six nurses who gave 
information to patients about Methotrexate through audio-recording semi-structured 
interviews.  This revealed that the nurses’ agendas during this process dominated the 
consultation resulting in a lot of information being given to patients.  Patients were 
described as appearing “bamboozled”, “dazed” and “shocked”, but the nurses perceived 
that the challenges of time pressure resulted in little opportunity for patients to ask 
questions, or if they did, the nurses sometimes went “off-track” with the flow of their 
consultations.  The nurses recognised that different patients had different learning needs, 
but it was not apparent that the nurses were tailoring their consultations to meet these 
different needs. All the nurses had learned their skills on the job, by watching peers and 
Rheumatologists in clinics, but they all agreed that structured formal training would have 
been more appropriate and would have had a positive impact on their knowledge, 
confidence and skills. 
 
The Nursing and Midwifery Council standards for pre-registration nursing education 
(Nursing and Council 2010, Nursing and Midwifery Council 2018) require student nurses to 
develop a range of communication skills in order to demonstrate those skills: 
“underpinning communication skills for assessing, planning, providing and managing best 
practice, evidence-based nursing care” (Nursing and Midwifery Council 2018:20). 
 
This appears to suggest that there is an expectation that the student nurse will understand 
how to actively listen, recognise and respond to verbal and non-verbal cues, make 
appropriate use on open and closed questioning and check understanding and use 
clarification techniques.  However, the emphasis appears to be on the development of the 
nurse’s knowledge rather than developing the underpinning consultation and teaching skills. 
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These latter skills are often emphasised more in postgraduate courses. This final third phase 
of the study aims to investigate more closely how nurses use open and closed questions 
during their consultations and whether they recognise and respond to verbal and non-
verbal cues from the patients. 
 
6.2 Phase III Introduction 
This phase of the study, investigating the actual domain from the philosophical critical 
realism perspective, was undertaken by video-recording ten nurse/patient consultations 
(Figure 6.1). 
 






Prior to commencing Methotrexate, patients receive information in a consultation with a 
nurse. The purpose of this is to give the patient sufficient information about the drug’s likely 
effects and possible side effects to allow them to take it safely and effectively. The patient’s 
wish to start the drug is confirmed and the arrangements for monitoring and supply are 
discussed. Results from the previous two phases of this study confirmed that further 
exploration of the consultation between nurses and patients when giving information about 
Methotrexate was required. As reported in Phase I, the national survey, nurses had variable 
and limited training in order to undertake this process. Confidence in this role took time to 
develop and was linked to gaining experience. The results from the semi-structured 
interviews (Chapter 5) showed that the nurses focused mainly on giving information which 
led to little opportunity for interaction and questions from the patient.  The objective of this 
phase of the study was therefore to video the interaction between the Rheumatology 
Specialist nurses and patients during the information giving process about Methotrexate for 
comparison with a consultation model and for thematic analysis in order to further explore 
and understand the nurse and patient experience of the interaction.  
  
6.3 Phase III Aims and Objectives 
6.3.1 Phase III Aims 
To investigate how nurses, deliver information about Methotrexate to patients, and how 
they ensure that patients have received and understood that information during the 
consultation process. 
6.3.2 Phase III Objectives 
1. Video record ten nurse/patient consultations. 
2. Analyse the video recordings using the Medical Interactive Process and the Calgary 
Cambridge Model. 
3. To understand the processes nurses, use in their interaction with the patients when 
giving information about Methotrexate. 
4. To understand the processes nurses, use to ensure that patients have understood 
the information given. 
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6.4 Methods 
6.4.1 Video-Recording  
The aim of this phase was to explore the non-verbal aspects of the interaction as well as the 
verbal aspects, and therefore video-recording was the most appropriate method of data 
collection. 
Video-recording has developed into a powerful tool for research in the social sciences (Janík, 
Seidel et al. 2009).  It allows the study of complex processes, increases inter-rater reliability, 
and coding from different perspectives can be undertaken (Hiebert, Gallimore et al. 1999). 
The use of a video camera could also be viewed as less intrusive than a physical presence by 
the researcher.  The video-recording allows the whole interaction between nurse and 
patient to be captured in order to investigate effectiveness of the consultation  (Heath, Luff 
et al. 2007). One option would have been to sit directly in the clinic and observe. This would 
only have allowed one “take” of the consultation which would therefore have been limited to 
an impression of how different aspects of the consultation were performed. This may have 
been suitable for scoring the consultation against pre-defined content as to how well the 
different items were performed, but it would not allow any more detailed analysis and the 
presence of the observer may have distorted the consultation. Audio recording of the 
consultation would have allowed the more detailed qualitative analysis but only of the verbal 
content of the consultation. The presence of the camera in the consulting room would be less 
intrusive than an observer and therefore less likely to distort the consultation (Heath, Luff et 
al. 2007). From previous experience the subjects very quickly appeared to forget that the 
camera was there. The analysis of the video-recordings was achieved through; scoring against 
the Calgary Cambridge model, scoring using the Medical Interaction Process System and 
thematic analysis of the transcripts.  The adoption of multiple analysis methods can add depth 
to the findings of a study and is therefore given further consideration in the following section. 
 
6.4.2 Triangulation 
The term “triangulation” originates in the field of navigation where a location can be 
determined from two known points (Heale and Forbes 2013) but in research it is the use of 
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more than one approach to addressing a research question. The objective is to add rigor, 
breadth complexity, richness and depth to the enquiry, (Denzin 2012) and is considered an 
important method regarding data analysis for qualitative studies to ensure reliability and 
validity of the results (Fusch, Fusch et al. 2018). Triangulation is generally associated with 
research methods and designs, but it also includes the adoption of multiple theories, data 
sources, methods or investigators within the phenomenon under examination (Williamson 
2005, Lauri 2011).  A discussion of mixed methods research has already been carried out in 
this thesis (see Chapter 3 section 3.5).  The review discussed criticisms concerning mixing 
qualitative and quantitative methods in a research project and whether these methods 
would be compatible (Creswell 2011).  However some researchers consider that not all 
research favours a single method approach and the strengths and limitations of the 
qualitative and quantitative paradigms add to the richness of the resulting conclusions and 
may capture a different perspective which may otherwise have been overlooked (Morse 
2009, Maxwell and Mittapalli 2010). The discussion of mixed methods in Chapter three 
concluded that the overall three phase study presented in this thesis can be regarded as 
truly mixed methods and triangulation of the methods of analysis for Phase III was adopted 
to add rigor and strength to the findings (Figure 6.2). 
 













Thematic Analysis of 
Transcripts 
Medical Interaction 
Process System  
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6.4.3 Calgary Cambridge Assessment Tool 
A number of consultation models have been developed, which were described in Chapter 3, 
but they were designed for use in the medical domain.  Consultation models create the 
framework of the consultation and most are patient-centric (Perry 2011).  Perry recognises 
that nurses will adapt and formulate their own consultation structure but seven key 
elements should be; establishing and maintaining a good rapport, structuring the 
consultation, obtaining and gathering relevant information, prioritising, clinical reasoning 
and judgement, information giving and management planning involving the patient.  The 
Calgary Cambridge Model is used in many medical schools to teach students how to carry 
out a consultation (Kurtz, Draper et al. 2017) and is widely practised amongst General 
Practitioners (GPS) (Burt, Abel et al. 2014). This model emphasizes the need to provide 
information in manageable chunks and to use the patient’s response to guide the 
consultation (Kurtz, Silverman et al. 2003).  Whilst this model was developed for the medical 
profession, it has been adapted to apply it in the nursing context (Munson and Willcox 
2007). The Calgary Cambridge consultation model (Kurtz and Silverman 1996) has five stages 
and two themes which run through the consultation (Denness 2013); 
 initiating the session to establish the reason for the consultation and set an agenda 
 gathering information about current knowledge, ideas concerns and expectations 
where open and closed questions would be used, also picking up on cues  
 physical examination 
 building the relationship with rapport and empathy and legitimising the patient view,  
 explanation and planning which includes, chunking of information and checking for 
understanding, using written information  
 closing the session, which would include summarising and ensuring that there is an 
agreed and clear plan 
 Providing a structure with a flow and clarity 
 
The Calgary Cambridge consultation model is a proven standard for consultations involving 
the transfer of knowledge and consultations by nurses using this model and nurse/patient 
communication skills can be improved by applying this consultation model.  In China Yian et 
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al  (2012) commented that training of nurses using this model resulted in improved 
observed communication and interview skills. Donnelly et al (2016) recognise that applying 
the Calgary Cambridge consultation model can result in more meaningful, empathetic 
communication between the nurse and patient in the palliative care setting.  McLeish and 
Snowdon (2017) applied the Calgary Cambridge consultation model to illustrate that 
prescribing decisions can be enhanced and provide direction to the consultation. Whilst 
nurses who talk to patients about Methotrexate do not necessarily need to apply the full 
model, elements of it could enhance their consultation skills for this particular role (Munson 
and Willcox 2007). Patients also have different preferences for communication (Macdonald, 
Stubbe et al. 2013) and, to optimize concordance, the nurse needs to be able to identify the 
patient’s information preference and meet it.  It meets the seven criteria described by Perry 
(2011) and has been adapted to be applied in the nursing context and was therefore 
selected as an appropriate model with which to assess the consultation techniques used by 
nurses in the video-recordings for this phase of the study. 
The videos were viewed in VLC Media Player which is a free playback application (Hughey 
and Maaks 2020) and allowed the researcher to stop and start each video-recording in order 
to code the data.  The videos were reviewed multiple times in order to ensure that every 
domain of the interview had been meticulously analysed. Each recording took 
approximately five hours to code. One video was scored separately by a second researcher, 
who was part of the supervisory team and was a Consultant Rheumatologist, for inter-coder 
reliability to achieve agreement. He was therefore familiar with the study and 
knowledgeable around the information which patients require in order to take 
Methotrexate safely and as prescribed. The aim of this was to ensure that the coding 
produced by the researcher could be reproduceable by other coders.  Inter-coder reliability 
is carried out by two or more equally proficient coders for the same data (Popping 2010) 
and inter-coder agreement is the discussion that the two or more coders have with regards 
to any coding discrepancies they may have had (Campbell, Quincy et al. 2013). The two 
researchers discussed and agreed the coding assessment tool prior to conducting the 
assessments.   
As discussed in Chapter 2 (section 2.7), a number of assessment tools are available to 
evaluate consultations including the Royal College of General Practitioners Consultation 
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Assessment Tool (COT) (2017) containing 13 items with which to score the consultation on a 
zero to three scoring scale.  However, as previously discussed, not all of the domains were 
applicable and there was some overlap with the Calgary Cambridge consultation model.  
Consequently, the scoring system was aligned with the domains of the Calgary Cambridge 
consultation model (Table 6.1), removing the domain around physical examination as this 
would not have been carried out during the consultation under investigation, but the zero 
to three scoring scale of the COT was retained (Table 6.2). 
 
TABLE 6. 1 SCORING SYSTEM BASED ON THE CALGARY CAMBRIDGE CONSULTATION MODEL DOMAINS 
Domains 
Initiating the Consultation 
Setting the Agenda 
Information/Knowledge 
Ideas/Concerns/Expectations 
Explanation and Content 




TABLE 6. 2 THE 4-ITEM SCORING SCALE BASE ON THE COT  
SCORE OBSERVATION 







6.4.4 The Medical Interaction Process System Scoring Tool 
Whilst the Calgary Cambridge model provide an overview on how healthcare professionals 
conduct their consultations ensuring that the patient is central to their care and 
understands and shares the decisions around their disease management, it did not factor in 
non-verbal communication.  Communication is a highly complex process involving far more 
than the spoken word (Kourkouta and Papathanasiou 2014). Kourkouta and Papathanasiou 
believe that not only understanding the patient is required but also the nurse must convey 
messages which the patient understands and are acceptable. They also believe that nurses 
require training in order to carry out this communication effectively. Characteristics of 
communication, which should be observed in order to achieve a meaningful interaction are 
described by Ford and colleagues  (2000) (Table 6.3). 
 
TABLE 6. 3 CRITERIA FOR AN INTERACTIVE PROCESS SYSTEM (BASED ON FORD ET AL 2000) 
CRITERIA CHARACTERISTICS 
Information Transfer Content – containing definitive and connotative information usually transmitted 
linguistically 
Relationship – affective information which can be transferred by facial gesture, 
tone of voice, grammar etc 
Context Refers to the current situation and adds to the relationship level 
Observation Method Video recordings capture all of the verbal and non-verbal behaviour 
Sequencing Observing the relationship between each statement and the verbal utterances 
between the participants 
Coding System Logical with clear concise understandable category definitions 
 
Non-verbal “body language” by some estimates, accounts for more than half of 
communication (Mehrabian 1981). In order to explore this further a more detailed analysis 
was undertaken.  One of the most detailed analyses described is the Medical Interaction 
Process System (MIPS) which codes every utterance and every movement by both the 
educator and the patient (Ford, Hall et al. 2000). This tool was based on the work of Roter 
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(1991), who developed the Roter Interaction Analysis System (RIAS) which is an instrument 
for observing and coding verbal interaction.  One of the limitations of the RIAS was that it 
did not consider the non-verbal behaviour and patient cues which adds a further dimension 
to the consultation. Therefore, Ford et al refined the RIAS so that these interactions could 
also be coded and analysed.  
The RIAS was considered at a method for data analysis for the study presented in this thesis 
as it has been used extensively in healthcare research (Pires and Cavaco 2014).  Pires and 
Cavaco conducted a systematic review of studies using the RIAS and from the 34 articles 
which were selected for their review, only four involved nurses.  Vinall-Collier et al (2016) 
video-recorded 18 healthcare professionals nine of which were Rheumatology nurse 
specialists.  The aim of that study was to compare the styles of interactions with patients 
between nurses and physicians.  They coded the videos using the RIAS which was 
categorised into four domains; data gathering, patient education and counsels, activate and 
partnership and building a relationship.  However, as previously discussed, the RIAS does 
not encompass the verbal and non-verbal domains which are part of the MIPS analysis.  
Thus, in order to explore both the verbal and non-verbal domains, and add greater depth to 
the findings of this study, the MIPS was adopted.  Further, a review of the literature did not 
reveal the use of the MIPS to code and analyse the interaction between nurse and patient in 
any studies, it was therefore of interest to adopt this coding method in a unique and novel 
setting. The basic unit of the MIPS is the utterance where each one is coded separately and 
the content of that utterance is coded which includes both verbal and non-verbal 
interactions.  This was a novel approach in the exploration of consultations between nurse 
and patient in Rheumatology. Further, the quantification of all verbal and non-verbal 
utterances and actions permitted a quantitative and potentially more objective analysis of 
the interaction.  
In order to carry out the analysis of each video-recorded consultation and observe the 
verbal and non-verbal interactions between the nurse and patient during the process of 
giving information about Methotrexate, the videos were viewed multiple times. The first 
ten-minute segment of each of the consultations was analysed.  The decision to analyse the 
first ten-minute section was reached because it allowed the researcher to explore the initial 
greeting made by the nurse to the patient, how she determined the patient agenda and 
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how she set the scene.  Further, it would also reveal how the nurse gave information to 
patients, and how she engaged with shared decision-making, putting the patient at the 
centre of the consultation.  Focussing the analysis to a ten-minute segment has been used in 
other studies.  Caris-Verhallen et al (1999) who observed the non-verbal behaviour of 
nurses in care homes and own home settings.  They followed Henbest and Fehrsen (1992) 
who noted that scoring a ten-minute segment of a communication was as reliable as scoring 
the whole encounter.  Further Kaner et al (2007), who conducted a video-based study 
comparing standard paper based guidelines with two forms of computer based decision aids 
to inform treatment decisions in a consultation between GPs and patients, also considered 
that scoring a ten-minute slice of the consultation as appropriate due to the high volume of 
complex data produced by video-recordings. The first ten-minute segment of each video 
was viewed minute by minute and followed the MIPS coding informed by Ford (2000) and 
Kaner (2007) (see Appendix 13).  Owing to the volume of utterances and non-verbal 
communication to be coded, each ten-minute segment took one full day to analyse.  The 
contents of each one-minute segment were coded into modes of exchange, which are 
presented in Tables 6.4 and 6.5.  Each of the modes of exchange were given a score of one 
















TABLE 6. 4 VERBAL MIPS MODES BASED ON FORD ET AL (2000) 
Behaviour (dependent) 





Asks closed question 

































TABLE 6. 5 NON-VERBAL MIPS MODES BASED ON FORD ET AL  (2000) 












Hand gestures (illustrative) 
Hand gestures (batonic 
 
Non-verbal kinesic behaviour (dichotomous) 
Shoulder position (twisted/square) 
Posture (closed/open) 
Body lean (backwards/forwards) 
Eye contact (maintenance/avoidance) 
Nurses: reading/writing (yes/no) 
Nurses: touching patient (yes/no) 
 
 
The combination of observing and coding the verbal and non-verbal dimensions allowed a 
greater yield of information strengthening the resultant analysis. It allowed the researcher 
to draw a clearer picture of the whole consultation between the patient and healthcare 
provider and to observe whether those verbal and non-verbal cues were observed and 
responded to by the nurse. 
 
6.4.4.1 Patient Cues 
Patients seldom express their emotions directly, but rather use cues to transmit their 
concerns (Uitterhoeve et al 2007). These cues are generally embedded in dialogues which 
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take place between the patient and the healthcare giver. It is important to recognise and 
respond to these cues and patients’ emotional and social needs may be overlooked (Farrell 
et al 2005). Uitterhoeve et al (2007) carried out an observational study with five oncology 
nurses who interviewed an actor playing the role of a patient. Three interviews took place 
and approximately 20 cues were embedded in each interaction. Cue responding behaviour 
was assessed with the Medical Interview Aural Rating Scale (MIARS) (Heaven and Green 
2001). The MIARS explores ten key interviewing skills, the number of cues and concerns the 
patient has and the responses of the nurse categorised into three domains(Heaven, Clegg et 
al. 2006). The MIARS identifies three levels of cues and how those cues are disclosed by the 
patient; level one is categorised into hints at an anxiety or concern; level two is where the 
patient explicitly expresses their concern and level three is a clear expression of emotion 
such as anger or crying (Heaven and Green 2001). Uitterhoeve et al (2008) classified cues 
into four levels; level zero involved neutral expressions, level one expression that hints at 
worry or concern, level two expressions which mention worry or concern and level three a 
clear expression of unpleasant emotion. The nurses explored about 32% of the cues, 17% 
were acknowledged and the nurses responded to 50% of the cues with distancing 
behaviour. The nurses were more likely to respond to the higher-level cues than the lower 
level cues. This suggests that recognising cues can be complex and therefore an interaction 
analysis could be limited if lower level cues are not identified. Most of the publications 
around cue responding behaviour has been carried out in cancer nursing, however the 
MIARS has been used in other specialities. Noordman et al (2013) applied the MIARS to gain 
insights into the perspectives of children and adolescents with type 1 Diabetes. It is also 
used in different parts of the world; Lin et al (2017) explored the cue responding behaviour 
of a cohort of 110 nurses in Taiwan. They remarked that Taiwanese nurses demonstrated 
more distancing behaviour (81% of the time) in relation to cue responses than in countries 
such as Hong Kong, the Netherlands and the UK (Heaven, Clegg et al. 2006, Uitterhoeve, 
Bensing et al. 2009, Chan 2014). 
Zimmerman et al (2007) undertook a literature review of observational studies carried out 
between 1975 and 2006 which involved patient-physician consultations and reported the 
findings of patient expressions of cues and/or concerns. They found that most cues and 
concerns were missed and physicians used behaviours to avoid further disclosures. As a 
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result of this, Del Piccolo et al (2011) formed an international group of experts to meet and 
share experience and language on cues and concerns which lead to the development of a 
new coding system the Verona Coding Definitions of Emotional Sequences (VR-CoDES). The 
patient codes and concerns are defined in the VR-CoDES-CC and the healthcare provider 
responses are explored with the VR-CoDES-P.  In this new system cues are defined as 
“verbal or non-verbal hints, which suggest an underlying unpleasant emotion and that lacks 
clarity”. Concerns are described as “clear and unambiguous expressions of an unpleasant 
current or recent emotion that are explicitly verbalised with or without a stated issue of 
importance”. 
 
6.5 Ethical Considerations 
Caldicott approval to undertake the video-recordings in the Trust and to ensure 
confidentiality of nurse and patient information, was given on 28th February 2019 (see 
Appendix 14).  A study protocol was written as well as participant information leaflets and 
consent forms for the nurse and patient participants (See Appendix 15). Ethical approval 
was sought and approval to conduct the study was given by London-Brent Research Ethics 
Committee and the Health Research Authority and Health and Care Research Wales (HCRW) 
on 08/04/2019 Reference 19/LO/0450 IRAS Number 250427 (see Appendix 16) and final 
confirmation of capability and capacity to deliver the study was given by Research and 
Development at Northumbria-Healthcare NHS Foundation Trust on 8th June 2019 (see 
Appendix 17). 
Consent to perform the videos was necessary from both the patient and the nurse involved. 
Consent was taken as per the Principles of Good Clinical Practice for Research (Guideline 
2001). Before consent was taken, the participants had the opportunity to read information 
sheets about the study and to ask questions. On completion of the recording, consent was 
confirmed to ensure that nothing had been revealed during the consultation that made 
either the nurse or the patient uncomfortable to have the video analysed. This process was 
approved by the Brent and Southwest Ethics Committee and it was also given Research and 
Development approval by Northumbria Healthcare NHS Foundation Trust. 
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6.6 Sampling Strategy 
As described in Chapter 5 (section 5.7), purposive sampling techniques are often used in 
qualitative research (Teddlie and Yu 2007) and can be defined as selecting units, namely 
groups or individuals, which have particular characteristics in common with the research 
question.  The same approach was used in Phase III of the study, which also aimed at 
targeting nurses who had the same role of giving information about Methotrexate and may 
exhibit similar feelings and experiences.  The sample size was based on the work of other 
researchers who had used video-recorded interviews.  Video-recordings to inform research 
and improve services has been used in different healthcare settings.  James et al (2020) 
video-recorded 14 consultations between practice nurses and patients to explore how they 
communicate lifestyles risks.  They identified that whilst the nurses demonstrated some 
communication skills, they felt that there was room for further development.  Brataas et al 
(2010) designed a study to investigate the goal-related communication between nurses and 
patients in cancer clinics in Norway.  They selected their eight nurse participants based on 
purposive sampling, ie they made a judgement on who they thought would be most 
representative and informative. They video-recorded eight conversations between each of 
the nurses and a patient in one cancer outpatient department and the recordings varied 
from 15 to 45 minutes.  They revealed that a clear goal of the nurses was to ensure the 
patients understood their cancer treatment as fully as possible to ensure optimal 
management.  However, the nurses gave a lot of information in long sequences with 
patients responding in short utterances only and they took those responses such as “yes” or 
“ok” to represent understanding.  This is paralleled in the findings of Phase III of this study 
and will be described later in this chapter.    
 
6.7 Participant Identification 
Four Specialist nurses in the Northumbria Rheumatology service agreed to be videoed. 
Ethics approval was given by London Brent Research Ethics Committee and the Health 
Research Authority on 8th April 2019 (see Appendix 16). All participants had the opportunity 
to read the Information Sheets about the study, and all participants gave written consent. 
Four Specialist nurses and ten patients took part in this phase of the project. 
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Ten consultations by the four Specialist Rheumatology Specialist nurses were recorded.  This 
department was situated in a different Trust than the two Trusts which were used to recruit 
the nurses for Phase II of this study.  Bickerton et al (2010) describes the use of video-
recordings to improve the implementation of patient-centred care in consultations.  They 
described two case studies in which the consultations were video-recorded and described in 
detail the communication between the healthcare professional and the patient.  Bickerton 
et al emphasise that the video-recordings do not necessarily diagnose problems, but rather, 
raise awareness and increase understanding of the consultation process. Therefore, the 
contribution of Phase III of this study, whilst limited to ten video-recordings from one 
Rheumatology service, the findings add to the body of literature in this area and raise 
further awareness of gaps in consultation style of Rheumatology Specialist nurses who give 
information to patients about Methotrexate.   
All participants were given information sheets about the study and given opportunities to 
ask questions before deciding to participate in the study.  Informed consent was taken from 
every nurse and patient participant and the original was stored in the study master file 
within the Research and Development Department at Northumbria-Healthcare NHS 
Foundation Trust, a copy of the consent form was given to each participant.  Every 
participant was also given the option to stop the video at any point, without having to give a 
reason, and that video-recording would be destroyed.  No participant asked for the video 
recording to be stopped and all gave consent for the video-recordings to be used in the 
study. 
 
6.8 Study Setting 
The nurses were all known to the researcher, but in order to ensure that each participant 
was comfortable with the video-recorder, it was set up in the nurse’s consulting room 
before the consultation with the patient took place.  This allowed the nurse and patient 
participants to become comfortable with the camera.  Also, the recording was started just 
before the consultation was initiated, which allowed the researcher to leave the room.  The 
aim of this was to allow participants to feel more relaxed and conduct their normal 
consultation without an observer which could have added more pressure to the nurse and 
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patient and could have impacted on the consultation itself.  The video recordings captured 
the consultation process between nurse and patient at the time the patient received 
information about Methotrexate.  None of the patients had received Methotrexate 
previously. 
 
6.8.1 Video-Recording 1 
The nurse (N1) was sitting directly in front of the table, the patient was sitting in a chair at 
right angles to the table which meant that the patient had to turn her head to the right to 
see the nurse, there was another chair to the left of the patient. The desk very small and 
was cluttered with notes. The nurse introduced herself briefly by name only, then goes 
straight into talking about the pulmonary function test results. 
 
6.8.2 Video-Recording 2 
The nurse (N1) was sitting in the clinic room as video-recording 1.  The patient sat in the 
chair at right angles to the desk and nurse.  The nurse was facing the patient but her 
shoulders were twisted towards the desk.  The patient notes were open on the desk and the 
computer screen showed the blood results of the patient.  The patient did not appear 
relaxed and at times appeared unhappy and distressed.  The nurse made no introductions or 
establish baseline knowledge of the patient.  The nurse continued the consultation giving 
information about Methotrexate but did not appear to have a relaxed rapport with the 
patient.  The patient appeared to want to talk about other issues, but the nurse either 
avoided this or did not pick up these cues. 
 
6.8.3 Video-Recording 3 
The nurse (N2) was sitting on a swivel chair in front of a large desk.  The patient notes were 
open on the desk, and there was a filing tray and two computer screens on the desk.  One of 
the computer screens was displaying the patient’s blood results. The patient was 
accompanied by her mother and they sat with their chairs facing the nurse.  The nurse 
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mostly faced the desk and wrote in the patient notes but swivelled occasionally to face the 
patient and her mother.  The nurse introduced herself by name and her role and also 
established that the patient was happy to continue and to take Methotrexate.  The nurse 
did not establish baseline knowledge with the patient.  The nurse introduced the 
Methotrexate booklet at the start of the consultation.    The patient looked slightly nervous 
and her mother did not speak any utterance throughout the consultation.  The nurse mostly 
addressed the patient throughout the conversation. 
 
6.8.4 Video-Recording 4 
The nurse (N3) was in a small clinic room and was sitting in front of a small desk.  The desk 
was cluttered with two computer screens, one of which was open to the lab results page, 
and there was also a set of filing trays on the desk.  The nurse was sitting facing the patient, 
who was sitting at right angles to the desk and was required to turn her shoulders slightly to 
face the nurse.  The patient appeared nervous, and “chewed” her lip frequently throughout 
the consultation.  The nurse’s manner was relaxed and confident. The nurse did not 
introduce herself or establish baseline knowledge, and she told the patient why she was 
there rather than ask her. The nurse’s rapport with the patient was professional but did not 
engage in empathic conversation. 
 
6.8.5 Video-Recording 5 
The nurse (N4) was in a clinic room, again the desk was cluttered, and it was very small.  It 
housed one computer screen and a printer, leaving little room for the nurse to write in the 
patient notes.  She was sitting on a swivel chair which she turned to face the patient.  The 
patient’s chair had been placed so that it was facing the nurse, but it was not at right angles 
to the desk.  The patient appeared relaxed and the nurse was smiling, which established a 
relaxed and friendly rapport with the patient.  The computer screen was also showing the 
lab results page.  The nurse did not introduce herself but did ask the patient if she had done 
any reading about Methotrexate in order to establish baseline knowledge.  
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6.8.6 Video-Recording 6 
The nurse (N3) sat in front of a cluttered desk, and turned to face the patient.  The patient 
notes were directly in front of her, between herself and the patient and the computer 
screen revealed the lab results page.  The patient was at right angles to the desk, and he 
was leaning away from the nurse to his right.  The nurse was confident, and had a 
professional approach.  There was no attempt to establish a friendly rapport with the 
patient and he did not appear engaged with the nurse.  The nurse did not introduce herself 
or establish any baseline knowledge with the patient. 
 
6.8.7 Video-Recording 7 
The nurse (N1) was sitting in the same clinic room as the video-recording 1.  There were two 
chairs at right angles to the side of the desk, but the patient was sitting in the chair furthest 
away from the nurse, so there was a chair space between them.  The nurse was sitting 
directly in front of the desk, with the patient notes open and the computer screen open to 
the patient blood results.  The patient appeared relaxed, but hard of hearing as she leaned 
forwards in her chair, inclining her ear towards the nurse.  The patient started the 
conversation by giving the nurse the results of her pulmonary function test and a list of her 
medication, which allowed the nurse to continue with this thread. 
 
6.8.8 Video-Recording 8 
The nurse (N3) sat in a clinic room in front of a small cluttered desk, which held a printer 
and computer screen, the screen was open at the lab results page.  The patient notes were 
open on the desk in front of the nurse.  She swivelled her chair to face the patient when 
talking to him, the patient’s chair was turned from the side of the desk, so that the patient 
faced the nurse without having to twist his shoulders.  The nurse was confident and told the 
patient why he was there and that he has Rheumatoid Arthritis which the patient agreed 
with.  The patient appeared relaxed and was wearing a showerproof jacket.  The nurse went 
straight into talking about inflammation which needed to be “dampened down”, rather than 
introduce herself and establish a rapport. 
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6.8.9 Video-Recording 9 
The nurse (N4) was in a clinic room, on the wall directly in front of the nurse was a poster 
which displayed “Ask 4 questions”, however the patient sat to the side of the poster and 
could not view it directly.  The nurse had the patient notes in front of her and the lab results 
page was open on the computer screen.  The patient was sitting on a chair at the side of the 
desk, and was leaning forwards with her arms on the desk.  She was smiling and appeared 
relaxed.  The nurse introduced herself by name and role. She also confirmed that the 
patient was there to start Methotrexate and asked if the patient has done any “Googling”, 
to which the patient affirmed that she had and the nurse went on to establish how much 
the patient learned from this.  The nurse established a friendly rapport with the patient 
from the start of the consultation. 
 
6.8.10 Video-Recording 10 
The nurse (N2) was in a spacious clinic room sitting in front of a small desk with room for a 
computer, screen and keyboard.  The nurse had the patient notes on the corner of the desk 
and had the lab results page open on the computer screen.  The patient was sitting on a 
chair at the side of the desk and angled herself towards the nurse.  The nurse sat on a swivel 
chair which allowed her to face the patient when talking to her.  The patient still wore her 
outdoor coat and scarf.  The nurse did not introduce herself, but established with the 
patient that she had seen her before.  The nurse established that the patient had been seen 
by one of the consultants who had diagnosed Rheumatoid Arthritis, with which the patient 
agreed.  The nurse was relaxed and friendly and the patient responded, establishing a 
friendly rapport. 
 
6.9 Data Transcription 
The audio-recording only was given to the transcriber and transcripts of the complete 
consultations were typed by the transcriber employed in Phase II of this study.  The 
transcripts were checked for accuracy by the researcher by playing back the video-
recording.  All participants were offered the opportunity to review the video-recording on 
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completion of the consultation, however this opportunity was not exploited.  The nurses 
were all sent copies of the typed transcripts to ensure they agreed that it reflected their 
consultation.   
 
6.10 Consultation Structure 
The flow of each consultation was very similar, occasionally the nurse would introduce 
herself by name only or also adding their job role.  The general flow of each consultation is 
shown in Table 6.6 with very little variation between all of the nurses, and all of the nurses 
followed a structure of information giving guided by the Methotrexate information booklet. 
 




















Tablet form and dose escalation 
Day of the week to take it – M for Monday - Methotrexate 




Effects on Immune System 
Infections 





Mouth Ulcers  






6.11 Analysis  
 
6.11.1 Thematic Analysis 
All of the transcripts were thematically analysed allowing a systematic identification and 
organisation of patterns of themes across the dataset (Braun and Clarke 2012) which has 
been discussed in Chapter 5 (section 5.16.1).  This methodology has been used in a similar 
study where the researchers sought to observe and analyse the interactions between 
general practitioners and patients who presented with osteoarthritis (Paskins, Sanders et al. 
2015).   
To protect the identity of the nurse participants, minimal demographic data was recorded.  
The nurses were aged between 30-60 years of age.  Nurses one and two (N1 and N2) had 
two years’ experience working in Rheumatology, nurse 3 (N3) had five years’ experience in 
Rheumatology and nurse four (N4) had 20 years’ experience working in Rheumatology.  
None of the nurses had undertaken any formal training; they learned from each other and 
from Rheumatologist colleagues and they attended Rheumatology meetings whenever the 
opportunity arose. The patient participants were aged 25-75 years and eight participants 
were female and three were male. The patient demographics can be seen in Table 6.7. 
 
TABLE 6. 7 PATIENT DEMOGRAPHICS 
Patient Age Male/Female Nurse Conducting Consultation 
P1 62 Female N1 
P2 54 Female N1 
P3 25 Female N2 
P4 27 Female N3 
P5 46 Female N4 
P6 44 Male N3 
P7 72 Female N1 
P8 68 Male N3 
P9 42 Female N4 
P10 74 Female N2 
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Each patient consultation took place in a clinic room.  On every occasion, the nurse sat in 
front of the desk with the patient notes open in front of her.  The computer screen was 
showing the NHS Trust’s results system with the patient results displayed.  Every nurse also 
had a Methotrexate information booklet ready to use to guide the consultation with the 
patient.  During the consultation with the patient, none of the nurses had any interruptions. 
 
6.11.2 Statistical Analysis 
Descriptive statistics were calculated using percentages, mean values and ranges.  Pearson’s 
correlations were calculated to establish any correlations between patients “positive 
responses” and nurses “giving information”.  Correlations were also calculated minute by 
minute, between the items of “nurse giving information” and the patient either “nodding” 




6.12.1 Calgary Cambridge Analysis using the Consultation Observation Tool  
Each video was scored using a scoring sheet, see Appendix 18 for an example of the scoring 
sheet.  The results of the Calgary Cambridge analysis are shown in Table 6.8, each category 












TABLE 6. 8 RESULTS OF THE CALGARY CAMBRIDGE ANALYSIS 
Category 
VIDEO Category 
Mean 1 2 3 4 5 6 7 8 9 10 
Initiating 1 0 2 2 1 2 1 1 2 2 1.4 
Agenda Setting 0 0 1 1 1 0 0 0 0 1 0.4 
Information/Knowledge 0 0 1 1 2 0 0 1 2 1 0.8 
Ideas/Concerns/Expectations 0 0 1 0 1 0 0 0 1 0 0.3 
Explanation and Content 2 2 2 3 3 2 2 2 3 3 2.4 
Chunking/Checking 0 0 0 0 0 0 0 0 0 0 0 
Written Information 3 2 2 2 2 2 3 2 2 2 2.2 
Closing Summary 1 1 1 0 2 1 0 1 0 1 0.8 
Future Plan 2 2 3 2 2 2 2 2 3 2 2.2 
Structure 2 2 3 3 2 2 2 2 3 3 2.4 
Clarity 2 2 3 2 3 3 2 3 3 2 2.5 
Rapport 2 2 2 2 3 2 2 3 3 2 2.3 
Empathy 1 2 2 2 3 1 1 2 2 2 1.8 
Patient Perspective 0 1 1 1 1 0 0 1 1 1 0.7 
Scores 16 16 24 21 26 17 15 20 25 22 20.2 
 
The nurses were competent or excellent at their explanation (mean score 2.4); using written 
information (mean score 2.2); planning (mean score 2.2); structure (mean score 2.4); clarity 
(mean score 2.5) and rapport (mean score 2.3). They were variable with initiating the 
purpose of the consultation (mean score 1.4); and with exhibiting empathy (mean score 
1.8). They were not specifically setting the agenda (mean score 0.4); gathering information 
(mean score 0.8); checking for understanding (mean score 0); summarising (mean score 0.8) 
or legitimising the patient perspective. (mean score 0.7).  
The time it took the nurse to complete the consultation was available from the video-
recorded data. This information was scrutinised for the amount of time the nurse and the 
patient were talking. Correlations between the Calgary Cambridge scores and timings were 
calculated using Pearson correlations.  The time taken for each nurse to conduct the 
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consultation varied from 12:20 to 23:40 minutes (mean 17 min 34 seconds). The total 
number of seconds where the nurse or patient was talking are shown in Table 6.9.  
 
TABLE 6. 9 THE PROPORTION OF TIME NURSE AND PATIENT SPENT TALKING DURING THE CONSULTATION 
 
 
The nurses spent 69% to 86% of the total time talking with the patient engaging in discourse 
only 14% – 31% of the consultation.  In the high scoring consultations, the nurse spent an 
average of 76% of the time talking (range 69% to 86%). In the low scoring it was 80% (75% 
to 85%). Correlation between the total Calgary Cambridge score and the time the patient 
spent talking showed a moderate albeit non-significant trend (r=0.5268, p=0.12). Correlation 
of the proportion of the time that the patient was talking with the Calgary Cambridge score 
was slightly lower (r=0.4298, p=0.22). There was a significant correlation between the 
proportion of time the patient spent talking and the length of the consultation (r=0.7055 
p=0.02). This suggests that the patients who were engaged were prolonging the 
Nurse Talking Patient Talking 
Seconds (%) Seconds (%) 
Video 1 913 (75) 310 (25) 
Video 2 515 (77) 163 (23) 
Video 3 950  (80) 237 (20) 
Video 4 705 (85) 124 (15) 
Video 5 915 (70) 399 (30) 
Video 6 654 (85) 118 (15) 
Video 7 785 (79) 213 (21) 
Video 8 655 (86) 105 (14) 
Video 9 761 (69) 341 (31) 
Video 10 1055 (74) 365 (26) 
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consultation but more on their agenda and indeed there was a trend to the greater length 
of the consultation correlating with the better Calgary Cambridge score (r=0.4903 p=0.15). 
 
6.12.2 Medical Interaction Process Analysis 
 
6.12.2.1 Intercoder Reliability 
Video seven was scored by the same two researchers; researcher A was the study 
researcher and researcher B was the Consultant Rheumatologist.   The results are shown in 
Table 6.10.  
 
Once complete, both researchers discussed their results.   Table 6.10 shows that overall, 
there was consistency between the two coders with 80 - 100% agreement of the codes, 
except for items where there were fewer than five codes and in these instances, there was 
never a discrepancy of more than one. Miles and Huberman (2018) suggest that an 80% 
agreement of 95% of codes is acceptable and Nueuendorf (2015) regards that values over 
90% would be acceptable to all.  There were some minor differences in the way that 
agreement had been coded, but after further discussion it was agreed that it was sometimes 
difficult to determine between what was agreement and what was a positive exclamation, 
as positive responses were often very short utterances that could be barely audible such as 
“uh huh” or even “uh” which could explain the discrepancy.  There was also a small 
disagreement in the way that negative exclamations had been coded for patients, but again 
after further discussion, it was agreed that these utterances were sometimes barely audible 
and could be missed.  Both researchers agreed that there was sufficient concordance 
between the two scores to show inter-coder agreement.  Table 6.11 shows which patient 

















  N1 N1 P7 P7 
Head Nodding 53 58 116 112 
Head Shaking 21 22 15 14 
Smiling 6 6 5 5 
Touching 45 40 34 34 
Pointing 6 7 0 0 
Illustrative gesture 6 5 1 1 
Batonic gesture 60 60 18 19 
Verbal Dependent         
Open question 0 0 0 0 
Closed question 2 2 3 3 
Giving information 48 47 12 13 
Reassurance 5 5 0 0 
Checking 1 2 2 1 
Directing 0 0 0 0 
summarising 1 2 4 3 
Interrupting 3 3 12 11 
Verbal Independent         
Orient/instruct 0 0 0 0 
Agreement 26 27 91 86 
Disagreement 0 0 3 3 
Positive exclamation 4 4 1 2 
Negative exclamation 0 0 15 11 
Register info 0 1 20 19 
Empathy 5 4 0 0 
Laughs 4 4 9 9 
Ask repeat 0 0 0 0 
Irritation 0 0 0 0 
Gratitude 0 0 1 1 
Apology 0 0 0 0 





TABLE 6. 11 THE PATIENT CONSULTATIONS EACH NURSE CONDUCTED 
N1 N2 N3 N4 
P1 P3 P4 P5 
P2 P10 P6 P9 
P7  P8  
 
The complete results of the coding for the ten videos are presented in Table 6.12 and the 






TABLE 6. 12 MIPS CODING FOR VIDEO-RECORDINGS 
  VIDEO RECORDING 
  1 2 3 4 5 6 7 8 9 10 
Domain N1 P1 N1 P2 N2 P3 N3 P4 N4 P5 N3 P6 N1 P7 N3 P8 N4 P9 N2 P10 
Head Nodding 46 91 30 78 21 102 18 54 54 80 19 83 53 116 28 34 23 87 48 36 
Head Shaking 10 22 15 8 8 2 15 1 13 10 11 9 21 15 6 0 10 12 10 11 
Smiling 2 2 10 2 0 0 3 15 19 6 1 2 6 5 1 1 4 5 4 4 
Touching 25 19 38 25 7 60 36 26 61 53 37 13 45 34 34 27 24 18 39 10 
Pointing 2 0 0 6 6 1 1 0 9 0 4 1 6 0 0 0 1 0 9 3 
Illustrative gesture 6 42 26 2 49 0 11 2 61 18 16 5 6 1 24 0 34 2 68 8 
Batonic gesture 66 7 34 4 21 0 18 3 19 22 40 0 60 18 26 5 36 0 43 24 
Verbal Dependant                                         
Open question 0 0 0 1 1 0 0 0 3 0 1 0 0 0 0 0 2 0 0 0 
Closed question 5 15 3 3 10 0 19 5 4 7 11 4 2 3 11 6 10 0 10 5 
Gives information 43 26 34 8 50 8 41 8 33 10 62 11 48 12 35 5 85 30 49 13 
Reassurance 0 1 0 0 10 0 6 1 4 0 0 0 5 0 14 0 7 1 5 2 
Checks 5 10 0 0 10 0 1 0 0 0 0 0 1 2 2 1 2 0 8 8 
Directs 0 0 0 0 12 0 18 0 0 0 0 0 0 0 2 0 2 1 0 0 
Summarises 0 0 0 0 2 0 2 0 0 0 0 0 1 4 3 0 0 0 5 2 
Interrupts 1 10 5 1 0 1 3 0 0 0 0 0 3 12 4 2 0 1 6 8 
Verbal Independent                                         
Orient/instruct 0 0 0 0 2 0 1 0 0 0 0 0 0 0 18 0 0 0 0 0 
Agreement 18 40 1 8 2 26 21 21 5 9 7 12 26 91 6 62 14 100 24 45 
Disagreement 0 1 0 1 0 1 0 5 0 1 0 0 0 3 0 1 1 4 0 3 
Positive exclamation 0 0 0 0 2 47 3 1 2 8 0 0 4 1 0 0 1 1 1 2 
Negative exclamation 0 0 0 0 0 1 1 2 5 3 0 0 0 15 0 0 1 0 0 0 
Register’s information 0 0 6 43 0 27 0 0 1 11 0 31 0 20 4 0 2 0 0 2 
Empathy 1 0 0 0 0 0 0 0 3 2 0 0 5 0 2 0 0 0 0 0 
Laughs 0 1 0 0 1 5 3 7 6 11 1 1 4 9 1 2 4 3 0 3 
Ask repeat 1 0 0 0 0 0 2 0 1 3 0 0 0 0 0 0 0 0 0 0 
Irritation 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 
Gratitude 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 
Apology 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 
Social Conversation 0 0 0 1 0 0 1 0 0 0 2 2 0 0 0 0 0 0 0 0 
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TABLE 6. 13 TOTAL SCORES FOR ALL VIDEO-RECORDINGS 
  Total 
Domain Nurse Patient 
Head Nodding 340 761 
Head Shaking 119 90 
Smiling 50 42 
Touching 346 275 
Pointing 38 11 
Illustrative gesture 301 80 
Batonic gesture 363 83 
Verbal Dependant     
Open question 7 1 
Closed question 85 48 
Gives information 480 131 
Reassurance 51 5 
Checks 29 21 
Directs 34 1 
Summarises 13 6 
Interrupts 22 35 
Verbal Independent     
Orient/instruct 21 0 
Agreement 124 414 
Disagreement 1 20 
Positive exclamation 13 60 
Negative exclamation 7 21 
Registers information 13 134 
Empathy 11 2 
Laughs 20 42 
Ask repeat 4 3 
Irritation 0 3 
Gratitude 0 2 
Apology 0 1 
Social conversation 11 9 
 
 
In order to investigate whether the patient positive responses were in response to the nurse 
“giving information”, correlations, minute by minute, between the items of “nurse giving 
information” and the patient either “nodding” or giving a “positive utterance” were 
calculated. Correlations were enormously variable with r values ranging from -0.349 to 
+0.893. When all ten videos were combined, the overall correlation was r = +0.486 
(p=0.00001). There was, therefore, a relationship between the nurse giving information and 
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the verbal or non-verbal positive responses from the patients. However, with an r squared 
value of 0.236, only 24% of the positive responses were explained by the giving of 
information, suggesting that the patients were making positive responses for other reasons 
as well. 
Compared to the nurses, patients more frequently showed disagreement an average of two 
per consultation (range 0 – 5), whereas there was only 12 nurse disagreement across all ten 
video-recordings.  Patients reacted with more interruptions an average of 3.5 per 
consultation (range 0 – 12) compared to nurses with an average of 2.2 per consultation 
(range 0 – 6).  Patients also exhibited more negative exclamations an average of 2.1 per 
consultation (range 0 – 15) compared to nurses who averaged 0.7 per consultation (range 0 
– 5).  Patients registered information more frequently, an average of 13.4 times per 
consultation (range 0 – 43) whereas nurses averaged 1.3 times per consultation (range 0 – 
6). Patients only occasionally express irritation, gratitude or apology a total of four times 
across all of the video-recordings and nurses did not express irritation, gratitude or apology 
in any of the video-recordings. This would be consistent with the patients reacting to the 
nurse dominating the encounter with their agenda of information giving. 
The nurses, did more directing, summarising and instructing on average 6.8 times per 
consultation (0 – 21) compared to patients who had an average score of 0.7 (range 0 – 4), 
this was mainly summarising.  Nurses exhibited more gestures of pointing averaging 3.8 
(range 0 – 9) compared to patients 1.1 times per consultation (range 0 – 6) and nurses 
touched more per consultation averaging 35 (range 7 – 61) compared to patients who 
averaged 29 (range 10 – 60).   Information was conveyed with empathy and reassurance by 
the nurses. Nurses asked most of the questions, however, and averaged 9.2 per consultation 
(range 3 – 19) the patient averaged 4.9 per consultation (range 0 – 15).  Patients did almost 
as much checking of their understanding as the nurses averaging 2.1 per consultation (range 
0 – 10) comparted to nurses who average 2.9 (0 – 10).  Table 6.14 shows the scores for the 
nurses and patients when mapped against the five highest scores compared to the five 





TABLE 6. 14 MIPS SCORES WHEN MAPPED AGAINST THE CALGARY CAMBRIDGE SCORES 
  Nurse Nurse Patient Patient 





Nodding 166 174 422 339 
Shaking 72 47 55 35 
Smiling 22 28 26 16 
Touching 181 165 117 158 
Pointing 13 25 7 4 
Illustrative gesture 65 236 52 28 
Batonic gesture 218 145 32 51 
Verbal Dependent   
Open question 1 6 1 0 
Closed question 40 45 30 18 
Gives information 228 252 65 66 
Reassurance 11 40 2 3 
Checks 7 22 12 9 
Directs 18 16 0 1 
Summarises 3 10 4 2 
Interrupts 12 10 23 12 
Verbal Independent   
Orient/instruct 1 20 0 0 
Agree 73 51 172 242 
Disagree 0 1 10 10 
Positive exclamation 7 6 2 58 
Negative exclamation 1 6 17 4 
Registers info 6 7 94 40 
Empathy 6 5 0 2 
Laugh 8 12 18 24 
Ask repeat 3 1 0 3 
Irritation 0 0 1 2 
Gratitude 0 0 1 1 
Apology 0 0 0 1 
Social conversation 8 3 8 1 
 
Totals are given on each item for the ten-minute section analysed. The most frequent nurse 
utterances were in the “gives information” item, average score 48, (range 33 – 85) and the 
patients responses were highest in the “nodding”, average score 76 (range 43 – 116) and, 
verbal “positive response” items average score 41.4 (range 9 – 100). The number of nods 
and positive responses was far higher than the number of nurses “giving information” 
utterances. 
 The five lower scoring consultations were compared with the five higher scoring 
consultations.  Nurses in high scoring consultations made many more illustrative gestures 
with a total of 236 across the five highest scoring consultations (mean= 47 per consultation) 
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compared to the five lower scoring videos with a total of 65 across those consultations 
(mean= 13 per consultation). Conversely fewer batonic movements were made by the 
nurses in the higher scoring consultations with 145 across all consultations (mean= 29) 
compared to the lower scoring consultations with 218 across all consultations (mean= 44). 
Nurses in the higher scoring consultations smiled more (mean= 6) and shook their heads 
less (mean= 9) but pointed more (mean= 5). Whereas nurses in the lower scoring 
consultations smiled an average of four times, shook their heads more (mean= 13) and 
pointed less (mean= 3).  Nurses in the higher scoring consultations asked an average of one 
open questions, but nurses in the lower scoring consultations did not ask any open 
questions. Nurses in the higher scoring consultations gave more reassurance (mean= 8), and 
checked for understanding and summarised more (mean= 6). Nurses in the higher scoring 
consultations also directed and orientated the patients more, 20 times over the five 
consultations whereas the nurses in the lower scoring consultations only did this once 
across the five recordings.  The nurses in the higher scoring consultations laughed more (12 
times over the five consultations) but engaged in less social conversation (three times over 
the five consultations). They also showed less positive agreement (mean= 10) and made 
more negative exclamations (mean= 6). The amount of times information was given to 
patients was similar between the higher and lower scoring interviews, as was their head 
nodding. 
Patients in low scoring consultations nodded (mean= 84) and shook their heads more 
(mean= 11); they made more illustrative (mean= 11) and fewer batonic gestures (mean= 6); 
they pointed more (seven times across the five consultations) and smiled more (seven times 
across the five consultations) but touched less (mean= 23); they asked more closed 
questions (mean= 6) but both the higher and lower scoring groups were similar when 
checking their understanding (mean= 2) but the lower scoring group interrupted more 
(mean= 5).  The lower scoring group had exhibited no positive exclamations, whereas the 
higher scoring group expressed an average of 11 per consultations.  The lower scoring group 
expressed more negative exclamations (mean= 3), they also registered information more 
(mean= 19) and engaged in social conversation more (average two) but they laughed slightly 
less (mean= 4).   
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There was some variation between the scores individual nurse patient consultations and are 
presented in Tables 6.15 to 6.18. 
 
TABLE 6. 15 RESPONSES FROM PATIENTS TO INFORMATION GIVEN BY N1 
DOMAIN 
N1 Mean 
P1 P2 P7 
Calgary Cambridge 
Scores 
16 16 15 15.6 
Head Nodding Nurse 46 30 53 43 
Head Nodding Patient 91 78 116 95 
Gives Information Nurse 43 34 48 41.6 
Shows Agreement 
Patient 
40 8 91 46.3 
 
 






24 22 23 
Head Nodding Nurse 21 48 34.5 
Head Nodding Patient 102 36 69 
Gives Information Nurse 50 49 49.5 
Shows Agreement 
Patient 










TABLE 6. 17 RESPONSES FROM PATIENTS TO INFORMATION GIVEN BY N3 
DOMAIN 
N3 Mean 
P4 P6 P8 
Calgary Cambridge 
Scores 
21 17 20 19.3 
Head Nodding Nurse 18 19 28 21.6 
Head Nodding Patient 54 83 116 84.3 
Gives Information Nurse 41 62 35 46 
Shows Agreement 
Patient 
21 12 62 31.6 
 
 




Calgary Cambridge Scores 26 25 25.5 
Head Nodding Nurse 54 23 38.5 
Head Nodding Patient 80 87 83.5 
Gives Information Nurse 33 85 59 
Shows Agreement Patient 9 100 54.5 
 
 
The lowest scoring nurse (N1) when scored against the Calgary Cambridge model gave the 
least amount of information (mean= 41.4) and had the highest head nodding from the 
patient (mean= 95).  N1 also demonstrated the highest number of head nodding by a nurse 
(average 43).  The highest scoring nurse (N4) demonstrated the highest amount of 
information given (mean= 59).   
 
The time it took each nurse to complete the consultations was also available from the video- 






TABLE 6. 19 TIME IT TOOK FOR EACH NURSE TO COMPLETE A CONSULTATION 
 
N1 N2 N3 N4 
P1 20:53    
P2 12:43    
P3  21:55   
P4   14:24  
P5    22:03 
P6   13:20  
P7 17:41    
P8   12:42  
P9    18:28 
P10  23:54   
Mean Calgary Cambridge Score 15.6 23 19.3 25.5 
 
 
The two highest scoring nurses (N2 and N4) took the longest time to conduct their 
consultations taking an average of 22 mins 55 secs and 20 mins 15 secs respectively. The 
lower scoring nurses, N1 and N3 took an average of 17 mins 05 secs and 13 mins and 28 secs 
respectively.   
 
The number of times the patients nodded their heads per minute and the number of times 
the patients showed agreement or understanding, by responding “yes” or indicating by a 










FIGURE 6. 3 TOTAL NUMBER OF HEAD NODDING AND AGREEMENT PER MINUTE FOR ALL PATIENTS 
 
 
Comparison of the totals between nurse and patient responses showed that the patients 
exhibit more positive responses with increased nodding and uttering positive exclamations. 
Some of these responses could be a response of “deference” to the perceived higher status 
of the nurse (Helweg-Larsen, Cunningham et al. 2004). Patients also show disagreement 
more and react with interruptions and negative exclamations. Patients display a higher 
degree of registering information and they occasionally express irritation, gratitude or 
apology. All of these are reactions to the information giving by the nurse and are consistent 
with the nurses dominating the encounter with their own agenda of information giving as 
















1 2 3 4 5 6 7 8 9 10
Head Nodding Showing Agreement/Understanding
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6.13 Findings of the Thematic Analysis of the Transcripts  
 
The same researchers as described in Chapter 5 (section 5.16) analysed the transcripts.  
Thematic analysis was the approach used, and has been described in Chapter 3.  All of the 
transcripts were read until the whole experience was understood (see Chapter 5 section 
5.16.2) then key themes were extracted. Significant statements relating to the themes were 
then highlighted to illustrate the themes.  
  
The thematic analysis of the video-recorded transcripts revealed three main themes: 
 The Nurse Agenda 
 Information Overload 
 Missed Cues 
 
6.13.1 Consultation Themes 
 
6.13.1.1. Theme One: The Nurse Agenda 
All of the consultations were structured around the content of the Methotrexate 
information booklet produced by Versus Arthritis (2019). This had the benefit of guiding the 
encounter, prescribing the content and providing written material for the patient. 
The focus on delivering all the information in the leaflet dominated all consultations with 
video example of nurses cutting the patients short and taking the agenda back to the next 
item in the leaflet.  
 
P9 “….I’m just worried…in case it interacts between the drugs I take already”. 
The patient gives the nurse a list of all of the medications the nurse comments: 
N4 “A nice little cocktail…” 
 
Once all of the drugs are recorded, the nurse goes on to say: 
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N4 “right, brilliant, brilliant, okay so the Methotrexate is not a painkiller, it’s a 
disease modifying drug…” 
 
Further indications that the patient is concerned emerged during the consultation: 
 
N4 “you can’t have them…one is called Septrin…” 
P9 “I’m allergic to it..” 
N4 “…the other one is Trimpethprim…” 
P9 “I’m allergic to it…” 
N4 “Perfect, so you are never going to have that problem” 
 
Finally, it emerges during the consultation: 
 
P9 “…they said that about the iron infusion I had as well, I had an anaphylactic 
shock with that...I nearly died…” 
 
This could be the reason why the patient was so anxious about drug reactions, and the 
nurse’s response appears to demonstrate that she understood this anxiety, but the nurse 
goes on to remark: 
 
N4 “Well, I haven’t heard of anybody yet having anaphylaxis…and I don’t want to 
hear about it either”. 
P9 “No and I’d rather it not be me…” 
 
The nurse may be trying to reassure the patient, but equally, the nurse is dismissing the 
patient’s anxiety and does not provide any further reassurance.  It is also clear, that the 
response from the patient indicates continued fear and anxiety. 
In another scenario, the nurse agenda extended to almost insisting that the patient had an 
Intra Muscular injection of steroid when the patient clearly preferred the tablets: 
 
N3 “do the injections work [steroid injections]…” 
P4 “I haven’t had one..” 
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N3 “You haven’t had one of those? Right..” 
P4 “I didn’t fancy one of them” 
N3 “Okay, we could probably do that today….” 
P4 “I’d really rather have the tablets…” 
 
 
Nurse N3 goes on to acknowledge this, but further remarks: 
 
N3 “Dr ---- is not actually here today so if I can’t get one [a prescription] it might 
be another option rather than you come off it [oral prednisolone] then go back on it 
…Okay…have a think about it…” 
 
This exchange appears to have been driven by the difficulty the nurse would have had to get 
a prescription signed for the oral Prednisolone.  
 
6.13.1.2 Theme Two: Information Overload 
The amount of information given to patients during a consultation can be considerable and 
the nurses were aware of this, as often at the end of the interview the nurse frequently 
acknowledged that a lot of information had been given that the patient could not have 
taken in: 
 
N3 “Okay, I’ve just kind of bombarded you there…so if you think of anything else 
feel free to give me a ring next week and we can explain anything with you…” 
N1 “If I’ve spoken too fast and you are not too sure then ring…” 
P2 “it’s a lot to take in…” 
N1 “Oh there is a lot……side effects are the…so nausea is the most common, it 
normally settles as your body gets used to it…”  “…breathlessness, fevers and chills 
can happen……” 
 
However, in order to ensure that the patient could get more information if they wished, 
further educational opportunities through a help line were usually offered: 
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P5 “…if I’ve got any problems I won’t hesitate to give you a call…” 
N4 “It’s what we are here for though…” 
 
6.13.1.3 Theme Three: Missed Cues 
The third theme to emerge from the data was missed cues from the patient, opportunities 
for the nurse to explore patient cues were missed because the primary objective of the 
consultation was to deliver all the information contained within the Methotrexate 
information leaflet: 
 
P1 “I really want to get off this…I really do want to get off [oral prednisolone]” 
 
N1 “In terms of your symptoms, how are you doing, have you had any visual 
disturbances and blurred vision”? 
 
P1 “I have a cataract…” 
 
N1 “Right, so, Methotrexate education…” 
 
P2 “…I can’t yawn properly…you know when you yawn you open your whole 
mouth…I can’t do that anymore…” 
 
N1 “Right, so I will give you the prescription and we will see you again in two 
weeks…but if there’s any issues ring the helpline”. 
 
P8 “I’m doing badly, I mean you do all the training and you don’t seem to get 
any fitter you know….because I was thinking about packing it all in…” 
 
N3 “Well, let’s see how this goes and you might just still be able to do it, alright, 
where did we get to…”? 
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However, there were occasions where the cues were recognised, and the nurse was within 
her sphere of knowledge and experience and therefore dealt with the cues well: 
 
P9 “Now with my knees and my joints are just…my fingers…even picking up a 
pen…” 
 
N4 “Have you seen an Occupational Therapist”? 
 
P9 “No, I haven’t”. 
 
N4 “I can refer you there…” 
 
P8 “I feel like my whole body is breaking down…” 
 
N3 “Right, so we need to get you some semblance of normality…” 
 
6.14 Discussion 
The Calgary Cambridge Model is used in many medical schools to teach students how to 
carry out a consultation (Kurtz, Draper et al. 2017) and is widely practised amongst GPs 
(Burt, Abel et al. 2014). This model emphasizes the need to provide information in 
manageable chunks and to use the patient’s response to guide the consultation (Kurtz, 
Silverman et al. 2003).  Whilst this model was developed for the medical profession, some 
attempts have been made to apply it in the nursing context (Munson and Willcox 2007). 
Whilst nurses who talk to patients about Methotrexate do not necessarily need to apply the 
full model, elements of it could enhance their consultation skills for this particular role 
(Munson and Willcox 2007). Patients also have different preferences for communication 
(Macdonald, Stubbe et al. 2013) and, to optimize concordance, the nurse needs to be able 
to identify the patient’s information preference and meet it.  
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The videos of ten nurse consultations were analysed from two different perspectives; 
comparison with a standard consultation model and analysing thematic analysis of the 
transcripts.  Ten videos were considered a pragmatic number for the pilot study. 
It is clear that the interaction between the nurse and patient is complex and no single 
analysis would pick up all of this complexity. Therefore, different analyses were used.  The 
results show that a lot of the consultation and information transfer works safely and well. 
The patients were informed of the important facts and processes, given written information 
for further reading, and all have a clear invitation to telephone call for further support and 
clarification. However, it appears that opportunities to address the patient agenda are 
missed because cues from the patients are being missed or ignored. This is considered 
further in the discussion section of this Chapter. There is evidence that consultations, which 
address the patient agenda, result in improved patient satisfaction (Carter and Berlin 2003).  
The missing of cues seems to be driven by an overriding need for the nurse to prioritise 
information giving which, could be driven by time pressures.  
The data on the time each participant spent talking suggests that the involvement of the 
patient, which resulted in higher scoring on the Calgary Cambridge scale, added to the 
length of the overall consultation. It was clear that during each consultation, the type of 
information given was consistently similar, and took a similar amount of time to deliver; this 
would explain why the “extra” involvement of the patient did add some time. However, 
there is evidence that recognising and dealing with cues can save time by focussing the 
consultation on the important items (Silverman 2008), which may save time at subsequent 
visits. It is therefore clear that education and training for nurses in this role could result in 
more satisfactory and more efficient consultations. 
Nurses were good at structuring the consultation, establishing rapport, giving information 
and instructions, all of which are central nursing skills. The content, flow and chunking of the 
consultation was consistent, driven by the use of the patient information sheet. The nurses 
missed opportunities to explore the patient’s expectations, concerns or needs throughout 
the consultations.  The overarching aim of the consultation was to deliver information, using 
the Methotrexate information leaflet as a guide. The nurses speaking for between 69 and 
86% of the time supports this. 
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Nurses were variable at assessing pre-knowledge and overlooked openings to evaluate the 
patient’s understanding of information during the consultation. Patient feelings about the 
drug were sometimes offered by the patient but not often explored by the nurses. Some 
patient cues were missed. A lot of the patient head nodding may not have reflected 
understanding, but it may have encouraged the nurses to perceive this as understanding, 
which resulted in missed cues. 
The interaction in any consultation is complex with a mixture of verbal and non-verbal 
behaviours and how these interactions are accommodated in a consultation is important to 
patient-centred care (James, Desborough et al. 2020).  Tailoring verbal and non-verbal 
messages to patients can have a positive impact on their individual coping, emotional and 
comprehension needs (D’Agostino and Bylund 2014).  The involvement of patients in a clear 
and tailored communication can improve patient care, satisfaction, trust and engagement in 
other health outcomes (Desborough, Phillips et al. 2018).  The consultations in Phase III had 
a very specific purpose of transferring knowledge to a patient and Phase II, the semi-
structured interviews study, (Chapter five) showed how much the nurse agenda to give this 
information dominated the interaction without exploration of the patient’s agenda.  Ospina 
et al (2019) conducted a secondary analysis of 112 video-recordings of clinician-patient 
encounters which had been carried out to assess the use of shared-decision-making tools in 
clinical practice.  Sixty-one of the recordings had been carried out in Primary Care and 51 in 
Secondary Care. The secondary analysis showed that the patient’s agenda was elicited in 40 
(36%) of the total encounters, more often from Primary Care (30/61 49%) than secondary 
care (10/51 20%).  They also found that interruptions occurred early in the encounter and 
patients were given little time to express their perspective. The analysis of the Phase III 
video-recordings appears to support Ospina et al (2019) in that the giving of information 
from the nurse to the patient was dominated by the amount of instruction and information 
that the nurses gave. The nurses asked the patients some questions which were related to 
their disease and current treatment, but there was little evidence of the nurse ‘checking’ 
the patient’s comprehension or tailoring the consultation to what information the patient 
would have liked to have received. A further observation from the analysis revealed that the 
patients were more likely to check their own understanding with the nurses, but this 
occurred infrequently throughout the course of all of the consultations. The qualitative 
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analysis showed that the opportunities to ask questions were infrequently presented to the 
patients during the consultations, and the use of the information leaflet by the nurses to 
guide them during their encounters, could have introduced some inflexibility which may 
have further restricted opportunities for the patients to ask questions. 
In response to the nurse giving information, the patients appeared to nod in agreement, this 
occurred frequently throughout all of the consultations. It is generally considered that head 
nodding represents showing agreement and understanding (Morris 1977, Petukhova and 
Bunt 2009, Thepsoonthorn, Yokozuka et al. 2016).  However, Helweg-Larsen et al (2004) 
conducted a study of students in a classroom situation with a Professor.  The expectation 
was that males would nod less frequently than females as this is a well-established 
observation (Dixon and Foster 1998).  But this was not the case, in the classroom situation 
the males nodded as much as the females, which was interpreted by Helweg-Larsen et al 
(2004) that the Professor was dominant, and the students held a lower status.  The results 
of the MIPS analysis on the ten videos between the nurses and patients also show a high 
degree of head nodding by the patients, compared to indicating agreement and 
understanding.  This head nodding behaviour could represent a similar situation where the 
nurse holds a higher status as the knowledge holder.  What could be of particular 
importance is the nurse’s perspective of this.  The nurse may have regarded this nodding 
behaviour as confirmation of understanding, which allowed them to continue their agenda 
regarding information giving, without feeling the need to stop to check understanding and 
this may have accounted for some missed cues.  It is possible that the head nodding by the 
patients may have been in response to their perception of the nurse being in the dominant 
position, (Helweg-Larsen, Cunningham et al. 2004) and therefore they portrayed a 
deferential response.  Ong et al (1995) believe that only 7% of effective communication is 
verbal, 22% is conveyed by the tone of voice and 55% is through visual cues.  Therefore 
assessing and recognising cues such as head nodding are important skills as they can be 
linked to higher patient satisfaction, compliance and positive clinical outcomes (Crane and 
Crane 2010). 
Conversational hand gestures are movements of the hands which occur when an individual 
is speaking, they are often unconsciously produced (Jacobs and Garnham 2007).  The 
analysis of Phase III showed that those nurses who scored higher in the MIPS analysis were 
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using more illustrative gestures to communicate.  Studies have found that using illustrative 
gestures during speech help to improve the addressee’s attention and thus accuracy of 
understanding (Maricchiolo, Gnisci et al. 2009).  Further, Cook (2018) considers that there is 
robust evidence to reveal the beneficial effects of conversational gesture on learning via a 
variety of cognitive processes such as memory, attentional and perception.   
The amount of information given and the content of the information was similar between all 
of the consultations which may suggest that this was a standard part of the interaction and 
was dictated by the flow of information contained in the Methotrexate information leaflet.   
Ford and Hall (2004) carried out a study of skilled and less skilled oncologists.  They video-
recorded ten oncology consultants who were considered to be skilled professionals and ten 
consultants who were considered less skilled.  They analysed the videos using the MIPS.  
They concluded that the more highly skilled doctors had a significantly higher focus on 
disease, psychological and physical status of the patients. Indicating that their consultations 
had a higher degree of patient focus which considered individual care. The more highly 
skilled consultants asked more questions, did more checking and summarising of 
information to ensure the patient understood and their consultations only took three 
minutes longer. A weakness of this study was that the oncologists were categorised, in 
terms of their skills and experience, on the opinion of one of the researchers. However, the 
study does  highlight several important points; that effective consultations skills identifying 
individual patient problems could lead to higher patient satisfaction (Maguire and Pitceathly 
2002); training courses will improve skills and consultations adopting effective techniques 
do not necessarily take more time.  The results of Phase II of this thesis, indicated that the 
nurses perceived that a time limited consultation impacted on their willingness to 
encourage patients to ask questions and used words such as “interrupt” if a patient did ask a 
question.  Thus, this perception of time pressure may have been a catalyst for the nurses’ 
agenda to become the focus of the consultation resulting in a lack of opportunities for 
patients to ask questions or discuss concerns.  Table 6.19 above shows that there was no 
statistical difference between the time it took the nurse to complete each consultation and 




This was a small study and the video recordings were of nurses from one Rheumatology 
service, therefore it does not necessarily reflect the wider national perspective.  However, 
the national questionnaire, Phase I of this study, does indicate that most nurses receive no 
training to conduct this role, of giving information to patients about Methotrexate.  Phase II 
further indicated that nurses, had their own agenda which was constrained by perceived 
time pressures, which resulted in rote type consultations with little emphasis on 
individualise patient care.  Therefore, whilst this is a small study, it does add to the limited 
body of knowledge around how nurses give information about Methotrexate and how they 
conduct their consultations. 
 
6.16 Conclusions 
Quantitative data can be extracted from the videos and it largely supports the qualitative 
findings. Whilst the nurses conducted their consultations professionally and generally 
attempted to establish a rapport with the patients, their techniques could be improved with 
further training.  All nurses gave adequate information about Methotrexate, as they had the 
booklet to guide them, but it was not tailored to suit the patient and there was no shared 
decision-making with the patient.  Improved consultation technique could also help the 
nurses to interpret patient behaviours that indicate the patient’s agenda and what is 











Chapter 7: General Discussion, Conclusions and Further 
Recommendations 
 
7.1 Chapter Overview 
The final chapter of this thesis will first restate the overall aims and objectives of this study 
and how they were fulfilled.  An overview of the findings from each of the three phases of 
the study and how they add to the extant literature will then be discussed. Following this 
there will be a discussion of how these findings contribute to original knowledge and the 
implications of this to practice.  There will be a discussion of the limitations of the findings 
followed by recommendations for further research and concluding remarks.  
 
7.2 Study Aims and Objectives 
 
7.2.1 Overarching Research Question 
How do Rheumatology Specialist nurses gain knowledge about consulting with patients on 
Methotrexate and do they deliver the information to patients using a consultation 
technique, further can elements of their consultation be identified for development? 
Which was investigated by: 
 Investigating, using a survey, the processes which nurses undertake to become 
knowledgeable about consulting with patients on Methotrexate and to understand 
how much knowledge and confidence they have in giving this information. 
 Exploring, through semi-structured interviews, the nurses’ experiences and 
perception of the delivery of information about Methotrexate to patients. 
 Identifying, through video analysis of consultations, the processes used by the nurses 
in their consultations with patients when giving information about Methotrexate and 
how the consultations may be further developed using the Calgary Cambridge 
model. 
 239 
The underpinning research philosophy was based on the three dimensions of critical realism 
using a mixed methods approach to collect the data and a phenomenological methodology 
to analyse the data. 
 
7.3 Conspectus/Study Overview 
This study contributed to the understanding of how Rheumatology Specialist nurses give 
information to patients about Methotrexate. It has developed the understanding of how 
these nurses conduct this role in their consultations and provided multiple original 
contributions to the extant literature. Thus, the purpose of this chapter is to bring together 
the findings of the three phases of this study, to identify the key messages and knowledge 
that has been revealed through this study and to discuss recommendations for future 
research, education and practice. 
The core findings of this study on how Rheumatology Specialist nurses gained knowledge 
about consulting with patients on Methotrexate and how they delivered the information to 
patients will be presented under the headings below: 
Summary of Findings of Phase I: The National Survey 
Summary of Findings of Phase II: The Semi-structured Interviews 
Summary of Findings of Phase III: The Video-Recorded Nurse Patient Consultations 
 
7.4 Summary of Findings of Phase I: The National Survey 
 
7.4.1 Phase I Aims  
The aims of the national survey were to explore the training that Rheumatology Specialist 
nurses had received for educating patients about Methotrexate.  Further, to identify their 
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confidence in conducting this role and to evaluate their knowledge around clinical situations 
relevant to Methotrexate use.  The aim of this is to reveal if any further training is required. 
 
7.4.2 Phase I Objectives 
1. To obtain data regarding training, qualifications and experience through a national 
questionnaire. 
2. To gauge nurses’ views regarding confidence and the time it takes to become 
confidence in conducting this role. 
3. To assess levels of knowledge Rheumatology Specialist nurses, have about 
Methotrexate.  
In response to the aims and objectives of Phase I, the findings identified that there was no 
gold standard training for nurses to conduct their role of giving information about 
Methotrexate to patients.  Nurses responded that their training mostly consisted of learning 
from their peers or sitting in on clinics with Rheumatology consultants.  Nurses were 
competent in their responses to multiple choice questions about Methotrexate, but their 
confidence in this role increased over time and there was overall agreement that more 
training would be useful.  The findings also revealed that nurses commonly used written 
information to guide their consultations, this was in the form of the Methotrexate 
Information Booklet produced by Versus Arthritis(2019), or in-house written information 
and checklists. 
A review of the literature in Chapter 2 revealed that there was little uniformity regarding 
the way nurses are trained to carry out their various roles in Rheumatology (Goh, Samanta 
et al. 2006, Royal College of Nursing 2009) and that there were few opportunities for nurses 
to enrol on a specific Rheumatology training course (Royal College of Nursing 2009).  
Further, the review highlighted the paucity of literature regarding how nurses are trained to 
meet the needs of their specialist roles in Rheumatology. However, more recently, since the 
study presented in this thesis was conducted, the Royal College of Nursing Rheumatology 
Forum has recognised that there is a lack of uniformity in the Rheumatology Specialist role 
across the UK and have gone some way to address this gap in the form of producing 
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competencies (Royal College of Nursing 2020).  Nonetheless, the findings of the national 
survey forming Phase I of this study did highlight clearly the variability of training that 
nurses are given to undertake their role.  Most nurses learn “on the job”, from their peers 
and from Rheumatology Consultants.  Keele University offers an MSc course in 
Rheumatology Practice thus those nurses who were fortunate to live nearby, could access 
dedicated training, but most nurses would not be able to access this due to location and 
limitations of numbers of students on the course.  Further findings revealed that 
approximately 5% of nurses had undertaken a prescribing course, but this was not specific 
to Methotrexate.  Thus, most nurses used either the Versus Arthritis booklet or in-house 
leaflets to guide their consultations and ensure that the pertinent information about 
Methotrexate was given to the patients.  The researcher’s own experience conducting this 
role was “here is the leaflet, go and tell that patient about Methotrexate” which may not be 
unique.   
Whilst there is a dearth of literature regarding the confidence nurses have in their roles as  
Rheumatology Specialist nurses, Cross et al (2014) conducted an electronic survey of 576 
nurses investigating confidence, training and knowledge in ostomy care. They revealed that 
confidence was greater in nurses who had undertaken more training and had more 
experience.  They regarded the greatest barrier to confidence was the lack of knowledge in 
their specialist area and thus concluded that opportunities for continuing education would 
improve confidence in nurses. The study survey in this thesis whilst the sample was smaller, 
revealed similar findings, that it takes three to 12 months for a nurse to feel confident, 
which also indicates that nurses are performing this role without confidence for significant 
periods of time; confidence developed through experience and also through gaining 
knowledge as a result of training. This supports Cross et al (2014) that improving training 
could lead to nurses gaining confidence earlier, thus improving the experience of both nurse 
and patient. The need and desire for more training was a finding in both the survey and the 




7.5 Summary of Findings of Phase II: The Semi-Structured Interviews 
 
7.5.1 Phase II Aim 
To explore the nurses’ experiences and perceptions of the delivery of information about 
Methotrexate to patients, using semi-structured interviews. 
7.5.2 Phase II Objectives 
1. To explore the training nurses had in order to carry out their role of giving 
information to patients on Methotrexate and how useful this was. 
2. To understand how confident nurses are carrying out this role and how they feel 
about the training they had. 
3. To understand how nurses, use written information to inform their consultations. 
4. To explore how nurses, respond to patient cues putting them at the centre of care. 
Phase II of this study explored the experiences and perceptions of six nurses who gave 
information to patients about Methotrexate through audio-recording semi-structured 
interviews.  (Rhee, Von Feldt et al. 2013)   Phase I revealed that the use of written 
information to guide consultations was universal, and it was usually the Versus Arthritis 
leaflet (2019) but some nurses also used locally written in-house material. The written 
information had many beneficial effects: it structured the encounter and ensured that the 
necessary content was covered; it “chunked” the information into usable amounts and the 
local information gave clarity of monitoring and follow up. It also, however, had some 
negative effects: it facilitated the nurses’ agenda taking priority and the nurses returning to 
the leaflet for the next item; it led to a feeling of overloading the patient with information 
and in the interviews the nurses expressed that it restricted the opportunities for the 
patient to ask questions. 
The nurses perceived that the challenges of time pressure resulted in little opportunity for 
patients to ask questions, or if they did, the nurses sometimes went “off-track” with the 
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flow of their consultations.  The nurses recognised that different patients had different 
learning needs, but it was not apparent that the nurses were tailoring their consultations to 
meet these different needs. There was agreement between all of the nurses that they had 
picked up knowledge and skills “on the job”, and this was achieved through watching peers 
and Rheumatologists in clinics, but they were all in agreement that structured formal 
training would have been more appropriate and would have had a positive impact on their 
knowledge, confidence and skills.  The lack of formal training may not have armed the 
nurses with consultation techniques which focus on the individual needs of the patients.  As 
a result of this, it was unclear how nurses ensured that patients understood the information 
given to them and whether a shared decision-making process was adopted during the 
consultation.  Thus, Phase III of the study aimed to investigate more closely how nurses 
conduct their consultations, how they engaged the patients in that process, how they used 
open and closed questions during their encounter with patients and whether the nurses 
recognised and responded to verbal and non-verbal cues from the patients, which is 
discussed in the next section. 
 
7.6 Summary of Findings of Phase III: The Video-Recorded Nurse Patient 
Consultations 
 
7.6.1 Phase III Aims 
To investigate how nurses, deliver information about Methotrexate to patients, and how 
they ensure that patients have received and understood that information during the 
consultation process. 
 
7.6.2 Phase III Objectives 
1. Explore the applicability of the Calgary Cambridge consultation model and whether it 
can be modified for use in Rheumatology nurse patient consultations. 
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2. To understand the processes nurses, use in their interaction with the patients when 
giving information about Methotrexate. 
3. To understand the processes nurses, use to ensure that patients have understood 
the information given. 
Analysis of the videos revealed that during the consultations the patients were generally not 
involved in the process of shared decision-making which supports the findings of a 
systematic review (Légaré, Adekpedjou et al. 2018). This generic systematic review of 87 
studies showed that whilst healthcare professionals were aware of the benefits of shared 
decision-making it was not necessarily put into practice.  Two studies by Mathijssen et al  
(2020; Mathijssen, Vriezekolk et al. 2020) also supported this conclusion. These studies 
explored the knowledge of healthcare professionals in Rheumatology around shared 
decision-making, but there was only a low to moderate level of shared decision-making put 
into practice.  These studies do suggest that the existing evidence around the application of 
shared decision-making could apply to nurses’ consultations when giving information about 
Methotrexate and could indicate the need for further specific research in this area.  The 
findings of the video-recordings revealed that the patients’ ideas, concerns and expectations 
were not explored and their understanding of the information given to them was not 
checked by any of the nurses.  Further, whilst the nurses interviewed in Phase II of this study 
agreed that individual patients have different learning needs, the findings of Phase III 
showed that tailoring the consultation to meet individual needs was not adopted during the 
consultations.  The Methotrexate leaflet (Versus Arthritis 2019) guided the consultations for 
all four nurses.  This was used as a checklist to ensure that all information was given to the 
patients.  Phase I revealed that checklists were commonly used by nurses during their 
encounters with patients, and the findings of Phase II showed that nurses described having 
a “speech” or “spiel”. Phase III showed that nurses used the Methotrexate leaflet to guide 
their consultation agenda in a rote fashion leaving little opportunity for the patients to be 
part of this process. 
Nurses were allocated ten-minute appointments to complete their consultations and thus 
perceived they had time pressures.  This perception of time pressure was also a finding of 
the semi-structured interviews in Phase II, which resulted in a focus on the transfer of 
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information which may have been at the expense of involving the patient in the 
consultation. This perception of time limits, may have been the reason why only seven open 
questions were asked by the nurses during all ten of the video-recordings.  However, the 
evidence on shared decision-making does not support the claim that it adds more time to a 
consultation (Légaré and Thompson-Leduc 2014).  A Cochrane systematic review analysed 
115 shared decision-making aids, ten of these measured the length of the consultation.  Two 
of the studies indicated that the shared decision-making intervention took slightly longer 
time to conduct the consultation, however they found that in six studies there was no 
difference in the length of the consultation (Stacey, Légaré et al. 2017).  Thus, the shared 
decision-making tools have a variable impact on the consultation and this could be a 
consideration when assessing time implications.   
Missed cues were also a significant finding.  The reasons behind missing these cues could 
have been either avoidance through perceived time pressures, lack of confidence in being 
able to address the concern raised or they were simply not picked up by the nurses.   It is 
also possible that some cues may have been overlooked because the nurses were receiving 
positive reactions from the patients in the form of head nodding and positive utterances.  
These may have been interpreted by the nurses as positive understanding from the 
patients, but these reactions may also have been deferential responses by the patients 
which does not necessarily indicate understanding (Thepsoonthorn, Yokozuka et al. 2016).  
A number of studies explore missed verbal cues, or opportunities for further discussion 
during a consultation (Ahluwalia, Levin et al. 2012, Hsu, Saha et al. 2012) and it has been 
suggested that a physician’s ability to detect emotional cues leads to higher patient 
satisfaction (Blanch-Hartigan 2013).  Blanch-Hartigan further reports that training of 
physicians has almost exclusively been focussed on the meaning of emotional cues rather 
than the detection of them.  Most research regarding missed cues have been conducted 
with physicians, and they are generally in the area of Oncology.  However, a study by Jansen 
et al (2010) investigated how nurses respond to emotional cues of cancer patients.  A total 
of 105 cancer patients were video-recorded during an educational consultation with a 
nurse, and the patients completed a recall questionnaire.  They used the Medical Interview 
Aural Rating Scale (MIARS) (see Chapter 6) to rate the consultations and found that the 
most common response to emotional cues was distancing (35.8%) followed by 
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acknowledgement (29.5%).  However, nurses responded to the majority of informational 
cues (65.7%).  Patient recall was negatively influenced by distancing responses.  The 
limitation of the MIARS is that it relies on verbal cues and does not consider the non-verbal 
cues that patients exhibit, thus the findings of the study presented in this thesis reflect a 
novel approach in that the non-verbal cues were analysed using the MIPS and is described 
further below. 
The literature review for this thesis (see Chapter 2) revealed that the utilisation of 
consultation techniques which would enhance the nurses’ understanding of body language 
and utterances is relatively understudied for nurses.  The training of consultation techniques 
is much more widely adopted in the medical field (Butler 1992, Coleman 2000, Neighbour 
2004, Paskins, McHugh et al. 2014).  Brataas et al (2010)  audio recorded the conversations 
between eight nurses and patients in an Oncology outpatient department.  The recordings 
were analysed and three core themes emerged around treatment plans, prognosis and 
psychosocial reactions.  They found that discussion around each theme varied depending on 
the needs of the patients, however when it came to information giving, the discussion was 
structured around the headings of a booklet, and during this time the communicative 
activity of the patients was minimal.  A clear goal of the nurses was to help the patients 
understand their treatment plan to ensure optimal management, and these were proposed 
by the nurse rather than through agreement with the patients.  Brataas et al (2010) 
concluded that more attention needs to be given to how nurses communicate and negotiate 
these goals with the patient, indicating that consultation technique is an important 
contributory factor to achieve the optimum nurse patient experience.  Further, the 
specialist area investigated by Brataas et al (2010) was Oncology, but the findings of their 
study are supported by the findings of Phase III of the body of work presented in this thesis, 
suggesting that nurses use written material to support their consultations in other specialist 
areas.  This viewpoint is supported by the work of Macdonald et al  (2013) who video-
recorded the consultations of ten nurses in primary care and they concluded that checklists 
and written material were extensively used during their discourse with the patients and was 
driven by the nurses agenda.  Thus, Phase III of the study presented in this thesis makes a 
significant contribution to the extant body of work in this area by highlighting that the use 
 247 
of written material and the domination of the nurses’ agenda during a consultation with 
patients, may be occurring more widely in different specialist areas.  
 
7.7 Methodological Considerations 
The methodological considerations of Phases I and II have been extensively discussed in 
Chapters 4 and 5.  As the nurse-patient interaction being scored in the project was a much 
more limited interaction which involved a specific aim of ensuring a patient had the 
information required to ensure they took the medication safely and as prescribed, it meant 
that not all of the items on the COT were relevant. There has also been previous discussion in 
the literature review, reasoning that the Calgary Cambridge consultation model (Denness 
2013) could be applied to the nursing scenario. Whilst the Calgary Cambridge model was 
originally designed for healthcare professionals in primary care, its patient-centred approach 
helps to build trusting relationships and can be adapted to suit a nursing model (Fawcett and 
Rhynas 2012). Themes for scoring the consultations was based on the Calgary Cambridge 
model and was specifically developed for this study. Themes around physical examination and 
gathering information to contribute to a diagnosis were removed as these did not apply to the 
nurse consultation.  The themes were scored using the scoring system of the COT.  
Whilst the Calgary Cambridge consultation model provided the structure on which to 
analyse the interaction between the nurses and patients, it did not specifically provide a 
structure with which to analyse the non-verbal behaviour and utterances of the nurses and 
patients and thus cues to the patients’ agendas could be missed (Butler 1992).  In order to 
address this and explore in more depth the interaction between the nurses and patients, 
the Medical Interaction Process System, (MIPS) was adopted, which was developed by Ford 
et al (2000) and was based on the work of Roter (1991).  It is a tool that allows the 
researcher to analyse and code verbal and non-verbal interactions between the doctor and 
the patient. This tool was developed to be applied to the field of Oncology where the 
conveyance of information can be distressing to the patients and the clinicians. It is 
therefore of the utmost importance that the information which is being conveyed is being 
delivered sensitively and successfully in order to ensure that the patient has received the 
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information accurately to reduce stress and anxiety. The MIPS has been discussed at length 
in Chapter 6, however it was adopted as the method of choice for the video-analysis as it 
incorporates the observation and scoring of all aspects of the interaction between nurses 
and patients during the consultation as described in the previous section, which resulted in 
richer data analysis. Each specific utterance or non-verbal behaviour of the nurse and 
patient in a ten-minute segment of the consultation was counted resulting in a score which 
provided quantitative data.  The integration of this method provided a distinctive 
opportunity to use a novel method in the analysis of video-recordings of nurse/patient 
consultations in Rheumatology.  This method has not been used in this context before and it 
gave the researcher a unique opportunity to observe and analyse, in fine detail, how nurses 
conduct their consultations when giving information about Methotrexate to patients.  
Whilst this was a very time-consuming analysis method, the added dimension of exploring 
the non-verbal behaviours of both nurse and patient highlighted that cues were frequently 
missed or ignored.  This supports the viewpoint that the nurses’ own agenda dominated, 
which resulted in missing non-verbal cues from patients indicating that they also had their 
own agenda that they wished to explore. 
 
7.8 Original Contribution to Knowledge 
There are currently no identified studies for direct comparison in this area of research and 
therefore, this study contributes to our understanding of how nurses give information to 
patients about Methotrexate during their consultations in a unique and original way.   
Some of the initial results of this study were presented at British Society of Rheumatology 
Annual Meeting in 2015 (Robinson, Ryan et al. 2015), the findings from Phase I and II have 
been published (Robinson, Hassell et al. 2017, Robinson, Ryan et al. 2018) and some of the 
findings from Phase III using the Calgary Cambridge scoring and MIPS analysis have also 
recently been published (Robinson, Scott et al. 2021).  A fourth manuscript describing the 
findings of the MIPS analysis is currently being prepared to submit for publication later in 
2021.   
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7.8.1 Original Contribution from Phase I 
 
7.8.1.1 Training 
The findings of Phase I revealed that most of the nurses who completed the online survey 
had not received any structured training to conduct their role of giving information to 
patients about Methotrexate.  A total of 31.5% (n=23) of respondents learned by observing 
peers and doctors, 25% (n=18) described self-directed learning and 15% (n=10) observed 
Rheumatology clinics. This highlighted the lack of training Specialist nurses in Rheumatology 
receive to conduct their roles.  There is little in the literature around Rheumatology nurse 
training, the RCN conducted a survey of this role (2009) which emphasized the extent of the 
Specialist nurses role in this field, but it did not expressly review the way in which nurses are 
training to conduct this role.  The RCN went further by producing a competency framework 
for Rheumatology Specialist nurses (2020), thus recognising the need for a national standard 
for Rheumatology Specialist nurses to work toward, but the implication is that the nurses 
have to use their own resources to achieve these competencies.  The findings of this study 
confirms that there is no standard national training for Rheumatology Specialist nurses, 
which can also be seen in other specialist areas and that the onus is often on the nurse to 
further their own post graduate education in specialist roles (Dury 2014, Cook, McIntyre et 
al. 2019). 
 
7.8.1.2 Confidence and Knowledge 
The findings from Phase I suggested that nurses had a reasonable knowledge of 
Methotrexate based on common clinical scenarios, which does indicate that nurses do seek 
out information themselves.  In terms of confidence, 60% (n=51) of the nurses were very 
confident in their role, however this confidence was related to how long they had been 
conducting this role and confidence increased over time.  There are few surveys which 
explore nurses knowledge and confidence in their role, Courtenay and Carey (2008) 
conducted a survey of diabetes nurses who were nurse prescribers, with the aim of 
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investigating how educationally prepared the nurses were to carry out this role.  Whilst all 
of the nurses had taken a prescribing course, almost half had not undertaken a diabetes 
course and their training consisted of in-house training and learning from peers and doctors, 
further 50% of the respondents felt underconfident in their role. The findings of Phase I 
supports these outcomes, but further adds to the extant literature as it is the first study to 
examine the knowledge and confidence of Rheumatology Specialist nurses in their role of 
giving information about Methotrexate to patients. 
 
7.8.1.3 Written Information 
Phase I further provided an original contribution to knowledge by highlighting the extent to 
which Rheumatology Specialist nurses may be using written information to guide their 
consultations with patients.  The Methotrexate Information Booklet (Versus Arthritis 2019) 
was widely used as well as checklists and information produced by the National Rheumatoid 
Arthritis Society, which was preferred by 26% (n=23) of respondents. There are few studies 
which specifically describe the use of written materials by nurses in their consultations,  but 
a study by Macdonald et al (2013) reported the extensive use of checklists and written 
materials by diabetes nurses during their consultations.  However, this study was not a 
national survey, but video-recordings of ten nurses in primary care.  Therefore, the findings 
from Phase I add original knowledge to the extant literature supporting the limited research 
that has been conducted in this area. 
 
7.8.2 Original Contribution Phase II 
Phase II consisted of semi-structured audio-recorded interviews with six Rheumatology 
Specialist nurses from two different Rheumatology services.  The typed transcripts were 
analysed and four main themes and two sub-themes emerged which will be discussed below 
regarding their contribution to original knowledge. 
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7.8.2.1 Theme One: Using Written Information to Structure the Content of the Consultation 
All of the nurses interviewed used the Methotrexate Information Booklet (2019) and in-
house written material to structure their consultations.  They described highlighting sections 
of the booklet during their consultations that they regarded as important for the patient and 
they further described using the headings of sections of the booklet to guide their 
consultations.  This indicated that their consultations were structured around the written 
material which may have dominated the nurse agenda.  The examination of the extent to 
which Rheumatology Specialist nurses use written material during their consultations with 
patients has not been researched before.  There is little coverage of this topic in any of the 
extant literature, there is more on the appropriateness of the educational materials for 
patients and their responses to those materials (Kääriäinen, Kukkurainen et al. 2011, Zangi, 
Ndosi et al. 2015, Oliffe, Thompson et al. 2019).  Thus, is appears in the literature, that there 
is an emphasis placed on the value of written materials for patients in Rheumatology, there 
is little evidence around how that information is imparted to the patient by the nurse.  This 
finding from Phase II is an important contribution to the extant literature as it adds a 
different perspective to be considered when researching this topic. 
 
7.8.2.2 Sub-theme: Overloading Patients with Information 
All of the nurses interviewed agreed that they often felt that they were bombarding the 
patient with information, describing patients as looking shocked or dazed.  There has been 
little research around information overload with Rheumatology patients, but some work has 
been carried out in the field of Oncology.  It has been recognised that many adults feel 
overwhelmed about the amount of information that they are exposed to which can have an 
impact on decision-making (Jensen, Pokharel et al. 2020).  Jensen et al investigated sun 
safety behaviour and found that those participants who showed signs of cancer information 
overload were more likely to not use sun safety behaviour.  Ramondt et al (2019) examined 
the impact of public nutrition information and found that diet information overload resulted 
in fatalistic beliefs which had a negative impact on preventative behaviours.  Thus, the 
finding of information overload in Phase II is important contribution as it could suggest that 
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giving too much information to patients may actually have a negative effect.  In relation to 
information giving by nurses in Rheumatology, this finding of information overload, requires 
more exploration. 
 
7.8.2.3 Sub-theme: Asking Questions 
The nurses recognised that patients did not always ask questions during their consultations 
despite recognising instances where the patient may have wanted to ask questions.  
However, some literature shows that patients can struggle to ask questions during their 
consultations (Kinnersley, Edwards et al. 2008) and health literacy may have an impact on 
this (Menendez, van Hoorn et al. 2017).  But it has long been known that encouraging 
patients to ask questions has a positive impact on satisfaction with their healthcare (Roter 
1977) and Shepherd et al (2016) developed three questions for patients to ask during their 
consultations with healthcare professionals.  These three questions encouraged the patients 
to take part in their consultations and thus supported the shared decision-making process.  
But the finding from Phase II seems to suggest that the nurses felt “interrupted” by 
questions from patients rather than encouraging question asking.  This important finding 
does imply that these nurses did not adopt a shared decision-making strategy during their 
consultations indicating that nurses require training to engage with this technique in order 
to put patients at the centre of care. 
 
7.8.2.4 Theme Two: Patients have Different Information Needs 
It is well recognised that patients need information to help them manage their 
Rheumatology conditions (Clerehan, Buchbinder et al. 2005, des Bordes, Gonzalez et al. 
2018) and factors such as gender (Marrie, Walker et al. 2019) and health literacy (Baker 
2006) which can make an impact on individual needs. Thus, the finding from Phase II in 
which nurses recognised that patients have different information needs, not only adds to 
this body of knowledge but also suggests that whilst there is awareness of individual 
information needs, it may not necessarily be explored with the patient.  Again, this is 
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another finding which requires more exploration with a bigger research project to really 
understand whether healthcare professionals explore different information needs with 
individual patients and tailor their consultations in order to meet those needs. 
 
7.8.2.5 Theme Three: Time Pressure 
Perceived time pressure was a finding from Phase II and it appeared to influence how the 
nurses conducted their consultations.  Time pressure that nurses experience has been well 
documented in the extant literature, but it is generally related to the pressures of a shortage 
of nurses and the impact of this on nursing care (Dierckx de Casterlé, Mertens et al. 2020, 
Labrague, De los Santos et al. 2020) and nurse burnout (Dall’Ora, Ball et al. 2020).  There is 
little in the literature investigating perceived time pressure in nurse consultations but it has 
been explored for medical consultations (Mazzi, Rimondini et al. 2016) and some GPs report 
that time pressure is a major barrier to treating disorders such as depression (Hutton and 
Gunn 2007).  From a patient’s perspective, they would consider that time matters and if 
time has been given to resolving issues, it would minimize further visits (Williams and Jones 
2006).  The nurses’ perceptions of time pressure during their consultations and how they 
manage this is under represented in the literature.  Thus, this finding from Phase II is an 
important contribution to the extant literature, as it emphasizes the need for further 
exploration of this subject and how nurses manage this through improved consultation 
technique. 
 
7.8.2.6 Theme Four: Training and Evolution of Practice 
There was agreement between all of the participants of Phase II that their practice had 
evolved over time, and that they did not have specific training to undertake their role of 
giving information to patients about Methotrexate.  This finding strengthens the finding 
from Phase I which indicated that nurses desired training to carry out their roles more 
confidently and effectively. 
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7.8.3 Original Contribution from Phase III 
The thematic analysis of the video-recordings and transcripts generated three main themes 
and their contribution to original knowledge will be described in the following sections. 
 
7.8.3.1 Theme One: The Nurses’ Agenda 
The findings of the analysis showed that the nurses’ agenda of giving information about 
Methotrexate dominated the consultation which did not put the patient at the centre of 
care or acknowledge the patient’s agenda.  However, it did have the benefit of structuring 
the encounter, ensuring that correct information was given and also provided the patient 
with written information.  Whilst there is little in the literature around this in Rheumatology, 
a study in cancer nursing confirms that the nurses agenda of giving information dominates 
and was considered a blocking behaviour resulting in dissatisfaction in cancer patients 
(Kruijver, Kerkstra et al. 2001).  A study by Siouta et al (2019) who audio-recorded nurses in 
a chemotherapy clinic also showed that the dominant feature of the discourse between the 
nurse and the patient was the medical and physiological theme.  This finding from Phase III, 
the dominance of the nurses’ agenda during their consultation with patients, supports 
findings from Phase II, information overload and time pressure.  It is possible that the nurses 
agenda dominates because of perceived time pressures and the need to ensure that all of 
the information from the Methotrexate Information booklet (Versus Arthritis 2019) has 
been divulged to the patient.  It has long been recognised that an improvement in the 
quality of a consultation can potentially improve aspects of healthcare (Middleton, McKinley 
et al. 2006). Thus, this is an important finding, because again, it emphasizes that there could 
be aspects of the Rheumatology nurse consultation which needs further exploration to 
adapt the consultation technique in order to put the patient at the centre of care, explore 





7.8.3.2 Theme Two: Information Overload 
This finding from Phase III supports the finding from the Phase II semi-structured interviews.  
It is important because it further confirms that Rheumatology Specialist nurses give a lot of 
information to patients and that they are aware that this is occurring.  This finding adds to 
the body of literature which explores nurse consultations and the implication that there are 
aspects of these encounters which could benefit from more training. 
 
7.8.3.3 Theme Three: Missed Cues 
The data from Phase III revealed this third finding, that opportunities for exploring the 
patient agenda were missed because these cues were not being recognised or were ignored.  
The findings from this study have already shown that nurses use written material such as 
the Methotrexate Information booklet, using the headings in the booklet to guide the 
discourse they have with the patients during their conversation.  This has the effect of 
dominating the conversation with the patient, it may also result in missing cues from the 
patient which would indicate that the patient had their own agenda.  Whilst the study did 
not specifically address why the nurses missed these cues, it could have been as a result of 
perceived time pressure, but there is some evidence which suggests that recognising and 
dealing with cues focussing on issues important to the patient, could in fact save time 
(Silverman, Kurtz et al. 2016).  Whilst research has been conducted around patient cues 
(Riley, Weiss et al. 2013, Farrell, Chan et al. 2020) these studies explore verbal cues only.  
However, they did conclude that nurses were more likely to respond to informational cues 
than psychosocial cues.  The significance of the findings from Phase III is that they add 
another dimension to the existing knowledge as they reveal that nurses also miss non-verbal 
cues relating to the patient’s agenda.  
The adoption of the Medical Interaction Process System to analyse the video-recordings of 
Phase III permitted the researcher to explore the non-verbal dimension of patient cues 
which is unique in Rheumatology nursing research.  It revealed a variety of verbal and non-
verbal items which could indicate whether the consultation between the nurse and patient 
is effectively addressing patient needs and putting them at the centre of care. Further the 
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use of the Medical Interaction Process System to analyse the video-recordings showed that 
it is possible to collect quantitative data giving the opportunity to compare individual nurse 
consultations. In those consultations which were scored higher, the nurse used more 
illustrative gestures and it has been seen that the use of illustrative hand gestures improves 
learning in foreign languages, as it aids recall (Tellier 2010, Macedonia and von Kriegstein 
2012, Krönke, Mueller et al. 2013).  In the lower scoring consultations the nurses used more 
batonic gestures, which are those hand gestures which follow a rhythm of speech 
(Navarretta 2019) rather than illustrate the speech thus it is possible that these types of 
gestures are not useful to memory recall.  This is an important finding because it has not 
been explored during the nurse patient consultation.  It is an area which requires more 
research as it may indicate that if nurses are taught how to use and gestures to aid recall, it 
may have a positive impact on the patient experience. 
 
7.8.4 Overall Study Contribution to Original Knowledge 
The overarching findings of this study indicate that nurses do not have national gold 
standard training to conduct their specialist role in Rheumatology, they do not receive 
training on how to conduct consultations and thus may be missing opportunities to address 
the patient’s agenda putting them at the centre of care and they use written information to 
guide their consultations which may have the effect of giving patients a lot of information 
without checking to make sure they have understood what has been said.  As a result of 
these findings, this researcher has collaborated with Versus Arthritis and has produced a 
sheet of “Top Tips” to guide Rheumatology Specialist nurses during their consultations 
which was published on the Versus Arthritis website (Versus Arthritis 2020).  These “Top 
Tips” (see Appendix 19) were based on the findings presented in this thesis and are an 
important education tool for nurses conducting consultations with patients when giving 
information about Methotrexate.  The “Top Tips” are intended to give nurses some 
guidance around how to give information to patients effectively.  The first tip suggests that 
written information, such as the Methotrexate information booklet, be sent to the patient 
before they arrive for their consultation with the nurse.  This effectively, allows the patient 
to familiarise themselves with the information first, and come to the consultation with 
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questions they want to ask.  The second tip involves setting the baseline in order to 
personalise their approach with the patient, to find out what the patient already knows 
about their treatment and what they want to learn.  The third tip is to chunk and check the 
information the nurse gives to the patient and ascertain how much that person has 
understood, by asking a question such as “what have you understood about what I have just 
discussed with you”.  The fourth tip is to avoid information overload and to emphasise that 
not every bit of information from the booklet needs to be given.  The most important 
information to give is that around maintaining safety when taking the drug.  The fifth tip is 
to let the patient talk, encouraging the nurse not to dominate the conversation or interrupt, 
but to legitimise the patient’s point of view.  The sixth tip is to listen and watch ensuring 
that the nurse is observing and responding to verbal and non-verbal cues.  The seventh tip is 
to summarise with the patient what has been said during the consultation and the eighth tip 
is to give the opportunity to the patient to ask question suggesting that the nurse could ask, 
“what questions do you have?”.  The final tip is then to give any written information, which 
could be about the Rheumatology service, blood monitoring appointments and how the 
patient can get in touch with the team between appointments such as via a helpline.  The 
Top Tips also include a section on the minimum amount of information to give, such as, 
what to take and how to take it; how long it takes for Methotrexate to work; monitoring 
requirements; whether changes to the patient’s experiences could relate to the drug; 
potentially serious illnesses and the helpline number to call if the patient needs assistance.  
These “Top Tips” can be viewed and downloaded by nurses and patients, without charge, 
via the Versus Arthritis website (Versus Arthritis 2020). 
Within the wider context of the specialist nursing role in different disease areas, it is clear 
that the findings of the three phases of this study support the extant literature that there is 
a lack of training for many Specialist nurses to develop their roles and consultation skills.  
Cook et al  (2019) comment on the lack of training for Gynaecology Specialist nurses, but 
consider them important members of the multi-disciplinary team. Dury et al (2014) 
comment that education programmes are available but there is no regulation or common 
training frameworks and often the onus of training is on the nurses themselves (Forbes, 
While et al. 2006).   
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There is recognition that the role of the Specialist Nurse in Rheumatology has changed and 
is highly respected as part of the multi-disciplinary team, (Goh, Samanta et al. 2006) but the 
training around preparing the nurses to meet the demands of this responsibility has not 
kept pace with the role development (Robinson, Hassell et al. 2017). 
 
7.9 Implications for Education and Practice 
The primary purpose of studying the interaction between the nurses and patients during the 
Methotrexate information process in consultations was to understand that interaction in 
detail, and to identify any areas where improvement could be made. There are clear 
messages from this thesis which are summarised in the conspectus, but essentially, nurses 
were not trained to carry out their role of giving information to patients about 
Methotrexate and they did not adopt consultation techniques during this process which put 
the patient at the centre of care; they used written information to guide their consultations 
which then dominated the nurses agenda; their knowledge of Methotrexate was adequate; 
they all agreed that specific training would have contributed to their knowledge and 
confidence in conducting this role.   
The research presented in this thesis also raised questions about general nurse education, in 
that consultation skills are not taught in undergraduate training, but there is a recognition 
that communication skills are important during the nurse-patient encounter (Nursing and 
Midwifery Council 2018) and as nurses become more specialised (Royal College of Nursing 
2009, Deighan 2011) consultations skills are likely to be of increasing importance to nurses 
as they take on roles in which they co-ordinate and run outpatient clinics in different 
specialist areas.  It is possible that eventually this training could become part of the general 
undergraduate training of nurses, but if it is to be postgraduate then it needs to be 
accessible to busy nurses with limited funding for training; an online package may be 
appropriate for this.  The Calgary Cambridge consultation model that was adopted for the 
analysis of the video-recorded consultations in Phase III of this thesis seems appropriate to 
assess the consultation technique of the nurses.  It was modified by the researcher, 
specifically to capture all of the elements which nurses undertake during their consultations.  
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As Rheumatology Specialist nurses do not regularly carry out physical examinations (other 
than joint assessments for tenderness and swelling), this domain of the Calgary Cambridge 
consultation model was removed.  The Calgary Cambridge consultation model was deemed 
to be appropriate for this study, because it had been considered as a model which 
complements the holistic approach of nurses (Munson and Willcox 2007) and has been 
adapted by professions other than medicine (Munson and Willcox 2007, Greenhill, 
Anderson et al. 2011, Englar, Williams et al. 2016).  It is a model which helps the nurse to 
establish a rapport with the patient; give information in chunks and then assess 
understanding by checking to determine what the patient understood; it allows the patient 
to be placed at the centre of care and tailor the consultation to individual needs.  It also 
guides the nurse on completing the session with a summary and signposting to further 
information if required. Thus, this model was specifically adapted by the researcher to focus 
on the assessment of the nurse consultations.  The purpose of the nurse consultation when 
giving information about Methotrexate is to ensure that the patient understands why they 
have been prescribed the drug, how to take it safely and how to recognise and report side 
effects.  The patients require individualised consultations tailored to their specific needs, the 
Calgary Cambridge consultation model provides the structure and flow in order to achieve 
this.  The adapted Calgary Cambridge consultation model could have wider reaching 
applications.  It could provide the basis of all consultations given by nurses, providing them 
with the skills and guidance to tailor their encounters with patients putting them at the 
centre of shared decision-making care.  However, it is outside of the scope of this thesis but 
it could provide the basis for future research. 
 
7.10 Limitations  
The limitations of each phase have been discussed in the results chapters, but to re-cap, it 
was not possible to determine whether the responses of the survey were truly 
representative.  Not every participant completed the survey to the end, but the n numbers 
have been stated to ensure transparency of the results.  The survey did not capture 
geographical data, which may have given the researcher a better representation of the 
generalisability of the results.  However, the survey was sent out by the Royal College of 
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Nursing (RCN) to all of its members in the Rheumatology forum which has over 1,000 
members from all over the UK (RCN 2021), and so whilst some variation is possible, it can 
reasonably be expected to be geographically representative.  Further, it must be 
acknowledged that the response rate of the electronic survey was typically low, (Monroe 
and Adams 2012).  Despite the extensive use of the electronic survey through the world 
wide web (www), it has been widely acknowledged that there are challenges to addressing 
the low response rate (Fan and Yan 2010).  The survey described in this thesis was 
distributed via the RCN Rheumatology forum via an email link.  This could have 
compromised the response rate, as spamming filters are increasingly being used to cut 
down on unnecessary www email traffic in to organisations (Daikeler, Bošnjak et al. 2020). 
Some authors also believe that participants are becoming increasing resistant to responding 
to surveys in general (Kohut, Keeter et al. 2012).   Further, web surveys are often overlooked 
because they are not mandatory and it is easier to put them aside as opposed to having 
personal contact with the participant by the researcher making more difficult to refuse to 
participate (Dillman, Smyth et al. 2014).  Incentives are strategies employed by some 
researchers to increase response rates (Monroe and Adams 2012), however, this particular 
strategy was not available to this researcher.  Hendra and Hill (2019) explain that some 
surveys can cost large amounts of money, therefore they explored the response rate of 
sixteen identical surveys, which included 12,000 participants and concluded that the pursuit 
of high response rates may offer little or no reduction of nonresponse bias, that samples 
with higher response rates had levels of nonresponse bias which were similar to those 
studies which had a lower response rate, thus costly incentives may be unnecessary.    
The interviewees from Phase II came from two different units with dissimilar appointment 
structures for the interaction with patients for giving information about Methotrexate and 
the nurses from one of the units had the opportunity to engage in a specific Rheumatology 
course run by a Nurse Consultant in their department, at their local university.  However, 
the analysis of resulting interviews showed little difference in the way that the nurses gave 
information to patients, the same themes emerged and the same lack of basic training was 
apparent. 
Whilst the video-recordings yielded a lot of data, all of the recordings came from one 
Rheumatology service.  Whilst the findings cannot be considered as necessarily 
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generalisable, the findings from Phase I and II demonstrated the same links and patterns, in 
that nurses generally did not receive training, they used written information to guide their 
consultations and they felt that structured training would have given them more confidence 
to carry out their role.  So, whilst this is a small study, the findings from this work adds to 
the extant literature as this is a unique study in Rheumatology nursing and enriches our 
understanding of how nurses are trained to conduct their role as Methotrexate information 
givers to patients, and also how they conduct their consultations.  It has also highlighted 
that consultation techniques are important skills which allowed the nurses to recognise 
cues, tailor their consultations to individual patients and to put the patient at the centre of 
their care in shared decision-making. 
 
7.11 Further Recommendations 
This researcher has recognised that the findings from this study shows that nurses use 
written information during their consultations consistently and that this information 
ensures that the nurse gives the pertinent information to the patient.  However, the written 
information usually takes the form of the Versus Arthritis booklet on Methotrexate which 
was designed and written for patients (Versus Arthritis 2019) and it dominates the nurse’s 
agenda leaving little opportunity for patients to interact during this process. This booklet 
contains information that patients need but it does not have the depth of information 
required by nurses to carry out their role.  It also has no guide around conducting the 
consultation, ensuring that patients understand the information they are being given and 
are part of the shared decision-making process leading to greater self-management (Elwyn, 
Frosch et al. 2012, El Miedany, El Gaafary et al. 2016, Mathijssen, Vriezekolk et al. 2020). 
Further, the influences of consumerism in the NHS (Latimer, Roscamp et al. 2017) and the 
rights of the patients to be involved in their care and decision-making processes (Sykes and 
Durham 2014) should be reflected in the way that nurses conduct their consultations when 
giving information to patients about Methotrexate.  Whilst in some cases there may be 
resource limits to patients choices which are unavoidable (Latimer, Roscamp et al. 2017), it 
should still be a priority to nurses to ensure that patients understand the choices available 
to them, ensuring that drug treatments such as Methotrexate are explained and understood 
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by patients so that they are placed at the centre of their care.  Therefore, this researcher is 
now designing a study to develop a nurse handbook, containing background information 
about Methotrexate and guidance on how to conduct a consultation by applying an 
adaptation of the Calgary Cambridge consultation model. This will provide information for 
nurses to develop the skills to ensure that nurses tailor their consultations to suit the 
individual needs of their patients, thus streamlining their interaction so that only the 
pertinent information is given.  The aim of this would be to ensure that nurses have a 
greater depth of information about the drug they are explaining to the patient, have the 
skills to ensure that patients are at the centre of care and to be able to use the time 
allocated to conduct their consultations in an efficient way.   Further the booklet will offer 
tips, based on the “Top Tips” to increase the effectiveness of their interactions which could 
suggest sending the patients the written information about Methotrexate prior to their 
appointment with the nurse, which will give patients time to read the material and have any 
queries or concerns ready, prior to the consultation.  This will then allow the nurses to 
concentrate on patients concerns ensuring that issues which are important are explored 
thus resulting in a consultation which focusses on individual needs for information and 
guidance. The handbook will also advise on time efficiency so that the nurse will feel less 
constrained by time perceptions and allows them to involve the patient more during the 
consultation without necessarily prolonging the interaction. The handbook will also be 
designed to guide nurses on the importance of patient cues and how to interpret verbal and 
non-verbal behaviours.  Further possible research could also investigate whether the use of 
the handbook results in behaviour change; whether other factors such as cultural and belief 
systems could impact on the use of the handbook and whether the handbook saves time 
during the consultation which could result in patients asking more questions.  Investigations 
such as these, could be tested with further research. 
 On a larger scale, a national training package to ensure that nurses have gold standard 
training for carrying out these roles would ensure that every nurse had the skills and 
training required to underpin their role.  It would need to include consultation skills, such as 
adapting the Calgary Cambridge consultation model to suit the nurse’s role and a greater 
level of drug information about drugs such as Methotrexate.  The Calgary Cambridge 
consultation model was adapted by the researcher to analyse Phase III of the work 
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presented in this thesis.  The adaptations involved removing those domains of the Calgary 
Cambridge consultation model which did not apply to the nurse consultation, such as 
physical examination and diagnosis.  However, the emphasis of the model is to provide 
information to the patient in manageable chunks and check understanding through the 
patient’s response.  Thus, the elements which were retained were; initiating the 
consultation, setting the agenda, checking the patient’s current knowledge/information, 
understanding the patients concerns, giving explanations and information by chunking and 
checking, supporting with written information and closing the consultation with 
summarising and an agreed plan.  This adapted model gives structure to the nurse 
consultation, provides clarity and flow putting the patient at the centre of care. 
Whilst this study concentrated on nurses giving information to patients about 
Methotrexate, there are many more drugs which are discussed by nurses with patients 
during their treatment.  A training package should include all of the commonest drugs which 
nurses encounter in the information giving process.  This is particularly important when 
giving information about drugs which have significant side effects and require the patient to 
recognise and report these in a timely manner. A number of drug companies have 
attempted to provide on-line training resources for Rheumatology Specialist nurses 
regarding different aspects of their role, (Eli Lilly 2021) however, these are not standardised 
or regulated and therefore have limitations.  Whilst the Royal College of Nursing has 
produced excellent competencies for Rheumatology Specialist nurses (Royal College of 
Nursing 2020) which was supported by AbbVie Pharmaceuticals Ltd (Finney, Parker et al. 
2020), achieving these competencies still require training.  Therefore, an online training 
resource based on those competencies and regulated by a recognised organisation such as 
the British Society of Rheumatology or the Nursing and Midwifery Council, could be a more 
appropriate way forward.  However, the development of this is outside the scope of this 




Previous studies (Sowden, Hassan et al. 2012, Walker, Robinson et al. 2012, Fayet, Savel et 
al. 2016) recommended that deficiencies in core knowledge of patients needed to be 
addressed.  Rheumatology Specialist nurses largely take on this role of giving information to 
patients about Methotrexate when they start this drug but little was known about how they 
are trained to carry out this role in a consultation (Royal College of Nursing 2009).  Thus, the 
findings of the research described in this thesis supports the viewpoint that structured gold 
standard training for nurses will improve confidence in conducting their role. 
This thesis has demonstrated the processes that nurses adopted in order to give information 
to patients about Methotrexate in their consultations. It showed that nurses used 
information leaflets to guide their consultations, and that this dominated the nurses’ 
agenda, thus reducing opportunities to implement a shared-decision-making process 
between the nurse and patient, and it also provided few openings for patients to express 
their concerns.  The domination of the nurses’ agenda also resulted in missing cues from the 
patients which may have impacted on the patient experience of the interaction with the 
nurses.  This thesis also showed that nurses want more training and they recognised that it 
would lead to feeling more confident to conduct their roles.  Further, the utilisation of the 
Calgary Cambridge consultation model could provide the framework with which nurses 
could structure their interaction with patients thus facilitating the patient agenda. This 
thesis has contributed to the extant literature on how nurses give information to patients 
about Methotrexate and it employed an analysis method, the Medical Interaction Process 
System, which was unique in this area of research.  The findings of this research have been 
published in three manuscripts, which can be seen in appendices 20, 21 and 22, and a fourth 
manuscript is currently being prepared. 
This researcher is now embarking on a further research project as a result of the findings of 
this work, highlighting the importance of consultation skills and conveying information to 
educate patients as identified in this thesis. As described in the previous section, this 
researcher will develop a handbook for nurses to guide them on their consultation 
technique.  It is envisaged that the first section of the handbook will describe the 
consultation process based on the Calgary Cambridge consultation model, this will give step 
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by step guidance on how to conduct this consultation, to support the nurse to tailor the 
discussion around the patient agenda.  The second section of the handbook will give the 
nurse more information about the drug they are discussing with the patient and the minimal 
amount of information the patient needs to ensure they understand why they are taking the 
drug, that they can take their treatment safely and recognise side effects which need to be 
reported early.  Once the handbook has been developed, it will be validated for 
effectiveness through a research study and amended based on the findings of that study.  It 
has already been highlighted that the lack of training for nurses in specialist roles occurs in 
other specialities, thus it is possible, that if the handbook is successful in Rheumatology, that 
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Appendix 1 Parliamentary Debates around the use of Cortisone 1949 – 1954  
 
Between 1949 and 1954 a series of debates around the availability of Cortisone was brought 
up in Parliament: 
Colonel J.R. Hutchison asked the Minister of Health what steps he was taking to encourage 
the production of the anti-arthritis discovery Cortisone, to which Mr Bevan replied: 
“The Medical Research Council……is promoting intensive research into Cortisone and 
other substances that might take its place and be available in adequate amounts” 
(Hansard 1949). 
In 1950 it was reported that Cortisone was readily available in America, Mr Blackburn a 
Conservative MP remarked: 
“Is it a fact that, as reported, Cortisone is being made available at drug stores in the 
United States next month?” (Hansard 1950). 
However, in 1951, Cortisone was still not available in the UK, even though it was being 
manufactured in America, as commented by Mr Crookshank, Minister for Health (1951 – 
1952); 
“Cortisone has not yet been made in this country.  The maximum quantities which 
can be made available by the American manufacturers are imported by my 
Department and distributed for continuing clinical research and for hospital 
treatment for cases which, on medical grounds, most need it.” (Hansard 1951). 
The “period of scarcity” ended in 1952 when  Murray and Peterson who worked for an 
American Pharmaceutical Company call Upjohn (Hetenyi Jr and Karsh 1997), discovered that 
a mould was discovered called Rhixopus Nigirans, converted progesterone into cortisone 
with an almost 100% yield.  It was now possible to produce cortisone in large quantities and 
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in 1953 Upjohn produced and marketed hydrocortisone, but there was still caution around 
its use in the UK as commented by Iain Macleod Conservative MP: 
“I must say that on the whole I prefer in these matters to proceed rather cautiously.  
For all the claims that are made about Cortisone there are very considerable 
unknown dangers in it”. (Hansard 1953). 
By 1954 Cortisone was becoming more available, but there was still caution in the air as Iain 
Macleod comments; 
“We are at the moment limiting the distribution of Cortisone – the supply position is 
rapidly becoming a great deal easier – to about 100 hospitals.  It is hoped to extend 
the distribution very considerably.  However, the use of the drug must, clearly, be 
entirely at the discretion of the doctors.  One obviously cannot deny Cortisone to a 
patient if it is thought desirable that he should have it….” (Hansard 1954). 
Despite the advance in the treatment of RA brought about through increased availability of 
hydrocortisone, treatment effects did not meet the expectations of the 1950s. Hart (1976, 
p763-765) wrote,  
“The treatment of an untreatable condition such as Rheumatoid Arthritis calls forth, 











Appendix 2 Annexe A 
 
1. Underpinning communication skills for assessing, planning, providing and managing 
best practice, evidence-based nursing care 
1. Actively listen, recognise and respond to verbal and non-verbal cues. 
2. Use prompts and positive verbal and non-verbal reinforcement, eye contact and 
personal space. 
3. Make appropriate use of open and closed questioning. 
4. Use caring conversation techniques. 
5. Check understanding and use clarification techniques. 
6. Be aware of own unconscious bias in communication encounters. 
7. Write accurate, clear, legible records and documentation. 
8. Confidently and clearly present and share verbal and written reports with individuals 
and groups. 
9. Analyse and clearly record and share digital information and data. 
10. Provide clear verbal, digital or written information and instructions when delegating 
or handing over responsibility for care. 
11. Recognise the need for, and facilitate access to, translator services and materials. 
 
2. Evidence-based, best practice approaches to communication for supporting people of all 
ages, their families and carers in preventing ill health and in managing their care 
1. Share information and check understanding about the causes, implications and 
treatment of arrange of common health conditions including anxiety, depression, 
memory loss, diabetes, dementia, respiratory disease, cardiac disease, neurological 
disease, cancer, skin problems, immune deficiencies, psychosis, stroke and arthritis. 
2. Use clear language and appropriate written materials, making reasonable 
adjustments where appropriate in order to optimise people’s understanding of what 
has caused their health condition and the implications of their care and treatment. 
3. Recognise and accommodate sensory impairments during all communications. 
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4. Support and manage the use of personal communication aides. 
5. Identify the need for and manage a range of alternative communication techniques. 
6. Use repetitive and positive reinforcement strategies. 
7. Assess motivation and capacity for behaviour change and clearly explain cause and 
effect relationships related to common health risk behaviours including smoking, 
obesity, sexual practice, alcohol and substance use. 
8. Provide information and explanation to people, families and carers and respond to 
questions about their treatment and care and possible ways of preventing ill health 
to enhance understanding. 
9. Engage in difficult conversations, including breaking bad news and support people 
who are feeling emotionally or physically vulnerable or in distress, conveying 
compassion and sensitivity. 
 
3. Evidence-based, best practice communication skills and approaches for providing 
therapeutic interventions 
1. Motivational interview techniques. 
2. Solution focussed therapies. 
3. Reminiscence therapies. 
4. Talking therapies. 
5. De-escalation strategies and techniques. 
6. Cognitive behavioural therapy techniques. 
7. Play therapy. 
8. Distraction and diversion strategies. 
9. Positive behaviour support approaches. 
 
4. Evidence-based, best practice communication skills and approaches for working with 
people in professional teams 
1. Demonstrate effective supervision, teaching and performance appraisal through the 
use of: 
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 Clear instructions and explanations when supervising, teaching or appraising 
others 
 Clear instructions and check understanding when delegating care 
responsibilities to others 
 Unambiguous, constructive feedback about strengths and weaknesses and 
potential for improvement 
 Encouragement to colleagues that helps them to reflect on their practice 
 Unambiguous records of performance 
2. Demonstrate effective person and team management through the use of: 
 Strengths based approaches to developing teams and managing change 
 Active listening when dealing with team members’ concerns and anxieties 
 A calm presence when dealing with conflict 
 Appropriate and effective confrontation strategies 
 De-escalation strategies and techniques when dealing with conflict 
 Effective co-ordination and navigation skills through: 
                         -  appropriate negotiation strategies 
                         -  appropriate escalation procedures 















Appendix 4 Rheumatoid Arthritis Mindmap 
RA Mindmap
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Appendix 5 The REALM 
 
 
REALM Health Literacy Test 
(Rapid Estimate of Adult Literacy in Medicine) 
How many of these words can you read aloud and 
pronounce correctly, each within fi ve seconds? Start with the 
first column, reading down. Skip those you cannot read. 
Fat Fatigue Allergic 
Flu Pelvic Menstrual 
Pill Jaundice Testicle 
Dose Infection Colitis 
Eye Exercise Emergency 
Stress Behavior Medication 
Smear Prescription Occupation 
Nerves Notify Sexually 
Germs Gallbladder Alcoholism 
Meals Calories Irritation 
Disease Depression Constipation 
Cancer Miscarriage Gonorrhea 
Caffeine Pregnancy Inflammatory 
Attack Arthritis Diabetes 
Kidney Nutrition Hepatitis 
Hormones Menopause Antibiotics 
Herpes Appendix Diagnosis 
Seizure Abnormal Potassium 
Bowel Syphilis Anemia 
Asthma Hemorrhoids Obesity 
Rectal Nausea Osteoporosis 
Incest Directed Impetigo 
SCORE 
Add up the number of words pronounced correctly. 
0—18 words Third grade or below You will not be able to read easy materials. You 
will need repeated oral instructions, materials composed primarily of 
illustrations, or audio or videotapes,  
19—44 words Fourth to sixth grade You will need easy materials. You will not be able 
to read prescription labels.  
45—60 words Seventh to eighth grade  You will struggle with most patient education 
materials and will not be offended by low-literacy materials.  
61—66 words High school You will be able to read most patient-education materials 
Source: Rapid Estimate.of Adult Literacy in Medicine 
The New York Times 
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Appendix 6 COREQ 32 item checklist for reporting qualitative studies 
 
Domain 1: Research team and reflexivity 
Personal characteristics  
1.  Interviewer/facilitator Which author/s conducted the interview/focus group? 
The researcher conducted all of the interviews. 
2. Credentials 
 
What were the researcher’s credentials? 
 
The researcher was a qualified nurse with 15 years’ experience in 
research and had previous experience with semi-structured 
interviews. 
3. Occupation What was their occupation at the time? 
 
Senior Nurse Researcher 
4. Gender Was the researcher male or female? 
 
Female 
5. Experience and training 
 
What experience/training did the researcher have? 
 
Completed Good Clinical Practice training, over 15 years’ 
experience in academic research. 
Relationship with participants  
6. Relationship established Was this established prior to the study? 
 
The researcher had the opportunity to meet all of the participants 
before the interviews, to talk about the project and their 
participation. 
7. Interviewer known to participant  Did the participant know the researcher? 
 
The participants had met the researcher previously and was 
known to them. 
8. Interviewer characteristics 
 
What characteristics were reported eg biases, assumptions. 
 
The participant characteristics were reported as some nurses had 
been carrying out the role for longer than others. 
Domain 2: study design 
Theoretical framework  
9. Methodological Orientation 
    And Theory                                                                  
What Methodology underpinned the study? 
A phenomenological methodology underpinned the semi-
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structured interviews as it seeks to explore lived experiences. 
Participant selection  
10. Sampling How were participants selected? 
 
Purposive sampling was applied and nurses from 2 Rheumatology 
centres were invited to take part in the study.  3 nurses from each 
centre consented to be interviewed. 
11. Method of approach How were participants approached? 
 
All of the nurses were approached, to ensure that 6 individual 
nurses could be interviewed. 
12. Sample Size How many participants were there? 
 
6 nurses agreed to be interviewed. 
13. Non participation                                                                                                                                                                                                                   How many participants refused/dropped out and why? 
 
No nurses dropped out, but the reason given for refusal to take 
part was that the nurse did not have time, or did not want to be 
interviewed. 
Setting  
14.Setting of data collection Where was the data collected? 
 
The interviews took place in a quiet, undisturbed office space in 
each Rheumatology Unit. 
15. Presence of non-participants      Was anyone else present? 
 
Only the interviewer and the interviewee were present during the 
interaction. 
16. Description of sample 
 
What are the important characteristics of the sample?   
 
All of the nurses were qualified as Registered Nurses, all of the 
nurses gave information to patients about Methotrexate.                       
Data collection  
17. Interview Guide Were questions/prompts/guides provided – was it pilot tested? 
 
The interview guide was developed by the researcher and it was 
then reviewed by peers and the researcher’s supervisors. 
18. Repeat Interviews Were interviews repeated, if so how many? 
 
No interviews were repeated. 
19. Audio/visual recording 
  
Was audio/visual recording used to collect data? 
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All of the interviews were recorded on a Dictaphone. 
 
 20. Field notes Were field notes made? 
 
Notes were made by the researcher and documented anything 
which could have impacted on the quality of the interviews such as 
her rapport with the interviewees, the comfort of the space in 
which the interviews took place, whether the interviewee was 
nervous or limited for time. 
21. Duration How long was the interview/focus group? 
 
Each interview took approximately 30 minutes. 
22. Data saturation Was data saturation discussed? 
 
Data saturation was discussed with the researcher’s supervisor. 
23. Transcripts returned 
 
Were transcripts given to participants for review? 
 
All transcripts were given back to the interviewees to check 
accuracy and ensure they did not want to add anything they may 
have missed. 
Domain 3: analysis and findings 
Data analysis  
2 
 
4. Data coders 
How many data coders were there? 
 
2 data coders coded the same transcript to determine inter-rater 
reliability.  Thereafter, the researcher coded the transcripts. 
25. Description of coding Is there a description of the coding tree? 
 
Notes were taken of the processes undertaken to examine the 
transcripts for emerging themes. 
26. Derivation of themes 
 
Were themes identified in advance or derived from the data? 
 
All themes were derived from the data. 
27. Software What, if any, software was used? 
 
A software package was not used. 
28. Participant checking Did participants provide feedback? 
 
The only feedback given by the participants was that they 
consented for the transcripts to be used. 
29. Quotations presented                                                                    Were quotes used to illustrate themes/findings and were they 
identified? 
 
Quotes were used to illustrate themes and were identified by an 
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anonymised participant number. 
 
30. Data/findings consistent 
 
Was there consistency between the data presented and the 
findings? 
 
There was consistency between the data presented and the 
findings. 
31. Clarity of major themes Were major themes clearly presented? 
 
All major themes were clearly presented. 
32. Clarity of minor themes 
 
Is there a discussion/description of minor themes? 
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Appendix 7 The Methotrexate Nurse Training Questionnaire 
 
1.  Do you advise/educate patients with respect to starting Methotrexate treatment? 
 
   Yes □  No □ 
 
2.  How many patients on average do you advise/educate per week? 
 
  1-4  
 




  Over 15  
 
3.  How long have you been doing this?  
 
  0-6 months  
 
  6-12 months  
 
  1-5 years 
 
  Over 5 years 
 
4. Would you describe yourself as a Rheumatology nurse specialist?        
  Yes □  No □ 
 
If NO what is your role? 
             
             
              
If YES how many years have you worked in Rheumatology? 
             
             
              
 
 
5. What year did you qualify? 
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No training  □  Some training  □  A lot of training  □ 
 
Please describe any training you had:  
             
             
             
             
              
    
7. If you had training, how helpful was it?  
(Please circle your answer) 
 
No help  □ Some help  □ Moderately helpful  □ Very helpful  □ 
 
 
8. Would you have liked more training?  YES  NO 
  Yes □  No □ 
 
If YES what kind of training would you have liked? 
             
             
             
             
     
9.  How confident are you at educating and advising patients on Methotrexate? 
 
Not at all   Somewhat  Confident  Very confident 
confident  confident 
     □      □       □   □ 
 
10. Has the way you advise patients changed from when you started? 
 
A lot □  In some ways □   Not at all □ 
 
Please describe: 
             
             
             
              
 
11. How long did it take you to become confident at advising patients about Methotrexate? 
 
  0-2 months  
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  6-12 months 
 
  Over 1 year 
 
12.  What training do you think nurses need to educate patients about Methotrexate?  
 
Communication skills: 
None □  A little  □  Some □  A lot □ 
 
Consultation skills: 
None □  A little  □  Some □  A lot □ 
 
Knowledge: 
None □  A little  □  Some □  A lot □ 
 
Experience: 
None □  A little  □  Some □  A lot □ 
 
Other             
             
             
              
 
13.  What written information do you use when educating patients about Methotrexate? (please tick all that 
apply) 
 
□  In house information leaflet 
□  ARUK leaflet 
□  NRAS 
□  Other, please state below 
             
             
             
              
 
14.  How useful is the written information you use? 
 
Not useful □ A little useful □  Quite useful □  Very useful □ 
 
 
15. Methotrexate is used to treat which of the following conditions? (There may be more than one answer, please tick 
all that apply) 
 □ Osteomalacia 
 □ Rheumatoid Arthritis 
 □ Psoriatic Arthritis 
 □ Vasculitis 
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16. A 61 year old man with RA for 7 years is going on holiday.  He normally takes Methotrexate 20 mg weekly, folic acid 
5 mg weekly, and atenolol 50mg daily for hypertension. Which of the following vaccinations should this patient NOT 
have? 
 
 □ Flu Vaccination 
 □ Tetanus 
 □ Yellow Fever 
 □ All of the above 
 
17.  A 45 year old lady with RA for 7 years arrives at clinic complaining that she has been very breathless for the last 
couple of days. She has been taking her treatment as usual which comprises Methotrexate 15mg weekly, folic acid 5mg 
weekly, sulfasalazine 2g daily, and cocodamol prn.  Do you: 
 
 □ Tell her to go to her GP as you suspect a chest infection 
 □ Tell her to increase her Folic Acid  
 □ Stop the drug and refer to a Rheumatologist 
□ Tell her not to worry as this is normal whilst on Methotrexate 
 
18.  A 72 year old lady with RA for 22 years is normally treated with Methotrexate 20mg weekly, folic acid 5mg daily, 
ramipril 2.5mg daily and atorvastatin. She is about to start antibiotics for cellulitis.   Which of the following antibiotics 
should she avoid? 
 
 □ Amoxycillin 
 □ Erythromycin 
 □ Flucloxacillin 
 □ Trimethoprim 
 
 
19. A 76 year old lady with RA for 15 years, normally treated with Methotrexate 20mg weekly, folic acid 5mg daily, 
bendroflumethiazide 2.5mg daily and atorvastatin, has suspected pyelonephritis and is to start treatment with 
Kefalexin.  What advice would you give regarding the Methotrexate? 
 
□ Carry on taking the Methotrexate but to drink more water 
□ Reduce the dose of Methotrexate until the infection has cleared 
□ Increase the dose of folic acid 
□ Stop the Methotrexate until the infection has cleared 
 
20. A previously fit 60 year old man with recently diagnosed RA is to start combination treatment with 
Methotrexate and hydroxychloroquine. He asks you whether he can continue to drink alcohol when he commences 
Methotrexate. Do you advise him: 
 
□ That it is safe to drink alcohol 
□ That he should not drink any alcohol 
□ To keep to the governments recommended amount of 21 units a week 
□ To limit his alcohol intake to no more than 4 units a week 
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21.  A 25 year old woman has a 3 year history of RA treated with Methotrexate 15mg weekly, sulfasalazine 2g 
daily and folic acid 5mg weekly. She and her partner wish to try for a family.  For how long should the patient stop 
Methotrexate before attempting to conceive? 
 
□ 2 weeks 
□ 2 months 
□ 3 months 
□ 6 months 
 
22.  A 30 year old man with RA for 6 years, treated with Methotrexate 20mg weekly and weekly folic acid, mentions he 
and his partner have decide to start a family.  He asks whether there is any advice with respect to taking his 
Methotrexate while they try to conceive. What do you advise? 
 
 □ No specific action regarding his treatment is required 
□ He should stop the Methotrexate for 2 weeks prior to them trying to conceive 
□ He should stop the Methotrexate for 2 months prior to them trying to conceive 
□ He should stop the Methotrexate for 3 months prior to them trying to conceive 
□ He should stop the Methotrexate for 6 months prior to them trying  
      to conceive 
 
23.  A 36 year old woman has had Rheumatoid Arthritis for 5 years.  She is currently treated with oral Prednisolone 
5mg/day; Methotrexate 20mg/week; Sulfasalazine 2 g/day and Folic Acid 5mg/week.  She attends your monitoring 
clinic concerned that she has been told by her GP that she has shingles affecting her left upper limb. State whether 
each of the following statements is true or false. 
 
a) Anyone can catch shingles from an infected person 
 
b) People are at risk of developing chicken pox from 
     contact with a person who has shingles. 
 
c) A person with a past history of chicken pox is 
 unlikely to catch shingles from an infected person 
 
d)  Shingles can be more severe in patients taking  
Methotrexate and Steroids 
 
5. Chicken Pox can be more severe in patients taking Methotrexate and Steroids 
 
24. A 56 year old man with a 10 year history of Rheumatoid Arthritis attends the monitoring clinic.  He is taking 
Methotrexate 15mg/week sc; Folic Acid 5mg 6 days/week; Hydroxychloroquine sulphate 200mg/day, Naproxen 250mg 






















June 1st 13.2 5.4 212 85 56 46 21 35 25 
July 1st 12.9 5.8 256 87 85 50 14 39 28 
Aug 1st 13.0 5.2 220 84 140 96 17 34 30 
True    False 
True    False 
True   False 
True   False 
True   False 
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Which drug is most likely to be a cause of the abnormality which has developed in the patient’s results? 
 
 1. Methotrexate 
 2. Hydroxychloroquine 
 3. Naproxen 
 4. Atenolol 
 5. Folic Acid 
 
25. A 56 year old man with a 10 year history of Rheumatoid Arthritis attends the monitoring clinic.  He is taking 
Methotrexate 15mg/week sc; Folic Acid 5mg 6 days/week; Hydroxychloroquine sulphate 200mg/day, Naproxen 250mg 






















June 1st 13.2 5.4 212 82 35 15 21 36 25 
July 1st 11.9 5.8 350 70 45 36 14 39 28 
Aug 1st 10.0 5.2 436 65 37 42 17 37 30 
Which drug is most likely to be a cause of the abnormality which has developed in the patient’s results? 
 
 1. Methotrexate 
 2. Hydroxychloroquine 
 3. Naproxen 
 4. Atenolol 
 5. Folic Acid 
 
26. A 76 year old woman with longstanding Rheumatoid Arthritis attends clinic.  Her treatment comprises 
Methotrexate 10mg/week; Folic Acid 5mg/week; Simvastatin 40mg/day and Ramipril 5mg/day. 
Urine dipstick testing show: 
 
Leucocytes Protein Nitrites Glucose 
++ Trace Positive Negative 
 
What course of action would you take? 
 
 1. Arrange an MSU 
 2. Stop Methotrexate 
 3. Start Amoxicillin 
 4. Refer to the patient’s GP 
 5. Refer to the Rheumatologist 
 
27.   Do you have any other comments? 
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Appendix 8 Ethics Approval for Phase I and Phase II 
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Appendix 9 Northumbria Healthcare NHS Foundation Trust R&D Approval for Phase 
I and Phase II 
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Appendix 10 Nurse Responses to the Way Nurses Change the Way They Give 
Information to Patients over Time 
 
in the language used in a consultation and tailoring to the pt needs 
The drug therapy is now licensed and storage in a fridge is no longer required. 
 Long shelf life Patients encouraged to administer their own injections. Previously had a set Methotrexate 
clinic. 
you gain experience through other patient's experiences and that enhances you knowledge and can enhance 
your education of the drug and leads to an enhanced counselling for the patient  
I use the purple Methotrexate booklet to guide most of the patient education.   
Then supplement this with facts about efficacy and risks as i have gained more education.  
 I have also used examples reported by patients and am developing a visual aid to demonstrate safety for 
patients who are unsure about commencing treatment based upon research papers looking at the safety 
profile of MTX 
More knowledgeable in pharmacology of MTX, side effects, monitoring and results.  More confident in dealing 
with 'non-compliant' patient. 
With experience come confidence 
give short bursts of information each visit rather than trying to cover everything in one go 
Patient empowerment therapies Educational /communication initiatives to improve compliance 
after my own research and observing other practice i have gained in knowledge and in confidence.  
I was initially not confident at all, but over the years my knowledge and experience has grown which has 
changed the way I feel. 
Guidelines change so need to keep up to date.  My confidence in the information I deliver  Initially, I was 
constantly referring to the RCN guidelines.  
I only see these patients in a small capacity as part of a more generalized role. I would say less than 6 per 
year 
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The way we use MTX now is different re dose increases being 5mg instead of 2.5mg 
   
I am more aware of risks associated with MTX and use the NPSA booklet with every prescription, ensuring the 
patient reads it though fully before they start. We also have a stamp that we use in the notes to list discussion 
around fertility, side effects, consent, monitoring etc. 
MORE KNOWLEDGEABLE AND CONFIDENT IN EDUCATING PATIENTS 
Use a lot more s/c Methotrexate now, also monitoring guidelines etc have changed  
Patients need to be educated about their disease first before MTX. Through this one provides the patient with 
a sound rationale for taking MTX.  
If they are convinced of the need patients will take on board the information more carefully. 
Yes. Patients are more likely to come to clinic armed with questions so its not just about talking to patients but 
about answering their concerns 
Written information provided to patients has changed Blood test frequency reduced. Changes to advice given 
alters as latest research is produced 
 e.g. Side effect profile  
I repeat important messages. I don't use written prompts anymore.  I feel more confident to answer any 
questions that arise   
Because I have experience of using MTX and know that it is a good drug I feel that I sell it better! 
The more experience I get the more confident I become. Also, completing the non-medical prescribing course 
a few years ago forced me to look further into the pharmacology aspect of Methotrexate.  
We now keep clear checklist records which are signed as a record of exactly what information we gave to the 
patient, and what their blood tests  
and chest x-ray results were at the time of starting. I guess careful documentation becomes more and more 
important over time.  
Changed with experience and became more confident, not what needed to be said but perhaps the delivery of 
the information.  Having done it a few times I can adapt what I say more to the individual 
a lot more structure    We have a proforma to follow as to what education all pt have to have had 
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More relaxed.  Emphasize the positive.  More familiar with tx  
Give information in stages.  Check at each visit that the patient has remembered what has been said 
I have changed my practice in some ways through learning from experience. If it works well with 1 patient, 
adapt and develop. Also useful to use articles from NRAS news as well as ARUK leaflets.  
Able to signpost patients where they can gain more information i.e. arthritis helplines or talking to another 
patient who is already taking it. 
From a dedicated session for counselling - 1 hour, now put into "normal" clinic for 30 mins only, as  we are 
shunted into private health care this may reduce even further as our workloads are increased but time allowed 
isn't.  With greater understanding and data available on the disease process and drug itself i have updated my 
education use the AR UK leaflets to go through, introduced packs with everything in needed for the patients to 
start Methotrexate. 
more flexible in my approach - able to work with the patients agenda rather than my own.  
Able to discuss in depth the details required by the patient and I am aware of up to date research and 
guidance to enable the patient to make an informed choice regarding their care.  Consistent in the quality of 
information given now.  Improved records of education sessions in patient notes. 
From when I started in Rheumatology 20years ago much has changed !!!, including the use of Methotrexate 
and education.    
 Knowing much more about history taking, diagnosis and it's importance per se; about the conditions such as 
RA, PsA etc ; the rationale for use of Methotrexate (MTX), it's mode/mechanism of action, the drugs' potential 
side-effects, use of Folic Acid, patient safety issues and guidance’s and monitoring, drug 
interactions/concomitant medications, screening, BSR/NICE/treat to target  
recommendations etc has undoubtedly changed the way and what I advise patients re: MTX. 
I update the information to reflect any new advice or research. I also read extensively to gain any useful 
information from other sources that would be helpful to pass on to patients 
Methotrexate was introduced with great caution within Rheumatology. Dosage was not escalated as it is 
today. We now treat much more aggressively and therefore when educating patients, patients are informed as 
to the benefits of treating aggressively and the use of Methotrexate alongside other drug regimens which can 
benefit the outcome / prognosis of their disease depends on the client. if rheum Specialist Nurse has given 
any updated information it is then incorporated into patient education. 
confidence comes with experience, 
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I have read extensively since joining my trust. I have managed to increase my knowledge in preparing 
patients for using MTX as a result. I have become more confident and competent, as my understanding and 
experience has grown. Im learning more about the drug and how it affects different people both good and 
pass, so I can pass this on I have learned from feedback from patients, fellow practitioners and patient support 
groups some helpful hints and how they experience taking Methotrexate. 
Yes, as I got more confident, I adapt to pts individually and write details into the Methotrexate monitoring 
booklet which was introduced in 2006 to help pt understanding.  This is a new role for me and I am still very 
much a novice Specialist Nurse within Rheumatology. I have only educated a very small number of patients 
on Methotrexate so far. The first time I felt very nervous and unsure of myself. I haven't seen enough patients 
to build on my confidence yet.    
 It is difficult to answer question 13 below as I have been in my role for less than 12 months. Therefore, I will 
have to answer that it took me over 1 year to become confident (as I think it probably will take that long).  I use 
to start mtx in low dose and increasing slowly, now pt are able to start at much high dose with close 
monitoring. I can explain how it works possible side effects, blood monitoring and results  I am more inclined 
to adapt what I say to the patients needs.  I am less like to try and persuade someone who does not want 
treatment but give them all the facts and bring them back to discuss it further. 
The education is more formal and we now use a check list that we sign and get the patient to sign ensuring 
that they have been well informed and making sure that any questions they may have been answered a lot 
more information, clinical trial evidence,  educational events/study days, overall  experience, networking with 
other nurses,  
I feel very confident and can draw on past experience and patient stories to aid education 
the drug therapy is now licensed unlicensed when i started pts were not allowed to administer their own a 
Methotrexate clinic was the norm for a long time. Hospital attendance a must.  I have more knowledge and 
understanding of the drug and its actions, more time allocated in clinics for education 
I've got more experience in educating patients and have more confidence in my role 
When I started I was ward based so many changes have occurred over the last 20 years, growing in 
confidence the more often you see patients, learning from colleagues initially but now after such a long time 
and also being an independent prescriber I am quite confident in my approach to counselling.  
I have only worked in this department, so I am still in the learning phase, however the way i advise patients 
had changed as my confidence and knowledge base increases. Knowledge gained from feed back from 
patients can be passed on to other patients. Have become more confident as my knowledge has improved as 
my knowledge increased and my confidence grew I found it easier to answer basic questions am now using a 
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lot of motivational interviewing techniques to help patients understand the need for Methotrexate.  I use a lot 
of my own experience and confidence in teaching patients about Methotrexate. 
As I have gained experience my knowledge base has grown 
As information on the drug changes or develops so does the education. 
I am now more confident and have more knowledge about DMARDs, inflammatory conditions and interpreting 
blood results. The way Methotrexate is stored is different so we advise the patients about this. (At room 
temperature). The syringes are now prefilled and the needles are attached and the service is audited with 
pharmacy who send out periodical questionnaires   
We have a home delivery service so more emphasis is placed on data protection as they are outside 
contractors. Storage safety and disposal of cytotoxic waste is explained in more detail as the home delivery 
service collect some sharps boxes.  We give an information booklet to the patients on home delivery with 
contact numbers of the coordinator from home delivery and our contact number 
Able to summarise key points to remember.  Eg infections.  Through experience more able to describe the 
positive benefits of Methotrexate. As my knowledge has increased I have been able to give patients more 
detailed advice. The more experience I have working with patients on MTX has helped my knowledge base, 
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A STUDY OF THE LEARNING NEEDS OF NURSES EDUCATING PATIENTS STARTING 
METHOTREXATE 
NURSE Information sheet and Consent form 
 
Protocol Number: 1.0 
Title: A STUDY OF THE LEARNING NEEDS OF NURSES EDUCATING PATIENTS 
STARTING METHOTREXATE 
 
Sponsor Northumbria Healthcare NHS Foundation trust 
Name of Institution: Northumbria Healthcare NHS Foundation Trust 
Address: North Tyneside General Hospital,  Rake Lane, North 
Shields, Tyne & Wear NE29 8NH 
Name of Participant:    
 (Last) (First) (Title) 
 
Invitation to participate in the study 
We would like to invite you to take part in a research study.  
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What is the purpose of the study? 
The purpose of this study is to identify the learning needs of nurses who educate patients prior to 
the commencement of Methotrexate. 
Why have I been invited? 
You have been chosen as a possible participant because you educated patients starting 
Methotrexate for the first time. 
 
Do I have to take part? 
Taking part in this study is entirely voluntary and if you decide to take part, you can withdraw your 
consent regarding the use and disclosure of your health information and leave the study at any 
time.  
What will happen to me if I take part? 
The study involves doing a semi-structured interview with nurses who educate patients starting 
Methotrexate. The interview will be audio-recorded but no identifiable information will be used, we 
will refer to you as either a study number or use a pseudonym. We would also like to video record 
the consultation process between the nurse and the patient who is receiving Methotrexate 
education.  If you decide to take part in this part of the study, you will be asked for your consent 
twice before the recording and you will have the opportunity to withdraw your consent for us to use 
your video recording after 48 hours, when one of the study team will telephone you to confirm your 
continued consent.   We will invite you to be interviewed by a member of the study team.  This 
interview will involve looking at excerpts from your video and asking for your views and feelings 
about the education session.  The interview will be audio recorded and we will ask for your consent 
before we start the interview.  This interview should take approximately 30 minutes. The interview 
will then be transcribed but we will delete any personal references to you or use a pseudonym if 
necessary. 
Expenses and payment 
You will not be paid to participate in this research study. 
What will I have to do? 
All you have to do is give your consent for the study team to audio record a semi-structure interview 
with you and/or video record the education interaction between you and the patient.  
What are the possible disadvantages and risks of taking part? 
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As this is an observational study, with no procedures being performed (apart from being video 
recorded) there are no foreseen risks or side effects from taking part in the study itself. 
You may feel uncomfortable being video recorded, and if this does occur, you may indicate this to 
the study team who will stop the recording immediately.  You may withdraw your consent and the 
video recording will be destroyed. 
What are the benefits of participating in this study? 
The data collected during this study will help to improve knowledge and understanding of the needs 
of nurses educating patients who are starting Methotrexate. 
The information gained from this study may help us to better assess the educational needs of 
nurses which, in the future, which could result in better education provision for nurses and therefore 
improved overall health care for patients suffering from RA. 
 
 
What if there is a problem? 
In the unlikely event that unprofessional behaviour, dangerous practice or poor education is 
observed the study team will be available to facilitate the resolution of any problems that we can 
help with.  We will seek further advice if we think you require more support or in the unlikely event 
that we feel this could be unsafe to patients we will be required to inform your line manager. 
If you have a concern about any aspect of the study, you should speak with the study team who will 
do their best to answer your questions.  Contact details can be found at the end of this information 
sheet. If you remain unhappy and wish to formally complain, you can do this through the NHS 
Complaints Procedure. Details can be obtained from the hospital.  
What will happen if I don't want to carry on with the study? 
If you agree to take part in this study and later change your mind, you are free to withdraw your 
consent and discontinue your participation at any time.  
We may withdraw you from the study without your consent for one or more of the following reasons: 
 The study is cancelled. 
 Unanticipated circumstances. 
 
Will my taking part in this study be kept confidential? 
     
354 
Yes. All the information about you participation in this study will be kept confidential.  
You have a right to privacy and all information obtained will be treated as confidential to the limit 
possible by the law.  For the purposes of this study you will be identified by a pseudonym.  In this 
way, if information from the study is submitted to health authorities or published, your name will not 
appear and your identity will remain confidential.   
What will happen to the results of the study? 
Your data will be analyzed by the study team. Certain statistical tests will be carried out on your 
data, along with that collected from the other patients who entered the study. The results may be 
used in the report of the study or for scientific presentations or publications.  You will not be 
identified by name in any study results. Your doctor will be advised of the results of the study which 
he can then share with you at your request. 
Who is organizing and funding the research? 
This study is sponsored by Northumbria Healthcare NHS Foundation Trust and is under the 
direction of Dr David Walker and research staff. This study has been approved by the Research 
and Development department who ensures that the rights of people taking part in clinical studies 
are protected at Northumbria Healthcare NHS Foundation Trust   
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a Research Ethics 
Committee to protect your safety, rights, wellbeing and dignity. This study has been reviewed and 
given favourable opinion by the Sunderland Research Ethics Committee. 
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Questions about the study  
You can ask your study doctor if you have any questions about the study. 
Contact information:   
Name: Dr David Walker, Department of Rheumatology - Phone: 08448118111 
or Miss Sandra Robinson, Research & Development Department - Phone: 0191 2934322 
Address: North Tyneside General Hospital, Rake Lane. North Shields, Tyne & Wear. NE29 
8NH 
You will be given a copy of this information sheet and a signed consent form to keep. 
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 Study Number:  
NURSE CONSENT FORM FOR VIDEO RECORDING A CONSULTATION 
Title of study: A Study of the Effectiveness of Nurse Education of Patients Taking 
Methotrexate. 
Name of Researcher:________________________________________________ 
 
Please initial box 
 
        
1. I confirm that I have read and understand the information sheet 
dated (11th March 2013 V1.1) for the above study and have had the 
opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason and I understand 
that any data that have been collected up to the point of my 
withdrawal from the study may continue to be used.  
 
3. I agree to a member of the study team contacting me in 48 hours to 
determine my continued consent to participate in this study. 
 
 
4. I agree to be interviewed at a time which is convenient to me.  This 
interview will be audio-taped and transcribed and will be used for 
research and education.  All indications to my identity will be 
removed and a pseudonym will be used if necessary. 
 
5. I agree that the information generated from my participation in the 
study may be processed, stored and used for research purposes. 
 
 
6. I understand that if I have any questions relating to my participation 
in this study, I may contact the study team. 
 
7. I agree to take part in the above study.  
   
   
   
 
   
   
   
     
357 
 
_________________________ ____________ _________________ __ 
Name of Patient Date                             Signature 
 
_________________________ ____________          _____________________ 
Name of Person taking consent Date                             Signature     



















Statement of the Nurse – please read carefully 
I understand the reason why the video recording is being taken. 
I understand the benefits and risks as described to me by the Study Team. 
I understand I can change my mind at any time BUT if recordings are released for 






 Consent 1 – 15 - 30 minutes pre-recording 





Signature ………………………………………………….…... Date ……../……../…….. 
(patient or in case of minor, legal guardian) 
 Consent 2 – At time of recording 
I consent to being video recorded and this recording to be used for teaching and 
research. 
 
Signature ………………………………………………….…... Date ……../……../…….. 
(patient or in case of minor, legal guardian) 
 
 Statement of responsible Healthcare Professional 
I have explained to the nurse the reason for taking the video recording. 
 
I have explained the benefits and risks of making the recording. 
 
 
Print name …………………………………….. Dept ……………………………………. 
 
Signature ………………………………………. Date ……../……../……………………. 
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Senior Nurse Researcher 
North Tyneside Hospital 
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1. Background 
It is essential before commencing any drug for the patient to understand what the expected 
benefit is, how that will manifest and to know the risks of the intervention. Indeed this 
should be part of the decision to prescribe/take the medication. This is especially so for 
medications such as Methotrexate (MTX) where the effect is delayed and side effects are 
anticipated and monitored for. Education of patients prior to starting MTX occurs in all 
Rheumatology units across the country on a daily basis. The purpose of this education is to 
allow the patient to take the medication more safely and effectively than if it were not 
given. This includes concording with monitoring requirements. We have demonstrated that 
knowledge in longer term patients on MTX is deficient in some areas (Walker 2012) and 
nurses in our units have expressed lack of confidence in giving of this education and 
described a learning curve when they first started to perform this function. They describe 
taking time to gain both confidence and competence in drug counselling. This study plans to 
explore this educational interaction in terms of content, delivery and learning needs for 
nurses commencing this activity. The purpose is to inform the content of an educational 
package for the nurse which will make more effective use of their time. 
A patient information leaflet for MTX has been produced by ARUK (ARUK 2012). This has 
been written by experts in the area and contains the important information patients need to 
be aware of prior to commencing MTX. It is used extensively across the country and the 
content accepted as appropriate. This forms the basis for patient education in many units. 
The literature on the effectiveness of education is largely on change of knowledge with 
change of behaviour being more difficult to show. Patients with higher educational 
achievement do however have a better outcome of their RA (Pincus 1985). For patient 
education about drugs, it has been shown that one to one education results in better 
adherence (Hill 2001) and that they are more likely to take a drug if they understand the 
purpose of the prescription (Arluke 1983). How patients wish to receive information, and 
where from, has been studied in Ankylosing Spondylitis in an ARUK study (Thompson 2010). 
The main findings were that patients wish to have information at times of change in their 
condition. This would include times of changing drugs as with commencing Methotrexate 
therapy. The other time they wish to have information is when their clinical condition 
changes, usually for the worse ie at times of crisis. 
Confidence of nurses giving education 
We have been able to identify only one study in the Rheumatology literature on this topic. 
This was a survey by the Royal College of Nursing (2009) of Rheumatology Specialist nurses, 
exploring the performance, activity and confidence of Rheumatology Specialist nurses. Two 
hundred and fifty Rheumatology Specialist nurses, of a variety of different bands (ie working 
at different levels: Staff Nurses; Sisters and Nurse specialists), were surveyed. When asked 
about their confidence in counselling a patient starting treatment with Methotrexate, 73% 
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were very confident ie 27% were less than very confident. It was not clear how this 
confidence related to seniority and experience. Sixty percent were very confident in dealing 
with side effects related to anti-rheumatic drugs. Similarly, 60% were confident about 
educating patients to manage their own disease. A substantial minority of these nurses 
were, therefore, not very confident in what we would regard as core specialist nursing 
activities. 
This survey measured “perceived” confidence not actual confidence, knowledge and 
certainly not competence. There was no patient perspective to this survey so we do not 
know how these educational events are received or how meaningful they are to the 
patients. In this same survey over 70% of the nurses stated that  
a) education regarding drug treatment and  
b) education regarding the disease and its management was a major part of their role. 
From the broader literature, there are studies showing some evidence that educational 
interventions can increase nurses’ confidence, knowledge and competence. In a study in 
mental health (Payne 2002), confidence increased in mental health nurses who received 
mental health training. The nurses were more confident and positive in treating depressed 
patients. In a study in palliative care (Shipman 2008), there was a statistically significant 
increase in confidence in palliative care competency and knowledge after participation in an 
education programme. Similarly, in the treatment of alcohol abuse, there was a statistically 
significant positive change in nurse confidence levels after a 4 hour educational intervention 
(Vadlamundi 2008). There is therefore reasonable evidence that the sort of educational 
package that this study is designed to inform may be beneficial. 
2. Aims and Objectives 
1) To assess the learning needs of nurses who deliver Methotrexate               education to 
patients, firstly through a broad national questionnaire of such nurses and  
2)  Secondly through more detailed interviews with nurses of varying experience of this 
counselling. 
3. Detailed Plan of Project 
3.1 Introduction 
The focus of this study will be on identifying learning needs of nurses who educate patients 
prior to the commencement of Methotrexate. A pilot study of videoing such consultations 
will also be undertaken. This will be achieved through a 2 phase study consisting of a 
specifically developed national questionnaire, semi-structured interview of nurses of varying 
experience and pilot study of videoing consultations. 
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Following the mentoring process, the validation of the Methotrexate knowledge 
questionnaire (MKQ) has been shelved in favour of a national questionnaire of nurses. The 
focus will be on identifying learning needs through this and the qualitative interviews. 
The interviews would provide detailed information on how both participants felt about the 
interaction with the patient.  
3.2 Phase 1  
National survey of nurses involved in delivery of patient education prior to commencing 
Methotrexate (MTX). 
A questionnaire which has been specifically developed for nurses performing this role will 
seek information about the role they have; the training they had prior to commencing it; the 
evolution of their skills and the perceived learning needs for themselves and new nurses. 
This has been developed with case scenarios to identify the areas that nurses are less 
confident in e.g. what action would you propose if a patient has a chest infection etc. This 
approach measures knowledge and will give us broad high number data that will 
complement the more detailed information that we will get from the qualitative phase of 
this project. The clinical scenarios will help to identify the specific areas where there is a 
deficit in knowledge skills and confidence. Clinical scenarios are likely to include: Nausea; 
breathlessness; vaccinations: blood abnormalities and alcohol use. 
The questionnaire will be available online and as a paper copy. It will be available to any 
nurse who performs a Methotrexate information giving role with patients, from the most 
junior and inexperienced to the most senior and most experienced. 
The questionnaire will be circulated throughout the UK through the membership of the 
Royal College of Nursing (RCN) Rheumatology Forum which includes Rheumatology 
Specialist nurses with a range of experience and seniority. The recruitment target is 80 – 100 
completed returned questionnaires to represent the breadth of nurse experience and 
opinion. If there is less response then we will recruit individual nurses through fora such as 
the RA special interest group of the British Healthcare Professionals in Rheumatology 
(BHPR). 
The results will be analysed quantitatively and qualitatively as appropriate to provide up to 
date information on the confidence; training and educational needs of nurses performing 
this task. It will also give us some indication of knowledge. 
3.3 Phase 2  
Qualitative interviews with nurses who perform this role 
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This is a qualitative study that will take place in Newcastle/North Tyneside and Stoke. 
Nurses willing to take part will be recruited in both centres. It is planned to recruit 3 nurses 
in two of the study centres, one nurse who has only recently started counselling for 
Methotrexate and two nurses who have been counselling longer. Semi-structured 
interviews of 40 to 60 minutes are planned. An interview schedule has been developed to 
explore in detail the training received prior to starting this function; the experience of 
delivering it; the evolution of confidence and exploration of experiences. Interviews will be 
recorded and transcribed verbatim for analysis. Interview data will be analysed using 
thematic analysis.  This is a well recognised method which seeks to identify themes arising 
from the data. 
4. Recruitment Procedures 
4.1 Phase 1 Recruitment 
The questionnaire will be available to any nurse who performs a Methotrexate information 
giving role with patients. We are keen to get a full cross section of nurses from the most 
junior and inexperienced to the most senior and most experienced.  
We will identify interested nurses in as many Rheumatology units across the country as 
possible. We will circulate the membership of the RCN Rheumatology Forum which includes 
Rheumatology Specialist nurses with a range of experience and seniority. This should 
produce 80 to 100 responses. This should be sufficient to represent the breadth of nurse 
experience and opinion. If there is less response then we will recruit individual nurses 
through forum such as the RA special interest group of the BHPR. 
4. Phase 2 Recruitment 
Nurses will be identified by the Principal Investigators at two Rheumatology centres.  These 
nurses will be given the staff information leaflet to read before they make a decision to take 
part in the study.  Permission from outpatients’ managers will also be sought before any 
procedures take place.   
5. Adverse Event Reporting 
5.1 Adverse Events 
For all adverse events, the investigator must pursue and obtain information adequate both 
to determine the outcome of the adverse event and to assess whether it meets the criteria 
for classification as a serious adverse event (see Section 5.5) requiring immediate 
notification to the Chief Investigator.  For all adverse events, sufficient information will be 
obtained by the investigator to determine the causality of the adverse event.  The 
investigator is required to assess causality.  For adverse events with a causal relationship to 
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the treatment product, follow-up by the investigator will be carried out until the event or its 
sequelae resolve or stabilize at a level acceptable to the Chief Investigator. 
5.2 Reporting Period 
Serious adverse events require immediate notification to the Chief Investigator beginning 
from the time that the subject provides informed consent, which is obtained prior to the 
subject’s participation in the trial, i.e. prior to undergoing any trial-related procedure and/or 
receiving and medication, through to and including 28 calendar days after the last 
administration of the trial medication.  Any serious adverse event occurring any time after 
the reporting period must be promptly reported if a causal relationship to the study 
medication is suspected. 
 Adverse events (serious and non-serious) should be recorded in the CRF from the 
time the subject has taken at least 1 dose of study medication through to the last 
subject visit. 
 
5.3 Definition of an Adverse Event 
An adverse event is any untoward medical occurrence in a clinical investigation subject 
administered a product or medical device; the event need not necessarily have a causal 
relationship with the treatment or usage.  Examples of adverse events include but are not 
limited to: 
 Abnormal test findings; 
 Clinically significant symptoms and signs; 
 Changes in physical examination findings; 
 Hypersensitivity; 
 Progression/worsening of underlying disease. 
Additionally, they may include the signs or symptoms resulting from: 
 Drug overdose; 
 Drug withdrawal; 
 Drug abuse; 
 Drug misuse; 
 Drug interactions; 
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 Drug dependency. 
 
5.4 Abnormal Test Findings 
The criteria for determining whether an abnormal objective test finding should be reported 
as an adverse event are as follows: 
 Test result is associated with accompanying symptoms, and/or 
 Test result requires additional diagnostic testing or medical/surgical intervention, 
and/or 
 Test result leads to a change in trial dosing or discontinuation from the trial, 
significant additional concomitant drug treatment, or other therapy, and/or 
 Test result is considered to be an adverse event by the Chief Investigator. 
Merely repeating an abnormal test, in the absence of any of the above conditions, does not 
constitute an adverse event.  Any abnormal test result that is determined to be an error 
does not require reporting as an adverse event. 
 
 
5.5 Serious Adverse Events 
A serious adverse event or serious adverse drug reaction is any untoward medical 
occurrence at any dose that: 
 Results in death; 
 Is life-threatening (immediate risk of death); 
 Requires inpatient hospitalization or prolongation of existing hospitalization; 
 Results in persistent or significant disability/incapacity. 
Medical and scientific judgment should be exercised in determining whether an event is an 
important medical event.  An important medical event may not be immediately life-
threatening and/or result in death or hospitalization.  However, if it is determined that the 
event may jeopardize the subject and may require intervention to prevent one of the other 
outcomes listed in the definition above, the important medical event should be reported as 
serious. 
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Examples of such events are intensive treatment in an emergency room or at home for 
allergic bronchospasm; blood dyscrasias or convulsions that do not result in hospitalization; 
or development of drug dependency or drug abuse. 
5.6 Hospitalization 
Adverse events reported from clinical trials associated with hospitalization or prolongation 
of hospitalization is considered serious.  Any initial admission (even if less than 14 hours) to 
a healthcare facility meets these criteria.  Admission also includes transfer within the 
hospital to an acute/intensive care unit (e.g. from the psychiatric wing to a medical floor, 
medical floor to a coronary care unit, neurological floor to a tuberculosis unit). 
Hospitalization does not include the following: 
 Rehabilitation facilities; 
 Hospice facilities; 
 Respite care (e.g. care giver relief); 
 Skilled nursing facilities; 
 Nursing Homes; 
 Routine emergency room admissions; 
 Same day surgeries (as outpatient/same day/ambulatory procedures). 
Hospitalization or prolongation of hospitalization in the absence of a precipitating, clinical 
adverse event is not in itself a serious adverse event.  Examples include: 
 Admission for treatment of a pre-existing condition not associated with the 
development of a new adverse event or with a worsening of the pre-existing 
condition (e.g. for work-up of persistent pre-treatment lab abnormality); 
 Social admission (e.g. the subject has no place to sleep); 
 Administrative admission (e.g. for yearly physical examination); 
 Protocol-specified admission during a clinical trial (e.g. for a procedure required by 
the trial protocol); 
 Optional admission not associated with a precipitating clinical adverse event (e.g. 
for elective cosmetic surgery); 
 Pre-planned treatments or surgical procedures should be noted in the baseline 
documentation for the entire protocol and/or for the individual subject. 
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Diagnostic and therapeutic non-invasive and invasive procedures, such as surgery, should 
not be reported as adverse events.  However, the medical condition for which the 
procedure was performed should be reported if it meets the definition of an adverse event.  
For example, an acute appendicitis that begins during the adverse event reporting period 
should be reported as the adverse event, and the resulting appendectomy should be 
recorded as treatment of the adverse event. 
5.7 Severity Assessment 
If required on the adverse event case report forms, the investigator will use the 
adjectives MILD, MODERATE or SEVERE to describe the maximum intensity of the 
adverse event.  For purposes of consistency, these intensity grades are defined as 
follows:  
MILD Does not interfere with the subject’s usual function. 
MODERATE Interferes to some extent with the subject’s usual function. 
SEVERE Interferes significantly with the subject’s usual function. 
 
Note the distinction between the severity and the seriousness of an adverse event.  A 
severe event is not necessarily a serious event.  For example, a headache may be severe 
(interferes significantly with the subject’s usual function) but would not be classified as 
serious unless it met one of the criteria for serious adverse events, listed above. 
5.8 Causality Assessment 
The investigator’s assessment of causality must be provided for all adverse events (serious 
and non-serious).  An investigator’s causality assessment is the determination of whether 
there exists a reasonable possibility that the investigational product caused or contributed 
to an adverse event.  If the investigator’s final determination of causality in unknown and 
the investigator does not know whether or not the study medication caused the event, then 
the event will be handled as “related to the study medication” for reporting purposes.  If the 
investigator’s causality assessment is “unknown but not related to the study medication”, 
this should be clearly documented on the trial records. 
In addition, if the investigator determines a serious adverse event is associated with trial 
procedures, the investigator must record this causal relationship in the source documents 
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and CRF, as appropriate, and report such as assessment in accordance with the serious 
adverse event reporting requirements, if applicable. 
5.9   Withdrawal Due to Adverse Events 
Withdrawal due to adverse even should be distinguished from withdrawal due to 
insufficient response, according to the definition of adverse event noted earlier, and 
recorded in the appropriate adverse event CRF page. 
When a subject withdraws due to a serious adverse event, the serious adverse event must 
be reported in accordance with the reporting requirements defined below. 
5.10   Eliciting Adverse Event Information 
The investigator is to report all directly observed adverse events and all adverse events 
spontaneously reported by the trial subject.  In addition, each trial subject will be 
questioned about adverse events. 
5.11  Reporting Requirements 
Each adverse event is to be assessed to determine if it meets the criteria for serious adverse 
event.  If a serious adverse event occurs, expedited reporting will follow local and 
international regulations, as appropriate. 
All adverse events will be reported on the adverse events page(s) in the CRF.  It should be 
noted that the form for collection of serious adverse event information is not the same as 
the adverse event CRF.  Where the same data are collected, the forms must be competed in 
a consistent manner.  For example, the same adverse event term should be used on both 
forms.  Adverse events should be reported using concise medical terminology on the CRFs 
as well as on the form for collection of serious adverse event information. 
5.11.1 Serious Adverse Event Reporting Requirements 
If a serious adverse event occurs the Chief Investigator is to be notified within 24 hours of 
awareness of the event.  In particular, if the serious adverse event is fatal or life-
threatening, notification to the Chief Investigator must be made immediately, irrespective 
of the extent of available adverse event information.  The timeframe also applies to 
additional new information (follow-up) on previously forwarded serious adverse event 
reports. 
In the rare event that the investigator does not become aware of the occurrence of a 
serious adverse event immediately (e.g. if an outpatient trial subject initially seeks 
treatment elsewhere), the investigator is to report the event within 24 hours after learning 
of it and document the time of his/her first awareness of the adverse event.  For all serious 
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adverse events, the investigator is obliged to pursue and provide information to the Chief 
Investigator in accordance with the timeframes for reporting specified above.  In addition, 
the Chief Investigator may request specific additional follow-up information in an expedited 
fashion.  This information may be more detailed than that captured on the adverse event 
case report form.  In general, this will include a description of the adverse event in sufficient 
detail to allow for a complete medical assessment of the case and independent 
determination of possible causality.  Information on other possible causes of the event, such 
as concomitant medications and illnesses must be provided.  In the case of a subject death, 
a summary of available autopsy findings must be submitted as soon as possible to the Chief 
Investigator. 
5.11.2 Non-serious Adverse Event Reporting Requirements 
Non-serious adverse events are to be reported on the adverse event CRFs which are to be 
submitted to the Chief Investigator. 
6. Quality Control and Quality Assurance 
During the trial, periodic monitoring will ensure that the protocol and Good Clinical 
Practices (GCPs) are being followed.  Source documents will be reviewed to confirm that the 
data recorded on CRFs is accurate. 
The trial site may be subject to review by the IRB/IEC and/or to inspection by appropriate 
regulatory authorities. 
7.  Data Handling and Record Keeping 
7.1 Case Report Forms (CRF) 
As used in this protocol the term CRF should be understood to refer to a paper form data 
record.   
A CRF is required and should be completed for each included patient.  It is the investigator’s 
responsibility to ensure completion and to review and approve all CRFs.  CRFs must be 
signed by the investigator or by an authorized staff member.  These signatures serve to 
attest that the information contained on the CRFs is true.  At all times, the investigator has 
final personal responsibility for the accuracy and authenticity of all clinical and laboratory 
data entered on the CRFs.  Patient source documents are the physician’s patient records 
maintained at the trial site.  In most cases the source documents will be the hospital’s or the 
physician’s chart.  In cases where the source documents are the hospital or the physician’s 
chart, the information collected on the CRFs must match those charts. 
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In some cases, the CRF may also serve as the source document.  In these cases, the Chief 
Investigator must prospectively document which items will be recorded in the source 
documents and for which items the CRF will stand as the source document. 
7.2 Record Retention 
To enable evaluations and/or audits from regulatory authorities the investigator agrees to 
keep records, including the identity of all participating (sufficient information to link records, 
e.g. CRFs and hospital records), all original signed informed consent forms, copies of all 
CRFs, serious adverse event forms, source documents and detailed records of treatment 
disposition.  The records should be retained by the investigator according to International 
Conference on Harmonization (ACH), local regulations, or as specified in the Clinical Study 
Agreement, whichever is longer. 
8.  Communications and publicity 
 
Study results will be discussed in peer reviewed Journals. 
9.      ETHICS 
9.1 Institutional Review Board/Independent Ethics Committee 
It is the responsibility of the investigator to have prospective approval of the trial protocol, 
protocol amendments, informed consent forms and other relevant documents e.g. 
advertisements, if applicable, from the IRB/IEC.  All correspondence with the IRB/IEC should 
be retained in the Investigator File. 
The only circumstance in which an amendment may be initiated prior to IRB/IEC approval is 
where the change is necessary to eliminate apparent immediate hazards to the subjects. 
9.2 Ethical Conduct of the Trial 
The trial will be performed in accordance with the protocol, IHC GCP guidelines and 
applicable local regulatory requirements and laws. 
9.3 Subject Information and Consent 
The informed consent form must be agreed to by the Chief Investigator and the IRB/IEC and 
must be in compliance with ICH GCP, local regulatory requirements and legal requirements. 
The investigator must ensure that each trial patient, or his/her legally acceptable 
representative, is fully informed about the nature and objectives of the trial and possible 
risks associated with participation.  The investigator will obtain written informed consent 
from each patient or the patient’s legally acceptable representative before any trial-specific 
activity is performed.  The informed consent form used in this trial, and any changes made 
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during the course of the trial, must be prospectively approved by both the IRB/IEC and the 
Chief Investigator before use.  The investigator will retain the original of each patient’s 
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Appendix 13 Example of MIPs Coding Sheets 
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It is essential before commencing any drug for the patient to understand what the expected benefit 
is, how that will manifest and to know the risks of the intervention. Indeed this should be part of 
the decision to prescribe/take the medication. This is especially so for medications such as 
Methotrexate (MTX) where the effect is delayed and side effects are anticipated and monitored 
for. Education of patients prior to starting MTX occurs in all Rheumatology units across the country 
on a daily basis. The purpose of this education is to allow the patient to take the medication more 
safely and effectively than if it were not given. This includes concordance with monitoring 
requirements. We have demonstrated that knowledge in longer term patients on MTX is deficient 
in some areas (Walker 2012) and nurses in our units have expressed lack of confidence in giving of 
this education and described a learning curve when they first started to perform this function. They 
describe taking time to gain both confidence and competence in drug counselling. This study plans 
to explore this educational interaction in terms of content, delivery and learning needs for nurses 
commencing this activity. The purpose is to inform the content of an educational package for the 
nurse which will make more effective use of their time. 
A patient information leaflet for MTX has been produced by ARUK (ARUK 2012). This has been 
written by experts in the area and contains the important information patients need to be aware of 
prior to commencing MTX. It is used extensively across the country and the content accepted as 
appropriate. This forms the basis for patient education in many units. 
The literature on the effectiveness of education is largely on change of knowledge with change of 
behaviour being more difficult to show. Patients with higher educational achievement do however 
have a better outcome of their RA (Pincus 1985). For patient education about drugs, it has been 
shown that one to one education results in better adherence (Hill 2001) and that they are more 
likely to take a drug if they understand the purpose of the prescription (Arluke 1983). How patients 
wish to receive information, and where from, has been studied in Ankylosing Spondylitis in an 
ARUK study (Thompson 2010). The main findings were that patients wish to have information at 
times of change in their condition. This would include times of changing drugs as with commencing 
Methotrexate therapy. The other time they wish to have information is when their clinical 
condition changes, usually for the worse ie at times of crisis. 
 
Confidence of nurses giving education 
We have been able to identify only one study in the Rheumatology literature on this topic. This was 
a survey by the Royal College of Nursing (RCN 2009) of Rheumatology Specialist nurses, exploring 
the performance, activity and confidence of Rheumatology Specialist nurses. Two hundred and fifty 
Rheumatology Specialist nurses, of a variety of different bands (ie working at different levels: Staff 
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Nurses; Sisters and Nurse Specialists), were surveyed. When asked about their confidence in 
counselling a patient starting treatment with Methotrexate, 73% were very confident ie 27% were 
less than very confident. It was not clear how this confidence related to seniority and experience. 
Sixty percent were very confident in dealing with side effects related to anti-rheumatic drugs. 
Similarly, 60% were confident about educating patients to manage their own disease. A substantial 
minority of these nurses were, therefore, not very confident in what we would regard as core 
specialist nursing activities. 
This survey measured “perceived” confidence not actual confidence, knowledge and certainly not 
competence. There was no patient perspective to this survey so we do not know how these 
educational events are received or how meaningful they are to the patients. In this same survey 
over 70% of the nurses stated that  
a) education regarding drug treatment and  
b) education regarding the disease and its management was a major part of their role. 
From the broader literature, there are studies showing some evidence that educational 
interventions can increase nurses’ confidence, knowledge and competence. In a study in mental 
health (Payne 2002), confidence increased in mental health nurses who received mental health 
training. The nurses were more confident and positive in treating depressed patients. In a study in 
palliative care (Shipman 2008), there was a statistically significant increase in confidence in 
palliative care competency and knowledge after participation in an education programme. 
Similarly, in the treatment of alcohol abuse, there was a statistically significant positive change in 
nurse confidence levels after a 4 hour educational intervention (Vadlamundi 2008). There is 
therefore reasonable evidence that the sort of educational package that this study is designed to 
inform may be beneficial. 
 
Pilot study of videoing consultations 
Videotaping of consultations has been used extensively for educational purposes in undergraduate 
(now part of all UK undergraduate curricula with simulated and/or actual patients) and 
postgraduate medical practice (eg used formatively in UK GP vocational training) as well as in 
postgraduate nursing practice. In addition, videotaping consultations has been used for research 
purposes in medical, particularly primary care, settings (reviewed by Coleman 2000) and, less 
commonly in nurse settings (eg Redsell et al 2004, Collins 2005). Videotaping, if well planned, 
affords the opportunity of capturing all aspects of the consultation. Coleman (2000) identified a 
range of research purposes of videotaped consultations in Primary Care, including development of 
methods of assessing consultation competence, describing doctor-patient communication 
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quantitatively, exploring how doctors detect and respond to patients with psychological problems, 
and investigating how patients and doctors view consultations. 
A variety of approaches are used in analysing videotaped consultations, including ethnographic 
approaches which usually incorporate participant observation (Hammersley and Atkinson 2007, 
Ventres et al 2005), thematic analysis using open coding to identify key themes (Howitt and Cramer 
2010; Fereday 2006), and conversation analysis in which consultations are analysed for the use of 
language, pauses, order of speaking (Maynard and Heritage 2005, Collins 2005). In addition, by 
showing recordings of the consultation to its participants (health professional or patient), it is 
possible to gain further insights into interpretations of events and discussions, as well as responses 
(Coleman 2000). 
Despite the potential usefulness of videotaped consultations in the context of nurse education of 
the Rheumatology patient, there appears a dearth of such work within Rheumatology. As discussed 
earlier, the Rheumatology nurse constitutes a lynchpin in co-ordinating the care of patients with 
inflammatory rheumatological diseases. Previous ARUK studies (Carr 2001; Ryan and Adams 2011) 
have revealed that a significant part of the Rheumatology nurse’s work entails counselling patients 
with respect to treatments. Analysis of such consultations would afford the opportunity of 
understanding what goes on in these consultations, understanding the responses of patients and 
nurses to the consultations, and would allow characterisation of nurses’ learning needs in this 
respect. Frameworks for appraising videotaped secondary care nurse consultations do exist 
(Redsell et al 2004). 
 
2. Aims and Objectives 
1) To pilot the use of video in recording this educational interaction for analysis using ethnographic 
and thematic approaches and in formative ways. 
2) To inform the content of an educational package for nurses commencing this activity if 
appropriate. 
 
3. Detailed Plan of Project 
3.1 Introduction 
The focus of this study will be on identifying learning needs of nurses who educate patients prior to 
the commencement of Methotrexate. Previous work has been published by the study team.  In 
2017 (Robinson et al 2017) a national survey of Rheumatology Specialist nurses revealed that 84 % 
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of the respondents had some or no training to carry out the role of Methotrexate educator and it 
could take up to a year for nurses to feel confident in this role.  6 semi-structured interviews were 
performed on nurses from 2 Rheumatology centres, (Robinson et al 2018) which showed that all 
participants lacked confidence when starting out on the role of Methotrexate educator, prompts in 
the form of check lists and booklets were used to ensure that all of the information was given to 
the patients, and there was little opportunity for patients interactions and questions. 
The study team aim to video-record 10 consultations between nurse and patient who are being 
educated about Methotrexate. 
We aim to recruit 4 nurses who will be video-recorded during 2 or 3 Methotrexate education 
sessions in their routine clinics.   
We will recruit from one Rheumatology Unit and aim to have nurses at various stages of their 
experience in order to explore the relationship between experience and knowledge and whether 
nurses working together pass on information to each other. 
 
Pilot study of practicality and analysis of videoing the patient education consultation. 
 
 (i) Establish a framework for videotaping nurse consultations for research purposes. This would 
include establishment of strategies for recruitment of patients and nurses, patient consent, and 
secure storage of recordings. 
(ii) Develop a suitable framework for the initial analysis of videotaped consultations and for 
interviewing participants post video recording of consultations. 
(iii) Three to four nurse led clinics will be video-recorded North Tyneside.  10 nurse/patient 
consultations will be recorded.  If the nurse or patient changes their minds, that video recording 
will be destroyed. 
 
4. Recruitment Procedures 
The patient participants will be identified by their Rheumatology Consultant in clinic at the point when 
Methotrexate is prescribed.  With the potential participant’s consent, the study team will post out the 
Patient Information Sheets pertaining to the study.  The potential participant will have the opportunity 
to ring the study team for more information and arrange a meeting if necessary.  If the potential 
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participant agrees to participate in the study, the study team will arrange for that person to be seen by 
one of the participating nurses. 
The nurse participants will be approached directly by the study team as they are known to the nurses.  
The potential nurse participants will be given nurse information sheets and the opportunity to ask 
more questions before arriving at a decision on whether they would like to participate. 
 
5. Quality Control and Quality Assurance 
During the trial, periodic monitoring will ensure that the protocol and Good Clinical Practices 
(GCPs) are being followed.  Source documents will be reviewed to confirm that the data recorded 
on CRFs is accurate. 
 
6.  Data Handling and Record Keeping 
6.1 Case Report Forms (CRF) 
As used in this protocol the term CRF should be understood to refer to a paper form data record.   
A CRF is required and should be completed for each included patient.  It is the investigator’s 
responsibility to ensure completion and to review and approve all CRFs.  CRFs must be signed by 
the investigator or by an authorized staff member.  These signatures serve to attest that the 
information contained on the CRFs is true.  At all times, the investigator has final personal 
responsibility for the accuracy and authenticity of all clinical and laboratory data entered on the 
CRFs.  Patient source documents are the physician’s patient records maintained at the trial site.  In 
most cases the source documents will be the hospital’s or the physician’s chart.  In cases where the 
source documents are the hospital or the physician’s chart, the information collected on the CRFs 
must match those charts. 
In some cases, the CRF may also serve as the source document.  In these cases, the Chief 
Investigator must prospectively document which items will be recorded in the source documents 
and for which items the CRF will stand as the source document. 
Data protection and patient confidentiality 
The study team will comply with the requirements of the Data Protection Act 1998 with regards to 




The recorded consultations will be stored in a locked cupboard in a locked office where only 
members of the study team have access. 
The recordings will be transcribed, and during this process all identifiable data will be 
deleted and dedicated study numbers will be used instead. 
The recordings will be deleted at the end of the study and all transcriptions will be   
stored for up to 15 years in a secure offsite premises in accordance with Northumbria Trust policy. 
 
7.  Communications and publicity 
Northumbria Healthcare NHS Foundation Trust will own the data arising from the study. 
On completion of the study, the recordings will be analysed by the study team.  The results of the 
study will be submitted to an appropriate Journal for publication and will also be offered for 
presentation at appropriate Rheumatology meetings. 
Should any study participants wish to receive the final report, the study team will take their details and 
send it to them upon completion of the report. 
Should any direct quotes from the recordings be used in the final report, they will be completely 
anonymised so that no identifiable data is used. 
 
8.      ETHICS 
8.1 Institutional Review Board/Independent Ethics Committee 
Before the start of the study, a favourable opinion will be sought from a REC for the study protocol, 
informed consent forms and other relevant documents.  
 Substantial amendments that require review by NHS REC will not be implemented 
until that review is in place and other mechanisms are in place to implement at site.   
 All correspondence with the REC will be retained. 
 The Chief Investigator will notify the REC of the end of the study. 
 An annual progress report (APR) will be submitted to the REC within 30 days of the 
anniversary date on which the favourable opinion was given, and annually until the 
study is declared ended. 
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 If the study is ended prematurely, the Chief Investigator will notify the REC, including 
the reasons for the premature termination. 
 Within one year after the end of the study, the Chief Investigator will submit a final 
report with the results, including any publications/abstracts, to the REC. 
Before any subjects are enrolled into the study, the Chief Investigator/Principal Investigator or 
designee will ensure that appropriate approvals from participating organisations are in place. For 
any amendment to the study, the Chief Investigator or designee, in agreement with the sponsor 
will submit information to the appropriate body in order for them to issue approval for the 
amendment.  
 
8.2 Ethical Conduct of the Trial 
The trial will be performed in accordance with the protocol, IHC GCP guidelines and applicable local 
regulatory requirements and laws. 
The study team consider that there is little risk to the participants in this study.  However, should 
any unethical or potentially harmful behaviour be observed during the recording of the 
consultation, the individuals concerned will be approached and further action may be taken in the 
interests of safety should the study team consider this necessary. 
 
An assessment of capacity will take place. The potential participant will: 
 understand the purpose and nature of the research  
 understand what the research involves, its benefits (or lack of benefits), risks 
and burdens  
 understand the alternatives to taking part  
 be able to retain the information long enough to make an effective decision 
 be able to make a free choice  
 be capable of making this particular decision at the time it needs to be made 
Any person who in the opinion of the study team is considered unable to give fully informed 
consent, will not be recruited to the study. 
The investigator will obtain written informed consent from each patient or the patient’s legally 
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NURSE INFORMATION SHEET AND CONSENT FORM 
Protocol Number: 1.0 
Title: AN EXPLORATION OF THE NURSE/PATIENT CONSULTATION WHEN 
GIVING INFORMATION ABOUT METHOTREXATE 
Sponsor Northumbria Healthcare NHS Foundation trust 
Name of Institution: Northumbria Healthcare NHS Foundation Trust 
Address: North Tyneside General Hospital,  Rake Lane, North Shields, Tyne 
& Wear NE29 8NH 
Name of Participant:    
 (Last) (First) (Title) 
 
Invitation to participate in the study 
We would like to invite you to take part in a research study.  
What is the purpose of the study? 
The purpose of this study is to identify the learning needs of nurses who educate patients prior to the 
commencement of Methotrexate.  This study is part of a PhD project by Sandra Robinson, one of the 
researchers, who undertook a national survey in 2017 asking nurses how they were educated to teach 
patients about Methotrexate; most nurses learned on the job, but became confident after about a year.  Six 
nurses were also interviewed, which showed that they were knowledgeable about Methotrexate, but used 
prompts and checklists which talking to patients about Methotrexate.  We feel that formal training would be 
better but we need to understand what the gaps are so that we can design a learning programme for all 
nurses who teach patients who are starting Methotrexate therapy.  If you would like further information 




Why have I been invited? 
You have been chosen as a possible participant because you educate patients starting Methotrexate for the 
first time. 
Do I have to take part? 
Taking part in this study is entirely voluntary and if you decide to take part, you can withdraw your consent 
regarding the use and disclosure of your health information and leave the study at any time.  
What will happen to me if I take part? 
The study involves video recording 2 - 3 consultations between you and the patient to whom you are giving 
Methotrexate education.  You will be asked for your consent before the recordings but you can withdraw 
your consent and the video-recording will be destroyed.  The recordings will be downloaded onto Trust 
computers as soon as possible after the recordings.  Once the recordings have been analysed by the 
research team, all visual and audio recordings will be destroyed. 
Expenses and payment 
You will not be paid to participate in this research study. 
What will I have to do? 
All you have to do is give your consent for the study team to video record the education interaction between 
you and the patient.  
What are the possible disadvantages and risks of taking part? 
As this is an observational study, there are no foreseen risks or side effects from taking part in the study 
itself. 
You may feel uncomfortable being video recorded, and if this does occur, you may indicate this to the study 
team who will stop the recording immediately.  You may withdraw your consent and the video recording will 
be destroyed. 
What are the benefits of participating in this study? 
The data collected during this study will help to improve knowledge and understanding of the needs of 
nurses educating patients who are starting Methotrexate. 
The information gained from this study may help us to better assess the educational needs of nurses which, 
in the future, which could result in better education provision for nurses and therefore improved overall 
health care for patients suffering from RA. 
What if there is a problem? 
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In the unlikely event that unprofessional behaviour, dangerous practice or poor education is observed the 
study team will be available to facilitate the resolution of any problems that we can help with.  We will seek 
further advice if we think you require more support or in the unlikely event that we feel this could be unsafe 
to patients we will be required to inform your line manager. 
If you have a concern about any aspect of the study, you should speak with the study team who will do their 
best to answer your questions.  Contact details can be found at the end of this information sheet. If you 
remain unhappy and wish to formally complain, you can do this through the NHS Complaints Procedure. 
Details can be obtained from the hospital.  
What will happen if I don't want to carry on with the study? 
If you agree to take part in this study and later change your mind, you are free to withdraw your consent 
and discontinue your participation at any time.  
We may withdraw you from the study without your consent for one or more of the following reasons: 
The study is cancelled. 
Unanticipated circumstances. 
Will my taking part in this study be kept confidential? 
Yes. All the information about you participation in this study will be kept confidential.  
You have a right to privacy and all information obtained will be treated as confidential to the limit possible 
by the law.  For the purposes of this study you will be identified by a pseudonym.  In this way, if information 
from the study is submitted to health authorities or published, your name will not appear and your identity 
will remain confidential.   
What will happen to the results of the study? 
Your data will be analyzed by the study team. Certain statistical tests will be carried out on your data, along 
with that collected from the other participants who entered the study. The results may be used in the report 
of the study or for scientific presentations or publications.  You will not be identified by name in any study 
results.  
Who is organizing and funding the research? 
This study is sponsored by Northumbria Healthcare NHS Foundation Trust and is under the direction of Dr 
David Walker Consultant Rheumatologist  and Sandra Robinson Enior Rheumatology Research Nurse. This 
study has been approved by the Research and Development department who ensures that the rights of 
people taking part in clinical studies are protected at Northumbria Healthcare NHS Foundation Trust.  
Who has reviewed the study? 
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All research in the NHS is looked at by an independent group of people, called a Research Ethics Committee 
to protect your safety, rights, wellbeing and dignity. This study has been reviewed and given favourable 
opinion by the London - Brent Research Ethics Committee.  It has also been reviewed by our colleagues at 
Northumbria Healthcare NHS Foundation Trust. 
Further information and contact details 
Northumbria Healthcare NHS Foundation Trust is the sponsor for this study based in the United Kingdom. 
We will be using information from your video recording in order to undertake this study and will act as the 
data controller for this study. This means that we are responsible for looking after your information and 
using it properly. Northumbria Healthcare NHS Foundation Trust will keep identifiable information about 
you for up to 15 years after the study has finished. 
Your rights to access, change or move your information are limited, as we need to manage your information 
in specific ways in order for the research to be reliable and accurate. If you wish to withdraw from the study, 
we will destroy your video-recording. To safeguard your rights, we will use the minimum personally-
identifiable information possible. 
Individuals from Northumbria Healthcare NHS Foundation Trust and regulatory organisations may look at 
your research records to check the accuracy of the research study. The Research Team will pass these details 
to Northumbria Healthcare NHS Foundation Trust along with the information collected from you. The only 
people in Northumbria Healthcare NHS Foundation Trust who will have access to information that identifies 
you will be people who may need to contact you to for the purposes of the study or audit the data collection 
process.  
If you would like further information about this study and how we will use your information, please contact 
Dr David Walker Chief Investigator or Sandra Robinson, on 0191 2934325 during office hours or 
07833650925 the Northumbria Healthcare NHS Foundation Trust on-call Rheumatology Research number 
during out of office and weekends. 
Thank you for taking the time to read this information leaflet and do not hesitate to ask any questions before 




Study Number:  
CONSENT FORM  
Title of study: An Exploration of the Nurse/Patient Consultation When Giving Information about 
Methotrexate 
Name of Researcher:________________________________________________              Please initial 
box          
_________________________ ____________ ______________________________ 
I confirm that I have read and understand the information sheet dated 21 March 
2019 for the above study and have had the opportunity to ask questions. 
 
 
I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason and I understand that any data that have 
been collected up to the point of my withdrawal from the study may continue to 
be used.  
 
 
I agree to be video-taped during a Methotrexate Education consultation which 
will be transcribed and will be used for research and education.  All indications to 
my identity will be removed and a pseudonym will be used if necessary. 
 
 
I agree that the information generated from my participation in the study may be 
processed, stored and used for research purposes. 
 
 
I understand that if I have any questions relating to my participation in this 














Name of Participant Date                             Signature  
 
_________________________ ____________          _____________________ 
Name of Person taking consent Date                             Signature     
 




















Statement of health professional  
I confirm that I have explained the levels of consent to the participant and that they 




Signed:…….…………………………………  Date ..………………….………. 
 
Name (PRINT) ……………………………  Job title…………………….….. 










Withdrawal of consent 
 
 
Participant signature ……………………….…………… Date ………..……..…… 
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Appendix 17 Trust Capacity and Capability Approval 
Dear Sandra 
Full Study Title: Nurse Patient Education Videos project 
Northumbria Healthcare NHS Foundation Trust is pleased to confirm that we have the capacity and 
capability to deliver the above study. 
Please could you ensure a signed copy of the Capability form/ confirmation emails are saved into the 






Jemma Fenwick  
Deputy Manager of Research & Development 
Clinical Trials Office, Education Centre  
North Tyneside General Hospital  
Rake Lane, North Shields  








From: Robinson Sandra (RTF) NHCT  
Sent: 08 May 2019 14:43 
To: Fenwick Jemma (RTF) NHCT; Ferguson Victoria (RTF) NHCT 
Cc: Heslop Peta (RTF) NHCT 









Senior Research Nurse (Rheumatology) 
Clinical Trials Office 
Education Centre 
North Tyneside General Hospital 
Rake Lane 
North Shields 
Tyne and Wear. 
NE29 8NH 













From: Robinson Sandra (RTF) NHCT  
Sent: 09 April 2019 14:25 
To: ResearchAndDevelopment 
Cc: Fenwick Jemma (RTF) NHCT 




I have completed the study capability form for this project.  It is not a portfolio study, I don’t have 
any costings to declare and this study will be completely run by myself and David in our own time as 
it is part of my PhD, there is no involvement from the participants except signing the consent form 
and no follow up visits, but I have completed the form as fully as possible. 
Let me know if there are any other forms I need to complete as soon as you can, as I’d like to get 




Senior Research Nurse (Rheumatology) 
Clinical Trials Office 
Education Centre 
North Tyneside General Hospital 
Rake Lane 
North Shields 
Tyne and Wear. 
NE29 8NH 




Appendix 18 The Calgary Cambridge Scoring Sheet 
 
Videos 1 2 3 4 5 6 7 8 9 10 Mean 
Initiating why patient here 1 0 2 2 1 2 1 1 2 2 1.4 
Setting the agenda 0 0 1 1 1 0 0 0 0 1 0.4 
Establishing knowledge 0 0 1 1 2 0 0 1 2 1 0.8 
Exploring Ideas Concerns Expectations 0 0 1 0 1 0 0 0 1 0 0.3 
Explanation of Content 2 2 2 3 3 2 2 2 3 3 2.4 
Chunking & checking of information 0 0 0 0 0 0 0 0 0 0 0 
Use of written information 3 2 2 2 2 2 3 2 2 2 2.2 
Closing summary of Consultation 1 1 1 0 2 1 0 1 0 1 0.8 
Future Plan 2 2 3 2 2 2 2 2 3 2 2.2 
Consultation Structure 2 2 3 3 2 2 2 2 3 3 2.4 
Clarity of Information 2 2 3 2 3 3 2 3 3 2 2.5 
Rapport with the Patient 2 2 2 2 3 2 2 3 3 2 2.3 
Empathy with the Patient 1 2 2 2 3 1 1 2 2 2 1.8 
Patient perspective addressed 0 1 1 1 1 0 0 1 1 1 0.7 
 
















Appendix 20 The National Survey Paper 
  
From: Sarah Ryan (RRE) MPFT [mailto:Sarah.Ryan2@mpft.nhs.uk]  
Sent: 01 May 2021 07:54 
To: Robinson Sandra (RTF) NHCT 
Subject: Re: ***EXTERNAL*** adding pdfs of our papers to the appendices of my thesis? 
  







There are no problems with you adding a copy of your journal papers to your appendices. It is great that 







From: Robinson Sandra (RTF) NHCT <Sandra.Robinson3@northumbria-healthcare.nhs.uk> 
Sent: 30 April 2021 13:53 
To: Sarah Ryan (RRE) MPFT <Sarah.Ryan2@mpft.nhs.uk> 








I would like to add pdfs of the three papers I published in Musculoskeletal Care and I would like to 
check to make sure that the Journal would have no objection to this.  Are there any processes I need 
to go through in order to get permission? 
  





Senior Nurse Researcher 
  
Research and Development 
Northumbria Healthcare NHS Foundation Trust 





Telephone No: 0191 2934325 
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Abstract
Objectives: Methotrexate is commonly used to treat patients with inflammatory
arthritis. A key role of a rheumatology nurse is to educate patients on how to take this
drug safely prior to the commencement of treatment. The objective of the present
study was to explore the experiences of rheumatology nurses conducting this role,
focusing on the content of the consultation and training received to perform the role.
Methods: A qualitative phenomenological approach was used. Six semi structured
interviews were performed with nurses from two hospitals who regularly counsel
patients prior to starting methotrexate. The interviews were thematically analysed
by two researchers and themes extracted.
Results: Four main themes were identified: (a) using written information to structure
the content of the consultation; (b) patients have different information needs; (c) time
pressures; and (d) training and evolution of practice. All participants described a lack of
confidence when they first started counselling patients commencing methotrexate,
with a wide variation in training. Participants reported that patients required different
information depending on whether they were commencing this agent on its own or
in combination with other drugs. All participants experienced some time pressure.
Conclusions: Participants reported that the majority of the consultation focused on
conveying information, with little opportunity for patient interaction and questions.
We suggest that there is a clear need for further exploration of these consultations,
to identify possible training needs. Participants also used standard written information
to guide both the structure and content of the consultation limiting patients’;
opportunities to ask questions.
KEYW ORDS
Nursing, Patient education, Qualitative research
1 | INTRODUCTION
Educating patients prior to starting disease modifying anti rheumatic
drugs (DMARDs) for inflammatory arthritis is a central role of rheuma-
tology specialist and monitoring nurses (Royal College of Nursing,
2011). In most rheumatology units, once the decision is made by a
clinician to commence methotrexate, the patient is then referred to
a rheumatology nurse to receive counselling regarding the commence-
ment of treatment (Royal College of Nursing, 2011). Patients need to
understand how to take the drug and what side effects to look out for,
in order to take it effectively and safely and improve concordance
(Hill, Lewis, & Bird, 2009).
Methotrexate is the most widely prescribed DMARD for rheu-
matoid arthritis and psoriatic arthritis (Bird, Griffiths, & Littlejohn,
2014) and education is particularly important because of its
delayed effect and the significant risk of side effects, which can
occasionally be fatal (Harrison & Jones, 2014; National Patients
Safety Agency, 2004). There are also tolerability problems in
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Appendix 22 The Video Analysis Paper 
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Abstract
Background: Prior to commencing methotrexate, patients routinely attend an ed-
ucation consultat ion with a rheumatology nurse. The purpose of the consultat ion is
to discuss the patients' expectat ions and concerns related to commencing metho-
trexate, the benefits of treatment, potential side effects and monitoring re-
quirements. The aim of this study was to use video analysis to assess the structure,
content and mode of delivery of the consultat ion.
Methods: Video recordings of 10 patient–nurse consultat ions, involving four
specialist rheumatology nurses, were analysed and transcribed. The consultat ions
were compared with the Calgary–Cambridge (CC) consultat ion model. Transcripts
were thematically analysed. Data were quantitat ively assessed for verbal and non‐
verbal behaviours.
Findings: Assessment of the video data using the CC model demonstrated good
structure, content and flow of the consultat ion, influenced by the use of an infor-
mation leaflet. Consultat ions generally consisted of communication from nurse to
patient rather than a dialogue; the nurse spoke for 69%–86% of the time; clarifi-
cation of the patient 's understanding of the information did not take place in any of
the consultat ions. Thematic analysis also showed that the nurse agenda dominated
and the nurse was aware of ‘overloading' the patient with information. Cues from
the patients to discuss items of importance were often missed.
Conclusion: Video analysis can be used to identify the aspects of the consultat ion
that work well and those areas of the consultat ion that could be improved with
specific training.
K EY W O RD S
clinical, communication, education, nursing
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